[
  {
    "Ref": "PHC0001",
    "Questions": "According to the Standard Treatment Guidelines and Essential Medicines List for South Africa Primary Healthcare Level 2020 Edition what is the first-line treatment for uncomplicated non-severe malaria at the PHC level?",
    "A": "Artemether/lumefantrine",
    "B": "Quinine",
    "C": "Doxycycline",
    "D": "Mefloquine",
    "Answer": "A",
    "Comment": "The guideline states that artemether/lumefantrine is the recommended first-line treatment for uncomplicated malaria, to be taken with fat-containing food for adequate absorption[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0002",
    "Questions": "What is the recommended treatment for impetigo in a patient with no known drug allergies?",
    "A": "Topical mupirocin",
    "B": "Oral penicillin V",
    "C": "Oral amoxicillin",
    "D": "Topical chloramphenicol",
    "Answer": "A",
    "Comment": "Topical mupirocin is recommended for limited impetigo[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0003",
    "Questions": "Which of the following is the standard prophylaxis for an HIV-exposed infant?",
    "A": "Cotrimoxazole from birth",
    "B": "Nevirapine at birth",
    "C": "Zidovudine from birth",
    "D": "Cotrimoxazole from 6 weeks of age",
    "Answer": "D",
    "Comment": "The guidelines state that cotrimoxazole prophylaxis for HIV-exposed infants should be initiated from 6 weeks of age[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0004",
    "Questions": "According to the guidelines which of the following is a risk factor for severe COVID-19 disease?",
    "A": "Being elderly",
    "B": "Being a healthcare worker",
    "C": "Being a teenager",
    "D": "Being a vegetarian",
    "Answer": "A",
    "Comment": "The guidelines identify the elderly as being at high risk for severe COVID-19 disease[cite: 7].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0005",
    "Questions": "What is the correct treatment for an acute gout attack?",
    "A": "Allopurinol",
    "B": "Colchicine",
    "C": "Probenecid",
    "D": "Indomethacin",
    "Answer": "B",
    "Comment": "The guidelines recommend colchicine as the treatment for acute gout[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0006",
    "Questions": "A patient presents with acute, uncomplicated cystitis. Which of the following is a recommended treatment?",
    "A": "Ciprofloxacin",
    "B": "Trimethoprim/sulfamethoxazole (Co-trimoxazole)",
    "C": "Amoxicillin/clavulanic acid",
    "D": "Nitrofurantoin",
    "Answer": "D",
    "Comment": "Nitrofurantoin is a recommended treatment for acute, uncomplicated cystitis[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0007",
    "Questions": "What is the recommended first-line treatment for scabies?",
    "A": "Permethrin 5% cream",
    "B": "Calamine lotion",
    "C": "Benzyl benzoate 25% lotion",
    "D": "Oral ivermectin",
    "Answer": "C",
    "Comment": "Benzyl benzoate 25% lotion is recommended as the first-line treatment for scabies[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0008",
    "Questions": "Which of the following is a sign of severe malaria?",
    "A": "Mild fever",
    "B": "Headache",
    "C": "Muscle and joint pains",
    "D": "Jaundice",
    "Answer": "D",
    "Comment": "The guideline lists jaundice as a clinical feature of severe malaria[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0009",
    "Questions": "According to the guidelines what is a key instruction for a patient on chronic therapy?",
    "A": "Take medication when symptoms appear",
    "B": "Stop medicine when feeling better",
    "C": "Inform other healthcare providers about all conditions and medicines",
    "D": "Adjust doses as needed without consulting a doctor",
    "Answer": "C",
    "Comment": "The guideline states that every patient on chronic therapy must inform other healthcare providers about any other condition/disease and its management when seeking medical attention for other complaints[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0010",
    "Questions": "What is the recommended first-line oral therapy for a child with tinea capitis?",
    "A": "Topical clotrimazole",
    "B": "Oral griseofulvin",
    "C": "Topical ketoconazole",
    "D": "Oral fluconazole",
    "Answer": "B",
    "Comment": "Oral griseofulvin is the recommended first-line treatment for tinea capitis in children[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0011",
    "Questions": "What is the first-line treatment for a patient with an acute dental abscess at a PHC level?",
    "A": "Oral amoxicillin",
    "B": "Oral penicillin V",
    "C": "Topical antiseptic",
    "D": "Referral for drainage and antibiotics",
    "Answer": "D",
    "Comment": "The guidelines recommend referral for drainage and antibiotics as the first line of management for a dental abscess[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0012",
    "Questions": "What is the recommended treatment for herpes simplex infections of the mouth and lips?",
    "A": "Oral aciclovir",
    "B": "Topical aciclovir",
    "C": "Oral antibiotic",
    "D": "Oral antiviral therapy",
    "Answer": "A",
    "Comment": "The guideline suggests oral aciclovir for herpes simplex infections of the mouth and lips[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0013",
    "Questions": "What is the recommended treatment for an adult with an uncomplicated urinary tract infection?",
    "A": "Trimethoprim",
    "B": "Ciprofloxacin",
    "C": "Nitrofurantoin",
    "D": "Cefalexin",
    "Answer": "C",
    "Comment": "Nitrofurantoin is a recommended first-line agent for uncomplicated urinary tract infection in adults[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0014",
    "Questions": "Which of the following is the recommended treatment for moderate persistent diarrhoea in a child?",
    "A": "Oral rehydration solution (ORS) only",
    "B": "Ciprofloxacin",
    "C": "Zinc sulphate",
    "D": "Oral antibiotic",
    "Answer": "C",
    "Comment": "The guideline recommends zinc sulphate as an adjunct to ORS for persistent diarrhoea in children[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0015",
    "Questions": "Which of the following is a key component in the management of Chronic Kidney Disease (CKD) at the PHC level?",
    "A": "Dialysis",
    "B": "ACE-inhibitors",
    "C": "Surgical intervention",
    "D": "Immunosuppressants",
    "Answer": "B",
    "Comment": "The guideline states that ACE-inhibitors are used in the management of Chronic Kidney Disease[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0016",
    "Questions": "Which of the following is the correct management for uncomplicated gingivitis?",
    "A": "Chlorhexidine mouthwash",
    "B": "Systemic antibiotics",
    "C": "Surgical debridement",
    "D": "Pain medication only",
    "Answer": "A",
    "Comment": "Uncomplicated gingivitis is managed with chlorhexidine mouthwash[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0017",
    "Questions": "What is the recommended first-line treatment for chronic anal fissure?",
    "A": "Topical antibiotic",
    "B": "Bulk-forming laxatives",
    "C": "Topical anaesthetic",
    "D": "Oral painkiller",
    "Answer": "B",
    "Comment": "Bulk-forming laxatives are recommended as the first-line treatment for chronic anal fissure[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0018",
    "Questions": "Which medicine is recommended for the treatment of uncomplicated bacillary dysentery?",
    "A": "Ciprofloxacin",
    "B": "Metronidazole",
    "C": "Azithromycin",
    "D": "Amoxicillin",
    "Answer": "C",
    "Comment": "The guideline recommends azithromycin as a treatment for bacillary dysentery[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0019",
    "Questions": "What is the recommended treatment for a patient with taenia (tapeworm) infestation?",
    "A": "Albendazole",
    "B": "Praziquantel",
    "C": "Mebendazole",
    "D": "Metronidazole",
    "Answer": "B",
    "Comment": "The guideline recommends praziquantel for the treatment of tapeworm infestation[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0020",
    "Questions": "What is the primary intervention for a patient with acute diarrhoea without blood?",
    "A": "Oral rehydration solution (ORS)",
    "B": "Loperamide",
    "C": "Oral antibiotics",
    "D": "Intravenous fluids",
    "Answer": "A",
    "Comment": "The primary intervention for acute diarrhoea is oral rehydration solution (ORS)[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0021",
    "Questions": "What is the recommended treatment for oral candidiasis (thrush)?",
    "A": "Nystatin oral suspension",
    "B": "Oral fluconazole",
    "C": "Oral amphotericin B",
    "D": "Topical chlorhexidine",
    "Answer": "A",
    "Comment": "Nystatin oral suspension is the recommended treatment for oral thrush[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0022",
    "Questions": "According to the guidelines what is the most common cause of treatment failure in malaria?",
    "A": "Vomiting the oral treatment",
    "B": "Using the wrong dose",
    "C": "Taking the medicine at the wrong time",
    "D": "Not taking the full course",
    "Answer": "A",
    "Comment": "The guideline states that vomiting oral treatment is one of the commonest reasons for treatment failure in malaria[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0023",
    "Questions": "What is the recommended management for a child with uncomplicated Severe Acute Malnutrition (SAM)?",
    "A": "Admission to hospital",
    "B": "Outpatient care with RUTF",
    "C": "Oral antibiotics",
    "D": "Intravenous fluids",
    "Answer": "B",
    "Comment": "Uncomplicated SAM is managed on an outpatient basis with ready-to-use therapeutic food (RUTF)[cite: 3].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0024",
    "Questions": "What is the first-line antihypertensive medication recommended for a patient with hypertension and diabetes mellitus?",
    "A": "Amlodipine",
    "B": "Hydrochlorothiazide",
    "C": "ACE-inhibitor",
    "D": "Atenolol",
    "Answer": "C",
    "Comment": "ACE-inhibitors are the first-line therapy for hypertension in adults with diabetes[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0025",
    "Questions": "What is the recommended treatment for a patient with post-herpes zoster neuropathy?",
    "A": "Acyclovir",
    "B": "Amitriptyline",
    "C": "Ibuprofen",
    "D": "Carbamazepine",
    "Answer": "B",
    "Comment": "The guideline states that amitriptyline is recommended for post-herpes zoster neuropathy[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0026",
    "Questions": "Which of the following is NOT a first-line treatment for hypertension in adults?",
    "A": "Thiazide diuretic",
    "B": "ACE-inhibitor",
    "C": "Beta-blocker",
    "D": "Angiotensin II Receptor Blocker (ARB)",
    "Answer": "C",
    "Comment": "The guideline states that beta-blockers are NOT a first-line treatment for hypertension, unless there are co-morbidities[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0027",
    "Questions": "According to the guidelines what is a key management step for a patient with acute myocardial infarction (AMI)/ST-elevation myocardial infarction (STEMI) at the PHC level?",
    "A": "Immediate referral",
    "B": "Streptokinase",
    "C": "Aspirin",
    "D": "Nitroglycerin",
    "Answer": "A",
    "Comment": "The guidelines recommend immediate referral of a patient with an AMI/STEMI[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0028",
    "Questions": "Which of the following is recommended for the prevention of rheumatic fever?",
    "A": "Penicillin V",
    "B": "Amoxicillin",
    "C": "Erythromycin",
    "D": "Doxycycline",
    "Answer": "A",
    "Comment": "Benzathine benzylpenicillin is recommended for the prevention of rheumatic fever[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0029",
    "Questions": "What is the recommended treatment for a chronic leg ulcer caused by cellulitis?",
    "A": "Oral amoxicillin/clavulanic acid",
    "B": "Topical corticosteroids",
    "C": "Oral cefalexin",
    "D": "Topical antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends oral cefalexin as a treatment for chronic lower leg ulcers[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0030",
    "Questions": "Which is a recommended treatment for mild non-specific headache?",
    "A": "Aspirin",
    "B": "Ibuprofen",
    "C": "Paracetamol",
    "D": "Naproxen",
    "Answer": "C",
    "Comment": "Paracetamol is a recommended treatment for mild, non-specific headache[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0031",
    "Questions": "What is the first-line treatment for moderate acute malnutrition (MAM) in children?",
    "A": "Ready-to-use therapeutic food (RUTF)",
    "B": "F100",
    "C": "F75",
    "D": "Corn-soya blend",
    "Answer": "D",
    "Comment": "The guidelines state that corn-soya blend (CSB++) is the recommended treatment for moderate acute malnutrition (MAM)[cite: 3].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0032",
    "Questions": "What is the recommended management for an uncomplicated case of ringworm?",
    "A": "Oral griseofulvin",
    "B": "Topical clotrimazole",
    "C": "Topical mupirocin",
    "D": "Oral fluconazole",
    "Answer": "B",
    "Comment": "The guideline recommends topical clotrimazole for uncomplicated ringworm (tinea corporis)[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0033",
    "Questions": "What is the initial management for a patient with a boil or abscess?",
    "A": "Incision and drainage",
    "B": "Systemic antibiotics",
    "C": "Topical antibiotic",
    "D": "Oral painkiller",
    "Answer": "A",
    "Comment": "The guideline states that incision and drainage is the initial management for a boil or abscess[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0034",
    "Questions": "According to the guidelines what is a common treatment for atopic eczema?",
    "A": "Oral steroids",
    "B": "Topical corticosteroids",
    "C": "Oral antibiotics",
    "D": "Topical antifungals",
    "Answer": "B",
    "Comment": "Topical corticosteroids are a common treatment for atopic eczema[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0035",
    "Questions": "What is the recommended treatment for an adult with urticaria?",
    "A": "Oral antihistamine",
    "B": "Topical steroid",
    "C": "Oral steroid",
    "D": "Topical antibiotic",
    "Answer": "A",
    "Comment": "Oral antihistamine is the recommended treatment for urticaria[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0036",
    "Questions": "What is the recommended management for a patient with a suspected ectopic pregnancy at a PHC level?",
    "A": "Immediate referral for surgery",
    "B": "Oral analgesics",
    "C": "Methotrexate",
    "D": "Expectant management",
    "Answer": "A",
    "Comment": "The guideline states that all patients with a suspected ectopic pregnancy must be referred for a surgical assessment[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0037",
    "Questions": "What is the initial management for a patient with incomplete miscarriage in the first trimester?",
    "A": "D&C (Dilatation and Curettage)",
    "B": "Mifepristone and misoprostol",
    "C": "Misoprostol",
    "D": "Immediate referral",
    "Answer": "C",
    "Comment": "The guideline recommends misoprostol as the initial management for incomplete miscarriage in the first trimester[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0038",
    "Questions": "Which is a recommended antenatal supplement for all pregnant women?",
    "A": "Folic acid and iron",
    "B": "Vitamin A",
    "C": "Vitamin C",
    "D": "Calcium",
    "Answer": "A",
    "Comment": "The guideline states that folic acid and iron supplements are recommended for all pregnant women[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0039",
    "Questions": "What is the management of a patient with mild to moderate gestational hypertension?",
    "A": "Immediate delivery",
    "B": "Bed rest and observation",
    "C": "Labetalol",
    "D": "Magnesium sulphate",
    "Answer": "B",
    "Comment": "The guidelines recommend bed rest and observation for mild to moderate gestational hypertension[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0040",
    "Questions": "What is the recommended management for a patient with eclampsia?",
    "A": "Immediate delivery and magnesium sulphate",
    "B": "Bed rest and observation",
    "C": "Oral antihypertensives",
    "D": "Fluid restriction",
    "Answer": "A",
    "Comment": "The guidelines recommend immediate delivery and magnesium sulphate for eclampsia[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0041",
    "Questions": "What is the recommended treatment for syphilis in pregnancy?",
    "A": "Oral doxycycline",
    "B": "Oral azithromycin",
    "C": "Parenteral benzathine benzylpenicillin",
    "D": "Intravenous ceftriaxone",
    "Answer": "C",
    "Comment": "The guideline recommends benzathine benzylpenicillin as the treatment for syphilis in pregnancy[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0042",
    "Questions": "Which of the following is NOT a risk factor for preterm labour?",
    "A": "Multiple pregnancy",
    "B": "Previous preterm birth",
    "C": "Urinary tract infection",
    "D": "Being of a higher socio-economic status",
    "Answer": "D",
    "Comment": "The guidelines state that urinary tract infection is a risk factor for preterm labour, not socio-economic status[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0043",
    "Questions": "According to the guidelines what is the recommended management for preterm prelabour rupture of membranes (PPROM)?",
    "A": "Oral antibiotics and betamethasone",
    "B": "Oral antibiotics only",
    "C": "Betamethasone only",
    "D": "Immediate delivery",
    "Answer": "A",
    "Comment": "The guideline recommends oral antibiotics and betamethasone for preterm prelabour rupture of membranes[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0044",
    "Questions": "When should neonatal resuscitation be initiated?",
    "A": "Immediately after birth if the baby is not breathing",
    "B": "After 30 seconds of observation",
    "C": "After 1 minute of observation",
    "D": "Only if the Apgar score is low",
    "Answer": "A",
    "Comment": "The guideline states that neonatal resuscitation should be initiated immediately after birth if the baby is not breathing[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0045",
    "Questions": "What is the recommended management for postpartum haemorrhage (PPH)?",
    "A": "Oral ergometrine",
    "B": "Parenteral oxytocin",
    "C": "Uterine massage",
    "D": "Immediate surgical intervention",
    "Answer": "B",
    "Comment": "Parenteral oxytocin is the recommended management for postpartum haemorrhage[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0046",
    "Questions": "Which of the following is a recommended treatment for chronic pelvic pain?",
    "A": "NSAIDs",
    "B": "Oral antibiotics",
    "C": "Hormone therapy",
    "D": "Surgical intervention",
    "Answer": "A",
    "Comment": "The guideline recommends NSAIDs as a treatment for chronic pelvic pain[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0047",
    "Questions": "What is the recommended treatment for a patient with chronic kidney disease and a GFR < 30ml/min?",
    "A": "Referral to a nephrologist",
    "B": "Angiotensin-converting enzyme inhibitor (ACE-i)",
    "C": "Angiotensin II receptor blocker (ARB)",
    "D": "Loop diuretic",
    "Answer": "A",
    "Comment": "The guidelines recommend referral to a nephrologist for patients with CKD and a GFR < 30ml/min[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0048",
    "Questions": "Which of the following is a key management step for a patient with acute kidney injury at the PHC level?",
    "A": "Fluid restriction",
    "B": "Diuretics",
    "C": "Immediate referral",
    "D": "Potassium supplementation",
    "Answer": "C",
    "Comment": "The guidelines recommend immediate referral for patients with acute kidney injury[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0049",
    "Questions": "What is the recommended treatment for symptomatic Benign Prostatic Hyperplasia (BPH)?",
    "A": "Alpha-adrenergic blocker",
    "B": "Finasteride",
    "C": "Doxazosin",
    "D": "Tamsulosin",
    "Answer": "D",
    "Comment": "Tamsulosin is the recommended treatment for symptomatic Benign Prostatic Hyperplasia[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0050",
    "Questions": "What is the first-line treatment for a patient with Type 1 Diabetes Mellitus?",
    "A": "Oral metformin",
    "B": "Insulin",
    "C": "Oral glibenclamide",
    "D": "Lifestyle modifications",
    "Answer": "B",
    "Comment": "Insulin is the recommended first-line treatment for Type 1 Diabetes Mellitus[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0051",
    "Questions": "What is the recommended initial management for a patient with diabetic ketoacidosis (DKA)?",
    "A": "IV fluids",
    "B": "Insulin",
    "C": "Oral glucose",
    "D": "Subcutaneous insulin",
    "Answer": "A",
    "Comment": "IV fluids are the recommended initial management for diabetic ketoacidosis (DKA)[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0052",
    "Questions": "Which of the following is a key management step for a patient with diabetic foot ulcers?",
    "A": "Daily dressing changes",
    "B": "Oral antibiotics",
    "C": "Topical antiseptics",
    "D": "Referral to a specialist",
    "Answer": "D",
    "Comment": "The guideline states that patients with diabetic foot ulcers should be referred to a specialist[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0053",
    "Questions": "What is the recommended treatment for adult hypothyroidism?",
    "A": "Levothyroxine",
    "B": "Carbimazole",
    "C": "Propylthiouracil",
    "D": "Radioactive iodine",
    "Answer": "A",
    "Comment": "The guideline recommends levothyroxine as the treatment for adult hypothyroidism[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0054",
    "Questions": "What is the recommended management for a patient with a confirmed case of measles?",
    "A": "Acyclovir",
    "B": "Antibiotics",
    "C": "Symptomatic and supportive care",
    "D": "Referral to a specialist",
    "Answer": "C",
    "Comment": "The guideline states that symptomatic and supportive care is the recommended management for a patient with a confirmed case of measles[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0055",
    "Questions": "What is the recommended treatment for non-severe/uncomplicated malaria in a child weighing >5-15kg?",
    "A": "Artemether/lumefantrine 1 tablet",
    "B": "Artemether/lumefantrine 2 tablets",
    "C": "Artemether/lumefantrine 3 tablets",
    "D": "Artemether/lumefantrine 4 tablets",
    "Answer": "A",
    "Comment": "For a child weighing >5-15kg, the recommended dose of artemether/lumefantrine is 1 tablet[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0056",
    "Questions": "Which of the following is NOT a complication of malaria?",
    "A": "Hypoglycaemia",
    "B": "Severe anaemia",
    "C": "Jaundice",
    "D": "Hypertension",
    "Answer": "D",
    "Comment": "Hypertension is not listed as a complication of malaria, whereas hypoglycaemia, severe anaemia and jaundice are[cite: 6].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0057",
    "Questions": "What is the recommended prophylaxis for meningococcal meningitis in close contacts?",
    "A": "Ciprofloxacin",
    "B": "Ceftriaxone",
    "C": "Rifampicin",
    "D": "Azithromycin",
    "Answer": "C",
    "Comment": "The guideline recommends rifampicin as prophylaxis for meningococcal meningitis[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0058",
    "Questions": "What is the recommended management for a patient with suspected viral haemorrhagic fever (VHF)?",
    "A": "Immediate referral",
    "B": "Antibiotics",
    "C": "Antivirals",
    "D": "Supportive care",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral of a patient with suspected viral haemorrhagic fever[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0059",
    "Questions": "What is the recommended management for a patient with HIV and oral candidiasis?",
    "A": "Oral fluconazole",
    "B": "Nystatin oral suspension",
    "C": "Topical clotrimazole",
    "D": "Oral amphotericin B",
    "Answer": "A",
    "Comment": "The guideline recommends oral fluconazole as the treatment for oral candidiasis in a patient with HIV[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0060",
    "Questions": "What is the recommended treatment for a patient with HIV and chronic herpes simplex ulcers?",
    "A": "Oral aciclovir",
    "B": "Oral antibiotic",
    "C": "Topical antibiotic",
    "D": "Oral antifungal",
    "Answer": "A",
    "Comment": "The guideline recommends oral aciclovir for chronic herpes simplex ulcers in a patient with HIV[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0061",
    "Questions": "According to the guidelines what is the recommended management for a patient with HIV and cryptococcosis?",
    "A": "Immediate referral",
    "B": "Oral fluconazole",
    "C": "Oral amphotericin B",
    "D": "IV amphotericin B",
    "Answer": "A",
    "Comment": "The guideline states that a patient with HIV and cryptococcosis should be immediately referred[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0062",
    "Questions": "What is the recommended prophylaxis for HIV-exposed infants?",
    "A": "Zidovudine",
    "B": "Nevirapine",
    "C": "Cotrimoxazole",
    "D": "Lopinavir",
    "Answer": "B",
    "Comment": "The guidelines recommend nevirapine as prophylaxis for HIV-exposed infants[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0063",
    "Questions": "Which of the following is a side effect of ART in a patient with HIV?",
    "A": "Lactic acidosis",
    "B": "Hepatitis",
    "C": "Nephritis",
    "D": "Gout",
    "Answer": "A",
    "Comment": "The guideline lists lactic acidosis as a side effect of ART[cite: 11].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0064",
    "Questions": "What is the recommended treatment for a patient with vaginal discharge syndrome (VDS)?",
    "A": "Ciprofloxacin",
    "B": "Metronidazole and azithromycin",
    "C": "Doxycycline",
    "D": "Amoxicillin",
    "Answer": "B",
    "Comment": "The guideline states that the treatment for vaginal discharge syndrome is metronidazole and azithromycin[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0065",
    "Questions": "Which of the following is a recommended treatment for male urethritis syndrome (MUS)?",
    "A": "Metronidazole",
    "B": "Ceftriaxone and azithromycin",
    "C": "Ciprofloxacin",
    "D": "Oral doxycycline",
    "Answer": "B",
    "Comment": "The guideline recommends ceftriaxone and azithromycin for male urethritis syndrome[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0066",
    "Questions": "What is the recommended treatment for genital ulcer syndrome (GUS)?",
    "A": "Oral acyclovir",
    "B": "Oral doxycycline",
    "C": "Benzathine benzylpenicillin and oral doxycycline",
    "D": "Ceftriaxone and oral acyclovir",
    "Answer": "C",
    "Comment": "The guideline states that the treatment for genital ulcer syndrome is benzathine benzylpenicillin and oral doxycycline[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0067",
    "Questions": "According to the guidelines what is the correct treatment for genital warts?",
    "A": "Topical podophyllin",
    "B": "Surgical excision",
    "C": "Cryotherapy",
    "D": "Imiquimod cream",
    "Answer": "A",
    "Comment": "The guideline states that topical podophyllin is the recommended treatment for genital warts[cite: 12].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0068",
    "Questions": "At what age is the first dose of the BCG vaccine given?",
    "A": "At birth",
    "B": "6 weeks",
    "C": "10 weeks",
    "D": "14 weeks",
    "Answer": "A",
    "Comment": "The guidelines state that the BCG vaccine is administered at birth[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0069",
    "Questions": "At what age is the measles vaccine given?",
    "A": "At birth",
    "B": "6 months",
    "C": "9 months",
    "D": "12 months",
    "Answer": "C",
    "Comment": "The measles vaccine is administered at 9 months[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0070",
    "Questions": "What is the correct storage temperature for vaccines?",
    "A": "2-8??C",
    "B": "0-2??C",
    "C": "-2 to 0??C",
    "D": "-8 to -2??C",
    "Answer": "A",
    "Comment": "The guideline states that vaccines must be stored in a cold chain at 2-8??C[cite: 13].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0071",
    "Questions": "What is the recommended treatment for an acute arthritis attack caused by Gout?",
    "A": "Allopurinol",
    "B": "Colchicine",
    "C": "Indomethacin",
    "D": "Ibuprofen",
    "Answer": "B",
    "Comment": "The guideline states that colchicine is the recommended treatment for acute gout[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0072",
    "Questions": "What is the recommended long-term treatment for chronic gout?",
    "A": "Allopurinol",
    "B": "Colchicine",
    "C": "Indomethacin",
    "D": "Ibuprofen",
    "Answer": "A",
    "Comment": "The guideline states that allopurinol is the recommended long-term treatment for chronic gout[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0073",
    "Questions": "Which of the following is a recommended treatment for osteoarthrosis?",
    "A": "NSAIDs",
    "B": "Corticosteroids",
    "C": "Opioids",
    "D": "Referral for surgery",
    "Answer": "A",
    "Comment": "The guideline recommends NSAIDs for the treatment of osteoarthrosis[cite: 14].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0074",
    "Questions": "What is the recommended management for a patient with an acute stroke?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Thrombolysis",
    "D": "Anticoagulants",
    "Answer": "A",
    "Comment": "The guideline states that all patients with an acute stroke should be referred immediately[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0075",
    "Questions": "Which of the following is a recommended initial treatment for a patient in status epilepticus?",
    "A": "Oral diazepam",
    "B": "Intramuscular midazolam",
    "C": "IV lorazepam",
    "D": "IV phenytoin",
    "Answer": "B",
    "Comment": "The guideline recommends intramuscular midazolam as the initial treatment for status epilepticus[cite: 18].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0076",
    "Questions": "What is the recommended management for a child with febrile convulsions?",
    "A": "Antipyretic and referral",
    "B": "Anticonvulsant medication",
    "C": "Antipyretic and observation",
    "D": "IV diazepam",
    "Answer": "A",
    "Comment": "The guideline recommends an antipyretic for the fever and referral for the febrile convulsions in children[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0077",
    "Questions": "What is the recommended treatment for a patient with acute meningitis?",
    "A": "Oral antibiotics",
    "B": "IV antibiotics and immediate referral",
    "C": "IM antibiotics and observation",
    "D": "IV antibiotics and referral",
    "Answer": "B",
    "Comment": "The guideline states that a patient with acute meningitis should receive IV antibiotics and be referred immediately[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0078",
    "Questions": "Which of the following is the recommended treatment for a patient with acute psychosis?",
    "A": "Haloperidol",
    "B": "Diazepam",
    "C": "Lorazepam",
    "D": "Carbamazepine",
    "Answer": "A",
    "Comment": "The guideline recommends haloperidol for the treatment of acute psychosis[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0079",
    "Questions": "What is the recommended treatment for a patient with an overdose of an antidepressant?",
    "A": "Immediate referral",
    "B": "Activated charcoal",
    "C": "Gastric lavage",
    "D": "Supportive care",
    "Answer": "B",
    "Comment": "The guideline recommends activated charcoal for the treatment of an overdose of an antidepressant[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0080",
    "Questions": "What is the recommended management for a patient with chronic psychosis (schizophrenia)?",
    "A": "Oral antipsychotic medication",
    "B": "Hospitalization",
    "C": "ECT (Electroconvulsive Therapy)",
    "D": "Referral to a specialist",
    "Answer": "A",
    "Comment": "The guideline recommends long-term use of oral antipsychotic medication for chronic psychosis[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0081",
    "Questions": "What is the recommended treatment for a patient with atopic eczema who has a superimposed bacterial infection?",
    "A": "Topical antibiotic",
    "B": "Oral amoxicillin",
    "C": "Topical fusidic acid",
    "D": "Oral cefalexin",
    "Answer": "D",
    "Comment": "The guideline recommends oral cefalexin for atopic eczema with a superimposed bacterial infection[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0082",
    "Questions": "According to the guidelines what is the recommended treatment for acute bacterial pneumonia in a child aged 3 years?",
    "A": "Amoxicillin",
    "B": "Azithromycin",
    "C": "Erythromycin",
    "D": "Ceftriaxone",
    "Answer": "A",
    "Comment": "The guidelines recommend amoxicillin for the treatment of acute bacterial pneumonia in children aged 3 years[cite: 17].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0083",
    "Questions": "What is the recommended management for a patient with a confirmed diagnosis of Bell's Palsy?",
    "A": "Oral corticosteroids",
    "B": "Oral antiviral medication",
    "C": "Oral antibiotic",
    "D": "Oral pain medication",
    "Answer": "A",
    "Comment": "The guideline recommends oral corticosteroids for Bell's Palsy[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0084",
    "Questions": "Which of the following is a recommended treatment for a patient with scabies?",
    "A": "Permethrin 5% cream",
    "B": "Calamine lotion",
    "C": "Benzyl benzoate 25% lotion",
    "D": "Oral ivermectin",
    "Answer": "C",
    "Comment": "The guideline recommends benzyl benzoate 25% lotion as a treatment for scabies[cite: 8].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0085",
    "Questions": "What is the recommended treatment for a patient with chronic hypertension who has developed a cough on an ACE-inhibitor?",
    "A": "Switch to a beta-blocker",
    "B": "Switch to a thiazide diuretic",
    "C": "Switch to an Angiotensin II Receptor Blocker (ARB)",
    "D": "Add a calcium channel blocker",
    "Answer": "C",
    "Comment": "The guideline states that if a patient on an ACE-inhibitor develops a cough, they should be switched to an ARB[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0086",
    "Questions": "What is the recommended management for a patient with a hypertensive emergency?",
    "A": "Oral nifedipine",
    "B": "Oral hydralazine",
    "C": "IV labetalol",
    "D": "Immediate referral",
    "Answer": "D",
    "Comment": "The guideline states that a patient with a hypertensive emergency should be referred immediately[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0087",
    "Questions": "What is the recommended treatment for an adult with stable angina?",
    "A": "Aspirin",
    "B": "Sublingual nitroglycerin",
    "C": "Oral beta-blocker",
    "D": "Oral calcium channel blocker",
    "Answer": "B",
    "Comment": "The guideline recommends sublingual nitroglycerin as the treatment for an adult with stable angina[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0088",
    "Questions": "What is the recommended treatment for a patient with an unstable angina?",
    "A": "Immediate referral",
    "B": "Oral nitroglycerin",
    "C": "Sublingual nitroglycerin",
    "D": "Aspirin",
    "Answer": "D",
    "Comment": "The guideline recommends aspirin as a treatment for unstable angina[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0089",
    "Questions": "Which of the following is the correct management for a patient with cardiac arrest?",
    "A": "Immediate referral",
    "B": "Cardio-pulmonary resuscitation (CPR)",
    "C": "Intravenous adrenaline",
    "D": "Oral aspirin",
    "Answer": "B",
    "Comment": "The guideline states that the correct management for cardiac arrest is cardio-pulmonary resuscitation (CPR)[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0090",
    "Questions": "What is the recommended treatment for a patient with mild congestive cardiac failure?",
    "A": "ACE-inhibitor and diuretic",
    "B": "ACE-inhibitor and beta-blocker",
    "C": "Digoxin",
    "D": "Diuretic",
    "Answer": "A",
    "Comment": "The guideline recommends ACE-inhibitor and diuretic as the treatment for mild congestive cardiac failure[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0091",
    "Questions": "What is the recommended treatment for acute pulmonary oedema?",
    "A": "IV furosemide",
    "B": "Oral furosemide",
    "C": "IV morphine",
    "D": "IV nitroglycerin",
    "Answer": "A",
    "Comment": "The guideline recommends IV furosemide for the treatment of acute pulmonary oedema[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0092",
    "Questions": "Which of the following is the recommended treatment for a child with rheumatic fever?",
    "A": "Oral amoxicillin",
    "B": "Oral erythromycin",
    "C": "Parenteral benzathine benzylpenicillin",
    "D": "Oral penicillin V",
    "Answer": "C",
    "Comment": "The guideline recommends parenteral benzathine benzylpenicillin as the treatment for a child with rheumatic fever[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0093",
    "Questions": "Which is a recommended treatment for dental caries?",
    "A": "Oral antibiotics",
    "B": "Topical fluoride varnish",
    "C": "Oral analgesics",
    "D": "Referral to a dentist",
    "Answer": "B",
    "Comment": "Topical fluoride varnish is a recommended treatment for dental caries[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0094",
    "Questions": "What is the recommended management for a patient with chronic diarrhoea?",
    "A": "Loperamide",
    "B": "Oral antibiotics",
    "C": "Referral for investigation",
    "D": "Oral rehydration solution (ORS)",
    "Answer": "C",
    "Comment": "The guideline states that chronic diarrhoea requires investigation and referral to determine the underlying cause[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0095",
    "Questions": "Which of the following is a key management step for a patient with complicated severe acute malnutrition (SAM)?",
    "A": "Outpatient care with RUTF",
    "B": "Inpatient care with F75",
    "C": "Oral antibiotics",
    "D": "Zinc sulphate",
    "Answer": "B",
    "Comment": "The guideline states that complicated SAM requires inpatient care, starting with F75[cite: 3].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0096",
    "Questions": "What is the recommended treatment for an adult with type 2 diabetes and hypertension?",
    "A": "Metformin",
    "B": "Glibenclamide",
    "C": "ACE-inhibitor",
    "D": "Insulin",
    "Answer": "C",
    "Comment": "The guideline recommends an ACE-inhibitor for a patient with type 2 diabetes and hypertension[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0097",
    "Questions": "What is the recommended treatment for an adult with type 2 diabetes and no comorbidities?",
    "A": "Metformin",
    "B": "Glibenclamide",
    "C": "Insulin",
    "D": "ACE-inhibitor",
    "Answer": "A",
    "Comment": "The guideline recommends metformin as the first-line treatment for type 2 diabetes in adults with no comorbidities[cite: 9].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0098",
    "Questions": "What is the recommended treatment for a patient with a viral haemorrhagic fever?",
    "A": "Supportive care",
    "B": "Oral antibiotics",
    "C": "Oral antivirals",
    "D": "IV fluids",
    "Answer": "A",
    "Comment": "The guideline states that the management for a viral haemorrhagic fever is supportive care[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0099",
    "Questions": "What is the recommended treatment for a patient with candidiasis of the skin?",
    "A": "Topical antifungal cream",
    "B": "Oral fluconazole",
    "C": "Oral nystatin",
    "D": "Oral ketoconazole",
    "Answer": "A",
    "Comment": "The guideline recommends topical antifungal cream for candidiasis of the skin[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0100",
    "Questions": "Which of the following is a recommended treatment for an adult with a perianal abscess?",
    "A": "Oral antibiotic",
    "B": "Incision and drainage",
    "C": "Topical antibiotic",
    "D": "Analgesics",
    "Answer": "B",
    "Comment": "The guideline states that incision and drainage is the recommended management for a perianal abscess[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0101",
    "Questions": "Which of the following is a recommended treatment for an adult with constipation?",
    "A": "Bulk-forming laxatives",
    "B": "Loperamide",
    "C": "Magnesium hydroxide",
    "D": "Bisacodyl",
    "Answer": "A",
    "Comment": "The guideline recommends bulk-forming laxatives for constipation in adults[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0102",
    "Questions": "What is the recommended treatment for a child with chronic constipation?",
    "A": "Lactulose",
    "B": "Oral paraffin",
    "C": "Bisacodyl",
    "D": "Loperamide",
    "Answer": "A",
    "Comment": "The guideline recommends lactulose for a child with chronic constipation[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0103",
    "Questions": "What is the recommended management for a patient with a suspected anal fissure?",
    "A": "Surgical referral",
    "B": "Topical corticosteroids",
    "C": "Bulk-forming laxatives",
    "D": "Antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends bulk-forming laxatives for a patient with a suspected anal fissure[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0104",
    "Questions": "What is the recommended treatment for an adult with acute uncomplicated diarrhoea?",
    "A": "Oral antibiotics",
    "B": "Oral rehydration solution",
    "C": "Loperamide",
    "D": "Oral probiotics",
    "Answer": "B",
    "Comment": "The guideline recommends oral rehydration solution for acute uncomplicated diarrhoea[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0105",
    "Questions": "What is the recommended treatment for a child with acute diarrhoea?",
    "A": "Oral antibiotics",
    "B": "Oral rehydration solution",
    "C": "Zinc supplementation",
    "D": "Loperamide",
    "Answer": "B",
    "Comment": "The guideline recommends oral rehydration solution for a child with acute diarrhoea[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0106",
    "Questions": "Which of the following is a recommended treatment for a patient with dysentery?",
    "A": "Oral ciprofloxacin",
    "B": "Oral azithromycin",
    "C": "Oral metronidazole",
    "D": "Oral amoxicillin",
    "Answer": "B",
    "Comment": "The guideline recommends oral azithromycin for dysentery[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0107",
    "Questions": "What is the recommended treatment for a patient with uncomplicated tinea pedis (athlete's foot)?",
    "A": "Oral griseofulvin",
    "B": "Topical antifungal cream",
    "C": "Topical antiseptic",
    "D": "Oral antibiotic",
    "Answer": "B",
    "Comment": "The guideline recommends a topical antifungal cream for uncomplicated tinea pedis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0108",
    "Questions": "What is the recommended treatment for a patient with tinea capitis (scalp ringworm)?",
    "A": "Topical antifungal cream",
    "B": "Oral griseofulvin",
    "C": "Oral fluconazole",
    "D": "Oral ketoconazole",
    "Answer": "B",
    "Comment": "The guideline recommends oral griseofulvin for tinea capitis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0109",
    "Questions": "What is the recommended management for a patient with a chronic lower leg ulcer?",
    "A": "Oral amoxicillin",
    "B": "Oral cefalexin",
    "C": "Topical antibiotic",
    "D": "Topical steroid",
    "Answer": "B",
    "Comment": "The guideline recommends oral cefalexin for a chronic lower leg ulcer[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0110",
    "Questions": "What is the recommended management for a patient with a boil?",
    "A": "Incision and drainage",
    "B": "Oral antibiotics",
    "C": "Topical antibiotics",
    "D": "Oral painkillers",
    "Answer": "A",
    "Comment": "The guideline states that the recommended management for a boil is incision and drainage[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0111",
    "Questions": "Which of the following is a recommended treatment for an adult with a sore throat?",
    "A": "Oral antibiotics",
    "B": "Oral analgesics",
    "C": "Referral to a specialist",
    "D": "Topical anaesthetic",
    "Answer": "B",
    "Comment": "The guideline recommends oral analgesics for a sore throat[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0112",
    "Questions": "What is the recommended management for a patient with a suspected deep vein thrombosis (DVT)?",
    "A": "Immediate referral",
    "B": "Anticoagulant medication",
    "C": "Bed rest",
    "D": "Elastic stockings",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected DVT[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0113",
    "Questions": "What is the recommended treatment for a patient with a nosebleed?",
    "A": "Pinching the nostrils and leaning forward",
    "B": "Pinching the nostrils and leaning backward",
    "C": "Packing the nose with cotton",
    "D": "Referral to a specialist",
    "Answer": "A",
    "Comment": "The guideline states that the recommended management for a nosebleed is to pinch the nostrils and lean forward[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0114",
    "Questions": "What is the recommended management for a patient with a suspected fracture?",
    "A": "Surgical referral",
    "B": "Immobilization and referral",
    "C": "Oral painkillers",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0115",
    "Questions": "Which of the following is a recommended treatment for a patient with a sprained ankle?",
    "A": "elevation (RICE)",
    "B": "Immobilization",
    "C": "Surgical referral",
    "D": "Oral antibiotics",
    "Answer": "A",
    "Comment": "The guideline recommends Rest, Ice, Compression, Elevation (RICE) for a sprained ankle[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0116",
    "Questions": "What is the recommended treatment for a patient with a foreign body in the eye?",
    "A": "Flushing the eye with water",
    "B": "Removal of the foreign body with a cotton swab",
    "C": "Referral to an ophthalmologist",
    "D": "Oral antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends referral to an ophthalmologist for a foreign body in the eye[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0117",
    "Questions": "What is the recommended management for a patient with a suspected retinal detachment?",
    "A": "Immediate referral to an ophthalmologist",
    "B": "Oral painkiller",
    "C": "Bed rest",
    "D": "Referral to a general practitioner",
    "Answer": "A",
    "Comment": "The guideline states that a patient with a suspected retinal detachment should be referred to an ophthalmologist immediately[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0118",
    "Questions": "What is the recommended management for a patient with acute otitis media?",
    "A": "Oral antibiotics",
    "B": "Referral to a specialist",
    "C": "Oral analgesics",
    "D": "Topical antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends oral analgesics for the management of acute otitis media[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0119",
    "Questions": "What is the recommended management for a patient with chronic otitis media?",
    "A": "Oral antibiotics",
    "B": "Topical antibiotics",
    "C": "Referral to a specialist",
    "D": "Oral painkiller",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a specialist for a patient with chronic otitis media[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0120",
    "Questions": "What is the recommended management for a patient with a suspected mastoiditis?",
    "A": "Immediate referral",
    "B": "Oral antibiotics",
    "C": "Intravenous antibiotics",
    "D": "Surgical referral",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected mastoiditis[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0121",
    "Questions": "What is the recommended treatment for a patient with suspected appendicitis?",
    "A": "Oral antibiotics",
    "B": "Analgesics",
    "C": "Immediate referral for surgery",
    "D": "Observation and pain management",
    "Answer": "C",
    "Comment": "The guideline recommends immediate referral for surgery for a patient with suspected appendicitis[cite: 2].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0122",
    "Questions": "Which is a recommended treatment for a patient with oral candidiasis?",
    "A": "Oral nystatin",
    "B": "Oral fluconazole",
    "C": "Topical antifungal cream",
    "D": "Oral itraconazole",
    "Answer": "A",
    "Comment": "The guideline recommends oral nystatin for the treatment of oral candidiasis[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0123",
    "Questions": "What is the recommended treatment for a patient with a dental abscess?",
    "A": "Oral antibiotics",
    "B": "Incision and drainage",
    "C": "Referral to a dentist",
    "D": "Oral pain medication",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a dentist for a dental abscess[cite: 1].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0124",
    "Questions": "What is the recommended treatment for a patient with a suspected cellulitis?",
    "A": "Oral antibiotics",
    "B": "Topical antibiotics",
    "C": "Topical steroids",
    "D": "Incision and drainage",
    "Answer": "A",
    "Comment": "The guideline recommends oral antibiotics for the treatment of a suspected cellulitis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0125",
    "Questions": "Which of the following is a recommended management step for a patient with impetigo?",
    "A": "Topical antibiotic",
    "B": "Oral antibiotic",
    "C": "Topical steroid",
    "D": "Incision and drainage",
    "Answer": "A",
    "Comment": "The guideline recommends a topical antibiotic for the treatment of impetigo[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0126",
    "Questions": "What is the recommended management for a patient with tinea corporis?",
    "A": "Oral antifungal",
    "B": "Topical antifungal",
    "C": "Oral antibiotic",
    "D": "Topical steroid",
    "Answer": "B",
    "Comment": "The guideline recommends a topical antifungal for the treatment of tinea corporis[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0127",
    "Questions": "Which of the following is the recommended treatment for a patient with a boil?",
    "A": "Incision and drainage",
    "B": "Oral antibiotics",
    "C": "Topical antibiotics",
    "D": "Oral painkillers",
    "Answer": "A",
    "Comment": "The guideline states that the recommended management for a boil is incision and drainage[cite: 5].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0128",
    "Questions": "What is the recommended management for a patient with a minor burn?",
    "A": "Topical antiseptic",
    "B": "Surgical debridement",
    "C": "Referral to a specialist",
    "D": "Cooling with water",
    "Answer": "D",
    "Comment": "The guideline recommends cooling a minor burn with water[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0129",
    "Questions": "What is the recommended management for a patient with a major burn?",
    "A": "Oral antibiotics",
    "B": "Immediate referral",
    "C": "Topical antibiotics",
    "D": "Pain medication",
    "Answer": "B",
    "Comment": "The guideline recommends immediate referral for a patient with a major burn[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0130",
    "Questions": "What is the recommended management for a patient with a suspected chemical burn?",
    "A": "Neutralizing the chemical with an alkali",
    "B": "Neutralizing the chemical with an acid",
    "C": "Irrigation with water",
    "D": "Topical antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends irrigation with water for a chemical burn[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0131",
    "Questions": "What is the recommended management for a patient with an electrical burn?",
    "A": "Immediate referral",
    "B": "Oral antibiotics",
    "C": "Topical antibiotics",
    "D": "Pain medication",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with an electrical burn[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0132",
    "Questions": "What is the recommended management for a patient with a suspected stroke?",
    "A": "Oral aspirin",
    "B": "IV thrombolysis",
    "C": "Immediate referral",
    "D": "Physical therapy",
    "Answer": "C",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected stroke[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0133",
    "Questions": "Which of the following is the correct management for a patient with chronic psychosis?",
    "A": "Oral antipsychotic medication",
    "B": "Hospitalization",
    "C": "ECT (Electroconvulsive Therapy)",
    "D": "Referral to a specialist",
    "Answer": "A",
    "Comment": "The guideline recommends long-term oral antipsychotic medication for chronic psychosis[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0134",
    "Questions": "What is the recommended treatment for a patient with a suspected overdose of a benzodiazepine?",
    "A": "Flumazenil",
    "B": "Activated charcoal",
    "C": "Supportive care",
    "D": "Referral for psychiatric evaluation",
    "Answer": "A",
    "Comment": "The guideline recommends flumazenil for a benzodiazepine overdose[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0135",
    "Questions": "What is the recommended management for a patient with a foreign body in the ear?",
    "A": "Removal of the foreign body",
    "B": "Irrigation",
    "C": "Referral to a specialist",
    "D": "Oral antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a specialist for a foreign body in the ear[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0136",
    "Questions": "What is the recommended management for a patient with a foreign body in the nose?",
    "A": "Removal of the foreign body",
    "B": "Irrigation",
    "C": "Referral to a specialist",
    "D": "Oral antibiotics",
    "Answer": "C",
    "Comment": "The guideline recommends referral to a specialist for a foreign body in the nose[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0137",
    "Questions": "What is the recommended management for a patient with a suspected head injury?",
    "A": "Immediate referral",
    "B": "Oral pain medication",
    "C": "Observation",
    "D": "CT scan",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected head injury[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0138",
    "Questions": "What is the recommended management for a patient with a suspected spinal injury?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Oral pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected spinal injury[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0139",
    "Questions": "What is the recommended management for a patient with a suspected hip fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected hip fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0140",
    "Questions": "What is the recommended management for a patient with a suspected femoral neck fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected femoral neck fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0141",
    "Questions": "What is the recommended management for a patient with a suspected humeral shaft fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected humeral shaft fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0142",
    "Questions": "What is the recommended management for a patient with a suspected radius fracture?",
    "A": "Immediate referral",
    "B": "Immobilization and referral",
    "C": "Pain medication",
    "D": "X-ray",
    "Answer": "B",
    "Comment": "The guideline recommends immobilization and referral for a patient with a suspected radius fracture[cite: 19].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0143",
    "Questions": "What is the recommended management for a patient with a suspected carpal tunnel syndrome?",
    "A": "Referral to a physiotherapist",
    "B": "Oral pain medication",
    "C": "Splinting",
    "D": "Surgical referral",
    "Answer": "C",
    "Comment": "The guideline recommends splinting for carpal tunnel syndrome[cite: 20].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0144",
    "Questions": "What is the recommended treatment for a patient with a suspected deep vein thrombosis (DVT)?",
    "A": "Immediate referral",
    "B": "Anticoagulant medication",
    "C": "Bed rest",
    "D": "Elastic stockings",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected DVT[cite: 20].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0145",
    "Questions": "What is the recommended management for a patient with a suspected pulmonary embolism?",
    "A": "Immediate referral",
    "B": "Anticoagulant medication",
    "C": "Oxygen therapy",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected pulmonary embolism[cite: 20].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0146",
    "Questions": "What is the recommended management for a patient with a suspected acute myocardial infarction (AMI)?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Nitroglycerin",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected AMI[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0147",
    "Questions": "What is the recommended management for a patient with a suspected unstable angina?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Nitroglycerin",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected unstable angina[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0148",
    "Questions": "What is the recommended management for a patient with a suspected acute cardiac failure?",
    "A": "Immediate referral",
    "B": "Diuretics",
    "C": "ACE-inhibitor",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute cardiac failure[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0149",
    "Questions": "What is the recommended management for a patient with a suspected acute pulmonary oedema?",
    "A": "Immediate referral",
    "B": "Diuretics",
    "C": "IV furosemide",
    "D": "Oxygen therapy",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute pulmonary oedema[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0150",
    "Questions": "What is the recommended management for a patient with a suspected acute hypertensive crisis?",
    "A": "Immediate referral",
    "B": "Oral nifedipine",
    "C": "IV labetalol",
    "D": "Oral hydralazine",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute hypertensive crisis[cite: 4].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0151",
    "Questions": "What is the recommended management for a patient with a suspected acute stroke?",
    "A": "Immediate referral",
    "B": "Aspirin",
    "C": "Thrombolysis",
    "D": "Anticoagulants",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected stroke[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0152",
    "Questions": "What is the recommended management for a patient with a suspected acute meningitis?",
    "A": "Immediate referral",
    "B": "IV antibiotics",
    "C": "Oral antibiotics",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected acute meningitis[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0153",
    "Questions": "What is the recommended management for a patient with a suspected encephalitis?",
    "A": "Immediate referral",
    "B": "IV antivirals",
    "C": "Oral antivirals",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected encephalitis[cite: 15].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0154",
    "Questions": "What is the recommended management for a patient with a suspected tetanus?",
    "A": "Immediate referral",
    "B": "Tetanus immunoglobulin",
    "C": "Oral antibiotics",
    "D": "Referral to a general practitioner",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected tetanus[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0155",
    "Questions": "What is the recommended management for a patient with a suspected rabies?",
    "A": "Immediate referral",
    "B": "Rabies vaccine",
    "C": "Rabies immunoglobulin",
    "D": "Oral antibiotics",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected rabies[cite: 10].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0156",
    "Questions": "What is the recommended management for a patient with a suspected snakebite?",
    "A": "Immediate referral",
    "B": "Antivenom",
    "C": "Pain medication",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected snakebite[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0157",
    "Questions": "What is the recommended management for a patient with a suspected spider bite?",
    "A": "Immediate referral",
    "B": "Antivenom",
    "C": "Pain medication",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected spider bite[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0158",
    "Questions": "What is the recommended management for a patient with a suspected scorpion sting?",
    "A": "Immediate referral",
    "B": "Antivenom",
    "C": "Pain medication",
    "D": "Observation",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected scorpion sting[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0159",
    "Questions": "What is the recommended management for a patient with a suspected drug overdose?",
    "A": "Immediate referral",
    "B": "Activated charcoal",
    "C": "Gastric lavage",
    "D": "Supportive care",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for a patient with a suspected drug overdose[cite: 21].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "PHC0160",
    "Questions": "What is the recommended management for a patient with a suspected suicidal attempt?",
    "A": "Immediate referral for psychiatric evaluation",
    "B": "Observation",
    "C": "Pain medication",
    "D": "Discharge home",
    "Answer": "A",
    "Comment": "The guideline recommends immediate referral for psychiatric evaluation for a patient with a suspected suicidal attempt[cite: 16].",
    "Source": "EDL PHC"
  },
  {
    "Ref": "Maternity0161",
    "Questions": "Which of the following is a key principle of respectful maternity care?",
    "A": "Always conduct examinations in public for transparency",
    "B": "Ensure informed consent and maintain confidentiality",
    "C": "Do not allow birth companions in labour wards",
    "D": "Share patient details with non-medical staff for safety",
    "Answer": "B",
    "Comment": "Respectful maternity care requires informed consent, privacy, and confidentiality to uphold women's dignity.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0162",
    "Questions": "According to the guidelines what proportion of women in South Africa experience intimate partner violence during or after pregnancy?",
    "A": "1 in 10",
    "B": "1 in 6",
    "C": "1 in 4",
    "D": "1 in 2",
    "Answer": "C",
    "Comment": "This is the figure quoted in the guideline",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0163",
    "Questions": "What is the first-line pharmacological treatment for moderate to severe perinatal depression or anxiety?",
    "A": "Tricyclic antidepressants",
    "B": "SSRIs",
    "C": "Benzodiazepines",
    "D": "Lithium",
    "Answer": "B",
    "Comment": "SSRIs are safe and effective as first-line treatment during pregnancy and breastfeeding.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0164",
    "Questions": "How is primary postpartum haemorrhage (PPH) defined?",
    "A": "Excessive bleeding within 12 hours post-delivery",
    "B": "Excessive bleeding from the genital tract within 24 hours",
    "C": "Blood loss greater than 1000ml within 48 hours",
    "D": "Blood loss greater than 2500ml at any point post-delivery",
    "Answer": "B",
    "Comment": "Primary PPH is defined as excessive bleeding within 24 hours after delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0165",
    "Questions": "Which of the following is a recognised risk factor for maternal mental health conditions?",
    "A": "High educational attainment",
    "B": "Refugee or asylum seeker status",
    "C": "Multiparity without complications",
    "D": "Access to social support networks",
    "Answer": "B",
    "Comment": "Being a refugee or asylum seeker is a recognised risk factor.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0166",
    "Questions": "What is the purpose of the BANC Plus antenatal schedule?",
    "A": "To reduce number of antenatal visits",
    "B": "To increase visits for improved monitoring",
    "C": "To replace ultrasound scans",
    "D": "To avoid routine laboratory tests",
    "Answer": "B",
    "Comment": "BANC Plus increased the number of visits to improve outcomes.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0167",
    "Questions": "Which of the following is NOT a type of disrespect and abuse in maternity care?",
    "A": "Failure to provide services due to prejudice",
    "B": "Denying mobility or food in labour",
    "C": "Encouraging chosen birth position",
    "D": "Unwanted physical contact",
    "Answer": "C",
    "Comment": "Encouraging chosen birth positions is part of respectful care.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0168",
    "Questions": "Which simple measure can improve respectful communication during labour?",
    "A": "Shouting instructions",
    "B": "Using patient???s preferred name",
    "C": "Withholding information until delivery",
    "D": "Allowing only one examination per labour",
    "Answer": "B",
    "Comment": "Calling women by their preferred name improves rapport and respect.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0169",
    "Questions": "Which statement about adolescent pregnancy is correct?",
    "A": "It carries lower risk than adult pregnancy",
    "B": "It is associated with higher risk of eclampsia and infections",
    "C": "It is always intended",
    "D": "It results in better neonatal outcomes",
    "Answer": "B",
    "Comment": "Adolescents face higher risks of complications such as eclampsia and infection.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0170",
    "Questions": "Which of the following should be done when a woman is experiencing pregnancy loss?",
    "A": "Leave her alone without explanation",
    "B": "Explain causes if known using simple language",
    "C": "Deny her access to the baby",
    "D": "Transfer her immediately without support",
    "Answer": "B",
    "Comment": "Women should receive explanations and compassionate support during loss.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0171",
    "Questions": "Which test is routinely used to screen for syphilis in pregnancy?",
    "A": "GeneXpert",
    "B": "RPR",
    "C": "CTG",
    "D": "HIV PCR",
    "Answer": "B",
    "Comment": "RPR is the standard screening test for syphilis in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0172",
    "Questions": "What is the recommended first-line uterotonic for prevention of postpartum haemorrhage?",
    "A": "Carboprost",
    "B": "Oxytocin",
    "C": "Misoprostol",
    "D": "Ergometrine",
    "Answer": "B",
    "Comment": "Oxytocin is the drug of choice for prevention of PPH.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0173",
    "Questions": "Which of the following defines pre-eclampsia with severe features?",
    "A": "Proteinuria only",
    "B": "BP ??�160/110 with organ dysfunction",
    "C": "BP ??�140/90 after 20 weeks with no symptoms",
    "D": "Any rise in BP in first trimester",
    "Answer": "B",
    "Comment": "Severe features include high BP with organ dysfunction such as headache, visual changes, or elevated creatinine.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0174",
    "Questions": "What is the management of a septic miscarriage?",
    "A": "Observation only",
    "B": "Immediate uterine evacuation and IV antibiotics",
    "C": "Oral antibiotics at home",
    "D": "Iron supplementation only",
    "Answer": "B",
    "Comment": "Septic miscarriage requires immediate uterine evacuation and IV antibiotics.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0175",
    "Questions": "Which fetal heart rate is considered normal during labour?",
    "A": "80???100 bpm",
    "B": "100???110 bpm",
    "C": "110???160 bpm",
    "D": "160???200 bpm",
    "Answer": "C",
    "Comment": "Normal fetal heart rate in labour is 110???160 bpm.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0176",
    "Questions": "What is the safest delivery method for a transverse lie at term?",
    "A": "Normal vaginal delivery",
    "B": "Forceps extraction",
    "C": "Caesarean section",
    "D": "Vacuum delivery",
    "Answer": "C",
    "Comment": "Transverse lie usually requires caesarean section for safe delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0177",
    "Questions": "What is the most appropriate response if a client is aggressive during labour care?",
    "A": "Argue and assert authority",
    "B": "Remain calm and acknowledge their emotions",
    "C": "Ignore the client",
    "D": "Remove their birth companion",
    "Answer": "B",
    "Comment": "Remaining calm and acknowledging emotion de-escalates situations.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0178",
    "Questions": "Which of the following is a recommended food supplement during pregnancy in South Africa?",
    "A": "Vitamin C",
    "B": "Folic acid and iron",
    "C": "High-dose Vitamin A",
    "D": "Calcium only",
    "Answer": "B",
    "Comment": "Folic acid and iron supplementation is standard in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0179",
    "Questions": "Which statement about kangaroo care is correct?",
    "A": "It should be avoided in preterm babies",
    "B": "It is recommended after delivery for bonding and warmth",
    "C": "It replaces breastfeeding",
    "D": "It is unsafe after caesarean delivery",
    "Answer": "B",
    "Comment": "Skin-to-skin contact improves bonding and thermoregulation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0180",
    "Questions": "What is the most important first step in managing antepartum haemorrhage?",
    "A": "Immediate caesarean section",
    "B": "Determine maternal stability and resuscitate",
    "C": "Start oxytocin infusion immediately",
    "D": "Discharge home with bed rest",
    "Answer": "B",
    "Comment": "Initial step is resuscitation and maternal stabilisation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0181",
    "Questions": "Which infection is specifically screened for at booking in antenatal care?",
    "A": "Hepatitis C",
    "B": "Malaria",
    "C": "HIV and syphilis",
    "D": "Dengue",
    "Answer": "C",
    "Comment": "HIV and syphilis are part of routine antenatal screening.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0182",
    "Questions": "Which of the following is NOT a feature of respectful workplace culture?",
    "A": "Positive feedback and support",
    "B": "Public criticism of colleagues",
    "C": "Constructive mentoring",
    "D": "Confidential performance feedback",
    "Answer": "B",
    "Comment": "Public criticism undermines respect and morale.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0183",
    "Questions": "What is the role of a birth companion during labour?",
    "A": "Provide emotional and practical support",
    "B": "Administer medications",
    "C": "Perform vaginal examinations",
    "D": "Direct medical management",
    "Answer": "A",
    "Comment": "Birth companions provide non-clinical emotional and practical support.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0184",
    "Questions": "What is the most common mental health condition affecting South African women during or after pregnancy?",
    "A": "Schizophrenia",
    "B": "Perinatal depression and anxiety",
    "C": "Bipolar disorder",
    "D": "PTSD",
    "Answer": "B",
    "Comment": "About 1 in 3 women experience perinatal depression or anxiety.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0185",
    "Questions": "Which of the following is a recommended screening schedule for maternal mental health?",
    "A": "Only postpartum",
    "B": "Once at booking and ideally each trimester",
    "C": "Only if patient has prior psychiatric history",
    "D": "Only in adolescents",
    "Answer": "B",
    "Comment": "Screening at booking and each trimester if possible helps early detection.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0186",
    "Questions": "Which of the following describes Baby Blues?",
    "A": "Persistent depression beyond 6 months",
    "B": "Temporary emotional changes resolving within 2 weeks",
    "C": "Severe psychosis needing admission",
    "D": "Anxiety disorder requiring benzodiazepines",
    "Answer": "B",
    "Comment": "Baby blues are transient emotional changes usually resolving within 2 weeks.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0187",
    "Questions": "What is the recommended first-line treatment for eclampsia?",
    "A": "Diazepam",
    "B": "Morphine",
    "C": "Magnesium sulphate",
    "D": "Phenytoin",
    "Answer": "C",
    "Comment": "Magnesium sulphate is the drug of choice for preventing and treating seizures in eclampsia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0188",
    "Questions": "Which sign is most suggestive of abruptio placentae rather than placenta praevia?",
    "A": "Painless vaginal bleeding",
    "B": "Painful bleeding with uterine tenderness",
    "C": "Fetal parts easily felt",
    "D": "Absence of uterine contractions",
    "Answer": "B",
    "Comment": "Abruptio placentae typically presents with painful bleeding and uterine tenderness.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0189",
    "Questions": "What is the safest method of induction of labour in a woman with a previous caesarean section?",
    "A": "High-dose oxytocin",
    "B": "Prostaglandin E2 gel",
    "C": "Mechanical methods such as Foley catheter",
    "D": "Oral misoprostol",
    "Answer": "C",
    "Comment": "Mechanical induction methods are safer in women with prior uterine scar.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0190",
    "Questions": "Which of the following is part of the active management of the third stage of labour?",
    "A": "Allowing placenta to deliver spontaneously",
    "B": "Administering oxytocin",
    "C": "Encouraging supine position only",
    "D": "Delaying cord clamping for 10 minutes",
    "Answer": "B",
    "Comment": "Active management includes oxytocin administration to reduce risk of PPH.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0191",
    "Questions": "What is the most appropriate management for shoulder dystocia?",
    "A": "Apply fundal pressure",
    "B": "McRoberts manoeuvre and suprapubic pressure",
    "C": "Delay interventions until contractions resume",
    "D": "Vacuum extraction immediately",
    "Answer": "B",
    "Comment": "First-line management includes McRoberts manoeuvre and suprapubic pressure.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0192",
    "Questions": "Which of the following is a key danger sign in postpartum women?",
    "A": "Mild lochia",
    "B": "Transient night sweats",
    "C": "Heavy vaginal bleeding",
    "D": "Fatigue only",
    "Answer": "C",
    "Comment": "Heavy vaginal bleeding is a key danger sign for PPH.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0193",
    "Questions": "What is the management of a retained placenta after vaginal delivery?",
    "A": "Observe for 24 hours",
    "B": "Uterine massage only",
    "C": "Manual removal under anaesthesia",
    "D": "Give oral antibiotics and discharge",
    "Answer": "C",
    "Comment": "Manual removal under anaesthesia is needed if placenta does not deliver.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0194",
    "Questions": "Which antiretroviral regimen is most commonly recommended for pregnant women living with HIV in South Africa?",
    "A": "AZT monotherapy",
    "B": "TLD regimen (Tenofovir, Lamivudine, Dolutegravir)",
    "C": "Efavirenz monotherapy",
    "D": "Protease inhibitors only",
    "Answer": "C",
    "Comment": "TLD is the current first line regimen",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0195",
    "Questions": "Which measure helps prevent neural tube defects?",
    "A": "Vitamin C",
    "B": "Folic acid supplementation",
    "C": "Iron only",
    "D": "Vitamin D",
    "Answer": "B",
    "Comment": "Folic acid supplementation before and during pregnancy reduces neural tube defects.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0196",
    "Questions": "Which of the following defines gestational diabetes?",
    "A": "Diabetes diagnosed before pregnancy",
    "B": "Hyperglycaemia first recognised in pregnancy",
    "C": "Type 1 diabetes in pregnancy",
    "D": "Any elevated glucose after delivery",
    "Answer": "B",
    "Comment": "Gestational diabetes is hyperglycaemia first recognised during pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0197",
    "Questions": "Which of the following maternal conditions increases risk of pre-eclampsia?",
    "A": "Multiparity",
    "B": "Obesity and chronic hypertension",
    "C": "Short stature only",
    "D": "History of appendicitis",
    "Answer": "B",
    "Comment": "Obesity and chronic hypertension are risk factors for pre-eclampsia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0198",
    "Questions": "What is the definition of preterm labour?",
    "A": "Labour before 28 weeks",
    "B": "Labour before 37 completed weeks",
    "C": "Labour before 20 weeks",
    "D": "Labour before 34 completed weeks",
    "Answer": "B",
    "Comment": "Preterm labour refers to labour occurring before 37 completed weeks.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0199",
    "Questions": "Which statement about VBAC (Vaginal Birth After Caesarean) is correct?",
    "A": "It is contraindicated in all women",
    "B": "It is possible in selected women with one previous low transverse scar",
    "C": "It is safest after three caesareans",
    "D": "It should be avoided in rural hospitals",
    "Answer": "B",
    "Comment": "VBAC can be safely attempted in selected women with one prior low transverse caesarean.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0200",
    "Questions": "What is the first step in neonatal resuscitation?",
    "A": "Administer oxygen",
    "B": "Check breathing and stimulate the baby",
    "C": "Give chest compressions immediately",
    "D": "Insert IV fluids",
    "Answer": "B",
    "Comment": "Initial neonatal resuscitation begins with checking breathing and stimulation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0201",
    "Questions": "Which of the following contraceptive methods is safe in breastfeeding women from 6 weeks postpartum?",
    "A": "Combined oral contraceptives",
    "B": "Progestogen-only methods",
    "C": "Estrogen patch",
    "D": "Emergency contraception only",
    "Answer": "B",
    "Comment": "Progestogen-only methods are safe for breastfeeding mothers from 6 weeks.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0202",
    "Questions": "Which infection in pregnancy requires intrapartum penicillin prophylaxis?",
    "A": "HIV",
    "B": "Group B Streptococcus",
    "C": "Malaria",
    "D": "Hepatitis B",
    "Answer": "B",
    "Comment": "Intrapartum penicillin prophylaxis is used for Group B Streptococcus.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0203",
    "Questions": "Which fetal presentation usually requires caesarean delivery?",
    "A": "Occiput anterior",
    "B": "Breech",
    "C": "Transverse lie",
    "D": "Face presentation",
    "Answer": "C",
    "Comment": "Transverse lie usually requires caesarean delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0204",
    "Questions": "Which measure reduces mother-to-child transmission of HIV at delivery?",
    "A": "Elective caesarean section only",
    "B": "Exclusive breastfeeding with ART",
    "C": "Formula feeding only",
    "D": "Withholding ART",
    "Answer": "B",
    "Comment": "Exclusive breastfeeding with ART significantly reduces HIV transmission.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0205",
    "Questions": "What is the management of mild anaemia in pregnancy?",
    "A": "No intervention",
    "B": "Blood transfusion",
    "C": "Oral iron and folate supplementation",
    "D": "IV antibiotics",
    "Answer": "C",
    "Comment": "Mild anaemia is managed with oral iron and folate supplementation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0206",
    "Questions": "Which of the following increases risk of postpartum depression?",
    "A": "Strong family support",
    "B": "History of psychiatric illness",
    "C": "Access to mental health care",
    "D": "Planned pregnancy",
    "Answer": "B",
    "Comment": "Past psychiatric history increases risk of postpartum depression.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0207",
    "Questions": "Which hypertensive disorder is defined as new hypertension after 20 weeks without proteinuria?",
    "A": "Chronic hypertension",
    "B": "Gestational hypertension",
    "C": "Pre-eclampsia",
    "D": "Secondary hypertension",
    "Answer": "B",
    "Comment": "Gestational hypertension is diagnosed after 20 weeks without proteinuria.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0208",
    "Questions": "Which of the following is the most effective emergency management of postpartum haemorrhage?",
    "A": "Delay until senior review",
    "B": "Immediate uterotonic drugs and uterine massage",
    "C": "Oral fluids and reassurance",
    "D": "Antibiotics only",
    "Answer": "B",
    "Comment": "Immediate use of uterotonic drugs and massage is essential.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0209",
    "Questions": "What is the first-line management of epilepsy in pregnancy?",
    "A": "Avoid medication",
    "B": "Phenytoin",
    "C": "Lamotrigine or sodium valproate",
    "D": "Carbamazepine",
    "Answer": "C",
    "Comment": "Lamotrigine or valproate are commonly used but valproate should be avoided if possible.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0210",
    "Questions": "Which maternal infection requires screening and treatment to prevent congenital anomalies?",
    "A": "Syphilis",
    "B": "Malaria",
    "C": "HIV",
    "D": "Chlamydia",
    "Answer": "A",
    "Comment": "Syphilis screening and treatment prevents congenital anomalies and stillbirth.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0211",
    "Questions": "Which of the following defines secondary postpartum haemorrhage?",
    "A": "Bleeding within 24 hours after delivery",
    "B": "Bleeding after 24 hours up to 12 weeks postpartum",
    "C": "Bleeding during caesarean only",
    "D": "Bleeding at time of miscarriage",
    "Answer": "B",
    "Comment": "Secondary PPH occurs after 24 hours up to 12 weeks postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0212",
    "Questions": "Which of the following is the leading cause of maternal death in South Africa?",
    "A": "Postpartum haemorrhage",
    "B": "Hypertensive disorders",
    "C": "HIV-related conditions",
    "D": "Sepsis",
    "Answer": "C",
    "Comment": "HIV-related conditions remain the leading cause of maternal mortality in South Africa.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0213",
    "Questions": "What is the most appropriate management of severe pre-eclampsia at 32 weeks?",
    "A": "Continue pregnancy with close observation",
    "B": "Immediate delivery after stabilisation",
    "C": "Bed rest until 37 weeks",
    "D": "Oral antihypertensives only",
    "Answer": "B",
    "Comment": "Definitive treatment of severe pre-eclampsia is delivery after maternal stabilisation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0214",
    "Questions": "What is the definition of puerperal sepsis?",
    "A": "Infection of the genital tract from miscarriage only",
    "B": "Infection of the genital tract from onset of rupture of membranes to 42 days postpartum",
    "C": "Any infection after 1 year",
    "D": "Infection restricted to caesarean wounds",
    "Answer": "B",
    "Comment": "Puerperal sepsis is infection of the genital tract from rupture of membranes to 42 days postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0215",
    "Questions": "Which of the following is a recommended intervention for small-for-gestational-age babies?",
    "A": "Routine induction at 28 weeks",
    "B": "Enhanced surveillance and Doppler studies",
    "C": "No intervention",
    "D": "Immediate caesarean section at diagnosis",
    "Answer": "B",
    "Comment": "Management of SGA babies involves close surveillance and Doppler monitoring.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0216",
    "Questions": "Which statement about breastfeeding in HIV-positive mothers is correct?",
    "A": "Breastfeeding is contraindicated",
    "B": "Exclusive breastfeeding with ART is recommended",
    "C": "Formula feeding is safer in all cases",
    "D": "Mixed feeding is encouraged",
    "Answer": "B",
    "Comment": "Exclusive breastfeeding with ART is recommended to reduce HIV transmission.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0217",
    "Questions": "Which of the following defines placenta praevia?",
    "A": "Placenta implanted in lower uterine segment covering cervix",
    "B": "Premature separation of normally implanted placenta",
    "C": "Any bleeding before labour",
    "D": "Fetal membranes rupturing early",
    "Answer": "A",
    "Comment": "Placenta praevia refers to placental tissue covering or near the cervical os.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0218",
    "Questions": "What is the most appropriate management of ectopic pregnancy in an unstable patient?",
    "A": "Methotrexate therapy",
    "B": "Expectant management",
    "C": "Laparotomy with resuscitation",
    "D": "Laparoscopic salpingostomy",
    "Answer": "C",
    "Comment": "Unstable ruptured ectopic pregnancy requires immediate laparotomy with resuscitation.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0219",
    "Questions": "Which vaccine is routinely recommended during pregnancy in South Africa?",
    "A": "Yellow fever",
    "B": "Influenza and Tdap",
    "C": "Polio",
    "D": "Measles",
    "Answer": "B",
    "Comment": "Influenza and Tdap vaccines are recommended in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0220",
    "Questions": "Which of the following defines threatened miscarriage?",
    "A": "All products expelled",
    "B": "Closed cervix with vaginal bleeding",
    "C": "Open cervix with fetal expulsion",
    "D": "No bleeding but abdominal pain",
    "Answer": "B",
    "Comment": "Threatened miscarriage is vaginal bleeding with a closed cervix.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0221",
    "Questions": "Which of the following best describes respectful postnatal care?",
    "A": "Separating mother and infant routinely",
    "B": "Encouraging skin-to-skin contact",
    "C": "Transferring baby without consent",
    "D": "Withholding breastfeeding advice",
    "Answer": "B",
    "Comment": "Respectful postnatal care includes encouraging skin-to-skin contact.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0222",
    "Questions": "Which is the most common cause of secondary postpartum haemorrhage?",
    "A": "Trauma to genital tract",
    "B": "Endometritis and retained tissue",
    "C": "Hypertension",
    "D": "Coagulopathy",
    "Answer": "B",
    "Comment": "Secondary PPH is most often due to retained tissue or infection.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0223",
    "Questions": "What is the appropriate management of a woman with placenta praevia presenting with bleeding at 36 weeks?",
    "A": "Immediate vaginal delivery",
    "B": "Elective caesarean delivery",
    "C": "Expectant outpatient management",
    "D": "Forceps delivery",
    "Answer": "B",
    "Comment": "Placenta praevia usually requires caesarean delivery at term.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0224",
    "Questions": "Which of the following is a complication of multiple pregnancy?",
    "A": "Reduced risk of preterm labour",
    "B": "Increased risk of fetal growth restriction",
    "C": "Reduced risk of malpresentation",
    "D": "Lower risk of anaemia",
    "Answer": "B",
    "Comment": "Multiple pregnancies carry higher risk of preterm labour and growth restriction.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0225",
    "Questions": "Which of the following defines complete miscarriage?",
    "A": "Bleeding with retained tissue",
    "B": "Bleeding with closed cervix",
    "C": "All products of conception expelled",
    "D": "Infection with sepsis",
    "Answer": "C",
    "Comment": "In complete miscarriage, all products of conception are expelled.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0226",
    "Questions": "What is the initial management of uterine inversion?",
    "A": "Immediate hysterectomy",
    "B": "Replace uterus manually",
    "C": "Delay management for theatre",
    "D": "Give only antibiotics",
    "Answer": "B",
    "Comment": "Immediate manual replacement of uterus is the first step.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0227",
    "Questions": "Which of the following is a recommended method of induction of labour with favourable cervix?",
    "A": "Mechanical methods",
    "B": "High-dose misoprostol",
    "C": "Oxytocin infusion",
    "D": "Elective caesarean",
    "Answer": "C",
    "Comment": "Oxytocin is used when cervix is favourable.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0228",
    "Questions": "What is the most common cause of perinatal mortality in South Africa?",
    "A": "Hypertensive disorders",
    "B": "HIV infection",
    "C": "Preterm birth complications",
    "D": "Birth asphyxia",
    "Answer": "C",
    "Comment": "Preterm birth complications are a leading cause of perinatal mortality.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0229",
    "Questions": "Which of the following is NOT part of active management of PPH?",
    "A": "Uterine massage",
    "B": "Immediate IV antibiotics",
    "C": "Uterotonics",
    "D": "Tranexamic acid",
    "Answer": "B",
    "Comment": "IV antibiotics are not part of active PPH management; they are used if infection is suspected.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0230",
    "Questions": "Which of the following defines inevitable miscarriage?",
    "A": "Bleeding with closed cervix",
    "B": "Bleeding with open cervix and products visible",
    "C": "No bleeding but abdominal pain",
    "D": "All products expelled",
    "Answer": "B",
    "Comment": "Inevitable miscarriage is bleeding with open cervix and visible products.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0231",
    "Questions": "What is the most appropriate management of asymptomatic bacteriuria in pregnancy?",
    "A": "No treatment required",
    "B": "Oral antibiotics",
    "C": "IV antibiotics",
    "D": "Increase fluids only",
    "Answer": "B",
    "Comment": "Asymptomatic bacteriuria requires oral antibiotics to prevent pyelonephritis.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0232",
    "Questions": "Which antihypertensive is safe for use in pregnancy?",
    "A": "ACE inhibitors",
    "B": "Methyldopa",
    "C": "Enalapril",
    "D": "Losartan",
    "Answer": "B",
    "Comment": "Methyldopa is a first-line antihypertensive safe in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0233",
    "Questions": "Which of the following is a feature of severe pre-eclampsia?",
    "A": "Mild headache only",
    "B": "Proteinuria with BP 130/80",
    "C": "Visual disturbances and elevated creatinine",
    "D": "No symptoms with mild hypertension",
    "Answer": "C",
    "Comment": "Severe pre-eclampsia involves high BP with organ dysfunction such as visual symptoms.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0234",
    "Questions": "Which of the following is the most common site for ectopic pregnancy?",
    "A": "Cervix",
    "B": "Ovary",
    "C": "Fallopian tube",
    "D": "Abdominal cavity",
    "Answer": "C",
    "Comment": "Most ectopic pregnancies occur in the fallopian tube.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0235",
    "Questions": "Which intervention is recommended in cases of chorioamnionitis?",
    "A": "Oral antibiotics only",
    "B": "Immediate delivery with IV antibiotics",
    "C": "No intervention until term",
    "D": "Bed rest only",
    "Answer": "B",
    "Comment": "Chorioamnionitis requires IV antibiotics and delivery.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0236",
    "Questions": "What is the most important step in preventing maternal deaths?",
    "A": "Only training doctors",
    "B": "Only equipping tertiary hospitals",
    "C": "Implementing evidence-based guidelines at all levels",
    "D": "Discouraging ANC attendance",
    "Answer": "C",
    "Comment": "Maternal deaths can be reduced by applying national evidence-based guidelines widely.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0237",
    "Questions": "Which of the following is a key principle of respectful care when engaging with adolescents?",
    "A": "Judging them for early pregnancy",
    "B": "Providing gentle and supportive care",
    "C": "Denying them antenatal care",
    "D": "Separating them from adult women",
    "Answer": "B",
    "Comment": "Adolescents need non-judgmental, supportive care to encourage ANC attendance and improve outcomes.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0238",
    "Questions": "What is the most appropriate management for malaria in pregnancy?",
    "A": "No treatment required",
    "B": "Artemisinin-based combination therapy",
    "C": "Quinine only",
    "D": "Delay treatment until postpartum",
    "Answer": "B",
    "Comment": "Artemisinin-based therapies are recommended for malaria in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0239",
    "Questions": "Which of the following is an indication for intrapartum CTG monitoring?",
    "A": "Low-risk term pregnancy",
    "B": "Induction of labour",
    "C": "Preterm labour or suspected fetal compromise",
    "D": "Postnatal period",
    "Answer": "C",
    "Comment": "CTG is indicated in high-risk cases such as preterm labour or suspected compromise.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0240",
    "Questions": "Which mental health condition is most likely to present with hallucinations postpartum?",
    "A": "Postnatal depression",
    "B": "Bipolar disorder",
    "C": "Postnatal psychosis",
    "D": "Anxiety disorder",
    "Answer": "C",
    "Comment": "Postnatal psychosis can present with hallucinations and requires urgent care.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0241",
    "Questions": "Which is the most common cause of maternal anaemia in South Africa?",
    "A": "Vitamin B12 deficiency",
    "B": "Iron deficiency",
    "C": "Folate deficiency",
    "D": "Chronic renal failure",
    "Answer": "B",
    "Comment": "Iron deficiency is the leading cause of maternal anaemia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0242",
    "Questions": "Which of the following is a danger sign in pregnancy requiring immediate referral?",
    "A": "Mild ankle swelling",
    "B": "Occasional nausea",
    "C": "Severe headache and blurred vision",
    "D": "Mild fatigue",
    "Answer": "C",
    "Comment": "Severe headache and blurred vision may indicate pre-eclampsia.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0243",
    "Questions": "Which contraceptive method can be safely initiated immediately postpartum?",
    "A": "Combined oral contraceptive",
    "B": "Progestogen-only implant",
    "C": "Estrogen patch",
    "D": "Intrauterine device in all cases",
    "Answer": "B",
    "Comment": "Progestogen-only methods can be safely initiated immediately postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0244",
    "Questions": "Which of the following defines postpartum sepsis?",
    "A": "Any fever after delivery",
    "B": "Genital tract infection within 42 days after birth",
    "C": "UTI during pregnancy only",
    "D": "Common cold after labour",
    "Answer": "B",
    "Comment": "Postpartum sepsis refers to genital tract infection within 42 days postpartum.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0245",
    "Questions": "Which is the most appropriate management of severe postpartum haemorrhage unresponsive to uterotonics?",
    "A": "Observation only",
    "B": "Uterine massage only",
    "C": "Uterine balloon tamponade or surgical intervention",
    "D": "Discharge home with iron supplements",
    "Answer": "C",
    "Comment": "When uterotonics fail, balloon tamponade or surgery may be required.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0246",
    "Questions": "Which of the following is the most important prevention strategy for obstetric fistula?",
    "A": "Early caesarean section for all",
    "B": "Preventing prolonged obstructed labour",
    "C": "Delaying first pregnancy",
    "D": "Use of high-dose oxytocin indiscriminately",
    "Answer": "B",
    "Comment": "Preventing prolonged obstructed labour is key to preventing obstetric fistula.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0247",
    "Questions": "Which of the following describes Tocophobia?",
    "A": "Fear of pregnancy",
    "B": "Abnormal persistent fear of childbirth",
    "C": "Postnatal depression",
    "D": "Obsession with neonatal health",
    "Answer": "B",
    "Comment": "Tocophobia is an abnormal, persistent fear of childbirth.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0248",
    "Questions": "Which condition is most strongly associated with neonatal death?",
    "A": "Preterm birth",
    "B": "Term vaginal delivery",
    "C": "Elective caesarean section",
    "D": "Post-term birth",
    "Answer": "A",
    "Comment": "Preterm birth is strongly associated with neonatal mortality.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0249",
    "Questions": "What is the first-line antibiotic for urinary tract infection in pregnancy?",
    "A": "Ciprofloxacin",
    "B": "Amoxicillin or cephalexin",
    "C": "Tetracycline",
    "D": "Doxycycline",
    "Answer": "B",
    "Comment": "Amoxicillin or cephalexin are safe first-line antibiotics in pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0250",
    "Questions": "Which of the following defines recurrent miscarriage?",
    "A": "Two or more consecutive miscarriages",
    "B": "Three or more consecutive miscarriages",
    "C": "One miscarriage after 20 weeks",
    "D": "Any miscarriage before 12 weeks",
    "Answer": "B",
    "Comment": "Recurrent miscarriage is defined as three or more consecutive losses.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0251",
    "Questions": "Which of the following is recommended for mothers experiencing Baby Blues?",
    "A": "SSRIs immediately",
    "B": "Compassionate support and monitoring",
    "C": "Electroconvulsive therapy",
    "D": "Benzodiazepines",
    "Answer": "C",
    "Comment": "Baby Blues usually resolve with support; careful monitoring is important.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0252",
    "Questions": "Which antiretroviral drug should be avoided in the first trimester due to risk of neural tube defects?",
    "A": "Dolutegravir",
    "B": "Tenofovir",
    "C": "Lamivudine",
    "D": "Efavirenz",
    "Answer": "A",
    "Comment": "Dolutegravir is avoided in the first trimester due to neural tube defect risk.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0253",
    "Questions": "What is the recommended management of prolonged pregnancy (>41 weeks)?",
    "A": "No intervention until 43 weeks",
    "B": "Induction of labour",
    "C": "Elective caesarean at 38 weeks",
    "D": "Discharge until labour starts naturally",
    "Answer": "B",
    "Comment": "Induction of labour is recommended for prolonged pregnancy.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0254",
    "Questions": "Which of the following is the safest analgesia for asthma in pregnancy?",
    "A": "Aspirin",
    "B": "NSAIDs",
    "C": "Paracetamol",
    "D": "High-dose morphine",
    "Answer": "C",
    "Comment": "Paracetamol is safe for pain relief in asthmatic pregnant women.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0255",
    "Questions": "Which infection requires IPTp (intermittent preventive treatment) in pregnancy?",
    "A": "HIV",
    "B": "Tuberculosis",
    "C": "Malaria",
    "D": "Syphilis",
    "Answer": "C",
    "Comment": "Malaria prevention during pregnancy includes intermittent preventive treatment in endemic areas.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0256",
    "Questions": "Which of the following is a contraindication to induction of labour at district hospital level?",
    "A": "Hypertension",
    "B": "Previous caesarean section",
    "C": "Post-term pregnancy",
    "D": "Preterm labour",
    "Answer": "B",
    "Comment": "Previous caesarean section is a contraindication to IOL at district level.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0257",
    "Questions": "Which of the following is part of respectful care when communicating across language barriers?",
    "A": "Use of hostile tone",
    "B": "Refusing to treat patient",
    "C": "Using simple sentences and translation",
    "D": "Only treating if interpreter is available",
    "Answer": "C",
    "Comment": "Simple communication, translation, and visual aids improve respectful care.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0258",
    "Questions": "What is the first-line management for an HIV-exposed infant after birth?",
    "A": "No prophylaxis needed",
    "B": "Nevirapine prophylaxis",
    "C": "Immediate ART initiation",
    "D": "Formula feeding only",
    "Answer": "B",
    "Comment": "HIV-exposed infants should receive nevirapine prophylaxis.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0259",
    "Questions": "Which of the following is the most effective immediate management of eclampsia?",
    "A": "IV fluids only",
    "B": "Magnesium sulphate",
    "C": "Diazepam and oxygen",
    "D": "Antihypertensives only",
    "Answer": "B",
    "Comment": "Magnesium sulphate is the immediate management for eclampsia seizures.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0260",
    "Questions": "What is the recommended first-line management of gestational diabetes?",
    "A": "Insulin therapy for all",
    "B": "Diet and lifestyle modification",
    "C": "Oral hypoglycaemic agents always",
    "D": "No treatment needed",
    "Answer": "B",
    "Comment": "Diet and lifestyle are first-line; insulin is added if inadequate.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "Maternity0261",
    "Questions": "Which of the following defines complete placenta praevia?",
    "A": "Placenta implanted low but not covering cervix",
    "B": "Placenta entirely covering cervical os",
    "C": "Placenta implanted normally",
    "D": "Placenta covering only uterine wall",
    "Answer": "B",
    "Comment": "Complete placenta praevia means placenta fully covers the cervical os.",
    "Source": "Maternal Care Guidelines"
  },
  {
    "Ref": "PaedsTB0262",
    "Questions": "What percentage of the estimated 27000 children with TB in South Africa were notified and reported to the WHO in 2022?",
    "A": 0.39,
    "B": 0.51,
    "C": 0.61,
    "D": 0.93,
    "Answer": "C",
    "Comment": "In 2022,  South Africa reported 16534 child TB notifications which accounts for 61% of the estimated 27000 children with TB in the country[cite: 30].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0263",
    "Questions": "According to the guideline which of the following is a key update in the revised South African recommendations?",
    "A": "The use of a clinical treatment decision algorithm to support clinicians at the tertiary level.",
    "B": "The use of additional specimens to confirm a diagnosis of TB in children.",
    "C": "A new focus on treatment lengthening for non-severe forms of TB.",
    "D": "The exclusive use of the Tuberculin Skin Test (TST) for diagnosis.",
    "Answer": "B",
    "Comment": "The new South African recommendations include key updates such as the use of additional specimens for diagnosis and a clinical treatment decision algorithm for primary health care clinicians[cite: 6, 7]",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0264",
    "Questions": "Which term has replaced 'latent TB' in the updated guidelines for children and adolescents?",
    "A": "TB disease",
    "B": "Presumptive TB",
    "C": "TB infection",
    "D": "Significant TB exposure",
    "Answer": "C",
    "Comment": "The term latent TB has been replaced by the term TB infection as children are mostly recently infected",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0265",
    "Questions": "What is the definition of 'Significant TB Exposure' according to the guideline?",
    "A": "Exposure for at least 1 night or frequent daytime periods to a TB source patient within the last 3 months.",
    "B": "Exposure within 12 months to a TB source patient who started treatment >3 months ago.",
    "C": "Any exposure to a TB source patient within the last 6 months.",
    "D": "Exposure within 12 months to a TB source patient in the same enclosed space for ??� 1 night or frequent daytime periods during the three months before the source patient started TB treatment.",
    "Answer": "D",
    "Comment": "Significant TB Exposure is defined as \"Exposure within the 12 months before the child/adolescent presents with presumed TB to a person (adult or adolescent) with pulmonary TB within the same enclosed space for ??� 1 night... or for frequent or extended daytime periods... during the three months before the source/index patient started TB treatment\"[cite: 46].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0266",
    "Questions": "Which of the following is NOT one of the \"puzzle pieces\" used to construct a TB diagnosis in children and adolescents?",
    "A": "Patient history",
    "B": "Clinical examination",
    "C": "Socio-economic status",
    "D": "HIV status",
    "Answer": "C",
    "Comment": "The 'puzzle pieces' include patient history, clinical examination, HIV status, CXR, and diagnostic testing[cite: 481]",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0267",
    "Questions": "A child is considered to have 'presumptive TB' when:?",
    "A": "The diagnosis of TB is bacteriologically confirmed.",
    "B": "TB is considered a possible cause of illness based on symptoms or signs.",
    "C": "The child has a positive TST result.",
    "D": "The child has a history of significant TB exposure.",
    "Answer": "B",
    "Comment": "A child or adolescent is believed to have presumptive TB when TB is considered a possible cause of illness in those who present with symptoms or signs suggestive of TB[cite: 51].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0268",
    "Questions": "What is the most common form of TB in children in high TB incidence countries like South Africa?",
    "A": "Extrapulmonary TB (EPT",
    "B": "Miliary TB",
    "C": "Pulmonary TB (PT",
    "D": "TB meningitis",
    "Answer": "C",
    "Comment": "Pulmonary TB (PT is the most common form of TB in children[cite: 428].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0269",
    "Questions": "Which of the following is a reason why TB in children is more difficult to diagnose bacteriologically compared to adults?",
    "A": "Children typically have a higher bacillary load.",
    "B": "Specimen collection is easier in children.",
    "C": "Children have paucibacillary disease with fewer bacilli.",
    "D": "The radiological picture is the same as in adults.",
    "Answer": "C",
    "Comment": "Younger children tend to have few detectable bacilli in their sputum/other respiratory specimens (paucibacillary disease) which makes detecting and confirming TB bacteriologically more difficult[cite: 429].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0270",
    "Questions": "According to the guideline the BCG vaccine is especially protective against which forms of TB?",
    "A": "Drug-resistant TB",
    "B": "Paucibacillary disease",
    "C": "Extrapulmonary TB",
    "D": "Severe forms of TB in infants and young children",
    "Answer": "D",
    "Comment": "The BCG vaccine is not fully protective against TB disease but is especially protective against severe forms of TB in infants and young children[cite: 434].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0271",
    "Questions": "What is the recommended intensive phase duration for the treatment of drug-susceptible TB in children?",
    "A": "1 month",
    "B": "2 months",
    "C": "4 months",
    "D": "6 months",
    "Answer": "B",
    "Comment": "The treatment consists of an intensive phase of 2 months[cite: 135].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0272",
    "Questions": "What is the recommended continuation phase duration for the treatment of non-severe PTB and/or cervical TB lymphadenitis if the child meets the eligibility criteria for treatment shortening?",
    "A": "2 months",
    "B": "4 months",
    "C": "6 months",
    "D": "10 months",
    "Answer": "A",
    "Comment": "In the patient with non-severe PTB and/or cervical TB lymphadenitis the continuation phase is two months provided the child meets the eligibility criteria for treatment shortening[cite: 137].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0273",
    "Questions": "What is the typical duration of the continuation phase for children with bone and joint TB?",
    "A": "2 months",
    "B": "4 months",
    "C": "6 months",
    "D": "10 months",
    "Answer": "D",
    "Comment": "In children with bone and joint TB the duration of the continuation phase is typically prolonged up to 10 months or even longer in specific circumstances[cite: 139].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0274",
    "Questions": "Which of the following is NOT a component of the comprehensive package of care for TB?",
    "A": "Providing anti-TB treatment.",
    "B": "Identifying adult TB source patients.",
    "C": "Providing psychosocial support.",
    "D": "Prescribing antibiotics for all concurrent illnesses.",
    "Answer": "D",
    "Comment": "The components of a comprehensive package of care for TB include providing anti-TB treatment identifying adult TB source patients preventing and managing co-morbid illnesses and providing psychosocial support[cite: 82 83].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0275",
    "Questions": "What is the main reason for patients discontinuing medications as stated in the guideline?",
    "A": "Lack of patient education",
    "B": "Inadequate management of side effects and adverse events",
    "C": "Poor psychosocial support",
    "D": "High cost of medication",
    "Answer": "B",
    "Comment": "Inadequate management of side effects and adverse events is the main reason patients discontinue medications and one of the primary reasons for treatment failure",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0276",
    "Questions": "Which of the following drugs is NOT listed as a potential cause of hepatotoxicity in children?",
    "A": "Isoniazid",
    "B": "Rifampicin",
    "C": "Pyrazinamide",
    "D": "Ethambutol",
    "Answer": "D",
    "Comment": "The most important adverse event on first-line medication is hepatotoxicity which can be caused by isoniazid rifampicin or pyrazinamide and very rarely by ethambutol[cite: 273]. which can be caused by isoniazid rifampicin or pyrazinamide and very rarely by ethambutol[cite: 273].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0277",
    "Questions": "When should bacteriological monitoring be re-evaluated for a child on TB treatment?",
    "A": "Every 2 weeks",
    "B": "If there is clinical deterioration or new exposure to a DR-TB source patient.",
    "C": "Only at the end of treatment.",
    "D": "Never, as it is rarely implemented in children",
    "Answer": "B",
    "Comment": "Re-evaluating the bacteriological status of a child becomes a priority if there is clinical deterioration or if there is a new exposure to a source patient with DR-TB[cite: 270].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0278",
    "Questions": "For a child on a four or six-month regimen what is the management for a cumulative treatment interruption of less than one month?",
    "A": "Start the regimen over from the beginning.",
    "B": "Add additional doses to the end of the relevant treatment phase.",
    "C": "Switch to a different regimen.",
    "D": "Stop treatment entirely.",
    "Answer": "B",
    "Comment": "For a cumulative interruption of less than 1 month add additional doses to the end of the relevant treatment phase[cite: 289].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0279",
    "Questions": "Which of the following statements about TB in children is correct?",
    "A": "They typically have a higher bacillary load than adults.",
    "B": "They usually develop TB within 24 months of exposure.",
    "C": "They may have a broad differential diagnosis for their symptoms.",
    "D": "They do not require a Chest X-ray for diagnosis.",
    "Answer": "C",
    "Comment": "Symptoms in children may be vague and may have a broad differential diagnosis[cite: 438].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0280",
    "Questions": "What is the Ghon complex?",
    "A": "The combination of a parenchymal focus in the lung and the nearest mediastinal lymph node.",
    "B": "The initial site of mycobacterial multiplication in the lung.",
    "C": "The spread of TB bacilli via the lymphatic system.",
    "D": "A form of extrapulmonary TB.",
    "Answer": "A",
    "Comment": "The Ghon complex is formed by the parenchymal focus in the lung and the nearest mediastinal lymph node[cite: 447].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0281",
    "Questions": "What are the risk factors for developing severe TB disease after exposure/infection in children?",
    "A": "Older age and being HIV negative.",
    "B": "Younger age, living with HIV, and/or having severe malnutrition",
    "C": "Being HIV positive but well-nourished.",
    "D": "Being an adolescent with adult-type TB.",
    "Answer": "B",
    "Comment": "Being of younger age living with HIV or HIV exposure and/or having severe malnutrition are all risk factors for developing TB disease after TB exposure/infection[cite: 432]. living with HIV or HIV exposure and/or having severe malnutrition are all risk factors for developing TB disease after TB exposure/infection[cite: 432].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0282",
    "Questions": "Which of the following is a key update in the revised South African guidelines mentioned in the foreword?",
    "A": "A focus on increasing the number of TB notifications in adults.",
    "B": "Practical guidance on treatment shortening for non-severe forms of TB in children and adolescents.",
    "C": "The use of a new anti-TB drug not yet approved by the WHO.",
    "D": "Exclusive reliance on bacteriological confirmation for diagnosis.",
    "Answer": "B",
    "Comment": "One of the key updates is \"practical guidance on implementation of treatment shortening for non-severe forms of TB in children and adolescents\"[cite: 6 7].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0283",
    "Questions": "What is the recommended management for a child who deteriorates on TB treatment or has treatment failure?",
    "A": "Continue the current regimen for a longer duration.",
    "B": "Refer the child to the next level of care for further assessment and management.",
    "C": "Stop all anti-TB medication immediately.",
    "D": "Switch to a different anti-TB regimen without further investigation.",
    "Answer": "B",
    "Comment": "Any child with persistent symptoms or who deteriorates on TB treatment should be referred to the next level of care for further assessment and management[cite: 285].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0284",
    "Questions": "Which of the following is NOT a routine monitoring test for children and adolescents on ART as per the guideline?",
    "A": "Weight and height",
    "B": "CD4 count",
    "C": "Liver function tests",
    "D": "Serum creatinine",
    "Answer": "C",
    "Comment": "Table 14 lists routine monitoring tests for children on ART as weight/height CD4 count VL creatinine FBC and electrolytes. Liver function tests are listed under a different heading (DILI)[cite: 13",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0285",
    "Questions": "What is the minimum level of integration primary care facilities should provide for a mother-child pair on the same day?",
    "A": "Level 1: Integrated care in one consulting room.",
    "B": "Level 2: Aligning visit schedules to attend the same facility on the same day.",
    "C": "Level 3: All needed care in the same room by the same provider.",
    "D": "No integration is necessary,  as long as care is provided.",
    "Answer": "A",
    "Comment": "Primary care facilities should at a minimum provide Level 1 integration[cite: 258].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0286",
    "Questions": "Which of the following statements about adolescents with TB is true?",
    "A": "They typically have paucibacillary disease.",
    "B": "Bacteriological confirmation is less likely than in younger children.",
    "C": "Their presentation and diagnostic approach are similar to adults.",
    "D": "They are not at risk for extrapulmonary TB.",
    "Answer": "C",
    "Comment": "The presentation of and approach to diagnosing PTB in adolescents (10-19 years) is similar to that for adults[cite: 435].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0287",
    "Questions": "Which two drug classes have significant drug interactions with rifampicin that reduce their blood concentrations?",
    "A": "NSAIDs and Paracetamol",
    "B": "Antihistamines and Beta-blockers",
    "C": "Antiretroviral drugs and oral contraceptives",
    "D": "Antiretroviral drugs and oral hypoglycaemic agents",
    "Answer": "C",
    "Comment": "Rifampicin has significant drug interactions with antiretroviral drugs that reduce ART concentrations in the blood and adolescents should be provided with contraception as appropriate due to these drug interactions[cite: 102 118].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0288",
    "Questions": "According to the guidelines when should a decision to start TB treatment NOT be delayed?",
    "A": "When a TST is positive,  but other tests are pending.",
    "B": "When a TST is positive,  but other tests are pending.",
    "C": "When the child is over 10 years of age and clinically stable.",
    "D": "When a social worker has not yet completed the home visit.",
    "Answer": "A",
    "Comment": "A decision to start TB treatment should not be delayed if the necessary investigations are not available, particularly in children at higher risk of developing severe disease, such as young children, malnourished children or those living with HIV[cite: 75].A decision to start TB treatment should not be delayed if the necessary investigations are not available, particularly in children at higher risk of developing severe disease, such as young children, malnourished children or those living with HIV[cite: 75].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0289",
    "Questions": "What is a key difference between TB in children and adults?",
    "A": "Children have a higher risk of poor outcomes if treated early.",
    "B": "The pathophysiology and clinical picture are identical.",
    "C": "Children have very good outcomes if started on appropriate treatment timeously.",
    "D": "Specimen collection is easier in children.",
    "Answer": "C",
    "Comment": "Children have very good outcomes if started on appropriate treatment timeously but the highest risk of poor outcomes if not treated[cite: 439].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0290",
    "Questions": "In the pathophysiology of TB what is the term for the initial parenchymal focus in the lung?",
    "A": "The Ghon complex",
    "B": "The primary focus or Ghon focus",
    "C": "The mediastinal lymph node",
    "D": "The pleural effusion",
    "Answer": "B",
    "Comment": "The initial parenchymal focus in the lung is called the primary focus or Ghon focus[cite: 446].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0291",
    "Questions": "Which of the following is a symptom of Pulmonary TB (PT listed in the document?",
    "A": "Diarrhoea",
    "B": "Persistent cough",
    "C": "Joint pain",
    "D": "Skin rash",
    "Answer": "B",
    "Comment": "Table 2 lists persistent cough (>2 weeks) as a symptom of Pulmonary TB[cite: 3].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0292",
    "Questions": "According to the guideline what is the recommended management of a child with miliary tuberculosis?",
    "A": "Treatment is not delayed,  and the drug regimen is the same as for TBM.",
    "B": "Treatment is delayed until bacteriological confirmation is obtained.",
    "C": "The drug regimen is the same as for non-severe PTB.",
    "D": "Corticosteroids are contraindicated.",
    "Answer": "A",
    "Comment": "Treatment should not be delayed while waiting for results; the anti-tuberculosis drug regimen is the same as for TBM[cite: 174].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0293",
    "Questions": "What is the recommended approach to breastfeeding for a mother being treated for TB?",
    "A": "Breastfeeding is not recommended.",
    "B": "Breastfeeding should be stopped.",
    "C": "Breastfeeding should be encouraged for all mothers still able to breastfeed.",
    "D": "Breastfeeding is only recommended for mothers with non-severe TB.",
    "Answer": "C",
    "Comment": "Breastfeeding should be encouraged for all mothers still able to breastfeed[cite: 117].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0294",
    "Questions": "What is the definition of a 'clinical diagnosis of TB'?",
    "A": "A diagnosis confirmed by a positive culture result.",
    "B": "A diagnosis based on history,  clinical findings,  and/or radiological features.",
    "C": "A diagnosis made when all bacteriological tests are positive.",
    "D": "A diagnosis made only in the absence of radiological features.",
    "Answer": "B",
    "Comment": "A diagnosis made on the grounds of history, clinical findings, radiological features, exposure history, growth trend, or a combination of the above, and where bacteriological tests were either not performed or the results were negative[cite: 52].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0295",
    "Questions": "When should a child with a known TB exposure be considered for TB preventive treatment (TPT)?",
    "A": "When they have no symptoms and no radiological changes on CXR.",
    "B": "Only if they are also living with HIV.",
    "C": "Never",
    "D": "as TPT is not part of the guideline.",
    "Answer": "B",
    "Comment": "Children with no symptoms and no radiological changes on CXR are classified as having TB infection (previously termed ???latent??? T and should be considered for TB preventive treatment (TPT)[cite: 449 450].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0296",
    "Questions": "In the context of the TB/HIV co-infected patient the guideline states that TB cannot be treated without also treating HIV. What is the reciprocal statement?",
    "A": "HIV can be treated without also treating TB.",
    "B": "HIV cannot be treated without also treating TB.",
    "C": "ART must be stopped during TB treatment.",
    "D": "TB treatment must be delayed until ART is started.",
    "Answer": "B",
    "Comment": "The guideline explicitly states: \"In a TB/HIV co-infected patient TB cannot be treated without also treating HIV and HIV cannot be treated without also treating TB!\"[cite: 104].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0297",
    "Questions": "Which of the following is a danger sign in a child with TB needing urgent attention?",
    "A": "Persistent cough for >2 weeks",
    "B": "Loss of appetite",
    "C": "Convulsions",
    "D": "Failure to thrive",
    "Answer": "C",
    "Comment": "Box 1 lists convulsions as a danger sign needing urgent attention[cite: 11].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0298",
    "Questions": "What is the recommended medication for supplemental pyridoxine?",
    "A": "Vitamin D",
    "B": "Pyridoxine",
    "C": "Zinc",
    "D": "Iron",
    "Answer": "B",
    "Comment": "Section 9.2 is titled \"Supplemental pyridoxine\" and lists the drug name[cite: 43].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0299",
    "Questions": "According to the guideline which of the following is NOT a reason for the link between TB and malnutrition?",
    "A": "Malnutrition reduces cell-mediated immunity,  increasing the risk of TB disease.",
    "B": "The catabolic effect of TB disease results in weight loss.",
    "C": "Malnutrition makes TB treatment drugs less effective.",
    "D": "TB disease worsens malnutrition.",
    "Answer": "C",
    "Comment": "Box 5 lists malnutrition's effect on immunity and the catabolic effect of TB disease as reasons for the link between TB and malnutrition[cite: 119].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0300",
    "Questions": "When should the BCG vaccine be repeated in an infant who initiated TPT or TB treatment in the first 6 weeks of life?",
    "A": "After completion of TPT or TB treatment",
    "B": "Never,  as it is a one-time vaccine.",
    "C": "Before TPT or TB treatment is started.",
    "D": "At 6 months of age,  regardless of treatment completion.",
    "Answer": "A",
    "Comment": "BCG should be repeated after completion of TPT or TB treatment[cite: 219].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0301",
    "Questions": "What is the recommended TB drug regimen for a child under three months of age weighing less than 3 kg given the challenges with ethambutol administration?",
    "A": "Isoniazid and Rifampicin",
    "B": "Isoniazid, Rifampicin, Pyrazinamide and Ethambutol",
    "C": "Isoniazid, Rifampicin, Pyrazinamide and Ethionamide",
    "D": "The regimen should be delayed until the child is older.",
    "Answer": "C",
    "Comment": "...ethionamide can be considered in infants younger than three months or weighing < 3kg, given the challenges with ethambutol administration and monitoring for ocular toxicity in the very young[cite: 135].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0302",
    "Questions": "In children with presumed or confirmed DS-TBM what is the recommended management for hyponatremia?",
    "A": "Restrict fluid intake",
    "B": "Encourage fluid intake",
    "C": "Administer IV fluids",
    "D": "Administer oral salt tablets",
    "Answer": "A",
    "Comment": "Table 10 recommends restricting fluids for hyponatremia due to SIADH[cite: 16].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0303",
    "Questions": "What is the recommended approach to Tuberculin Skin Test (TST) in the diagnostic process?",
    "A": "It is the first and only test needed.",
    "B": "It is only useful if there is no known TB exposure.",
    "C": "It is used to confirm bacteriological diagnosis.",
    "D": "It is a replacement for the chest X-ray.",
    "Answer": "B",
    "Comment": "The TST is only useful if no known TB exposure[cite: 62].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0304",
    "Questions": "Which of the following is NOT a routine TB programme activity that should be completed for monitoring and evaluation purposes?",
    "A": "Recording and reporting",
    "B": "Bacteriological monitoring",
    "C": "Identifying adult TB source patients",
    "D": "Assessing post-TB health",
    "Answer": "B",
    "Comment": "Bacteriological monitoring is a part of patient monitoring but recording reporting identifying source patients and assessing post-TB health are listed as routine programme activities[cite: 83].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0305",
    "Questions": "According to the guideline which of the following statements about drug adverse events in children is true?",
    "A": "They are more common in children than in adults.",
    "B": "Hepatotoxicity is rare,  occurring in less than 5% of children on first-line medication.",
    "C": "Hepatotoxicity is most likely to occur after 6 months of treatment.",
    "D": "All adverse events require hospitalisation.",
    "Answer": "B",
    "Comment": "Adverse events caused by TB medications are less common in children than in adults and \"Hepatotoxicity... are rare (5% or lower) in children\"[cite: 272 274]. 274].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0306",
    "Questions": "The guideline suggests that for adolescents the approach to diagnosing PTB is similar to that of adults. What is a key reason for this similarity?",
    "A": "They have paucibacillary disease.",
    "B": "They are less likely to have EPTB.",
    "C": "Bacteriological confirmation is more likely.",
    "D": "They are not at risk for severe TB.",
    "Answer": "C",
    "Comment": "Bacteriological confirmation is more likely in adolescents who often have adult-type (cavitary) PTB disease[cite: 436].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0307",
    "Questions": "Which of the following is a common Chest X-ray feature in perinatal TB?",
    "A": "Cavities",
    "B": "Pleural effusion",
    "C": "Miliary infiltrates",
    "D": "Normal chest x-ray",
    "Answer": "C",
    "Comment": "Table 12 lists miliary infiltrates as a common Chest X-ray feature occurring in 30-40% of cases[cite: 190].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0308",
    "Questions": "What is the recommended initial TB treatment regimen for a child with presumed or confirmed DS-TBM?",
    "A": "A 4-drug intensive phase for 2 months,  followed by a 2-drug continuation phase for 4 months.",
    "B": "A 4-drug intensive phase for 2 months,  followed by a 2-drug continuation phase for 7 months.",
    "C": "A 4-drug intensive phase for 2 months,  followed by a 2-drug continuation phase for 10 months.",
    "D": "The guideline defers to a specialist.",
    "Answer": "A",
    "Comment": "Table 9 on page 45 shows a 2 month intensive phase and a 10 month continuation phase[cite: 1718 19]. shows a 2 month intensive phase and a 10 month continuation phase[cite: 17",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0309",
    "Questions": "What is the main reason for the increased risk of disengagement and loss-to-follow-up (LTF) in TB management?",
    "A": "Inadequate psychosocial support.",
    "B": "Failure to combine care into an integrated package.",
    "C": "High cost of treatment.",
    "D": "Lack of patient education.",
    "Answer": "B",
    "Comment": "Failure to combine care leads to increased visit schedules and significantly increases the risk of disengagement and loss-to-follow-up (LTF)[cite: 88].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0310",
    "Questions": "When should a healthcare professional seek immediate care for a child on TB treatment?",
    "A": "If the child has a persistent cough.",
    "B": "If the child develops jaundice,  abdominal pain or vomiting.",
    "C": "If the child has a mild fever.",
    "D": "If the child has a loss of appetite.",
    "Answer": "B",
    "Comment": "The guideline instructs to seek immediate care if the child develops jaundice abdominal pain or vomiting[cite: 125].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0311",
    "Questions": "What is the primary role of the Road to Health Booklet (RTH in TB management?",
    "A": "To serve as a legal document for TB treatment.",
    "B": "To provide a list of all TB drugs.",
    "C": "To document all relevant information regarding the child's TB diagnosis and treatment.",
    "D": "To replace the TB treatment register.",
    "Answer": "C",
    "Comment": "It is important to always take the RTHB along for any healthcare visits as it documents all relevant information regarding the child's TB diagnosis and treatment[cite: 128 129].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0312",
    "Questions": "Which of the following is a consideration for TB treatment in co-infected children?",
    "A": "They are considered to have non-severe HIV disease.",
    "B": "They are at a lower risk of developing severe disease.",
    "C": "They are at the highest risk of death if not treated.",
    "D": "They can be treated without also treating HIV.",
    "Answer": "C",
    "Comment": "CALHIV and TB are at the highest risk of death if not treated[cite: 100].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0313",
    "Questions": "Which of the following tests should NOT be used to monitor response to treatment?",
    "A": "Smear microscopy",
    "B": "Culture",
    "C": "NAAT testing",
    "D": "Clinical examination",
    "Answer": "C",
    "Comment": "NAAT testing should NOT be used to monitor response to treatment[cite: 269].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0314",
    "Questions": "In the management of a newborn exposed to TB when should the infant be separated from the mother for infection control?",
    "A": "If the mother is known to be contagious.",
    "B": "For the first 24 hours after birth.",
    "C": "When the infant develops symptoms of TB.",
    "D": "Separation is not recommended,  even if the mother is still contagious.",
    "Answer": "D",
    "Comment": "It is not recommended that infants be separated from their mothers after birth even if the mother is known to still be contagious[cite: 200].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0315",
    "Questions": "Which of the following is a definition of bacteriologically confirmed TB?",
    "A": "Diagnosis based on a positive TST and CXR.",
    "B": "Diagnosis confirmed by clinical findings and exposure history.",
    "C": "Diagnosis confirmed using genotypic testing (TB-NAAT),  mycobacterial culture,  and/or smear microscopy.",
    "D": "Diagnosis made in the absence of bacteriological tests.",
    "Answer": "C",
    "Comment": "Bacteriologically confirmed TB is when the diagnosis of TB disease is confirmed using genotypic testing (TB-NAAT) mycobacterial culture and/or smear microscopy for acid-fast bacilli (AF[cite: 53].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0316",
    "Questions": "Which type of TB is defined as involving organs other than the lungs airways and intrathoracic lymph nodes?",
    "A": "Pulmonary TB",
    "B": "Miliary TB",
    "C": "Drug-susceptible TB",
    "D": "Extrapulmonary TB",
    "Answer": "D",
    "Comment": "Extrapulmonary TB is defined as \"any bacteriologically confirmed or clinically diagnosed patient with TB involving organs other than the lungs airways and intrathoracic lymph nodes\"[cite: 55].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0317",
    "Questions": "In adolescents which type of TB disease is most likely to be bacteriologically confirmed?",
    "A": "Paucibacillary disease",
    "B": "Adult-type (cavitary) PTB disease",
    "C": "Extrapulmonary TB",
    "D": "TB infection",
    "Answer": "B",
    "Comment": "Bacteriological confirmation is more likely in adolescents who often have adult-type (cavitary) PTB disease[cite: 436].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0318",
    "Questions": "What is the typical duration of the intensive phase for all children and adolescents with DS-TB (excluding TBM other forms of CNS TB and miliary T?",
    "A": "1 month",
    "B": "2 months",
    "C": "4 months",
    "D": "6 months",
    "Answer": "B",
    "Comment": "All children and adolescents with DS-TB (excluding TBM other forms of CNS TB and miliary T will initiate the same intensive phase of TB treatment using four anti-TB medications. The duration is 2 months[cite: 136 137].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0319",
    "Questions": "What is the recommended management of a child with Tuberculoma?",
    "A": "Anti-tuberculosis therapy is the same as for TBM.",
    "B": "Corticosteroids are not recommended.",
    "C": "A different regimen from TBM is used.",
    "D": "Treatment is only required if neurological symptoms are present.",
    "Answer": "A",
    "Comment": "Anti-tuberculosis therapy is the same as for TBM. Prednisone is also recommended[cite: 167 169].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0320",
    "Questions": "Which of the following is NOT a factor that influences the timing of ART initiation in a TB/HIV co-infected patient?",
    "A": "The specific antiretroviral drug selection.",
    "B": "The patient's age and weight.",
    "C": "Drug interactions with rifampicin.",
    "D": "Adherence due to increased pill burden.",
    "Answer": "B",
    "Comment": "The timing of ART initiation is affected by antiretroviral drug selection drug interactions with rifampicin adherence due to increased pill burden and side effects due to overlapping toxicities[cite: 101102 103].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0321",
    "Questions": "What is a key difference in TB management between children and adults as stated in the guideline?",
    "A": "Treatment is always the same for both age groups.",
    "B": "Children may have more rapid disease progression.",
    "C": "Adults have better treatment outcomes.",
    "D": "Diagnosis is easier in children.",
    "Answer": "B",
    "Comment": "CALHIV may have more rapid TB disease progression and are at higher risk of developing severe disease[cite: 99].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0322",
    "Questions": "What is the recommended drug regimen for the intensive phase of treatment for perinatal TB?",
    "A": "Isoniazid and Rifampicin",
    "B": "Isoniazid, Rifampicin, Pyrazinamide,  and Ethambutol or Ethionamide",
    "C": "Isoniazid, Rifampicin, and Pyrazinamide",
    "D": "Ethionamide and Rifampicin",
    "Answer": "B",
    "Comment": "The intensive phase consists of four drugs: isoniazid rifampicin and pyrazinamide and a fourth drug: either ethambutol or ethionamide[cite: 191].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0323",
    "Questions": "What is the purpose of the clinical treatment decision algorithm mentioned in the foreword?",
    "A": "To replace clinical judgement completely.",
    "B": "To enable and support clinicians at the primary health care level to start TB treatment.",
    "C": "To be used only at the tertiary level of care.",
    "D": "To determine which patients are eligible for surgery.",
    "Answer": "B",
    "Comment": "The clinical treatment decision algorithm is intended \"to enable and support clinicians at the primary health care level to start TB treatment\"[cite: 7].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0324",
    "Questions": "What is the reason given for replacing the term 'latent TB' with 'TB infection' in children?",
    "A": "Children are mostly recently infected.",
    "B": "The term 'latent' is considered outdated.",
    "C": "'TB infection' is a more accurate term for all age groups.",
    "D": "The term 'latent' is only used for adults.",
    "Answer": "A",
    "Comment": "The term ???latent TB??� has been replaced by the term ???TB infection??� as children are mostly recently infected[cite: 49].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0325",
    "Questions": "What is the main purpose of the SHINE trial mentioned in Annexure 4?",
    "A": "To study drug-resistant TB in adults.",
    "B": "To assess the efficacy of treatment shortening in children with non-severe TB.",
    "C": "To find a new drug for TB treatment.",
    "D": "To compare different diagnostic tests for TB.",
    "Answer": "B",
    "Comment": "SHINE was a multi-centre phase 3 open-label treatment-shortening non-inferiority trial in children with non-severe symptomatic smear-negative presumed drug-susceptible (DS)-TB[cite: 312].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0326",
    "Questions": "Which of the following is a correct statement about a child with TB who is on ART?",
    "A": "ART is not needed if the child is already on TB treatment.",
    "B": "ART should be stopped during TB treatment.",
    "C": "The child should be on ART, clinically well, and have a CD4% > 25 to receive a BCG",
    "D": "The BCG vaccine can be given at any time regardless of CD4",
    "Answer": "C",
    "Comment": "If the infant is also LHIV they should be on ART clinically well and have a CD4 > 25% to be able to receive BCG[cite: 219]. clinically well",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0327",
    "Questions": "What is the recommended management of a child with spinal arachnoiditis identified on an MRI?",
    "A": "It should be managed as TBM.",
    "B": "It should be managed with anti-inflammatory drugs only.",
    "C": "No treatment is necessary unless there is bone disease.",
    "D": "The regimen should be the same as for non-severe PTB.",
    "Answer": "A",
    "Comment": "If this is identified on an MRI it should be managed as TBM[cite: 171].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0328",
    "Questions": "According to the guideline what is the role of Chest X-rays in TB diagnosis?",
    "A": "It is the only puzzle piece needed for diagnosis.",
    "B": "It is a puzzle piece if available,  but not always required to start treatment.",
    "C": "It replaces the need for diagnostic testing.",
    "D": "It is only useful in adolescents.",
    "Answer": "B",
    "Comment": "The CXR is a puzzle piece used to construct a TB diagnosis if it is available[cite: 483 492]. A decision to start treatment should not be delayed if necessary investigations like a CXR are not available particularly in high-risk children[cite: 75].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0329",
    "Questions": "What is the recommended waiting period after the last anti-TB treatment dose before an infant can receive the BCG vaccine?",
    "A": "24 hours",
    "B": "5 days",
    "C": "2 months",
    "D": "6 months",
    "Answer": "A",
    "Comment": "BCG vaccination should be done 24 hours after the last anti-TB treatment dose[cite: 223].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0330",
    "Questions": "What is the recommended use of corticosteroids in children with miliary tuberculosis?",
    "A": "They are not recommended.",
    "B": "They are recommended for all children with miliary tuberculosis.",
    "C": "They are only recommended if there are neurological features.",
    "D": "Their use is not mentioned in the guideline.",
    "Answer": "B",
    "Comment": "The use of prednisone in all children with miliary tuberculosis is recommended[cite: 176].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0331",
    "Questions": "What are the components of the intensive phase of treatment for drug-susceptible PTB and EPTB (excluding TBM,  other forms of CNS TB and miliary T?",
    "A": "Isoniazid and Rifampicin, Pyrazinamide, Levofloxacin",
    "B": "Isoniazid and Rifampicin",
    "C": "Isoniazid, Rifampicin, Pyrazinamide,  and Ethambutol",
    "D": "Isoniazid, Rifampicin, Pyrazinamide,  and Ethambutol or Ethionamide",
    "Answer": "D",
    "Comment": "The intensive phase consists of 4 drugs: isoniazid rifampicin and pyrazinamide and a fourth drug which is either ethambutol or ethionamide[cite: 135].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0332",
    "Questions": "Which of the following is NOT a reason for providing patient education to a child/adolescent and their family?",
    "A": "To empower the patient/caregiver",
    "B": "To alleviate fear and anxiety",
    "C": "To increase the cost of treatment",
    "D": "To improve adherence",
    "Answer": "C",
    "Comment": "The guideline states that patient education is aimed at an informed and empowered patient/caregiver who is less fearful and this results in better treatment outcomes[cite: 123].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0333",
    "Questions": "What is the definition of Pulmonary Tuberculosis (PT?",
    "A": "TB involving only the lung tissue.",
    "B": "TB involving the lung tissue, airways or draining lymph nodes",
    "C": "TB involving only the intrathoracic lymph nodes.",
    "D": "TB involving organs other than the lungs.",
    "Answer": "B",
    "Comment": "Pulmonary tuberculosis (PT refers to TB involving the lung tissue airways or draining lymph nodes[cite: 54]. airways or draining lymph nodes[cite: 54].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0334",
    "Questions": "What is the recommended duration of the continuation phase for a child with severe PTB and most EPTB?",
    "A": "2 months",
    "B": "4 months",
    "C": "6 months",
    "D": "10 months",
    "Answer": "B",
    "Comment": "For severe PTB and most EPTB the continuation phase duration is 4 months[cite: 142].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0335",
    "Questions": "What is the purpose of U-LAM testing in children living with HIV (CLHIV)?",
    "A": "To test for drug resistance.",
    "B": "To assess for drug-susceptible TB.",
    "C": "To diagnose advanced HIV disease.",
    "D": "The guideline does not mention U-LAM.",
    "Answer": "B",
    "Comment": "U-LAM is listed under 'Special investigations' in Figure 2 in the box for assessing for TB infection or TB disease[cite: 62].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "PaedsTB0336",
    "Questions": "Which of the following is a definition of a drug-susceptible TB (DS-T?",
    "A": "M.tb strains that are resistant to first-line agents.",
    "B": "M.tb strains that are susceptible to first-line agents rifampicin and isoniazid.",
    "C": "Any patient with TB involving organs other than the lungs.",
    "D": "The form of TB that requires the longest treatment regimen.",
    "Answer": "B",
    "Comment": "Drug-susceptible TB (DS-T is defined as M.tb strains that are susceptible to the first-line agents rifampicin and isoniazid[cite: 56].",
    "Source": "Paeds and Adolescent TB"
  },
  {
    "Ref": "Paeds0337",
    "Questions": "In anaphylaxis in a child, the recommended initial route and dose of adrenaline (epinephrine) is:",
    "A": "IV 0.1 mL/kg of 1:10 000",
    "B": "IM 0.01 mL/kg of 1:1000",
    "C": "SC 0.02 mL/kg of 1:1000",
    "D": "Oral 0.01 mL/kg of 1:1000",
    "Answer": "B",
    "Comment": "IM adrenaline 1:1000 at 0.01 mL/kg (10 ?g/kg) is first-line; do not give IV initially.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0338",
    "Questions": "Maximum single IM dose of adrenaline for anaphylaxis per the guideline is:",
    "A": "0.2 mL",
    "B": "0.5 mL",
    "C": "1.0 mL",
    "D": "2.0 mL",
    "Answer": "B",
    "Comment": "The guideline states a max per IM dose of 0.5 mL (1:1000).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0339",
    "Questions": "If a child fails to respond to several IM doses of adrenaline in anaphylaxis, the guideline next recommends:",
    "A": "Nebulised adrenaline only",
    "B": "Start IV adrenaline infusion (very low dose)",
    "C": "Give high-dose IV hydrocortisone only",
    "D": "Wait and observe for biphasic reaction",
    "Answer": "B",
    "Comment": "IV infusion may be used if IM doses fail; guideline gives an IV infusion rate example.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0340",
    "Questions": "For maintenance of arterial oxygen saturation �95% in severe anaphylaxis the guideline recommends:",
    "A": "Nasal prongs at 0.5 L/min",
    "B": "Face mask with reservoir at 15 L/min",
    "C": "Simple face mask at 2 L/min",
    "D": "No supplemental oxygen unless hypoxic",
    "Answer": "B",
    "Comment": "Severe anaphylaxis requires high-flow oxygen via facemask with reservoir (�15 L/min).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0341",
    "Questions": "In ETAT triage, which of the following is a sign mandating immediate emergency treatment (category ?Emergency?)?",
    "A": "Mild cough only",
    "B": "Cold hands with capillary refill �3 seconds and weak fast pulse",
    "C": "Isolated low-grade fever (37.8�C)",
    "D": "History of mild diarrhoea without dehydration",
    "Answer": "B",
    "Comment": "These are ETAT emergency circulation signs.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0342",
    "Questions": "Per ETAT, which infant is automatically a priority (place ahead of queue)?",
    "A": "7-month-old with mild rhinorrhoea",
    "B": "Infant < 3 months old presenting to facility",
    "C": "10-year-old with controlled asthma",
    "D": "Teenager with controlled epilepsy",
    "Answer": "B",
    "Comment": "Young infant (<3 months) is a priority sign in ETAT.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0343",
    "Questions": "During paediatric resuscitation, if chest rise is inadequate with bag-mask ventilation, the guideline advises to first:",
    "A": "Intubate immediately without further checks",
    "B": "Reassess airway patency and reposition airway / insert oropharyngeal airway",
    "C": "Give a fluid bolus before adjusting airway",
    "D": "Give sodium bicarbonate",
    "Answer": "B",
    "Comment": "Adjust airway position and consider airway adjuncts before intubation.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0344",
    "Questions": "In cardiorespiratory arrest, the recommended oxygen flow via bag-valve mask is:",
    "A": "1?2 L/min",
    "B": "6?10 L/min only",
    "C": "Connect to high-flow oxygen (�15 L/min)",
    "D": "No oxygen required during initial ventilation",
    "Answer": "C",
    "Comment": "Bag-valve-mask ventilation should be connected to high-flow oxygen (�15 L/min).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0345",
    "Questions": "The PAWPER tape is used to:",
    "A": "Measure blood pressure in neonates",
    "B": "Estimate weight considering body habitus",
    "C": "Calculate oxygen requirements only",
    "D": "Assess capillary refill time",
    "Answer": "B",
    "Comment": "PAWPER tape accounts for body habitus to estimate weight.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0346",
    "Questions": "For severe acute malnutrition stabilisation feeding, the guideline prescribes F75 at:",
    "A": "50 mL/kg/day",
    "B": "130 mL/kg/day",
    "C": "200 mL/kg/day from the start",
    "D": "10 mL/kg/day",
    "Answer": "B",
    "Comment": "F75 stabilisation feed is given at 130 mL/kg/day, divided into 3-hourly feeds.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0347",
    "Questions": "During the transition/rehabilitation phase for severe malnutrition the guideline recommends F100; the target approximate total volume is:",
    "A": "~100 mL/kg/day",
    "B": "~130 mL/kg/day",
    "C": "~200 mL/kg/day",
    "D": "No oral feeds allowed",
    "Answer": "C",
    "Comment": "Rehabilitation (F100) volumes to ~200 mL/kg/day for rebuilding/catch-up.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0348",
    "Questions": "The guideline?s advice about starting iron in severely malnourished children is to:",
    "A": "Start iron immediately on admission",
    "B": "Never give iron to malnourished children",
    "C": "Delay iron until appetite returns and weight gain begins (usually week 2)",
    "D": "Give large bolus IV iron on day 1",
    "Answer": "C",
    "Comment": "Do not give iron initially; begin once gaining weight and oedema resolve",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0349",
    "Questions": "If a severely malnourished child has symptomatic anaemia (e.g., Hb ~3 g/dL), the guideline recommends:",
    "A": "No transfusion; give oral iron only",
    "B": "Packed red cells 5 mL/kg IV over 3 hours + furosemide 1 mg/kg at start",
    "C": "Immediate rapid bolus 20 mL/kg packed cells over 15 min",
    "D": "Exchange transfusion only",
    "Answer": "B",
    "Comment": "Blood transfusion is given cautiously: 5 mL/kg over 3 hours with furosemide.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0350",
    "Questions": "For diarrhoea in children, the guideline advises routine use of antibiotics:",
    "A": "Yes ? for all diarrhoea cases",
    "B": "No ? antibiotics are not routinely used for diarrhoea",
    "C": "Only loperamide is first-line",
    "D": "Always use metronidazole first-line",
    "Answer": "B",
    "Comment": "Antibiotics are not routine; used selectively (e.g., dysentery, cholera, severe cases).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0351",
    "Questions": "WHO-style ORS rehydration per guideline for a non-shocked child with severe dehydration is:",
    "A": "10 mL/kg over 1 hour",
    "B": "80 mL/kg over 4 hours by frequent small sips (or NGT alternative)",
    "C": "200 mL/kg over 2 hours",
    "D": "No ORS; IV only",
    "Answer": "B",
    "Comment": "ORS 80 mL/kg over 4 hours is recommended for severe/some dehydration if not shocke",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0352",
    "Questions": "In shock (non-malnourished child), the guideline recommends initial fluid bolus of:",
    "A": "5 mL/kg over 60 minutes",
    "B": "Sodium chloride 0.9% 10 mL/kg over 20 minutes (repeat as needed)",
    "C": "Ringer?s lactate 100 mL/kg immediately",
    "D": "No fluids, start dopamine immediately",
    "Answer": "B",
    "Comment": "Initial shock bolus 10 mL/kg over 20 minutes, reassess and repeat as neede",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0353",
    "Questions": "In a child with severe malnutrition and shock, the guideline suggests caution and recommends:",
    "A": "No fluid boluses at all",
    "B": "Sodium chloride 0.9% 10 mL/kg over 20 minutes; up to 4 boluses may be given with frequent reassessment",
    "C": "Rapid 20 mL/kg boluses repeated without limit",
    "D": "Use albumin as first-line fluid bolus",
    "Answer": "B",
    "Comment": "Shock treatment in malnutrition is cautious: 10 mL/kg with up to 4 boluses, monitor for overloa",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0354",
    "Questions": "For cholera or epidemic diarrhoea the guideline advises:",
    "A": "Routine antimotility agents for all ages",
    "B": "Treat according to susceptibilities of organisms in current epidemics",
    "C": "Always give ciprofloxacin irrespective of context",
    "D": "Avoid ORS entirely",
    "Answer": "B",
    "Comment": "Cholera management depends on current epidemic susceptibilities.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0355",
    "Questions": "The guideline recommends zinc supplementation for all children with diarrhoea at what dose?",
    "A": "2 mg/day for 7 days",
    "B": "10 mg/day for 14 days",
    "C": "50 mg/day for 5 days",
    "D": "No zinc recommended",
    "Answer": "B",
    "Comment": "Zinc elemental 10 mg/day for 14 days is recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0356",
    "Questions": "For suspected shigella dysentery, the guideline lists which of the following options?",
    "A": "Ceftriaxone IV 100 mg/kg once daily for 5 days OR ciprofloxacin oral 15 mg/kg 12-hourly for 3 days",
    "B": "Amoxicillin only for 3 days",
    "C": "Metronidazole only",
    "D": "No antibiotics ever for dysentery",
    "Answer": "A",
    "Comment": "Those are the dysentery treatment options liste",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0357",
    "Questions": "In pneumonia (non-severe) the guideline recommends which empiric antibiotic?",
    "A": "Amoxicillin oral 45 mg/kg/dose 12 hourly for 5 days",
    "B": "Azithromycin only once",
    "C": "No antibiotics ? supportive care only",
    "D": "Vancomycin IV 15 mg/kg 6 hourly",
    "Answer": "A",
    "Comment": "Non-severe pneumonia: oral amoxicillin 45 mg/kg twice daily for 5 days.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0358",
    "Questions": "For severe or very severe pneumonia, initial IV therapy per guideline is:",
    "A": "Oral amoxicillin only",
    "B": "Amoxicillin/clavulanate IV 25 mg/kg (amoxicillin component) 8 hourly",
    "C": "Erythromycin oral only",
    "D": "Ciprofloxacin IV 50 mg/kg 4 hourly",
    "Answer": "B",
    "Comment": "Severe pneumonia: IV amoxicillin/clavulanate at that dose; limit clavulanate exposure.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0359",
    "Questions": "If pneumonia is suspected to be due to Mycoplasma, the guideline suggests:",
    "A": "Start high-dose penicillin only",
    "B": "Consider macrolide therapy such as azithromycin",
    "C": "Give amphotericin B",
    "D": "Macrolides are contraindicated",
    "Answer": "B",
    "Comment": "Mycoplasma/atypical pneumonias are treated with macrolide (azithromycin).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0360",
    "Questions": "In recurring pneumonia evaluations, the guideline recommends checking for all EXCEPT:",
    "A": "HIV and TB status",
    "B": "Structural lung abnormality or immune deficiency",
    "C": "Repeated use of inhaled bronchodilators as sole cause",
    "D": "Possible foreign body aspiration",
    "Answer": "C",
    "Comment": "While bronchodilator overuse isn't the investigation target per se, the guideline emphasizes TB, HIV, structural causes, foreign body.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0361",
    "Questions": "For bronchiolitis, which management is recommended by the guideline?",
    "A": "Routine antibiotics and steroids for all cases",
    "B": "Nebulised ?2-agonist trial; reserve chest X-ray for severe/complicated cases",
    "C": "Immediate intubation for all infants <2 years",
    "D": "Routine chest X-ray in all mild cases",
    "Answer": "B",
    "Comment": "Bronchiolitis: consider bronchodilator trial if wheeze; CXR reserved for severe cases.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0362",
    "Questions": "Tachypnoea cutoff for pneumonia diagnosis in a 3-month-old (2?12 months) according to the guideline is:",
    "A": ">40 breaths/min",
    "B": ">50 breaths/min",
    "C": ">60 breaths/min",
    "D": ">30 breaths/min",
    "Answer": "B",
    "Comment": "For 2?12 months tachypnoea >50/min is the threshol",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0363",
    "Questions": "For acute febrile seizures (not complex) initial acute management per guideline includes:",
    "A": "Immediate long-term antiepileptic therapy",
    "B": "Supportive measures and treat fever; only treat prolonged seizures as status epilepticus",
    "C": "Always perform lumbar puncture immediately",
    "D": "Immediate phenobarbitone prophylaxis for recurrence prevention in every child",
    "Answer": "B",
    "Comment": "Febrile seizures typically need supportive care; prolonged seizures require active anticonvulsant therapy.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0364",
    "Questions": "In status epilepticus (convulsive), the guideline lists initial IV anticonvulsant of choice as:",
    "A": "Phenobarbitone 20 mg/kg as single IV dose (or IM/oral alternative if IV not available)",
    "B": "Phenytoin 50 mg/kg orally",
    "C": "Diazepam oral only",
    "D": "Sodium valproate first-line for all children immediately",
    "Answer": "A",
    "Comment": "Phenobarbitone 20 mg/kg IV is presented as an option where indicate",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0365",
    "Questions": "The correction formula for hyponatraemia fluid calculation in the guideline uses volume = (130 ? Na) ? body weight ? 4 (mL). This is applied for:",
    "A": "Severe symptomatic hyponatraemia requiring controlled correction",
    "B": "Chronic hypertension management",
    "C": "Calculating ORS volumes only",
    "D": "Estimating maintenance glucose needs",
    "Answer": "A",
    "Comment": "The guideline provides formula for calculating sodium chloride volume in significant hyponatraemi",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0366",
    "Questions": "For acute severe malnutrition, hypoglycaemia (blood glucose <3 mmol/L) in asymptomatic child is treated with:",
    "A": "IV bolus Dextrose 50% 5 mL/kg immediately",
    "B": "Stabilisation/F75 formula oral 15 mL/kg OR Dextrose 10% oral 10 mL/kg (if asymptomatic)",
    "C": "No treatment necessary",
    "D": "IV Dextrose 50% 10 mL/kg IM injection",
    "Answer": "B",
    "Comment": "Guideline recommends oral F75 or dextrose 10% oral for asymptomatic hypoglycaemia; IV 10% 5 mL/kg if symptomati",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0367",
    "Questions": "In severe malnutrition, which of the following is TRUE about IV fluids?",
    "A": "Start large-volume IV infusions as in healthy children without caution",
    "B": "Avoid IV infusions if possible; treat dehydration carefully due to poor cardiac reserve",
    "C": "Use albumin routinely for rehydration",
    "D": "Give potassium immediately on admission to all children",
    "Answer": "B",
    "Comment": "Children with severe malnutrition have poor cardiac reserves?avoid IV fluids when possible and reassess frequently.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0368",
    "Questions": "According to the guideline, which of these is an immediate life-threatening anaphylactic sign?",
    "A": "Mild urticaria only",
    "B": "Upper airway obstruction with stridor and hypotension",
    "C": "Itching alone with normal vitals",
    "D": "Isolated diarrhoea without respiratory compromise",
    "Answer": "B",
    "Comment": "Stridor with airway compromise and hypotension are life-threatening.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0369",
    "Questions": "In anaphylaxis, steroids (e.g., hydrocortisone) are recommended as:",
    "A": "First-line sole therapy",
    "B": "Adjunctive therapy only?not first line?e.g., hydrocortisone IV 5 mg/kg 4?6 hourly for 12?24 h",
    "C": "Contraindicated entirely",
    "D": "Given instead of adrenaline in mild cases",
    "Answer": "B",
    "Comment": "Steroids are adjuncts and not first-line; guideline gives dose range.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0370",
    "Questions": "For stridor associated with anaphylaxis the guideline suggests nebulised adrenaline (1:1000) every:",
    "A": "5?10 minutes continuously",
    "B": "15?30 minutes until obstruction abolished",
    "C": "Once only on arrival",
    "D": "Every 6 hours only",
    "Answer": "B",
    "Comment": "Nebulised adrenaline 1:1000 diluted as stated every 15?30 minutes for stridor.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0371",
    "Questions": "Which statement regarding observation after anaphylaxis is recommended?",
    "A": "Discharge immediately once symptoms subside",
    "B": "Observe for 24 hours because of risk of biphasic reactions",
    "C": "No observation needed after IM adrenaline",
    "D": "Observe for 1 hour only irrespective of severity",
    "Answer": "B",
    "Comment": "Guideline advises observation for 24 hours to watch for biphasic reactions.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0372",
    "Questions": "Per the guideline, in a child with pneumonia and empyema suspected due to S. aureus, you should suspect S. aureus especially when:",
    "A": "Only mild cough present",
    "B": "Empyema, pulmonary cavitation, pneumatocoele formation, or extrapulmonary pyogenic infections present",
    "C": "Tachycardia only without respiratory signs",
    "D": "Viral prodrome only",
    "Answer": "B",
    "Comment": "Those features point to staphylococcal pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0373",
    "Questions": "Which of the following antibiotics and dosing is recommended for severe malnutrition with suspected sepsis?",
    "A": "Ampicillin IV 50 mg/kg 6 hourly PLUS gentamicin IV 6 mg/kg once daily for 5 days",
    "B": "Amoxicillin oral only for 3 days",
    "C": "Ciprofloxacin IV 100 mg/kg for 1 day",
    "D": "No antibiotics ? only nutritional support",
    "Answer": "A",
    "Comment": "Guideline lists ampicillin + gentamicin for severe malnutrition/sepsis.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0374",
    "Questions": "Gentamicin dosing recommended in many paediatric severe infections (single daily dose) per guideline is:",
    "A": "1 mg/kg/day",
    "B": "3 mg/kg/day",
    "C": "6 mg/kg/day as a single daily dose",
    "D": "20 mg/kg/day",
    "Answer": "C",
    "Comment": "Gentamicin 6 mg/kg is cited as single daily dose in several indications.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0375",
    "Questions": "For typhoid fever, the guideline recommends ceftriaxone IV at:",
    "A": "10 mg/kg once daily for 3 days",
    "B": "100 mg/kg once daily for 10?14 days",
    "C": "50 mg/kg twice daily for 1 day only",
    "D": "Oral amoxicillin only for 2 days",
    "Answer": "B",
    "Comment": "Ceftriaxone 100 mg/kg IV once daily for 10?14 days for typhoid is specifie",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0376",
    "Questions": "The guideline recommends routine chest X-ray for pneumonia in which situation?",
    "A": "All outpatient mild pneumonia cases",
    "B": "Only when failure to respond to therapy, severe disease with suspected complications or for admissions",
    "C": "Never do chest X-ray for children",
    "D": "Only for neonates < 1 week old",
    "Answer": "B",
    "Comment": "CXR reserved for complicated or non-responding cases or admissions.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0377",
    "Questions": "For oxygen therapy in respiratory distress (non-critically ill children), the guideline prefers:",
    "A": "No oxygen until intubation",
    "B": "Oxygen at 1?2 L/min humidified by nasal prongs until sat �92% off oxygen",
    "C": "Always use a non-rebreather mask at 15 L/min for every case",
    "D": "Use oxygen only if SaO2 <70%",
    "Answer": "B",
    "Comment": "Nasal prongs 1?2 L/min preferred for many children until resolution (sat �92%).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0378",
    "Questions": "A child with diarrhoea who is breastfeeding should be managed per guideline by:",
    "A": "Stopping breastfeeding temporarily",
    "B": "Continuing breastfeeding and adding ORS in addition to feeds",
    "C": "Replacing breast milk entirely with ORS",
    "D": "Giving only solid foods and no fluids",
    "Answer": "B",
    "Comment": "Continue breastfeeds; give ORS in addition for rehydration.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0379",
    "Questions": "Which of these medications is explicitly stated as having no role in routine management of acute diarrhoea?",
    "A": "ORS",
    "B": "Zinc supplementation",
    "C": "Loperamide (antidiarrhoeal)",
    "D": "Continued feeding",
    "Answer": "C",
    "Comment": "Antidiarrhoeal medications like loperamide are not for routine use.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0380",
    "Questions": "For infants <60 days diagnosed with pneumonia, the guideline diagnostic triggers include:",
    "A": "Only cough without tachypnoea",
    "B": "A general danger sign or lower chest wall indrawing or tachypnoea >60/min",
    "C": "Only fever >37�C",
    "D": "Only rhinorrhoea without other signs",
    "Answer": "B",
    "Comment": "For <60 days, those signs indicate severe disease per guideline.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0381",
    "Questions": "In management of persistent diarrhoea (>14 days), the guideline suggests stepwise diet modification. By day 3?7 you should:",
    "A": "Continue full-strength feeds with additional ORS; change to lactose-free feeds if necessary",
    "B": "Force fasting for 48 hours",
    "C": "Start standard adult antidiarrhoeal drugs",
    "D": "Stop all feeds and only give IV fluids indefinitely",
    "Answer": "A",
    "Comment": "The stepwise protocol includes full-strength feeds, then lactose-free if needed, et",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0382",
    "Questions": "For neonates with hypoglycaemia who are symptomatic, the guideline recommends IV dextrose 10% at:",
    "A": "5 mL/kg IV bolus",
    "B": "50 mL/kg IV bolus",
    "C": "1 mL/kg IV bolus",
    "D": "No IV dextrose; only oral feeds",
    "Answer": "A",
    "Comment": "Symptomatic or persistent hypoglycaemia in malnourished child: Dextrose 10% IV 5 mL/kg.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0383",
    "Questions": "Which is true about the use of promethazine in anaphylaxis per guideline?",
    "A": "It is first-line in children of all ages",
    "B": "Promethazine IV/IM 0.25?0.5 mg/kg/dose is listed but contraindicated in children <2 years old",
    "C": "Promethazine should be given orally only",
    "D": "Promethazine is preferred to antihistamines like chlorphenamine in all cases",
    "Answer": "B",
    "Comment": "Promethazine is contraindicated under 2 years and used with caution otherwise.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0384",
    "Questions": "For suspected severe malaria (P. falciparum) the guideline indicates management in which chapter?",
    "A": "Alimentary tract only",
    "B": "Infectious diseases (Malaria section)",
    "C": "Dermatology chapter",
    "D": "Cardiology chapter",
    "Answer": "B",
    "Comment": "Malaria is covered under Infectious Diseases chapter (Chapter 8).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0385",
    "Questions": "Per the guideline, for severe pneumonia with poor response or nosocomial pneumonia, empiric change includes which combination?",
    "A": "Switch to piperacillin/tazobactam IV 100 mg/kg 8 hourly PLUS amikacin IV 15 mg/kg once daily",
    "B": "Continue oral amoxicillin only",
    "C": "Stop all antibiotics and observe",
    "D": "Give metronidazole only",
    "Answer": "A",
    "Comment": "That regimen is suggested when poor response to first-line and nosocomial pathogens suspecte",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0386",
    "Questions": "For Mycoplasma pneumonia in a severely ill child, initial IV macrolide dosing (azithromycin) per guideline is:",
    "A": "Azithromycin IV 10 mg/kg daily for 2 days (then oral)",
    "B": "Azithromycin oral 1 mg/kg once only",
    "C": "Erythromycin IM 100 mg/kg single dose",
    "D": "Doxycycline first-line in infants <8 years",
    "Answer": "A",
    "Comment": "Guideline suggests IV azithromycin 10 mg/kg daily for 2 days for severe illness then switch to oral.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0387",
    "Questions": "Which of the following is a danger sign in ETAT requiring urgent attention?",
    "A": "Mild irritability only",
    "B": "Restless, continuously irritable or lethargic child",
    "C": "Slow-growing child without acute signs",
    "D": "Single episode of sneezing",
    "Answer": "B",
    "Comment": "Persistent irritability/lethargy are priority signs in ETAT.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0388",
    "Questions": "Per the guideline, which is TRUE about oxygen targets in pneumonia?",
    "A": "Stop oxygen when sat �92% off oxygen",
    "B": "Aim for sat �70% only in children",
    "C": "Oxygen is contraindicated in pneumonia",
    "D": "Aim for sat �99% at all times by any means",
    "Answer": "A",
    "Comment": "Continue oxygen until respiratory distress resolves and saturation �92% off oxygen.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0389",
    "Questions": "Which is correct about amoxicillin dosing for non-severe pneumonia per guideline?",
    "A": "45 mg/kg/dose given once daily for 2 days",
    "B": "45 mg/kg/dose 12 hourly for 5 days",
    "C": "10 mg/kg/dose every 8 hours for 10 days",
    "D": "No amoxicillin is indicated",
    "Answer": "B",
    "Comment": "Amoxicillin 45 mg/kg/dose 12 hourly for 5 days for non-severe pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0390",
    "Questions": "In severe malnutrition, vitamin A dosing per guideline for children 12 months?5 years is:",
    "A": "50,000 IU single dose",
    "B": "200,000 IU single dose",
    "C": "No vitamin A recommended",
    "D": "1,000 IU daily for 1 month",
    "Answer": "B",
    "Comment": "Children 12 months?5 years: 200,000 IU single dose per guideline.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0391",
    "Questions": "For neonatal hypoglycaemia prevention in severe malnutrition, the guideline recommends:",
    "A": "Keep the child NPO for 24 hours",
    "B": "Feed immediately (within 30 minutes) and then ensure every feed given day and night",
    "C": "Give only IV fluids once per day",
    "D": "Delay feeding until day 3",
    "Answer": "B",
    "Comment": "Early feeding is crucial to prevent hypoglycaemia in severe malnutrition.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0392",
    "Questions": "What is the guideline advice regarding chest x-ray in bronchiolitis?",
    "A": "Routine chest x-ray for all bronchiolitis cases",
    "B": "Reserve chest x-ray for clinically severe or complicated bronchiolitis",
    "C": "Never perform chest x-ray under any circumstances",
    "D": "Mandatory CT chest in all infants with bronchiolitis",
    "Answer": "B",
    "Comment": "CXR is reserved for severe/complicated cases in bronchiolitis.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0393",
    "Questions": "Per guideline, in children with diarrhoea and persistent hypokalaemia (< normal), supplement with potassium chloride oral dosing is:",
    "A": "125 mg for <6 months; 250 mg for >6 months given 8 hourly",
    "B": "1 g every hour for all ages",
    "C": "No KCl should ever be given in diarrhoea",
    "D": "5000 mg single dose only",
    "Answer": "A",
    "Comment": "KCl dosing per guideline: infants <6 months 125 mg; >6 months 250 mg q8h.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0394",
    "Questions": "In management of severe dehydration with shock, the guideline states that after each bolus you should:",
    "A": "Assume the child is corrected and stop assessment",
    "B": "Reassess for persistence of shock or evidence of circulatory overload before repeating bolus",
    "C": "Always give a total of 10 boluses regardless of response",
    "D": "Immediately start inotropes without reassessment",
    "Answer": "B",
    "Comment": "Reassessment after each bolus is mandated to guide further therapy.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0395",
    "Questions": "Which of the following is recommended as first-line analgesic for discomfort in respiratory disease per guideline?",
    "A": "Paracetamol oral/NGT 15 mg/kg 6 hourly as required",
    "B": "Morphine IV for mild discomfort only",
    "C": "No analgesia permitted in respiratory disease",
    "D": "NSAIDs are always contraindicated",
    "Answer": "A",
    "Comment": "Paracetamol 15 mg/kg 6-hourly is used to relieve discomfort.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0396",
    "Questions": "For meningitis suspicion in severe pneumonia with very ill child, the guideline suggests:",
    "A": "Do nothing; treat only pneumonia",
    "B": "In severe/very severe disease perform blood culture and consider LP where indicated before antibiotics if safe",
    "C": "Always do LP immediately before any resuscitation even if unstable",
    "D": "Only do viral PCR tests and never culture",
    "Answer": "B",
    "Comment": "In severe disease perform blood culture (preferably before antibiotics); LP if indicated and safe.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0397",
    "Questions": "Which is TRUE about dosing of vancomycin for MRSA pneumonia per guideline?",
    "A": "Vancomycin IV 15 mg/kg/dose 6 hourly infused over 1 hour for 14 days",
    "B": "Vancomycin oral 100 mg/kg once daily for 3 days",
    "C": "Vancomycin is not effective for MRSA",
    "D": "Vancomycin given IM only",
    "Answer": "A",
    "Comment": "This IV vancomycin dosing is specified for MRSA pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0398",
    "Questions": "For acute management of suspected sepsis in a very young infant <2 months, guideline empiric antibiotics include:",
    "A": "Oral amoxicillin only",
    "B": "Ampicillin IV 25?50 mg/kg 6 hourly PLUS gentamicin IV 6 mg/kg once daily for 5 days",
    "C": "Ceftriaxone alone PO for 2 days",
    "D": "No antibiotics until culture positive",
    "Answer": "B",
    "Comment": "Neonatal sepsis empiric coverage includes ampicillin + gentamicin.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0399",
    "Questions": "Which of the following is an ETAT priority sign (place ahead of normal queue)?",
    "A": "Temperature 36.8�C and active play",
    "B": "Severe pallor or trauma",
    "C": "History of mild cough for 1 day only",
    "D": "Routine immunisation visit",
    "Answer": "B",
    "Comment": "Severe pallor and trauma are ETAT priority signs.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0400",
    "Questions": "Per the guideline, the first step in treatment of shock is:",
    "A": "Give antibiotics first then fluids",
    "B": "Reassess airway/breathing and call for help; then give fluid bolus as needed",
    "C": "Immediate CT scan before any treatment",
    "D": "Begin enteral feeding only",
    "Answer": "B",
    "Comment": "Always call for help and begin resuscitative measures including appropriate fluid bolus.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0401",
    "Questions": "Which statement about measurements of medication levels does the guideline recommend?",
    "A": "Routine measurement for all medications in all patients",
    "B": "Monitor only when there is a specific clinical question (e.g., narrow therapeutic index, toxicity suspicion)",
    "C": "Therapeutic drug monitoring is useless and discouraged",
    "D": "Levels must be measured daily for paracetamol in all children",
    "Answer": "B",
    "Comment": "Therapeutic drug monitoring should be tailored to answer a clinical question.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0402",
    "Questions": "Which is TRUE regarding prescription writing in children per the guideline?",
    "A": "Abbreviations and decimal points are encouraged for speed",
    "B": "Prescriptions should include generic name, route, dose, frequency, duration, and child's weight/age",
    "C": "Do not include the prescriber?s contact details",
    "D": "Use Greek mu (�) for micrograms to save space",
    "Answer": "B",
    "Comment": "Guideline emphasizes full, clear prescription details including weight and prescriber info.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0403",
    "Questions": "In paediatric DKA management (chapter present in guideline), which of the following is typically a key concern mentioned?",
    "A": "Cerebral oedema risk during rehydration and insulin therapy",
    "B": "No risk of electrolyte disturbance",
    "C": "Rapid bolus insulin recommended at 1 U/kg IV immediately",
    "D": "Always withhold potassium irrespective of levels",
    "Answer": "A",
    "Comment": "Cerebral oedema is a major complication to consider in DKA; manage fluids/insulin cautiously.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0404",
    "Questions": "Regarding neonatal jaundice (unconjugated hyperbilirubinaemia), the guideline is likely to recommend:",
    "A": "Immediate exchange transfusion for any bilirubin level regardless of age/gestation",
    "B": "Use of phototherapy and age/weight-adjusted thresholds for exchange transfusion",
    "C": "No treatment is ever necessary for neonatal jaundice",
    "D": "Use of antibiotics as first-line therapy",
    "Answer": "B",
    "Comment": "Standard neonatal jaundice management includes phototherapy and exchange per thresholds (chapter on newborns).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0405",
    "Questions": "For management of seizures in neonates, guideline dosing for phenobarbitone single IV dose is:",
    "A": "5 mg/kg",
    "B": "20 mg/kg as single IV dose",
    "C": "100 mg/kg",
    "D": "0.5 mg/kg only",
    "Answer": "B",
    "Comment": "Phenobarbitone IV 20 mg/kg as a loading dose is recommended for neonatal seizures.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0406",
    "Questions": "Which of the following is a sign of severe dehydration per ETAT/diarrhoea chapter?",
    "A": "Sunken eyes, lethargy, very slow skin pinch (>2 sec) with Fluid loss plus two features",
    "B": "Mild thirst only",
    "C": "Normal skin turgor and active play",
    "D": "Slight dry lips only",
    "Answer": "A",
    "Comment": "Severe dehydration is fluid loss plus two features like lethargy, sunken eyes, slow skin pinch.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0407",
    "Questions": "Per the guideline, in children with pneumonia the presence of hypoxia or hypercapnia indicates:",
    "A": "No further care needed",
    "B": "Indication for ventilatory support",
    "C": "Immediate discharge home",
    "D": "Give only oral analgesia",
    "Answer": "B",
    "Comment": "Hypoxia (SATS monitor) or hypercapnia (blood gas) indicate ventilatory support requirement.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0408",
    "Questions": "In management of persistent diarrhoea, the guideline lists semi-elemental formula as appropriate during which days?",
    "A": "Day 0 only",
    "B": "Day 8?13 as a step when earlier steps have failed",
    "C": "Never indicated",
    "D": "Only in adults",
    "Answer": "B",
    "Comment": "Semi-elemental formula (sucrose- and lactose-free) is suggested in day 8?13 step.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0409",
    "Questions": "According to the guideline, which of these is NOT recommended to routinely give to children with acute watery diarrhoea?",
    "A": "ORS and continued feeding",
    "B": "Zinc supplementation",
    "C": "Antiemetics and antimotility drugs like loperamide routinely",
    "D": "Counselling on feeding and follow-up",
    "Answer": "C",
    "Comment": "Antidiarrhoeal drugs and routine antiemetics are not recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0410",
    "Questions": "For a child with severe pneumonia and suspected MRSA, the guideline recommends adding which agent?",
    "A": "Vancomycin IV 15 mg/kg/dose 6 hourly",
    "B": "Oral amoxicillin only",
    "C": "Metronidazole only",
    "D": "Isoniazid prophylaxis immediately",
    "Answer": "A",
    "Comment": "Vancomycin is recommended for confirmed MRSA pneumoni",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0411",
    "Questions": "Which of the following is recommended for supportive care in pneumonia per guideline?",
    "A": "Bed rest, clear nasal/oral secretions, monitor vitals including SaO2 and hydration",
    "B": "Routine immediate chest physiotherapy for all children",
    "C": "No monitoring required if child seems well",
    "D": "Isolate and withhold feeding permanently",
    "Answer": "A",
    "Comment": "These supportive measures are recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0412",
    "Questions": "Which is TRUE about enteral feeding in children with respiratory distress per guideline?",
    "A": "If RR >60/min, consider small frequent feeds via oro/nasogastric tube or IV fluids if enteral feeds not tolerated",
    "B": "Stop all enteral feeds permanently if RR >40/min",
    "C": "Always feed large boluses by mouth irrespective of RR",
    "D": "Enteral feeding contraindicated in all respiratory diseases",
    "Answer": "A",
    "Comment": "Maintain nutrition; consider NGT feeds if high RR or intolerance.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0413",
    "Questions": "Which of the following is an appropriate sodium chloride bolus for initial resuscitation of dehydrating watery diarrhoea in children (non-malnourished) per guideline?",
    "A": "1 mL/kg over 1 minute",
    "B": "Sodium chloride 0.9% IV 10 mL/kg given as a bolus over 20 minutes (if shock)",
    "C": "100 mL/kg bolus immediately for all children",
    "D": "No saline bolus, use dopamine first",
    "Answer": "B",
    "Comment": "Initial bolus 10 mL/kg over 20 minutes for shock is recommende",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0414",
    "Questions": "In paediatric intensive care vasopressor/inotrope table, low-dose adrenaline infusion may be used for:",
    "A": "Symptomatic bradycardia unresponsive to atropine and for shock with low CO/low SVR",
    "B": "Always first-line for hypertension only",
    "C": "Analgesia adjunct only",
    "D": "Not indicated in shock management",
    "Answer": "A",
    "Comment": "Adrenaline is indicated for low CO/low SVR shock and symptomatic bradycardi",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0415",
    "Questions": "Which iv concentration is given in the guideline for vasopressor adrenaline infusion preparation?",
    "A": "1 ?g/mL only",
    "B": "100 ?g/mL (5 mg in 50 mL normal saline)",
    "C": "1000 ?g/mL in 10 mL saline always",
    "D": "No recommended concentration presented",
    "Answer": "B",
    "Comment": "The guideline gives concentration: adrenaline 100 ?g/mL (5 mg in 50 mL NS).",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0416",
    "Questions": "Which of the following best describes the guideline?s stance on patient adherence in chronic paediatric conditions?",
    "A": "Adherence is unimportant in chronic conditions",
    "B": "Adherence must be assessed regularly with a multi-method approach (including self-report) and simplified regimens are preferred",
    "C": "Never change regimens based on adherence concerns",
    "D": "Adherence is only the caregiver?s responsibility and not discussed with the child",
    "Answer": "B",
    "Comment": "The guideline emphasizes assessing adherence and simplifying regimens to improve it.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0417",
    "Questions": "Which is recommended about prescription frequency wording?",
    "A": "Use qid, tid abbreviations for speed",
    "B": "Avoid Greek/Roman frequency abbreviations; state frequency in hours or times per day (e.g., ?8 hourly? or ?3 times daily?)",
    "C": "Always write in Latin abbreviations only",
    "D": "Frequency can be omitted if dose is obvious",
    "Answer": "B",
    "Comment": "The guideline recommends avoiding abbreviations and writing frequency clearly.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0418",
    "Questions": "Which of the following is emphasized about formulation selection in the EML?",
    "A": "Always prescribe brand names to ensure clarity",
    "B": "The EML is provided at generic (INN) level; local formularies select preferred members of classes based on tender/pricing",
    "C": "Choose the most expensive drug always",
    "D": "Do not consult local formularies?use this book only",
    "Answer": "B",
    "Comment": "The EML lists INNs; local formularies specify preferred agents.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0419",
    "Questions": "Which of the following is TRUE about measuring aminoglycoside levels per guideline?",
    "A": "Peak and trough levels can help identify dosing adequacy and toxicity risk; troughs before next dose are valuable",
    "B": "Levels are never useful and should not be measured",
    "C": "Only peaks are useful, troughs are irrelevant",
    "D": "Aminoglycosides are safe in renal impairment without monitoring",
    "Answer": "A",
    "Comment": "The guideline notes trough levels help detect potential toxicity; aminoglycosides contraindicated in renal impairment without caution/monitoring.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0420",
    "Questions": "Which of these is an advised step before prescribing a new medicine for chronic disease, per the adherence guidance?",
    "A": "Do not tell the patient purpose or possible side effects",
    "B": "Establish the patient?s daily routine, occupation, and preferences to adapt dosing times and reduce regimen complexity",
    "C": "Prescribe complex multiple dosing schedules by default",
    "D": "Blame the patient if they fail to adhere",
    "Answer": "B",
    "Comment": "The guideline advocates tailoring regimens to patient?s routine to improve adherence.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0421",
    "Questions": "Which of the following statements regarding antibiotic use during diarrhoea is correct per guideline?",
    "A": "Oral antibiotics for systemic action are best given parenterally when absorption may be impaired by diarrhoea",
    "B": "Give oral antibiotics always for systemic infections irrespective of absorption concerns",
    "C": "Avoid parenteral antibiotics in all children with diarrhoea",
    "D": "Antibiotics are first-line for all watery diarrhoea",
    "Answer": "A",
    "Comment": "Diarrhoea may impair absorption; parenteral route preferred for systemic effect.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0422",
    "Questions": "Which of the following steps is part of the 10-step inpatient management of severe acute malnutrition?",
    "A": "Hypoglycaemia, hypothermia, dehydration, electrolytes, infection, micronutrients, stabilisation feeding, catch-up growth, sensory stimulation, prepare for follow up",
    "B": "Immediate high-volume IV fluids then discharge",
    "C": "No monitoring of weight until 6 months",
    "D": "Only give vitamin C and no other nutrients",
    "Answer": "A",
    "Comment": "The 10-step approach is listed in guideline.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0423",
    "Questions": "Per the guideline, when should nasogastric tube (NGT) feeding be used in the stabilisation phase of severe malnutrition?",
    "A": "When feeds are refused/not finished (<80% intake) or the child is very weak",
    "B": "Never use NGT in malnourished children",
    "C": "Only for adults",
    "D": "For routine use in all children regardless of intake",
    "Answer": "A",
    "Comment": "If feeds <80% or child very weak, NGT feeding is advise",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0424",
    "Questions": "Which of the following is TRUE about referral during an acute anaphylactic episode per guideline?",
    "A": "Patients should be referred immediately during the acute phase regardless of stability",
    "B": "Do not refer during the acute phase; transfer only once patient is stable",
    "C": "Referral is never necessary",
    "D": "Home management is sufficient for severe anaphylaxis always",
    "Answer": "B",
    "Comment": "The guideline cautions against transfer during the acute phase; stabilize first.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0425",
    "Questions": "Which of the following is recommended as a preventive/harm-reduction measure for allergic patients in the guideline?",
    "A": "Provide no education to families",
    "B": "Ensure patients wear allergy identification disc/bracelet and train in self-administered adrenaline auto-injector if appropriate",
    "C": "Never give adrenaline auto-injectors to children",
    "D": "Prescribe only antihistamines for known anaphylaxis history",
    "Answer": "B",
    "Comment": "Allergy ID and training for auto-injector are recommended prevention measures.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0426",
    "Questions": "Which of these medications is recommended for nebulised treatment of associated bronchospasm in anaphylaxis?",
    "A": "Salbutamol nebulised (1 mL salbutamol solution in 3 mL NaCl) at 20-min intervals",
    "B": "Ipratropium only once a week",
    "C": "No bronchodilator should be used",
    "D": "Oral theophylline only",
    "Answer": "A",
    "Comment": "Nebulised salbutamol regimen given for bronchospasm associated with anaphylaxis.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0427",
    "Questions": "Which of the following is true about fever triage in ETAT?",
    "A": "Temperature >38�C or <36.4�C in young infant is a priority sign",
    "B": "Fever is never a priority sign",
    "C": "Only temperatures >40�C are significant",
    "D": "All febrile children should be treated as emergencies regardless of other signs",
    "Answer": "A",
    "Comment": "Very high or low temperature in young infants is a priority sign.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0428",
    "Questions": "For treatment of ENT peritonsillar abscess (tonsillitis complicated), the guideline likely recommends:",
    "A": "Conservative management with analgesia only always",
    "B": "Drainage � appropriate antibiotics such as IV amoxicillin/clavulanate depending on severity",
    "C": "No antibiotics and immediate tonsillectomy for all cases",
    "D": "High-dose aspirin for 6 weeks",
    "Answer": "B",
    "Comment": "Complicated tonsillitis (e.g., peritonsillar abscess) requires drainage and targeted antibiotics; see ENT chapter.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0429",
    "Questions": "What is the guideline advice about immediate management of a child with suspected foreign body airway obstruction (inhalation)?",
    "A": "Start chest compressions only and wait for deterioration",
    "B": "Follow airway manoeuvres appropriate to age (back blows/chest thrusts or abdominal thrusts as per paediatric resuscitation algorithms) and call for help",
    "C": "Immediately give bronchodilator only",
    "D": "Give oral fluids to help dislodge object",
    "Answer": "B",
    "Comment": "The emergencies chapter covers foreign body inhalation and standard manoeuvres/advanced resuscitation.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0430",
    "Questions": "In severe malnutrition, the guideline recommends vitamin/mineral supplementation including vitamin A dosing. Which of these is correct for infants <6 months?",
    "A": "Vitamin A 50,000 IU single dose",
    "B": "Vitamin A 200,000 IU single dose",
    "C": "No vitamin A for infants <6 months ever",
    "D": "Vitamin C 100,000 IU daily",
    "Answer": "A",
    "Comment": "Infants <6 months: 50,000 IU single dose per vitamin A dosing table.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0431",
    "Questions": "Which of the following describes the guideline?s approach to oxygen therapy in respiratory distress with hypoxia?",
    "A": "Use humidified nasal prongs 1?2 L/min and continue until sat �92% off oxygen",
    "B": "Immediately proceed to intubation without oxygen trial",
    "C": "Oxygen only if saturations <70%",
    "D": "Discontinue oxygen as soon as patient appears less distressed even if sat <92%",
    "Answer": "A",
    "Comment": "Preferred oxygen delivery is humidified nasal prongs at 1?2 L/min until sat targets met.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0432",
    "Questions": "Which of the following is stated in the EML about essential medicines concept?",
    "A": "Essential medicines must be updated regularly to reflect therapeutic options, resistance patterns and needs",
    "B": "Essential medicines list never changes once published",
    "C": "Only brand-name drugs can be on the EML",
    "D": "EML is only relevant to tertiary hospitals, not primary care",
    "Answer": "A",
    "Comment": "EML concept emphasizes regular updating to reflect changing needs.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0433",
    "Questions": "Which of the following is included in the guideline?s recommended basic resuscitation oxygen flows for optimization of oxygen delivery?",
    "A": "High-flow oxygen 15 L/min via facemask with reservoir bag or 6?10 L/min (depending on device)",
    "B": "No oxygen during resuscitation",
    "C": "Only nasal prongs at 0.2 L/min",
    "D": "50 L/min always regardless of device (not specified)",
    "Answer": "A",
    "Comment": "Guideline suggests high-flow oxygen via reservoir mask (~15 L/min) or alternative flows.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0434",
    "Questions": "Which of the following is a correct guideline statement about blood transfusion in severe malnutrition with severe anaemia?",
    "A": "Packed red cells 5 mL/kg over 3 hours plus furosemide 1 mg/kg at start",
    "B": "Give 20 mL/kg rapidly over 15 minutes regardless of condition",
    "C": "Avoid transfusion even if Hb <4 g/dL",
    "D": "Use whole blood only at 50 mL/kg over 30 minutes",
    "Answer": "A",
    "Comment": "That's the recommended transfusion regimen in severe malnutrition with anaemi",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0435",
    "Questions": "Which of the following is recommended after discharge of a malnourished child per guideline?",
    "A": "No follow-up needed",
    "B": "Prepare discharge plan: social assessment, link to PHC/follow-up, ensure immunisations up to date, consider RUTF supply if available",
    "C": "Discharge immediately to any caregiver with no instructions",
    "D": "Discontinue vitamins after discharge forever",
    "Answer": "B",
    "Comment": "The guideline details discharge preparation including social and follow-up arrangements.",
    "Source": "Paeds EML (2023)"
  },
  {
    "Ref": "Paeds0436",
    "Questions": "Which of the following best summarises the guideline?s recommendation about phototherapy/exchange transfusion thresholds for neonatal jaundice?",
    "A": "Use fixed bilirubin numbers irrespective of gestational age or risk factors",
    "B": "Use age/weight/clinical-risk adjusted thresholds to decide phototherapy and exchange transfusion (i.e., contextualized thresholds)",
    "C": "Never use phototherapy; always exchange transfuse",
    "D": "Phototherapy is contraindicated in neonates",
    "Answer": "B",
    "Comment": "Neonatal jaundice management uses risk- and age-adjusted thresholds for phototherapy/exchange.",
    "Source": "Paeds EML (2023)"
  },  
  {
    "Ref": "Paeds0001",
    "Questions": "In the initial management of a child with compensated septic shock who is refractory to 40 mL/kg of IV fluid bolus, which of the following is the recommended initial vasoactive agent according to the guideline’s principles of shock management?",
    "A": "Vasopressin, titrated up to 0.005 units/kg/hour",
    "B": "Dopamine, 10-20 mcg/kg/minute via central line",
    "C": "Adrenaline (Epinephrine), 0.05-1 mcg/kg/minute via central line",
    "D": "Noradrenaline (Norepinephrine), 0.5-2 mcg/kg/minute via central line",
    "Answer": "C",
    "Comment": "Adrenaline is the recommended first-line vasoactive agent for fluid-refractory compensated septic shock in children, generally preferred over Dopamine. The dose range is provided in the ICU section for continuous infusion. The Shock section 1.1.8 also highlights the principles of management.",
    "Source": "Paeds EML (2023) Page 1.15, 23.31"
  },
  {
    "Ref": "Paeds0002",
    "Questions": "A 5-year-old child presents with an acute, severe anaphylactic reaction. What is the correct initial dose and route of administration for intramuscular adrenaline (epinephrine)?",
    "A": "0.01 mg/kg (maximum 0.4 mg), administered IV, slowly.",
    "B": "0.05 mg/kg (maximum 3 mg), administered IM.",
    "C": "0.01 mg/kg (maximum 0.5 mg), administered IM.",
    "D": "0.1 mg/kg (maximum 5 mg), administered IM.",
    "Answer": "C",
    "Comment": "The initial dose of Adrenaline for anaphylaxis is 0.01 mg/kg IM, with a maximum single dose of 0.5 mg, which can be repeated if required. The IV route is reserved for cardiorespiratory arrest or profound shock.",
    "Source": "Paeds EML (2023) Page 1.5, 23.31"
  },
  {
    "Ref": "Paeds0003",
    "Questions": "Which of the following interventions is strictly CONTRAINDICATED in the immediate supportive management of a child who has ingested a caustic or corrosive substance?",
    "A": "Gastric lavage or induced emesis",
    "B": "Administration of large volumes of water or milk for dilution",
    "C": "Insertion of a nasogastric tube",
    "D": "Urgent endoscopy for grade 3 burns",
    "Answer": "A",
    "Comment": "The guideline explicitly states that gastric lavage, induced emesis, and activated charcoal are contraindicated in all cases of caustic or corrosive agent ingestion due to the high risk of re-injury or aspiration.",
    "Source": "Paeds EML (2023) Page 18.9"
  },
  {
    "Ref": "Paeds0004",
    "Questions": "A 10-year-old child in the Emergency Centre has refractory convulsive Status Epilepticus. Which drug is recommended as the third-line agent (after benzodiazepines and phenytoin/fosphenytoin) in the standard algorithm?",
    "A": "Phenobarbitone",
    "B": "Sodium Valproate",
    "C": "Levetiracetam",
    "D": "Lacosamide",
    "Answer": "A",
    "Comment": "While institutional practices may vary, the guideline's standard approach for refractory Status Epilepticus often lists Phenobarbitone (or continuous infusion Midazolam) as the next step after failure of two first/second-line agents.",
    "Source": "Paeds EML (2023) Page 13.6"
  },
  {
    "Ref": "Paeds0005",
    "Questions": "What is the recommended duration of antibiotic therapy for a child with uncomplicated acute osteomyelitis that is managed with sequential parenteral and oral therapy, after an initial 14 days of parenteral treatment?",
    "A": "A total of 3 weeks (parenteral + oral)",
    "B": "A total of 4 weeks (parenteral + oral)",
    "C": "A total of 6 weeks (parenteral + oral)",
    "D": "A total of 8 weeks (parenteral + oral)",
    "Answer": "C",
    "Comment": "Acute osteomyelitis generally requires a total of 6 weeks of antibiotic therapy. The guideline's standard approach involves switching to oral treatment once clinically stable, completing a 6-week course.",
    "Source": "Paeds EML (2023) Page 8.49"
  },
  {
    "Ref": "Paeds0006",
    "Questions": "In the management of severe, complicated *Plasmodium Falciparum* malaria, what is the correct loading dose and frequency of intravenous Artesunate for a child weighing 30 kg?",
    "A": "3.0 mg/kg at 0, 12, and 24 hours, then daily.",
    "B": "2.4 mg/kg at 0, 12, and 24 hours, then daily.",
    "C": "1.2 mg/kg stat, then 0.6 mg/kg every 6 hours.",
    "D": "5.0 mg/kg at 0, 12, and 24 hours, then daily.",
    "Answer": "B",
    "Comment": "For children ≥ 20 kg, the dose is 2.4 mg/kg at hours 0, 12, and 24, then daily. The higher 3.0 mg/kg dose is reserved for children < 20 kg.",
    "Source": "Paeds EML (2023) Page 8.15"
  },
  {
    "Ref": "Paeds0007",
    "Questions": "A child is diagnosed with Chronic Kidney Disease (CKD) Stage 3. According to the guideline, at what estimated Glomerular Filtration Rate (eGFR) should the child typically be referred for evaluation for renal replacement therapy (RRT)?",
    "A": "eGFR < 60 mL/min/1.73m²",
    "B": "eGFR < 30 mL/min/1.73m²",
    "C": "eGFR < 15 mL/min/1.73m²",
    "D": "eGFR < 10 mL/min/1.73m² (or symptomatic for uraemia)",
    "Answer": "D",
    "Comment": "Referral to a tertiary facility for RRT consideration (dialysis or transplant) is typically initiated when eGFR falls below 10 mL/min/1.73m² or the patient becomes symptomatic for uraemia.",
    "Source": "Paeds EML (2023) Page 6.20"
  },
  {
    "Ref": "Paeds0008",
    "Questions": "Which of the following is the key diagnostic feature on a lateral neck X-ray suggestive of Acute Bacterial Tracheitis, as opposed to viral croup (laryngotracheobronchitis)?",
    "A": "Steeple sign",
    "B": "Hazy tracheal air column with pseudomembrane formation",
    "C": "Thumb sign",
    "D": "Ballooning of the hypopharynx",
    "Answer": "B",
    "Comment": "Acute Bacterial Tracheitis is characterised by marked subglottic oedema, ulceration, pseudomembrane formation, and thick secretions. The investigations section mentions a hazy tracheal air column on X-ray. The Steeple sign is associated with viral croup, and the Thumb sign with epiglottitis.",
    "Source": "Paeds EML (2023) Page 17.4"
  },
  {
    "Ref": "Paeds0009",
    "Questions": "A 10-year-old on long-term opioid analgesia for palliative care develops signs of acute spinal cord compression. What is the recommended immediate high-dose Dexamethasone regimen?",
    "A": "Loading dose of 0.5 mg/kg (max 8 mg), followed by 0.25 mg/kg/dose every 6 hours.",
    "B": "Loading dose of 2 mg/kg (max 100 mg), followed by 1 mg/kg/day.",
    "C": "Loading dose of 1 mg/kg (max 16 mg), followed by 0.5 mg/kg/dose every 6 hours.",
    "D": "Loading dose of 4 mg IV stat, followed by 4 mg orally every 6 hours.",
    "Answer": "A",
    "Comment": "The guideline recommends commencing high-dose Dexamethasone with a loading dose of 0.5 mg/kg (max 8 mg) IV/oral, followed by a maintenance dose of 0.25 mg/kg/dose every 6 hours (up to 4 mg/dose).",
    "Source": "Paeds EML (2023) Page 21.19"
  },
  {
    "Ref": "Paeds0010",
    "Questions": "What is the prophylactic dose of oral Vitamin D recommended for premature babies in order to prevent rickets?",
    "A": "400 IU, once daily.",
    "B": "800 IU, once daily.",
    "C": "1000 IU, once daily.",
    "D": "5000 IU, once daily.",
    "Answer": "B",
    "Comment": "For premature babies, the guideline recommends Vitamin D, oral, 800 IU, once daily for prophylaxis.",
    "Source": "Paeds EML (2023) Page 2.49"
  },
  {
    "Ref": "Paeds0011",
    "Questions": "In a child with a febrile illness and known Type 1 Diabetes Mellitus, what is the primary adjustment recommended for their basal/long-acting insulin regimen?",
    "A": "Reduce the total daily dose by 20% to prevent hypoglycaemia.",
    "B": "Keep the basal/long-acting insulin dose unchanged.",
    "C": "Omit the dose until oral intake improves to prevent nausea/vomiting.",
    "D": "Increase the basal/long-acting insulin dose by 10% to account for stress hormones.",
    "Answer": "B",
    "Comment": "The guidelines for management of diabetics on sick days stress that basal/long-acting insulin should never be omitted, and generally should be kept unchanged or only modestly increased, not reduced, as the primary risk is DKA due to insulin deficiency.",
    "Source": "Paeds EML (2023) Page 7.16"
  },
  {
    "Ref": "Paeds0012",
    "Questions": "Which class of anti-hypertensives is generally CONTRAINDICATED in sexually active adolescent females due to potential teratogenicity and is therefore a critical point of discussion during chronic hypertension management?",
    "A": "Beta-blockers",
    "B": "Angiotensin Converting Enzyme (ACE) Inhibitors",
    "C": "Calcium Channel Blockers (CCBs)",
    "D": "Diuretics (e.g., Hydrochlorothiazide)",
    "Answer": "B",
    "Comment": "ACE inhibitors are potent teratogens and are strictly contraindicated in women who are or may become pregnant. This is a critical consideration in the management of chronic hypertension in adolescents.",
    "Source": "Paeds EML (2023) Page 4.36"
  },
  {
    "Ref": "Paeds0013",
    "Questions": "In a patient presenting with suspected complications of acute bacterial rhinosinusitis, which sign is most suggestive of possible intracranial involvement (e.g., brain abscess or meningitis) and necessitates urgent neuroimaging and specialist consultation?",
    "A": "Persistent facial pain/pressure despite 72 hours of antibiotics.",
    "B": "Signs of meningeal irritation (e.g., neck stiffness or positive Kernig's sign).",
    "C": "Unilateral periorbital oedema and erythema (preseptal cellulitis).",
    "D": "Recurrent epistaxis.",
    "Answer": "B",
    "Comment": "Signs of meningeal irritation, increased intracranial pressure (hypertension, bradycardia), or involvement of orbital structures (proptosis, ophthalmoplegia) are red flags for complicated sinusitis with intracranial extension, demanding urgent investigation (CT scan) and management.",
    "Source": "Paeds EML (2023) Page 17.12"
  },
  {
    "Ref": "Paeds0014",
    "Questions": "In children with established Myasthenia Gravis, a Myasthenic Crisis (MC) is a life-threatening complication. Which of the following is considered the primary first-line treatment for MC according to the guideline?",
    "A": "Oral Pyridostigmine up-dosing",
    "B": "High-dose intravenous immunoglobulin (IVIG) or Plasmapheresis",
    "C": "Intravenous high-dose Corticosteroids",
    "D": "IV Midazolam for muscle spasms",
    "Answer": "B",
    "Comment": "Myasthenic Crisis is a medical emergency primarily treated with IVIG or Plasmapheresis to remove autoantibodies, alongside ventilatory support. Up-dosing anticholinesterases like Pyridostigmine can worsen symptoms due to cholinergic crisis.",
    "Source": "Paeds EML (2023) Page 13.23"
  },
  {
    "Ref": "Paeds0015",
    "Questions": "For a child who is a close household contact of a confirmed Diphtheria case, what is the recommended prophylactic regimen for a child over 6 years of age with no severe penicillin allergy?",
    "A": "Azithromycin oral, 500 mg stat.",
    "B": "Benzylpenicillin, 1.2 million units, IM, single dose.",
    "C": "Erythromycin oral, 250 mg four times daily for 7 days.",
    "D": "Benzylpenicillin, 600 000 units, IM, single dose.",
    "Answer": "B",
    "Comment": "For close contacts over 6 years of age (including adults) without severe penicillin allergy, the guideline recommends a single dose of 1.2 million units of IM Benzylpenicillin. For children < 6 years, the dose is 600 000 units.",
    "Source": "Paeds EML (2023) Page 8.11"
  },
  {
    "Ref": "Paeds0016",
    "Questions": "What is the maximum single dose of Naloxone (IV) recommended for the reversal of opioid-induced respiratory depression (apnoea/respiratory depression) in a child?",
    "A": "0.002 mg",
    "B": "0.01 mg/kg (up to 0.4 mg)",
    "C": "0.01 mg/kg (up to 2 mg)",
    "D": "0.4 mg/kg (up to 5 mg)",
    "Answer": "B",
    "Comment": "For the reversal of apnoea/respiratory depression, the dose is Naloxone, IV, 0.01 mg/kg, repeated every 2 minutes, if required, up to 4 times, with a maximum dose of 0.4 mg.",
    "Source": "Paeds EML (2023) Page 22.16"
  },
  {
    "Ref": "Paeds0017",
    "Questions": "In the initial fluid management of Diabetic Ketoacidosis (DKA), which of the following is the most critical and potentially dangerous complication to monitor for, and what fluid is used for replacement?",
    "A": "Pulmonary oedema; 5% Dextrose Saline",
    "B": "Cerebral oedema; Normal Saline (0.9% NaCl)",
    "C": "Hypokalemia; Ringer's Lactate",
    "D": "Hyperglycemia; 0.45% Saline",
    "Answer": "B",
    "Comment": "The most feared complication is Cerebral Oedema. The guideline specifies a separate section for its management and notes that initial fluid replacement typically uses 0.9% Normal Saline.",
    "Source": "Paeds EML (2023) Page 7.18, 7.19"
  },
  {
    "Ref": "Paeds0018",
    "Questions": "Which statement best describes the use of oral iron therapy for the treatment of uncomplicated Iron Deficiency Anaemia in children?",
    "A": "Treatment should continue for 6 months after the haemoglobin level has normalised.",
    "B": "Treatment should continue for 3 months after the haemoglobin level has normalised.",
    "C": "Treatment should be stopped as soon as the haemoglobin level is within the normal range.",
    "D": "Treatment should be stopped after 3 months, irrespective of the haemoglobin level.",
    "Answer": "B",
    "Comment": "The guideline recommends continuing iron therapy for 3 months after the haemoglobin has normalised to ensure iron stores are replenished.",
    "Source": "Paeds EML (2023) Page 3.9"
  },
  {
    "Ref": "Paeds0019",
    "Questions": "What is the recommended duration of steroid therapy for a child newly diagnosed with steroid-sensitive Nephrotic Syndrome who is in the initial remission phase?",
    "A": "8 weeks total (4 weeks high dose, 4 weeks weaning)",
    "B": "12 weeks total (6 weeks high dose, 6 weeks weaning)",
    "C": "16 weeks total (8 weeks high dose, 8 weeks weaning)",
    "D": "6 months total (initial high dose, then alternate-day weaning)",
    "Answer": "D",
    "Comment": "The standard protocol for a first episode of steroid-sensitive nephrotic syndrome is a prolonged course, typically 6 months total, including an initial daily dose phase followed by a long alternate-day weaning schedule.",
    "Source": "Paeds EML (2023) Page 6.8"
  },
  {
    "Ref": "Paeds0020",
    "Questions": "What is the initial diagnostic and management approach recommended for an asymptomatic child with suspected ingestion of a caustic substance?",
    "A": "Urgent esophagogastroduodenoscopy (EGD) within 2 hours.",
    "B": "Administer activated charcoal and observe for 24 hours.",
    "C": "Monitor for symptom development; a 12-hour symptom-free period usually indicates no intervention is necessary.",
    "D": "Induce emesis and administer a proton pump inhibitor (PPI).",
    "Answer": "C",
    "Comment": "Asymptomatic patients are monitored, and a 12-hour symptom-free period is usually sufficient to rule out significant injury. EGD is typically reserved for symptomatic patients.",
    "Source": "Paeds EML (2023) Page 18.9"
  },
  {
    "Ref": "Paeds0021",
    "Questions": "In the management of HIV-exposed infants, when should a definitive virological test (e.g., HIV DNA PCR) be performed to exclude infection, provided the child has stopped breastfeeding for 6 weeks?",
    "A": "At birth, at 10 weeks, and at 6 months.",
    "B": "At 18 months, using an antibody test.",
    "C": "At 6 weeks post-cessation of all breastfeeding.",
    "D": "At 10 weeks of age, irrespective of feeding status.",
    "Answer": "C",
    "Comment": "The guideline specifies that a definitive diagnosis (test of cure) is typically performed at 6 weeks after cessation of all breastfeeding to account for the diagnostic window period.",
    "Source": "Paeds EML (2023) Page 9.3"
  },
  {
    "Ref": "Paeds0022",
    "Questions": "Which of the following is the primary non-drug measure recommended for the management of paediatric chronic cholestasis and liver disease?",
    "A": "High protein, low carbohydrate diet",
    "B": "Supplementation with water-soluble vitamins only",
    "C": "Supplementation with fat-soluble vitamins (A, D, E, K)",
    "D": "Fluid restriction and high sodium diet",
    "Answer": "C",
    "Comment": "Chronic cholestasis impairs the absorption of fat-soluble vitamins, necessitating routine supplementation of Vitamins A, D, E, and K.",
    "Source": "Paeds EML (2023) Page 2.28"
  },
  {
    "Ref": "Paeds0023",
    "Questions": "The use of what medication class is associated with the development of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrosis (TEN) and requires careful monitoring in a range of paediatric conditions, including epilepsy?",
    "A": "Non-steroidal anti-inflammatory drugs (NSAIDs)",
    "B": "Selective Serotonin Reuptake Inhibitors (SSRIs)",
    "C": "Aromatic anti-epileptic drugs (e.g., Carbamazepine, Phenytoin)",
    "D": "Angiotensin Converting Enzyme (ACE) Inhibitors",
    "Answer": "C",
    "Comment": "Aromatic anti-epileptic drugs are well-known to be high-risk for severe cutaneous adverse reactions like SJS/TEN. The guideline addresses SJS/TEN in Chapter 5.",
    "Source": "Paeds EML (2023) Page 5.5"
  },
  {
    "Ref": "Paeds0024",
    "Questions": "In a child requiring TB Preventive Therapy (TPT) for household exposure, what is the recommended duration of high-dose Isoniazid (INH) monotherapy for children under 5 years of age?",
    "A": "3 months",
    "B": "6 months",
    "C": "9 months",
    "D": "12 months",
    "Answer": "C",
    "Comment": "The standard TPT regimen for young children is 9 months of Isoniazid monotherapy. Shorter regimens are available for older children/adolescents in specific contexts.",
    "Source": "Paeds EML (2023) Page 10.18"
  },
  {
    "Ref": "Paeds0025",
    "Questions": "A 4-year-old child presents with a hypercyanotic spell (Tetralogy of Fallot spell). Which intervention is considered the most immediate non-pharmacological step to improve systemic vascular resistance (SVR) and reduce right-to-left shunting?",
    "A": "Administering 100% oxygen via a non-rebreather mask.",
    "B": "Placing the child in the knee-chest position.",
    "C": "Starting a continuous Prostaglandin E1 infusion.",
    "D": "Administering a fluid bolus of 20 mL/kg Normal Saline.",
    "Answer": "B",
    "Comment": "Placing the child in the knee-chest position increases SVR, which is a key mechanism for aborting a hypercyanotic spell.",
    "Source": "Paeds EML (2023) Page 4.6"
  },
  {
    "Ref": "Paeds0026",
    "Questions": "Which of the following is the hallmark pathological criterion for Acute Disseminated Encephalomyelitis (ADEM)?",
    "A": "Inflammation and demyelination in the central nervous system (CNS), typically monophasic.",
    "B": "Relapsing-remitting course with multiple sclerotic plaques in the CNS white matter.",
    "C": "Inflammation restricted to the peripheral nervous system (PNS) and nerve roots.",
    "D": "Primary neuronal loss in the basal ganglia.",
    "Answer": "A",
    "Comment": "ADEM is characterised by a monophasic demyelinating event, often following an infection or vaccination, distinguishing it from MS.",
    "Source": "Paeds EML (2023) Page 13.25"
  },
  {
    "Ref": "Paeds0027",
    "Questions": "In a child with known Duchenne Muscular Dystrophy (DMD), what is the primary purpose of early initiation of corticosteroid therapy (e.g., Prednisone or Deflazacort)?",
    "A": "To treat associated cardiac dysrhythmias.",
    "B": "To prevent respiratory tract infections.",
    "C": "To slow the progression of muscle weakness and prolong ambulation.",
    "D": "To prevent the development of cognitive impairment.",
    "Answer": "C",
    "Comment": "Corticosteroids are the standard of care for DMD to slow disease progression, preserve muscle strength, and prolong the ability to walk.",
    "Source": "Paeds EML (2023) Page 13.23"
  },
  {
    "Ref": "Paeds0028",
    "Questions": "What is the recommended maximum duration for which a high-risk child (e.g., child on chemotherapy) may be kept on IV Aciclovir for suspected acute viral Meningo-encephalitis/encephalitis if Herpes Simplex Virus (HSV) PCR results are still pending?",
    "A": "7 days",
    "B": "10 days",
    "C": "14 days",
    "D": "21 days",
    "Answer": "C",
    "Comment": "The guideline recommends continuing IV Aciclovir until the diagnosis is excluded. If HSV is confirmed, the total course is typically 14–21 days. If it's still uncertain/pending in a high-risk scenario, a full course is often necessary, but the empiric course is often up to 14 days before stopping if negative.",
    "Source": "Paeds EML (2023) Page 8.26"
  },
  {
    "Ref": "Paeds0029",
    "Questions": "Which diagnostic finding is essential to confirm the diagnosis of Active Rickets before initiating high-dose Vitamin D treatment (5000 IU daily)?",
    "A": "Elevated serum Alkaline Phosphatase (ALP) only.",
    "B": "Elevated serum Parathyroid Hormone (PTH) only.",
    "C": "Confirmation of active rickets on X-ray.",
    "D": "Low serum 25(OH)D levels only.",
    "Answer": "C",
    "Comment": "The guideline explicitly states: 'Treat only after confirmation of active rickets on X-ray'.",
    "Source": "Paeds EML (2023) Page 2.49"
  },
  {
    "Ref": "Paeds0030",
    "Questions": "In the management of chronic, maintenance Heart Failure (HF) in a child with a structural heart defect, which drug class is typically introduced AFTER optimising diuretic therapy (e.g., Furosemide)?",
    "A": "Angiotensin Receptor Blockers (ARBs)",
    "B": "Calcium Channel Blockers (CCBs)",
    "C": "Angiotensin Converting Enzyme (ACE) Inhibitors (e.g., Enalapril)",
    "D": "Digoxin (to improve contractility)",
    "Answer": "C",
    "Comment": "ACE Inhibitors are cornerstones of chronic HF management, typically added after initial stabilisation with diuretics, to reduce afterload and slow ventricular remodelling. Digoxin is added if symptoms persist.",
    "Source": "Paeds EML (2023) Page 4.22"
  },
  {
    "Ref": "Paeds0031",
    "Questions": "What is the specific type of imaging recommended for initial investigation of a child with suspected raised intracranial pressure (ICP) to look for signs of hydrocephalus or mass lesions prior to a diagnostic lumbar puncture?",
    "A": "CT scan of the head.",
    "B": "MRI scan of the brain with angiography.",
    "C": "Ultrasound of the head (if fontanelle is open).",
    "D": "Transcranial Doppler (TCD).",
    "Answer": "C",
    "Comment": "In infants with an open fontanelle, bedside ultrasound is often the first and safest imaging modality to assess for hydrocephalus, intraventricular haemorrhage, or masses prior to other invasive procedures or expensive scans.",
    "Source": "Paeds EML (2023) Page 13.30"
  },
  {
    "Ref": "Paeds0032",
    "Questions": "A 15-year-old boy is diagnosed with Tuberculous Meningitis (TBM). What is the recommended minimum duration of the initial intensive phase (multi-drug) treatment regimen for TBM?",
    "A": "2 months",
    "B": "4 months",
    "C": "6 months",
    "D": "12 months",
    "Answer": "A",
    "Comment": "The standard intensive phase for TBM is 2 months (with Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol, plus Corticosteroids), followed by a prolonged continuation phase.",
    "Source": "Paeds EML (2023) Page 10.13"
  },
  {
    "Ref": "Paeds0033",
    "Questions": "Which finding is the MOST concerning sign of a potential complication (e.g., cerebral oedema) in a child actively being treated for Diabetic Ketoacidosis (DKA)?",
    "A": "Persistent ketones in the urine.",
    "B": "Worsening headache, bradycardia, and hypertension.",
    "C": "A rapid fall in blood glucose from 40 mmol/L to 15 mmol/L.",
    "D": "Serum sodium level failing to rise with fall in glucose.",
    "Answer": "B",
    "Comment": "Worsening headache, a drop in heart rate (bradycardia), and an increase in blood pressure (hypertension) are part of Cushing's triad and are critical signs of cerebral oedema, a life-threatening complication of DKA.",
    "Source": "Paeds EML (2023) Page 7.18"
  },
  {
    "Ref": "Paeds0034",
    "Questions": "In a child with a history of Rheumatic Fever (RF) who presents with active carditis, what is the recommended primary drug for Secondary Prophylaxis to prevent recurrent RF episodes?",
    "A": "Oral Penicillin V (Phenoxymethylpenicillin)",
    "B": "Intramuscular Benzathine Penicillin G",
    "C": "Oral Sulfadiazine",
    "D": "Oral Clarithromycin",
    "Answer": "B",
    "Comment": "Intramuscular Benzathine Penicillin G (typically every 3-4 weeks) is the gold standard for secondary RF prophylaxis due to superior adherence and guaranteed drug levels.",
    "Source": "Paeds EML (2023) Page 4.13"
  },
  {
    "Ref": "Paeds0035",
    "Questions": "For a child presenting with Acute Kidney Injury (AKI) due to severe dehydration (pre-renal), what is the key therapeutic difference compared to AKI from intrinsic renal causes (e.g., Acute Tubular Necrosis)?",
    "A": "Pre-renal AKI requires urgent fluid boluses (20 mL/kg), while intrinsic AKI requires fluid restriction.",
    "B": "Pre-renal AKI requires high-dose IV corticosteroids, while intrinsic AKI requires dialysis.",
    "C": "Pre-renal AKI requires furosemide challenge, while intrinsic AKI requires fluid boluses.",
    "D": "Pre-renal AKI requires urgent blood transfusion, while intrinsic AKI requires IV antibiotics.",
    "Answer": "A",
    "Comment": "The cornerstone of pre-renal AKI management is volume expansion with fluid boluses to restore renal perfusion. Intrinsic AKI often requires fluid management with restriction to prevent volume overload.",
    "Source": "Paeds EML (2023) Page 6.15"
  },
  {
    "Ref": "Paeds0036",
    "Questions": "What is the recommended initial management for a child presenting with a mild, acute asthma attack who is able to tolerate oral medication?",
    "A": "Inhaled high-dose Corticosteroids and systemic Prednisone.",
    "B": "Inhaled short-acting beta-agonists (SABAs) alone.",
    "C": "Continuous nebulised SABA (e.g., Salbutamol) and IV Magnesium Sulfate.",
    "D": "Inhaled SABA, Inhaled Corticosteroid, and a short course of oral Corticosteroids.",
    "Answer": "D",
    "Comment": "Management of an acute attack requires SABA, and typically a short course of oral corticosteroids (e.g., Prednisone) is added for all but the mildest attacks to reduce inflammation.",
    "Source": "Paeds EML (2023) Page 15.18"
  },
  {
    "Ref": "Paeds0037",
    "Questions": "A 1-year-old child presents with a first-time febrile seizure. Which is the MOST critical intervention in the immediate post-seizure period?",
    "A": "Administering a loading dose of Phenytoin to prevent recurrence.",
    "B": "Initiating a maintenance dose of oral Diazepam for the duration of the fever.",
    "C": "Identifying the source of the fever and ruling out a central nervous system (CNS) infection.",
    "D": "Sending the child home with a diagnosis of simple febrile seizure.",
    "Answer": "C",
    "Comment": "The priority in a first febrile seizure is to rule out serious underlying pathology, particularly meningitis/encephalitis, by performing a thorough physical exam and potentially a lumbar puncture if red flags exist.",
    "Source": "Paeds EML (2023) Page 13.4"
  },
  {
    "Ref": "Paeds0038",
    "Questions": "Which of the following conditions is explicitly listed as warranting a **High** dose of corticosteroids in the management of Acute Rheumatic Fever (RF)?",
    "A": "RF with no carditis.",
    "B": "RF with mild carditis (only diastolic murmur).",
    "C": "RF with moderate carditis (mitral regurgitation).",
    "D": "RF with severe carditis and Heart Failure (HF).",
    "Answer": "D",
    "Comment": "Corticosteroids are reserved for patients with severe carditis and/or associated Heart Failure (HF) that is unresponsive to conventional HF therapy. Milder cases only require salicylate (e.g., Aspirin) therapy.",
    "Source": "Paeds EML (2023) Page 4.13"
  },
  {
    "Ref": "Paeds0039",
    "Questions": "In a child being treated for Severe Acute Malnutrition (SAM), what is the primary initial dietary intervention during the stabilisation phase to prevent refeeding syndrome and cardiac failure?",
    "A": "High protein, low carbohydrate diet.",
    "B": "A low-osmolarity, low sodium, low protein, and high energy feed (e.g., F-75 formula).",
    "C": "Immediate introduction of a high-energy, high-protein rehabilitation feed (e.g., F-100 formula).",
    "D": "Total Parenteral Nutrition (TPN).",
    "Answer": "B",
    "Comment": "The stabilisation phase requires cautious, low-osmolarity feeds (F-75 is a standard) to manage fluid and electrolyte shifts and avoid overwhelming the compromised cardiovascular system.",
    "Source": "Paeds EML (2023) Page 2.37"
  },
  {
    "Ref": "Paeds0040",
    "Questions": "What is the recommended duration of empiric antibiotic therapy for Neonatal Sepsis (early or late onset) if all cultures (blood, CSF, urine) remain negative and the child is clinically well?",
    "A": "Stop antibiotics after 48 hours.",
    "B": "Stop antibiotics after 7 days.",
    "C": "Stop antibiotics after 72 hours.",
    "D": "Continue antibiotics for a full 14-day course.",
    "Answer": "A",
    "Comment": "If a neonate is clinically well, and all cultures are negative, antibiotics can usually be discontinued after a 48-hour observation period, thus limiting antibiotic exposure.",
    "Source": "Paeds EML (2023) Page 19.33 (Neonatal Infections)"
  },
  {
    "Ref": "Paeds0041",
    "Questions": "In the management of Acute Hyperkalaemia (potassium > 6.5 mmol/L or any level with ECG changes), what is the first-line membrane-stabilising agent to prevent life-threatening cardiac dysrhythmias?",
    "A": "Furosemide",
    "B": "Intravenous Calcium Gluconate (or Chloride)",
    "C": "Insulin/Glucose infusion",
    "D": "Salbutamol nebulisation",
    "Answer": "B",
    "Comment": "Calcium is the immediate life-saving treatment to stabilise the myocardial membrane and counteract the effects of high potassium on the heart, given first before agents that shift potassium intracellularly (e.g., Insulin/Glucose).",
    "Source": "Paeds EML (2023) Page 7.35"
  },
  {
    "Ref": "Paeds0042",
    "Questions": "Which investigation is considered mandatory in the initial workup of a child presenting with Acute Lymphoblastic Leukaemia (ALL)?",
    "A": "Lumbar Puncture (LP) for CSF cytology and pressure measurement.",
    "B": "Bone scan to look for lytic lesions.",
    "C": "CT scan of the abdomen to assess for splenic rupture.",
    "D": "Urine analysis for tumour lysis syndrome markers.",
    "Answer": "A",
    "Comment": "A diagnostic LP is essential in ALL workup to determine CNS involvement, which dictates staging and subsequent treatment intensity (CNS-directed therapy).",
    "Source": "Paeds EML (2023) Page 24.1 (Oncology)"
  },
  {
    "Ref": "Paeds0043",
    "Questions": "In a child with newly diagnosed Kawasaki Disease (KD), what is the recommended primary treatment regimen to reduce the risk of coronary artery aneurysms?",
    "A": "High-dose Aspirin only.",
    "B": "Intravenous Immunoglobulin (IVIG) and high-dose Aspirin.",
    "C": "Intravenous Methylprednisolone and low-dose Aspirin.",
    "D": "Plasmapheresis and Warfarin.",
    "Answer": "B",
    "Comment": "The cornerstone of KD treatment is IVIG, given early (within 10 days of onset), combined with high-dose Aspirin (initially anti-inflammatory dose, then anti-platelet dose).",
    "Source": "Paeds EML (2023) Page 12.7"
  },
  {
    "Ref": "Paeds0044",
    "Questions": "Which clinical feature, when present with a cough and tachypnoea, distinguishes severe pneumonia from non-severe pneumonia in a child?",
    "A": "Lower chest wall indrawing (or retraction).",
    "B": "Nasal flaring.",
    "C": "Fever > 39°C.",
    "D": "Crying during the examination.",
    "Answer": "A",
    "Comment": "Lower chest wall indrawing/retraction is the single most important clinical sign of severe pneumonia and is an indication for hospital admission and parenteral antibiotics, according to WHO/IMCI criteria adapted in the guideline.",
    "Source": "Paeds EML (2023) Page 15.1"
  },
  {
    "Ref": "Paeds0045",
    "Questions": "A 7-year-old child presents with painless, macroscopic haematuria one week after a severe pharyngitis episode. Which nephrological condition is most likely and requires supportive care as the mainstay of treatment?",
    "A": "IgA Nephropathy (Berger's Disease).",
    "B": "Minimal Change Disease (MCD).",
    "C": "Post-Streptococcal Glomerulonephritis (PSGN).",
    "D": "Membranoproliferative Glomerulonephritis (MPGN).",
    "Answer": "C",
    "Comment": "The classic presentation of PSGN is a child with haematuria (dark/smoky urine) 1-3 weeks post-streptococcal infection. Management is largely supportive, including BP control and fluid balance.",
    "Source": "Paeds EML (2023) Page 6.1"
  },
  {
    "Ref": "Paeds0046",
    "Questions": "For a child on an antiretroviral therapy (ART) regimen who develops new-onset seizures, which antiepileptic drug (AED) should be avoided due to significant, well-documented drug-drug interactions (DDI) involving cytochrome P450 induction, potentially leading to ART failure?",
    "A": "Levetiracetam",
    "B": "Sodium Valproate",
    "C": "Phenytoin",
    "D": "Ethosuximide",
    "Answer": "C",
    "Comment": "Potent enzyme-inducing AEDs (like Phenytoin, Carbamazepine, Phenobarbitone) significantly lower the concentration of many ARVs (especially protease inhibitors and NNRTIs), risking virological failure. Levetiracetam and Valproate are preferred due to minimal DDI.",
    "Source": "Paeds EML (2023) Page 13.14"
  },
  {
    "Ref": "Paeds0047",
    "Questions": "In a child diagnosed with severe hypertension (Acute Severe Hypertension, ASH), what is the maximum recommended *initial* percentage reduction in mean arterial pressure (MAP) to avoid cerebral hypoperfusion and stroke?",
    "A": "25% over the first hour.",
    "B": "50% over the first hour.",
    "C": "10% over the first 24 hours.",
    "D": "35% over the first 6 hours.",
    "Answer": "A",
    "Comment": "The goal in ASH management is a controlled reduction of MAP, typically 20-25% reduction over the first 6-8 hours, with an initial goal of 25% reduction in the first 8 hours to prevent severe complications like posterior reversible encephalopathy syndrome (PRES).",
    "Source": "Paeds EML (2023) Page 4.35"
  },
  {
    "Ref": "Paeds0048",
    "Questions": "Which anti-inflammatory agent is the first-line systemic treatment for a child presenting with acute Rheumatic Fever (RF) who only has polyarthritis but no signs of carditis?",
    "A": "Prednisone (systemic corticosteroids).",
    "B": "High-dose Aspirin (Salicylate).",
    "C": "Colchicine.",
    "D": "Methotrexate.",
    "Answer": "B",
    "Comment": "For RF without carditis, high-dose Aspirin is the anti-inflammatory drug of choice. Corticosteroids are reserved for cases with severe carditis.",
    "Source": "Paeds EML (2023) Page 4.13"
  },
  {
    "Ref": "Paeds0049",
    "Questions": "What is the primary management for a child presenting with Acute Hypoglycaemia (blood glucose < 2.5 mmol/L) who is conscious and able to swallow?",
    "A": "Intravenous Dextrose 10% (0.2 g/kg bolus).",
    "B": "Intramuscular Glucagon.",
    "C": "Oral Glucose or a carbohydrate-rich drink.",
    "D": "50% Dextrose (1 mL/kg bolus).",
    "Answer": "C",
    "Comment": "The most appropriate treatment for a conscious child is oral glucose/carbohydrate. IV Dextrose or IM Glucagon is reserved for unconscious children or those unable to swallow.",
    "Source": "Paeds EML (2023) Page 7.31"
  },
  {
    "Ref": "Paeds0050",
    "Questions": "In the initial management of a child with severe burns (>10% TBSA), what is the most critical element of fluid resuscitation in the first 8 hours post-burn?",
    "A": "Administering a colloid-based solution (e.g., Albumin).",
    "B": "Administering the first half of the total 24-hour calculated fluid volume.",
    "C": "Administering the entire total 24-hour calculated fluid volume.",
    "D": "Giving 20 mL/kg fluid bolus, repeated as needed.",
    "Answer": "B",
    "Comment": "The Parkland formula (or similar) dictates that half of the total 24-hour fluid requirement should be administered over the first 8 hours post-burn, with the remaining half over the subsequent 16 hours. Ringer's Lactate is the preferred fluid.",
    "Source": "Paeds EML (2023) Page 1.22"
  },
  {
    "Ref": "Paeds0051",
    "Questions": "Which clinical scenario represents an absolute indication for emergency Intravenous Immunoglobulin (IVIG) in a child presenting with Immune Thrombocytopaenic Purpura (ITP)?",
    "A": "Platelet count < 10 x 10⁹/L and minimal bruising.",
    "B": "Platelet count < 50 x 10⁹/L and persistent petechiae.",
    "C": "Any platelet count with evidence of severe, life-threatening bleeding (e.g., intracranial haemorrhage).",
    "D": "Platelet count < 20 x 10⁹/L that fails to spontaneously improve after 48 hours.",
    "Answer": "C",
    "Comment": "Treatment for ITP is generally based on bleeding severity, not just the platelet count. IVIG/corticosteroids are indicated for severe bleeding (e.g., intracranial, major GI, or retinal haemorrhage) irrespective of the platelet count.",
    "Source": "Paeds EML (2023) Page 3.16"
  },
  {
    "Ref": "Paeds0052",
    "Questions": "Which of the following is NOT an investigation recommended for a child with suspected raised intracranial pressure (ICP)?",
    "A": "Fundoscopy to look for papilloedema.",
    "B": "Neuroimaging (CT/MRI) before Lumbar Puncture.",
    "C": "Lumbar Puncture (LP) for pressure measurement and CSF analysis.",
    "D": "Routine administration of Mannitol before imaging.",
    "Answer": "D",
    "Comment": "Mannitol/Hypertonic Saline should be reserved for confirmed or highly suspected cerebral oedema, not administered routinely before diagnosis/imaging. The other three are essential diagnostic steps.",
    "Source": "Paeds EML (2023) Page 13.30"
  },
  {
    "Ref": "Paeds0053",
    "Questions": "In the management of Chronic Hepatitis B in children, which criterion MUST be met before initiating Antiviral Therapy (ART)?",
    "A": "Serum HBsAg positive for less than 6 months.",
    "B": "Low viral load (HBV DNA < 2000 IU/mL).",
    "C": "Evidence of significant liver fibrosis, inflammation, or cirrhosis.",
    "D": "Concurrent diagnosis of Chronic Hepatitis C.",
    "Answer": "C",
    "Comment": "Treatment for chronic Hep B is generally reserved for active liver disease, demonstrated by high viral load, elevated ALT/AST, and evidence of significant liver damage (fibrosis/cirrhosis) on biopsy or non-invasive markers.",
    "Source": "Paeds EML (2023) Page 2.31"
  },
  {
    "Ref": "Paeds0054",
    "Questions": "The use of which drug is indicated for the treatment of severe, non-motor symptoms associated with paediatric Behavioural Problems in Intellectual Disability, at the lowest effective dose?",
    "A": "Fluoxetine (SSRI)",
    "B": "Risperidone (Atypical Antipsychotic)",
    "C": "Methylphenidate (Stimulant)",
    "D": "Clonidine (Alpha-agonist)",
    "Answer": "B",
    "Comment": "Risperidone is specifically mentioned for use in severe behavioural problems (e.g., aggression, self-injurious behaviour) associated with intellectual disability, after non-pharmacological methods have failed.",
    "Source": "Paeds EML (2023) Page 14.40"
  },
  {
    "Ref": "Paeds0055",
    "Questions": "In a patient presenting with severe Hypothyroidism in older children and adolescents, which monitoring parameter is essential to titrate the Levothyroxine dose and should be checked 4-6 weeks after each dose adjustment?",
    "A": "TSH (Thyroid-Stimulating Hormone).",
    "B": "Free T3 and T4 levels.",
    "C": "Serum Cholesterol.",
    "D": "Basal Metabolic Rate (BMR).",
    "Answer": "A",
    "Comment": "TSH is the primary parameter used for monitoring and dose titration in both congenital and acquired hypothyroidism, aiming to keep it within the normal range for age.",
    "Source": "Paeds EML (2023) Page 7.38"
  },
  {
    "Ref": "Paeds0056",
    "Questions": "Which of the following is the most definitive clinical diagnostic criterion for Chronic Suppurative Otitis Media (CSOM)?",
    "A": "Recurrent episodes of acute Otitis Media (AOM) treated with antibiotics.",
    "B": "Persistent fever and otalgia despite 2 weeks of antibiotic therapy.",
    "C": "Chronic, painless discharge from the ear through a persistent tympanic membrane perforation (for > 2 weeks).",
    "D": "Evidence of Retropharyngeal Abscess on imaging.",
    "Answer": "C",
    "Comment": "CSOM is defined by chronic (usually > 2 weeks) ear discharge through a persistent perforation, as opposed to AOM or Otitis Media with Effusion (OME).",
    "Source": "Paeds EML (2023) Page 17.9"
  },
  {
    "Ref": "Paeds0057",
    "Questions": "The diagnosis of Takayasu Arteritis (TA) in children relies on specific criteria, often requiring angiography. Which of the following is a key feature of TA?",
    "A": "Aneurysmal dilatation of the abdominal aorta and renal arteries.",
    "B": "Aortic coarctation and aortic valve disease.",
    "C": "Granulomatous inflammation leading to stenosis/occlusion of the aorta and its major branches.",
    "D": "Small vessel vasculitis primarily affecting the lungs and kidneys.",
    "Answer": "C",
    "Comment": "TA is a chronic, large-vessel vasculitis of the aorta and its branches, leading to stenosis, occlusion, or sometimes aneurysms, often resulting in blood pressure discrepancies/pulseless disease.",
    "Source": "Paeds EML (2023) Page 12.11"
  },
  {
    "Ref": "Paeds0058",
    "Questions": "In the management of Severe Acute Malnutrition (SAM), what is the key therapeutic component added to the F-75 feed during the initial stabilisation phase to address the associated electrolyte disturbances?",
    "A": "Potassium and Magnesium supplementation.",
    "B": "Aggressive Sodium loading.",
    "C": "Bicarbonate for acidosis.",
    "D": "High-dose Calcium infusions.",
    "Answer": "A",
    "Comment": "Children with SAM are invariably potassium and magnesium depleted, which is managed by routine supplementation with these electrolytes during stabilisation, as they are crucial for cardiac function and metabolism.",
    "Source": "Paeds EML (2023) Page 2.37"
  },
  {
    "Ref": "Paeds0059",
    "Questions": "Which of the following is the most important clinical sign to look for in a patient with a head injury, suggestive of severe Traumatic Brain Injury (TBI) and necessitating urgent neurosurgical consultation?",
    "A": "Single episode of vomiting.",
    "B": "Post-traumatic headache.",
    "C": "GCS score of 13-15 with no loss of consciousness.",
    "D": "Evidence of neurological deterioration (e.g., progressive decrease in GCS, pupillary changes).",
    "Answer": "D",
    "Comment": "Progressive neurological deterioration, including a decrease in GCS or the development of focal neurological signs (e.g., fixed/dilated pupil), is the most critical sign of severe TBI requiring immediate intervention.",
    "Source": "Paeds EML (2023) Page 1.30"
  },
  {
    "Ref": "Paeds0060",
    "Questions": "What is the recommended approach to antibiotic prophylaxis for a child with a prosthetic heart valve prior to an invasive dental procedure?",
    "A": "No prophylaxis is necessary, only meticulous oral hygiene.",
    "B": "Oral Amoxicillin (or Clindamycin if penicillin allergic) one hour before the procedure.",
    "C": "Intravenous Vancomycin one hour before the procedure.",
    "D": "Oral Clindamycin for 3 days starting the day before the procedure.",
    "Answer": "B",
    "Comment": "Children with prosthetic valves are high-risk for Infective Endocarditis and require a single prophylactic dose of antibiotics (Amoxicillin or alternative) before high-risk procedures like dental extractions.",
    "Source": "Paeds EML (2023) Page 4.38"
  },
  {
    "Ref": "Paeds0061",
    "Questions": "In a child with known Von Willebrand Disease (VWD) type 1 presenting with moderate epistaxis refractory to local measures, which medication is the standard first-line therapy?",
    "A": "Factor VIII concentrate.",
    "B": "Intramuscular Vitamin K.",
    "C": "Desmopressin (DDAVP).",
    "D": "Platelet transfusion.",
    "Answer": "C",
    "Comment": "Desmopressin (DDAVP) is the mainstay of treatment for VWD type 1 (and some type 2 variants) as it stimulates the release of stored VWF from endothelial cells, improving secondary haemostasis.",
    "Source": "Paeds EML (2023) Page 3.15"
  },
  {
    "Ref": "Paeds0062",
    "Questions": "Which management step is considered an absolute contraindication during the acute phase of a patient with suspected or confirmed Acute Bacterial Meningitis (ABM) until the infection is excluded, especially if a mass lesion is suspected?",
    "A": "Administration of high-dose Dexamethasone.",
    "B": "Obtaining a blood culture.",
    "C": "Performing a Lumbar Puncture (LP).",
    "D": "Initiating empiric broad-spectrum antibiotics.",
    "Answer": "C",
    "Comment": "A Lumbar Puncture is relatively contraindicated if signs of increased ICP (e.g., papilloedema) are present, as it risks cerebral herniation. Empiric antibiotics must be started immediately while imaging (CT scan) is arranged.",
    "Source": "Paeds EML (2023) Page 8.20"
  },
  {
    "Ref": "Paeds0063",
    "Questions": "In the context of palliative care for chronic renal failure, which anti-emetic is generally preferred due to its broad anti-dopaminergic effect and its minimal interaction with opioids?",
    "A": "Metoclopramide",
    "B": "Ondansetron",
    "C": "Domperidone",
    "D": "Haloperidol",
    "Answer": "B",
    "Comment": "While Metoclopramide is often used, its pro-kinetic effect and risk of extrapyramidal symptoms can be problematic in chronic/palliative care. Ondansetron (a 5-HT3 antagonist) is often preferred for broad spectrum use in chronic conditions, with Haloperidol reserved for refractory cases (e.g., high opioid load).",
    "Source": "Paeds EML (2023) Page 21.4"
  },
  {
    "Ref": "Paeds0064",
    "Questions": "For an infant diagnosed with Congenital Hypothyroidism, when should Levothyroxine replacement therapy ideally be initiated to prevent permanent neurodevelopmental impairment?",
    "A": "Within the first 12 months of life.",
    "B": "After 6 months of age, once all screening tests are confirmed.",
    "C": "Immediately upon diagnosis, ideally within the first 2 weeks of life.",
    "D": "Only when clinical signs of cretinism become evident.",
    "Answer": "C",
    "Comment": "Early detection via newborn screening and immediate initiation of Levothyroxine (ideally within 2 weeks) is critical for preventing irreversible intellectual disability.",
    "Source": "Paeds EML (2023) Page 7.37"
  },
  {
    "Ref": "Paeds0065",
    "Questions": "What is the recommended first-line treatment for a child presenting with Acute Otitis Media (AOM) who has no specific risk factors or complications?",
    "A": "Observation only, with Ibuprofen/Paracetamol for pain (initial watchful waiting).",
    "B": "Oral Amoxicillin for 10 days.",
    "C": "Oral Amoxicillin-Clavulanate for 7 days.",
    "D": "A single dose of IM Ceftriaxone.",
    "Answer": "A",
    "Comment": "For uncomplicated AOM, initial watchful waiting with pain management is recommended, reserving antibiotics for cases that fail to improve or for high-risk patients (e.g., < 6 months, severe symptoms).",
    "Source": "Paeds EML (2023) Page 17.7"
  },
  {
    "Ref": "Paeds0066",
    "Questions": "Which of the following is the most likely pathogen to cause Acute Bacterial Tracheitis (ABT) in a child, as noted in the guideline?",
    "A": "*Haemophilus influenzae* type B.",
    "B": "*Streptococcus pyogenes* (Group A Strep).",
    "C": "*Staphylococcus aureus*.",
    "D": "*Moraxella catarrhalis*.",
    "Answer": "C",
    "Comment": "The guideline specifically states that ABT is 'Commonly due to S. aureus.'",
    "Source": "Paeds EML (2023) Page 17.4"
  },
  {
    "Ref": "Paeds0067",
    "Questions": "What is the primary management for a neonate diagnosed with Hypoxic-Ischemic Encephalopathy (HIE) who meets criteria for therapeutic hypothermia, as outlined in the perinatal guidelines?",
    "A": "Aggressive fluid resuscitation with plasma expanders.",
    "B": "Strict seizure control with Phenytoin and Phenobarbitone.",
    "C": "Controlled whole-body or selective head cooling to 33-34°C for 72 hours.",
    "D": "Immediate high-dose systemic corticosteroid therapy.",
    "Answer": "C",
    "Comment": "Therapeutic hypothermia (cooling) is the standard of care for term/near-term neonates with moderate-to-severe HIE who meet specific criteria, as it reduces neuronal injury.",
    "Source": "Paeds EML (2023) Page 19.42"
  },
  {
    "Ref": "Paeds0068",
    "Questions": "Which of the following is a key feature of the systemic manifestations seen in a child with Multisystem Inflammatory Syndrome in Children (MIS-C) related to COVID-19?",
    "A": "Isolated, severe respiratory distress requiring mechanical ventilation.",
    "B": "Persistent fever with evidence of inflammation and multi-organ dysfunction (e.g., shock, cardiac involvement).",
    "C": "Chronic, relapsing polyarthritis and uveitis.",
    "D": "Haemolytic anaemia and acute renal failure (Atypical HUS).",
    "Answer": "B",
    "Comment": "MIS-C is characterised by persistent fever, elevated inflammatory markers, and evidence of dysfunction in two or more organ systems (e.g., cardiac, renal, gastrointestinal, neurological).",
    "Source": "Paeds EML (2023) Page 8.54"
  },
  {
    "Ref": "Paeds0069",
    "Questions": "A child on the second-line Antiretroviral Therapy (ART) regimen is diagnosed with new-onset Drug-Resistant TB (DR-TB). The management of this child is primarily complicated by which factor?",
    "A": "Antiretroviral drugs cannot be taken with TB drugs.",
    "B": "The risk of immune reconstitution inflammatory syndrome (IRIS).",
    "C": "Significant drug-drug interactions between DR-TB medications (e.g., Bedaquiline) and ARVs.",
    "D": "The need to discontinue all ART while on DR-TB treatment.",
    "Answer": "C",
    "Comment": "Managing co-infection requires expert consultation due to severe drug-drug interactions, particularly between the newer DR-TB agents (e.g., Bedaquiline, Delamanid) and the ART regimen (e.g., Protease Inhibitors or NNRTIs).",
    "Source": "Paeds EML (2023) Page 9.2, 10.19"
  },
  {
    "Ref": "Paeds0070",
    "Questions": "Which of the following is the most appropriate first-line oral anti-hypertensive agent for the chronic maintenance therapy of essential (primary) hypertension in an adolescent boy?",
    "A": "Angiotensin Converting Enzyme (ACE) Inhibitor (e.g., Enalapril).",
    "B": "Spironolactone (Potassium-sparing diuretic).",
    "C": "Atenolol (Beta-blocker).",
    "D": "Nifedipine (Calcium Channel Blocker).",
    "Answer": "A",
    "Comment": "ACE inhibitors are generally well-tolerated and effective first-line agents for chronic essential hypertension in non-pregnant adolescents, often preferred for their renal protective effects.",
    "Source": "Paeds EML (2023) Page 4.36"
  },
  {
    "Ref": "Paeds0071",
    "Questions": "For a child presenting with Acute Viral Meningo-encephalitis/encephalitis, which medication should be initiated empirically while awaiting viral studies, given its efficacy against the most common treatable cause?",
    "A": "Ganciclovir (for CMV).",
    "B": "Ribavirin (for RSV).",
    "C": "Aciclovir (for HSV).",
    "D": "Oseltamivir (for Influenza).",
    "Answer": "C",
    "Comment": "Empiric Aciclovir is mandatory for all children with suspected encephalitis until HSV is ruled out, as delayed treatment for HSV encephalitis results in high mortality and severe morbidity.",
    "Source": "Paeds EML (2023) Page 8.26"
  },
  {
    "Ref": "Paeds0072",
    "Questions": "What is the recommended first-line diagnostic modality for a neonate or young infant with suspected Gastro-oesophageal Reflux Disease (GORD) causing respiratory symptoms and feeding difficulties?",
    "A": "Barium Swallow/Upper GI Series.",
    "B": "24-hour oesophageal pH monitoring.",
    "C": "Empiric trial of thickened feeds and positional therapy.",
    "D": "Upper GI endoscopy with biopsy.",
    "Answer": "C",
    "Comment": "GORD is a clinical diagnosis in infants, and the first-line management involves non-pharmacological measures like thickened feeds and positional changes. Diagnostic tests (Barium swallow, pH probe) are usually reserved for refractory cases or to rule out other causes.",
    "Source": "Paeds EML (2023) Page 2.24"
  },
  {
    "Ref": "Paeds0073",
    "Questions": "In a child with a severe Tetanus infection, what is the role of Tetanus Immunoglobulin (TIG) administration in the immediate management?",
    "A": "TIG is administered to neutralise circulating, unbound Tetanus toxin.",
    "B": "TIG is administered to treat the established muscle spasms.",
    "C": "TIG is administered to provide active, long-lasting immunity.",
    "D": "TIG is administered to treat secondary bacterial infection at the wound site.",
    "Answer": "A",
    "Comment": "TIG provides passive immunity by neutralising any circulating or unbound toxin. It must be administered before or concurrent with debridement. It does not treat established neurological effects.",
    "Source": "Paeds EML (2023) Page 8.34"
  },
  {
    "Ref": "Paeds0074",
    "Questions": "A child is diagnosed with Chronic Diarrhoea, non-infectious in origin, and is losing weight. Which diagnostic investigation is essential to rule out Cystic Fibrosis (CF) as a cause?",
    "A": "Stool microscopy for fat globules.",
    "B": "Coeliac serology (Anti-tTG).",
    "C": "Sweat Chloride Test.",
    "D": "Colonoscopy with biopsy.",
    "Answer": "C",
    "Comment": "The Sweat Chloride Test remains the gold standard screening test for CF, which can present with chronic diarrhoea and failure to thrive due to pancreatic insufficiency.",
    "Source": "Paeds EML (2023) Page 2.7"
  },
  {
    "Ref": "Paeds0075",
    "Questions": "Which haematological condition is primarily treated with splenectomy in severe, refractory cases, but typically first managed with IVIG and/or high-dose corticosteroids?",
    "A": "Haemophilia A.",
    "B": "Iron Deficiency Anaemia.",
    "C": "Immune Thrombocytopaenic Purpura (ITP).",
    "D": "Thalassaemia Major.",
    "Answer": "C",
    "Comment": "ITP is an acquired bleeding disorder where antibodies destroy platelets. Splenectomy is a treatment option for refractory, severe chronic ITP cases after failure of medical therapies (IVIG, steroids).",
    "Source": "Paeds EML (2023) Page 3.16"
  },
  {
    "Ref": "Paeds0076",
    "Questions": "In the management of Severe Acute Malnutrition (SAM), what is the correct time to introduce the rehabilitation phase feeds (e.g., F-100 formula)?",
    "A": "Immediately upon admission to aggressively treat weight loss.",
    "B": "Only after the child has recovered appetite, no signs of infection, and oedema has resolved (Stabilisation phase complete).",
    "C": "Only after serum albumin has normalized.",
    "D": "48 hours after admission, irrespective of clinical stability.",
    "Answer": "B",
    "Comment": "The rehabilitation phase (with higher energy/protein feeds like F-100) must only be initiated after the critical stabilisation phase is complete, which includes resolution of shock, correction of electrolytes, and return of appetite.",
    "Source": "Paeds EML (2023) Page 2.37"
  },
  {
    "Ref": "Paeds0077",
    "Questions": "A child with Type 1 Diabetes Mellitus (T1DM) requires management of Dyslipidaemia (high LDL cholesterol). At what age is initiation of statin therapy generally considered, provided lifestyle and dietary changes have failed?",
    "A": "At diagnosis of T1DM, irrespective of age.",
    "B": "Only after 18 years of age.",
    "C": "Typically after 10 years of age.",
    "D": "Only if there are associated macrovascular complications.",
    "Answer": "C",
    "Comment": "While primary management is lifestyle, for persistent dyslipidaemia, statin therapy may be considered in children typically over 10 years of age, especially those with other cardiovascular risk factors.",
    "Source": "Paeds EML (2023) Page 7.26"
  },
  {
    "Ref": "Paeds0078",
    "Questions": "Which of the following conditions is an absolute contraindication to the use of a combination vaccine containing Pertussis (whooping cough)?",
    "A": "History of mild local reaction to a previous dose.",
    "B": "History of a simple febrile seizure after a previous dose.",
    "C": "History of encephalopathy not attributable to another cause within 7 days of a previous dose.",
    "D": "History of documented cow's milk protein allergy.",
    "Answer": "C",
    "Comment": "A severe neurological reaction (encephalopathy) not otherwise explained, occurring within 7 days of a previous dose, is a contraindication to subsequent doses of the Pertussis containing vaccine.",
    "Source": "Paeds EML (2023) Page 8.29"
  },
  {
    "Ref": "Paeds0079",
    "Questions": "In the management of a child with Systemic Lupus Erythematosus (SLE) and active Lupus Nephritis (Class III/IV), what is the recommended initial combination immunosuppressive therapy?",
    "A": "Hydroxychloroquine monotherapy.",
    "B": "Cyclophosphamide or Mycophenolate Mofetil (MMF) combined with high-dose corticosteroids.",
    "C": "Rituximab monotherapy.",
    "D": "Methotrexate and low-dose Prednisone.",
    "Answer": "B",
    "Comment": "Active Lupus Nephritis requires aggressive immunosuppression, typically high-dose corticosteroids combined with either Cyclophosphamide (for induction) or Mycophenolate Mofetil (for induction or maintenance).",
    "Source": "Paeds EML (2023) Page 12.9"
  },
  {
    "Ref": "Paeds0080",
    "Questions": "What is the recommended long-term prophylaxis for a child with severe Haemophilia A?",
    "A": "Weekly Factor VIII concentrate infusions.",
    "B": "On-demand Factor VIII concentrate infusions only for bleeds.",
    "C": "Monthly administration of tranexamic acid.",
    "D": "Daily oral Desmopressin (DDAVP).",
    "Answer": "A",
    "Comment": "The standard of care for severe Haemophilia A is regular (often 2-3 times weekly or weekly) prophylactic infusions of Factor VIII concentrate to prevent spontaneous joint bleeds and long-term joint damage.",
    "Source": "Paeds EML (2023) Page 3.12"
  },
  {
    "Ref": "Paeds0081",
    "Questions": "Which of the following is an early clinical sign of Spinal Cord Compression in a child with a known malignancy in the palliative care setting?",
    "A": "Positive Lhermitte’s sign (electric shock-like pain on neck flexion).",
    "B": "Complete paraplegia of the lower limbs.",
    "C": "Complete loss of bladder and bowel function.",
    "D": "Fixed, dilated pupils.",
    "Answer": "A",
    "Comment": "Lhermitte’s sign and a change in the nature of long-standing pain are important early signs of compression. Paraplegia and incontinence are late signs.",
    "Source": "Paeds EML (2023) Page 21.19"
  },
  {
    "Ref": "Paeds0082",
    "Questions": "In the management of chronic constipation, what is the role of a hypertonic phosphate enema in children?",
    "A": "First-line maintenance therapy for all children.",
    "B": "First-line therapy for faecal disimpaction (faecal loading).",
    "C": "A contraindication in children due to risk of electrolyte derangement.",
    "D": "Reserved for faecal disimpaction only if oral options (e.g., Movicol) fail.",
    "Answer": "D",
    "Comment": "Phosphate enemas are generally reserved for difficult faecal disimpaction after oral agents have failed, as they carry a risk of electrolyte disturbances (hyperphosphatemia, hypocalcemia), especially in younger or fluid-restricted children.",
    "Source": "Paeds EML (2023) Page 2.6"
  },
  {
    "Ref": "Paeds0083",
    "Questions": "Which of the following is the defining feature used to differentiate a simple febrile seizure from a complex febrile seizure?",
    "A": "Presence of a fever > 39.5°C.",
    "B": "Age of onset (simple is < 6 years).",
    "C": "Duration of the seizure (> 15 minutes is complex).",
    "D": "Need for anti-epileptic drug treatment (complex requires treatment).",
    "Answer": "C",
    "Comment": "A complex febrile seizure is defined by a duration of > 15 minutes, focal features, or occurring more than once within 24 hours.",
    "Source": "Paeds EML (2023) Page 13.4"
  },
  {
    "Ref": "Paeds0084",
    "Questions": "What is the recommended initial IV fluid bolus volume for a child in compensated septic shock (hypovolaemia due to capillary leak) who has no features of cerebral malaria or cardiac failure?",
    "A": "5 mL/kg, repeated up to 2 times.",
    "B": "10 mL/kg, repeated up to 2 times.",
    "C": "20 mL/kg, repeated up to 3 times (total 60 mL/kg).",
    "D": "30 mL/kg, given as a single bolus.",
    "Answer": "C",
    "Comment": "The standard of care for shock involves repeated 20 mL/kg fluid boluses, with the protocol usually permitting up to 60 mL/kg before escalating to vasoactive agents, provided no signs of fluid overload develop.",
    "Source": "Paeds EML (2023) Page 1.15"
  },
  {
    "Ref": "Paeds0085",
    "Questions": "In a child with known Sickle Cell Anaemia (SCA) presenting with an acute painful crisis, what is the most important element of the immediate supportive management plan?",
    "A": "Urgent Exchange Transfusion.",
    "B": "Aggressive, titrated opioid analgesia and hydration.",
    "C": "High-dose oral iron supplementation.",
    "D": "Continuous intravenous Dextrose 50% infusion.",
    "Answer": "B",
    "Comment": "Immediate management focuses on pain control (opioids) and hydration to reverse sickling and manage the vaso-occlusive crisis. Exchange transfusion is reserved for severe complications (e.g., Acute Chest Syndrome, stroke).",
    "Source": "Paeds EML (2023) Page 3.6"
  },
  {
    "Ref": "Paeds0086",
    "Questions": "What is the recommended maintenance therapy for a child with chronic, steroid-sensitive Nephrotic Syndrome who is in remission?",
    "A": "Daily Prednisone indefinitely.",
    "B": "Alternate-day Prednisone (low dose, tapered off after 6 months).",
    "C": "Alternate-day Prednisone (low dose) for an extended period (months to years).",
    "D": "Daily Cyclophosphamide for 12 weeks.",
    "Answer": "C",
    "Comment": "Relapse prevention in frequent relapsing/steroid-dependent nephrotic syndrome often involves long-term, low-dose alternate-day Prednisone, or second-line agents like Levamisole/MMF, tailored by specialist review.",
    "Source": "Paeds EML (2023) Page 6.8"
  },
  {
    "Ref": "Paeds0087",
    "Questions": "For a child presenting with Acute Bacterial Tracheitis (ABT) who is intubated, what is the initial recommended empiric antibiotic regimen to cover the most common pathogen (*S. aureus*)?",
    "A": "Ampicillin and Gentamicin.",
    "B": "Penicillin G and Chloramphenicol.",
    "C": "A third-generation Cephalosporin (e.g., Ceftriaxone) and Vancomycin.",
    "D": "Oral Amoxicillin/Clavulanate.",
    "Answer": "C",
    "Comment": "ABT is often caused by *S. aureus* (including MRSA) and requires broad-spectrum IV coverage, typically a third-generation cephalosporin plus an agent like Vancomycin (if high MRSA prevalence or no response), pending cultures.",
    "Source": "Paeds EML (2023) Page 17.4"
  },
  {
    "Ref": "Paeds0088",
    "Questions": "Which drug is a second-line agent, indicated for children who fail to respond to the first-line oral therapy for Tinea Capitis?",
    "A": "Topical Ketoconazole cream.",
    "B": "Oral Fluconazole.",
    "C": "Oral Griseofulvin.",
    "D": "Topical Nystatin.",
    "Answer": "B",
    "Comment": "Oral Griseofulvin remains the preferred first-line treatment for Tinea Capitis. Oral Fluconazole or Terbinafine are alternatives for cases resistant to Griseofulvin or where compliance is an issue.",
    "Source": "Paeds EML (2023) Page 5.14"
  },
  {
    "Ref": "Paeds0089",
    "Questions": "A 1-year-old on first-line ART (e.g., Lopinavir/ritonavir-based) is switched to a Dolutegravir-based regimen. When should the first viral load (VL) measurement be performed after this switch to monitor for virological success?",
    "A": "3 months after the switch.",
    "B": "6 months after the switch.",
    "C": "12 months after the switch.",
    "D": "Only when the child develops signs of clinical failure.",
    "Answer": "A",
    "Comment": "Virological monitoring is critical. A follow-up VL should be performed 3-6 months after initiating or switching an ART regimen to ensure suppression.",
    "Source": "Paeds EML (2023) Page 9.13"
  },
  {
    "Ref": "Paeds0090",
    "Questions": "What is the most common cause of acute onset, massive lower gastrointestinal bleeding in a pre-school aged child (3-5 years) that requires surgical consultation?",
    "A": "Infectious Colitis (e.g., *C. difficile*).",
    "B": "Oesophageal Varices from Portal Hypertension.",
    "C": "Meckel's Diverticulum.",
    "D": "Henoch-Schönlein Purpura (HSP) vasculitis.",
    "Answer": "C",
    "Comment": "Meckel's Diverticulum (containing ectopic gastric mucosa) is the most common cause of painless, massive lower GI bleeding in this age group. HSP causes GI bleeding, but typically with abdominal pain/vasculitis symptoms.",
    "Source": "Paeds EML (2023) Page 2.4 (Alimentary Tract)"
  },
  {
    "Ref": "Paeds0091",
    "Questions": "Which of the following is the key initial intervention in a child presenting with severe Bleeding Oesophageal Varices (Portal Hypertension)?",
    "A": "Urgent packed red cell transfusion.",
    "B": "Administration of Octreotide/Terlipressin to reduce portal pressure.",
    "C": "Endoscopic Variceal Ligation (EVL).",
    "D": "Placement of a Transjugular Intrahepatic Portosystemic Shunt (TIPS).",
    "Answer": "B",
    "Comment": "Pharmacological reduction of portal pressure (Octreotide/Terlipressin) is initiated immediately upon suspicion, along with supportive care, while arrangements for definitive endoscopic management (EVL) are made.",
    "Source": "Paeds EML (2023) Page 2.29"
  },
  {
    "Ref": "Paeds0092",
    "Questions": "In a child being treated for Diabetic Ketoacidosis (DKA), Dextrose (glucose) is added to the IV fluids when the blood glucose level drops to or below which threshold?",
    "A": "15 mmol/L",
    "B": "12 mmol/L",
    "C": "10 mmol/L",
    "D": "8 mmol/L",
    "Answer": "A",
    "Comment": "Dextrose (e.g., 5% or 10%) is typically added to the maintenance fluids once the plasma glucose concentration reaches 12-15 mmol/L (or 250 mg/dL) to prevent hypoglycaemia while allowing insulin infusion to continue to clear ketones.",
    "Source": "Paeds EML (2023) Page 7.19"
  },
  {
    "Ref": "Paeds0093",
    "Questions": "Which diagnostic finding is the most sensitive indicator of active Tuberculous Meningitis (TBM) in the Cerebrospinal Fluid (CSF) of a child, even if PCR is negative?",
    "A": "Elevated glucose (> 4 mmol/L).",
    "B": "Very high neutrophil count (> 1000 cells/mm³).",
    "C": "Low glucose (< 2.2 mmol/L) and elevated protein (> 1.0 g/L).",
    "D": "Red Blood Cells (RBCs) > 1000 cells/mm³.",
    "Answer": "C",
    "Comment": "TBM classically causes a profound disturbance in CSF biochemistry: high protein and low glucose (often less than half the blood glucose), reflecting impaired reabsorption and consumption by the organism/inflammation.",
    "Source": "Paeds EML (2023) Page 10.13"
  },
  {
    "Ref": "Paeds0094",
    "Questions": "A neonate presents with hypocalcaemia. What is the recommended IV bolus dose for Calcium Gluconate (10%)?",
    "A": "0.1 mL/kg IV slow push.",
    "B": "0.5 mL/kg IV slow push.",
    "C": "1.0 mL/kg IV slow push.",
    "D": "10 mL/kg IV infusion.",
    "Answer": "C",
    "Comment": "The standard dose for acute treatment of hypocalcaemia in children/neonates is 1.0 mL/kg of 10% Calcium Gluconate, given slowly over 10 minutes, with cardiac monitoring.",
    "Source": "Paeds EML (2023) Page 19.51 (Neonatal Hypocalcaemia)"
  },
  {
    "Ref": "Paeds0095",
    "Questions": "In the ongoing care of a child with HIV, when is it appropriate to discontinue *Pneumocystis Jiroveci Pneumonia* (PJP) prophylaxis (e.g., Cotrimoxazole)?",
    "A": "Only after the child is older than 5 years of age.",
    "B": "When the child has been on ART for 6 months, irrespective of CD4 count.",
    "C": "When the child is clinically stable and has achieved sustained viral suppression and/or age-appropriate CD4 count recovery.",
    "D": "Prophylaxis must be continued for life once initiated.",
    "Answer": "C",
    "Comment": "PJP prophylaxis is discontinued after clinical and immunological criteria are met, specifically following sustained viral suppression and CD4 count recovery, indicating restored immune function.",
    "Source": "Paeds EML (2023) Page 9.13"
  },
  {
    "Ref": "Paeds0096",
    "Questions": "What is the recommended maximum duration of oral prednisolone therapy for a child with a typical presentation of a simple, acute wheeze (Bronchiolitis)?",
    "A": "Prednisolone is the first-line treatment for all acute wheezing.",
    "B": "A 3-day course is standard for all viral wheeze.",
    "C": "Steroids are generally NOT recommended for typical, simple Bronchiolitis.",
    "D": "A 7-day course is mandatory to prevent hospital admission.",
    "Answer": "C",
    "Comment": "The guideline, reflecting consensus, states that corticosteroids are not recommended for typical, simple viral bronchiolitis, as they have not shown consistent benefit in reducing disease severity or length of stay.",
    "Source": "Paeds EML (2023) Page 15.11"
  },
  {
    "Ref": "Paeds0097",
    "Questions": "A 4-year-old child presents with a massive haemorrhage following trauma. Which blood product component is most critical to replace during massive transfusion to prevent coagulopathy?",
    "A": "Packed Red Cells (PRCs) only.",
    "B": "PRCs and Fibrinogen concentrate only.",
    "C": "PRCs, Fresh Frozen Plasma (FFP), and Platelets in a balanced ratio.",
    "D": "IV Immunoglobulin (IVIG).",
    "Answer": "C",
    "Comment": "Massive haemorrhage requires Massive Transfusion Protocol (MTP), which necessitates replacing clotting factors (FFP) and platelets along with red cells in a high/balanced ratio to prevent dilutional coagulopathy.",
    "Source": "Paeds EML (2023) Page 1.19"
  },
  {
    "Ref": "Paeds0098",
    "Questions": "What is the primary intervention for a child presenting with Acute Liver Failure due to Acetaminophen (Paracetamol) overdose, provided the ingestion time is known and within the therapeutic window?",
    "A": "Urgent liver transplant evaluation.",
    "B": "Administration of Intravenous N-Acetylcysteine (NAC).",
    "C": "High-dose intravenous Corticosteroids.",
    "D": "Activated charcoal and whole bowel irrigation.",
    "Answer": "B",
    "Comment": "NAC is the specific antidote for Acetaminophen toxicity, and its administration is the critical, first-line medical intervention to prevent or mitigate the severity of liver injury.",
    "Source": "Paeds EML (2023) Page 2.34"
  },
  {
    "Ref": "Paeds0099",
    "Questions": "In a patient undergoing procedural sedation and analgesia (PSA), which of the following is considered the primary goal for the supervising clinician?",
    "A": "To achieve deep sedation where the patient cannot be aroused by verbal stimuli.",
    "B": "To ensure patient safety, maintaining cardiorespiratory stability and airway patency.",
    "C": "To ensure complete amnesia of the procedure.",
    "D": "To avoid the use of any benzodiazepines.",
    "Answer": "B",
    "Comment": "Patient safety is paramount. The goal of PSA is to use a combination of agents to manage pain/anxiety while maintaining cardiorespiratory function and protective reflexes (airway patency).",
    "Source": "Paeds EML (2023) Page 20.17"
  },
  {
    "Ref": "Paeds0100",
    "Questions": "Which pharmacological agent is the first-line treatment for a child presenting with Hyperthyroidism (Graves' Disease)?",
    "A": "Radioactive Iodine (RAI) therapy.",
    "B": "Surgical thyroidectomy.",
    "C": "Carbimazole or Propylthiouracil (PTU).",
    "D": "Oral Dexamethasone.",
    "Answer": "C",
    "Comment": "Antithyroid medications (Carbimazole or PTU) are the standard first-line medical treatment for paediatric Graves' disease, with Propylthiouracil generally reserved for thyroid storm due to hepatotoxicity risk.",
    "Source": "Paeds EML (2023) Page 7.39"
  },
  {
    "Ref": "DRTB0001",
    "Questions": "According to the 2023 guidelines, what is the recommended duration for the BPaL-L regimen?",
    "A": "4 months",
    "B": "6 months",
    "C": "9 months",
    "D": "18 months",
    "Answer": "B",
    "Comment": "The BPaL-L regimen is a 6-month all-oral regimen comprising bedaquiline, pretomanid, linezolid and levofloxacin.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 5"
  },
  {
    "Ref": "DRTB0002",
    "Questions": "Which laboratory test will replace the Line Probe assay for detecting fluoroquinolone resistance?",
    "A": "Culture-based DST",
    "B": "GeneXpert XDR (Xpert MTB/XDR) cartridge",
    "C": "Phenotypic testing",
    "D": "TB-NAAT",
    "Answer": "B",
    "Comment": "The GeneXpert XDR cartridge will be phased in to replace Line Probe assay for detecting fluoroquinolone and INH resistance.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 5"
  },
  {
    "Ref": "DRTB0003",
    "Questions": "What defines Pre-XDR-TB according to the updated WHO definitions?",
    "A": "Resistance to rifampicin and isoniazid only",
    "B": "Resistance to rifampicin and fluoroquinolones",
    "C": "Resistance to rifampicin, fluoroquinolones, and bedaquiline",
    "D": "Resistance to all first-line drugs",
    "Answer": "B",
    "Comment": "Pre-XDR-TB is defined as resistance to rifampicin (and may also be resistant to isoniazid) and fluoroquinolones.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 7"
  },
  {
    "Ref": "DRTB0004",
    "Questions": "What defines XDR-TB according to the updated WHO definitions?",
    "A": "Resistance to rifampicin and fluoroquinolones only",
    "B": "Resistance to rifampicin, fluoroquinolones, and any injectable",
    "C": "Resistance to rifampicin, fluoroquinolones, and at least one Group A drug (BDQ or LZD)",
    "D": "Resistance to all available TB drugs",
    "Answer": "C",
    "Comment": "XDR-TB is defined as resistance to rifampicin, fluoroquinolones, and at least one Group A drug (bedaquiline or linezolid).",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 7"
  },
  {
    "Ref": "DRTB0005",
    "Questions": "What is the main indication for hospitalization of RR-TB patients according to the guidelines?",
    "A": "All RR-TB patients must be hospitalized",
    "B": "Only patients with positive cultures",
    "C": "Respiratory insufficiency, CNS disease, BMI <18, or clinically unstable patients",
    "D": "Patients refusing treatment",
    "Answer": "C",
    "Comment": "Main indications include respiratory insufficiency, Hb <8.0 g/dL, BMI <18 kg/m², CNS RR-TB, and clinical instability.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 9"
  },
  {
    "Ref": "DRTB0006",
    "Questions": "Which patients should be referred to the NCAC for management advice?",
    "A": "All RR-TB patients",
    "B": "Only pediatric patients",
    "C": "Failed XDR-TB, complicated children's cases, CNS RR-TB, and rescue regimens",
    "D": "Patients with HIV co-infection only",
    "Answer": "C",
    "Comment": "NCAC input should be sought for complicated patients including failed XDR-TB, complicated children's RR-TB, CNS RR-TB, and rescue regimens.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 10"
  },
  {
    "Ref": "DRTB0007",
    "Questions": "What is the estimated turnaround time for GeneXpert XDR cartridge results?",
    "A": "24 hours",
    "B": "48 hours",
    "C": "72 hours",
    "D": "1 week",
    "Answer": "B",
    "Comment": "The GeneXpert XDR cartridge has an estimated turnaround time of 48 hours for susceptibility testing.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 12"
  },
  {
    "Ref": "DRTB0008",
    "Questions": "For children under 15 years with RR-TB, what determines the treatment duration?",
    "A": "Age only",
    "B": "Weight only",
    "C": "Site and severity of disease, plus extent of drug resistance",
    "D": "HIV status only",
    "Answer": "C",
    "Comment": "Treatment duration in children is based on site and severity of disease, as well as extent of drug resistance.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 19"
  },
  {
    "Ref": "DRTB0009",
    "Questions": "What defines 'severe TB disease' in children under 15 years?",
    "A": "Any pulmonary involvement",
    "B": "Bilateral disease, cavities, or EPTB other than peripheral LNs or simple pleural effusion",
    "C": "Positive culture results only",
    "D": "Weight loss >10%",
    "Answer": "B",
    "Comment": "Severe disease includes bilateral disease, cavities, mediastinal LNs with airway compression, or EPTB other than peripheral LNs or simple pleural effusion.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 20"
  },
  {
    "Ref": "DRTB0010",
    "Questions": "For children with non-severe RR-TB, what is the typical treatment duration?",
    "A": "4 months",
    "B": "6 months",
    "C": "9 months",
    "D": "12 months",
    "Answer": "B",
    "Comment": "Children with non-severe RR-TB disease can be successfully treated with shorter (6-month) regimens containing at least 4 effective drugs.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 19"
  },
  {
    "Ref": "DRTB0011",
    "Questions": "Which regimen should be used for children with RR-TB CNS disease?",
    "A": "BDQ – LFX – CFZ – TRD for 6 months",
    "B": "BDQ – LFX – LZD – CFZ – TRD – DLM for 12-18 months",
    "C": "Standard 4-drug regimen for 9 months",
    "D": "Injectable-based regimen",
    "Answer": "B",
    "Comment": "CNS disease requires BDQ – LFX – LZD – CFZ – TRD – DLM for 12-18 months, with LFX if strain is susceptible.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 21"
  },
  {
    "Ref": "DRTB0012",
    "Questions": "What is a key exclusion criterion for the BPaL-L short regimen?",
    "A": "HIV co-infection",
    "B": "Previous TB treatment",
    "C": "Severe extrapulmonary TB (meningitis, pericarditis, osteoarticular, abdominal, disseminated)",
    "D": "Age over 65 years",
    "Answer": "C",
    "Comment": "Severe EPTB including meningitis, pericarditis, osteoarticular, abdominal or disseminated/miliary disease excludes patients from BPaL-L.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 25"
  },
  {
    "Ref": "DRTB0013",
    "Questions": "What is the recommended linezolid dose in the BPaL-L regimen?",
    "A": "300 mg daily",
    "B": "600 mg daily",
    "C": "900 mg daily",
    "D": "1200 mg daily",
    "Answer": "B",
    "Comment": "Linezolid dose is 600 mg daily and should be given for at least 8 weeks in the BPaL-L regimen.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 23"
  },
  {
    "Ref": "DRTB0014",
    "Questions": "When should a patient be switched from BPaL-L to a long individualized regimen?",
    "A": "After 2 months of treatment",
    "B": "If resistance to bedaquiline, pretomanid, or linezolid is detected",
    "C": "If the patient experiences any side effects",
    "D": "Routinely after 4 months",
    "Answer": "B",
    "Comment": "Switch to long regimen if resistance to bedaquiline, pretomanid, clofazimine, delamanid or linezolid is detected.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 26"
  },
  {
    "Ref": "DRTB0015",
    "Questions": "What is the duration of individualized long regimens for RR-TB?",
    "A": "9 months",
    "B": "12 months",
    "C": "18 months",
    "D": "24 months",
    "Answer": "C",
    "Comment": "Persons who do not qualify for the short RR-TB regimen will receive a long individualized 18-month regimen.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 26"
  },
  {
    "Ref": "DRTB0016",
    "Questions": "According to WHO drug groupings, which drugs are in Group A?",
    "A": "Levofloxacin, bedaquiline, linezolid",
    "B": "Clofazimine, terizidone",
    "C": "Ethambutol, pyrazinamide",
    "D": "Amikacin, streptomycin",
    "Answer": "A",
    "Comment": "Group A includes levofloxacin/moxifloxacin, bedaquiline, and linezolid - all should be included where possible.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 27"
  },
  {
    "Ref": "DRTB0017",
    "Questions": "What is the bedaquiline reloading dose after an interruption of 2-4 weeks?",
    "A": "7 days of 400mg daily",
    "B": "3 days of 400mg daily",
    "C": "14 days of 400mg daily",
    "D": "No reloading needed",
    "Answer": "B",
    "Comment": "For interruptions of 2-4 weeks, reload with 3 days of 400mg bedaquiline daily.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0018",
    "Questions": "What should be included in rescue regimens for XDR-TB?",
    "A": "Only oral agents",
    "B": "Delamanid if no previous exposure, carbapenems with clavulanic acid",
    "C": "Standard first-line drugs",
    "D": "Injectable agents only",
    "Answer": "B",
    "Comment": "Rescue regimens should include delamanid (if no previous exposure) and carbapenems with clavulanic acid (as amoxicillin-clavulanate).",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0019",
    "Questions": "What is the recommended frequency for levofloxacin in patients with creatinine clearance <30 ml/min?",
    "A": "Daily",
    "B": "Three times per week",
    "C": "Twice weekly",
    "D": "Once weekly",
    "Answer": "B",
    "Comment": "For creatinine clearance <30 ml/min or hemodialysis, levofloxacin should be given 750-1000 mg three times per week.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 30"
  },
  {
    "Ref": "DRTB0020",
    "Questions": "Why are pregnant women excluded from the BPaL-L regimen?",
    "A": "Bedaquiline is contraindicated in pregnancy",
    "B": "Pretomanid safety has not been established in pregnancy",
    "C": "Levofloxacin causes birth defects",
    "D": "All TB drugs are contraindicated in pregnancy",
    "Answer": "B",
    "Comment": "Pregnant women don't qualify for BPaL-L because pretomanid safety has not been established in pregnancy.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 31"
  },
  {
    "Ref": "DRTB0021",
    "Questions": "What alternative regimen can be considered for pregnant women with RR-TB?",
    "A": "BPaL without levofloxacin",
    "B": "Bedaquiline, delamanid, linezolid and levofloxacin for 6 months",
    "C": "Injectable-based regimen",
    "D": "Delay treatment until after delivery",
    "Answer": "B",
    "Comment": "Pregnant patients may benefit from a 6-month regimen with bedaquiline, delamanid, linezolid and levofloxacin based on BEAT Tuberculosis study experience.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 31"
  },
  {
    "Ref": "DRTB0022",
    "Questions": "What is the preferred ART regimen for RR-TB/HIV co-infected patients?",
    "A": "Efavirenz-based regimen",
    "B": "Protease inhibitor-based regimen",
    "C": "TLD (tenofovir, lamivudine, dolutegravir)",
    "D": "Zidovudine-based regimen",
    "Answer": "C",
    "Comment": "TLD is the optimized regimen of choice for RR-TB/HIV co-infected patients, provided normal renal function.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 32"
  },
  {
    "Ref": "DRTB0023",
    "Questions": "Why is efavirenz contraindicated with bedaquiline?",
    "A": "Increases bedaquiline toxicity",
    "B": "Efavirenz induces hepatic metabolism and decreases bedaquiline exposure",
    "C": "Causes drug-resistant mutations",
    "D": "Both drugs cause QT prolongation",
    "Answer": "B",
    "Comment": "Efavirenz induces hepatic metabolism of bedaquiline and decreases bedaquiline exposure, making concomitant use contraindicated.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 34"
  },
  {
    "Ref": "DRTB0024",
    "Questions": "When should ART be initiated in RR-TB patients with CD4 <50 cells/mm³?",
    "A": "Immediately with RR-TB treatment",
    "B": "Within 2 weeks of starting RR-TB therapy",
    "C": "After 8 weeks of RR-TB treatment",
    "D": "After completing RR-TB treatment",
    "Answer": "B",
    "Comment": "In patients with CD4 <50 cells/mm³, ART should be started within 2 weeks of starting RR-TB therapy.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 33"
  },
  {
    "Ref": "DRTB0025",
    "Questions": "What is the monitoring schedule for ECG in patients on BPaL-L regimen?",
    "A": "Baseline only",
    "B": "Baseline and monthly",
    "C": "Baseline, at 2 weeks, then monthly",
    "D": "Weekly throughout treatment",
    "Answer": "C",
    "Comment": "ECG monitoring should be done at baseline, 2 weeks, then monthly thereafter for QT interval assessment.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 36"
  },
  {
    "Ref": "DRTB0026",
    "Questions": "How frequently should full blood count be monitored in weeks 2-8 of BPaL-L treatment?",
    "A": "Weekly",
    "B": "Every 2 weeks",
    "C": "Monthly",
    "D": "Only if symptomatic",
    "Answer": "B",
    "Comment": "For weeks 2-8, full blood count should be done every 2 weeks to monitor for linezolid-induced myelosuppression.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 38"
  },
  {
    "Ref": "DRTB0027",
    "Questions": "What hemoglobin level requires hospital admission for RR-TB patients?",
    "A": "Below 10 g/dL",
    "B": "Below 9 g/dL",
    "C": "Below 8 g/dL",
    "D": "Below 7 g/dL",
    "Answer": "C",
    "Comment": "If hemoglobin drops below 8 g/dL, the patient should be admitted for close follow-up and possible transfusion.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 38"
  },
  {
    "Ref": "DRTB0028",
    "Questions": "When does peripheral neuropathy typically peak in linezolid treatment?",
    "A": "2 weeks",
    "B": "8 weeks",
    "C": "16 weeks",
    "D": "24 weeks",
    "Answer": "C",
    "Comment": "Peripheral neuropathy tends to occur later in treatment, with peak onset around 16 weeks.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 38"
  },
  {
    "Ref": "DRTB0029",
    "Questions": "What visual assessment should be done at baseline and each visit for linezolid monitoring?",
    "A": "Fundoscopy only",
    "B": "Visual acuity using Snellen test",
    "C": "Color vision testing only",
    "D": "Slit lamp examination",
    "Answer": "B",
    "Comment": "Visual acuity should be measured using Snellen test at baseline and each visit when patient is on linezolid.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 39"
  },
  {
    "Ref": "DRTB0030",
    "Questions": "What constitutes a 'Cured' treatment outcome for RR-TB?",
    "A": "Completed treatment regardless of culture results",
    "B": "Negative smear at end of treatment",
    "C": "Bacteriological conversion with no reversion and no evidence of failure",
    "D": "Clinical improvement only",
    "Answer": "C",
    "Comment": "Cured means bacteriologically confirmed DR-TB patient who completed treatment with bacteriological conversion, no reversion, and no evidence of failure.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 43"
  },
  {
    "Ref": "DRTB0031",
    "Questions": "How is 'Loss to Follow Up' defined in RR-TB treatment?",
    "A": "Missing 1 month of treatment",
    "B": "Interrupting treatment for ≥2 consecutive months without medical approval",
    "C": "Any treatment interruption",
    "D": "Missing final appointment",
    "Answer": "B",
    "Comment": "Loss to follow up is defined as interrupting treatment for ≥2 consecutive months for any reason without medical approval.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 43"
  },
  {
    "Ref": "DRTB0032",
    "Questions": "When should post-treatment follow-up visits occur?",
    "A": "3 and 9 months post-treatment",
    "B": "6 and 12 months post-treatment",
    "C": "Annually for 5 years",
    "D": "Only if symptoms develop",
    "Answer": "B",
    "Comment": "All patients who complete treatment need evaluation at 6 and 12 months post-treatment with physical examination and sputum culture.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 44"
  },
  {
    "Ref": "DRTB0033",
    "Questions": "What is the minimum number of drugs required in a pediatric RR-TB regimen?",
    "A": "3 drugs",
    "B": "4 drugs",
    "C": "5 drugs",
    "D": "6 drugs",
    "Answer": "B",
    "Comment": "The regimen should include at least 4 drugs considered to be effective, with possible addition of a 5th drug if needed for severe disease.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 18"
  },
  {
    "Ref": "DRTB0034",
    "Questions": "Which age group should be managed by experienced clinicians for RR-TB?",
    "A": "All children under 18",
    "B": "Children under 10 years",
    "C": "Very young children under 5 years with any form of RR-TB",
    "D": "Only neonates",
    "Answer": "C",
    "Comment": "Very young children (under 5 years) with any form of RR-TB should be treated under guidance of experienced pediatric RR-TB clinicians.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 19"
  },
  {
    "Ref": "DRTB0035",
    "Questions": "What is the key difference between severe and non-severe TB in children?",
    "A": "Presence of symptoms",
    "B": "Bilateral disease/cavities vs unilateral disease <1 lobe without cavities",
    "C": "Culture positivity",
    "D": "Age of the child",
    "Answer": "B",
    "Comment": "Severe disease includes bilateral disease or cavities, while non-severe includes unilateral disease <1 lobe without cavities.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 20"
  },
  {
    "Ref": "DRTB0036",
    "Questions": "What should be done if GeneXpert XDR results are pending beyond 30 days?",
    "A": "Wait for results before starting treatment",
    "B": "Start empirical treatment and submit repeat sample",
    "C": "Use Line Probe assay instead",
    "D": "Start first-line TB treatment",
    "Answer": "B",
    "Comment": "If no GeneXpert XDR results within 30 days, submit repeat sample for DR-TB reflex testing while continuing short regimen.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 16"
  },
  {
    "Ref": "DRTB0037",
    "Questions": "Which specimens should be collected for children suspected of having RR-TB?",
    "A": "Sputum only",
    "B": "At least two good-quality specimens sent separately for Xpert and culture",
    "C": "Blood cultures only",
    "D": "Urine specimens",
    "Answer": "B",
    "Comment": "At least two good-quality specimens should be collected and sent separately for Xpert MTB/RIF Ultra and mycobacterial culture and DST.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 16"
  },
  {
    "Ref": "DRTB0038",
    "Questions": "What is the recommended approach when discordant DST results occur?",
    "A": "Repeat all tests",
    "B": "Use the most sensitive result",
    "C": "Treat based on the 'most resistant' scenario and consult PCAC/NCAC",
    "D": "Ignore discordant results",
    "Answer": "C",
    "Comment": "For discordant results, treatment should be based on the 'most resistant' scenario and clinician should consult with PCAC or NCAC.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 16"
  },
  {
    "Ref": "DRTB0039",
    "Questions": "What is the role of pyridoxine in BPaL-L treatment?",
    "A": "Must be prescribed for all patients",
    "B": "Only for malnourished patients",
    "C": "Does not need to be prescribed in patients receiving BPaL-L",
    "D": "Only for patients with neuropathy",
    "Answer": "C",
    "Comment": "Pyridoxine does not need to be prescribed in patients receiving BPaL-L regimen.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 23"
  },
  {
    "Ref": "DRTB0040",
    "Questions": "When can the BPaL-L regimen be extended to 9 months?",
    "A": "For all patients routinely",
    "B": "For persons with extensive pulmonary disease at clinician's discretion",
    "C": "Only if treatment fails",
    "D": "Never",
    "Answer": "B",
    "Comment": "Persons with extensive pulmonary disease should have their treatment extended to 9 months, and BPaL-L can be extended to 9 months at clinician's discretion.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 23-25"
  },
  {
    "Ref": "DRTB0041",
    "Questions": "What defines 'extensive pulmonary disease' in the context of RR-TB?",
    "A": "Any bilateral involvement",
    "B": "Bilateral cavitary disease with significant fibrosis, scarring or cavities in three or more lung zones",
    "C": "Single cavity",
    "D": "Pleural effusion",
    "Answer": "B",
    "Comment": "Extensive pulmonary disease is bilateral cavitary disease with significant fibrosis, scarring or cavities in three or more lung zones.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 25"
  },
  {
    "Ref": "DRTB0042",
    "Questions": "Which patients require extended DST?",
    "A": "All RR-TB patients",
    "B": "Only pediatric patients",
    "C": "Patients with RR-TB regimen failing, resistant to BDQ/LZD, or previous second-line drug exposure",
    "D": "Patients with HIV co-infection",
    "Answer": "C",
    "Comment": "Extended DST is requested when RR-TB regimen is failing, resistant to BDQ or LZD, or previous exposure to second-line drugs.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 12"
  },
  {
    "Ref": "DRTB0043",
    "Questions": "What is the primary reason for switching from BPaL-L to individualized long regimen?",
    "A": "Patient preference",
    "B": "Side effects",
    "C": "Documented resistance to core BPaL-L components",
    "D": "Cost considerations",
    "Answer": "C",
    "Comment": "The primary reason is documented resistance to bedaquiline, pretomanid, clofazimine, delamanid or linezolid.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 26"
  },
  {
    "Ref": "DRTB0044",
    "Questions": "How should linezolid toxicity be managed in weeks 16+ of treatment?",
    "A": "Continue regardless of symptoms",
    "B": "Reduce dose only",
    "C": "Permanently discontinue if culture conversion has occurred",
    "D": "Switch to injectable agent",
    "Answer": "C",
    "Comment": "In weeks 16+, permanently discontinue linezolid if culture conversion has occurred and continue with remaining drugs.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 39"
  },
  {
    "Ref": "DRTB0045",
    "Questions": "What is the significance of a positive culture at month 4 in BPaL-L treatment?",
    "A": "Normal finding, continue treatment",
    "B": "Indicates treatment failure, switch to individualized regimen",
    "C": "Reduce drug doses",
    "D": "Add injectable agent",
    "Answer": "B",
    "Comment": "Positive culture at month 4 indicates delayed culture conversion or reconversion, requiring switch to individualized regimen after excluding resistance.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 26"
  },
  {
    "Ref": "DRTB0046",
    "Questions": "Which Group B drugs should be added to long individualized regimens?",
    "A": "Ethambutol and pyrazinamide",
    "B": "Clofazimine and terizidone",
    "C": "Amikacin and ethionamide",
    "D": "Delamanid and PAS",
    "Answer": "B",
    "Comment": "Group B drugs include clofazimine and terizidone - add one or both if possible to long individualized regimens.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 27"
  },
  {
    "Ref": "DRTB0047",
    "Questions": "When should carbapenems be used in RR-TB treatment?",
    "A": "First-line for all patients",
    "B": "In rescue regimens for XDR-TB with no previous exposure",
    "C": "Only for pediatric patients",
    "D": "As monotherapy",
    "Answer": "B",
    "Comment": "Carbapenems should be used in rescue regimens for XDR-TB if no previous exposure, and must be given with clavulanic acid.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0048",
    "Questions": "What must be given with carbapenems when used for RR-TB treatment?",
    "A": "Pyridoxine",
    "B": "Amoxicillin-clavulanate 30 minutes prior to infusion",
    "C": "Probenecid",
    "D": "Normal saline",
    "Answer": "B",
    "Comment": "Carbapenems must be given with clavulanic acid as amoxicillin-clavulanate 30 minutes prior to the carbapenem infusion.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0049",
    "Questions": "What is the bedaquiline reloading dose for interruptions >12 months?",
    "A": "3 days of 400mg daily",
    "B": "7 days of 400mg daily", 
    "C": "14 days of 400mg daily",
    "D": "No reloading needed",
    "Answer": "C",
    "Comment": "For interruptions >12 months, reload with 14 days of 400mg bedaquiline daily.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0050",
    "Questions": "Which drug requires therapeutic drug monitoring when used in RR-TB treatment?",
    "A": "Bedaquiline",
    "B": "Linezolid",
    "C": "Amikacin",
    "D": "Levofloxacin",
    "Answer": "C",
    "Comment": "Amikacin requires therapeutic drug monitoring and formal hearing assessments throughout treatment.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0051",
    "Questions": "What dose adjustment is needed for terizidone in renal impairment (CrCl <30ml/min)?",
    "A": "No adjustment needed",
    "B": "250 mg once daily or 500 mg three times per week",
    "C": "Increase to 750 mg daily",
    "D": "Stop the medication",
    "Answer": "B",
    "Comment": "For CrCl <30ml/min, terizidone should be 250mg once daily or 500mg three times per week.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 30"
  },
  {
    "Ref": "DRTB0052",
    "Questions": "Which drug should NOT be used in pregnancy due to fetal ear toxicity?",
    "A": "Bedaquiline",
    "B": "Linezolid",
    "C": "Amikacin",
    "D": "Levofloxacin",
    "Answer": "C",
    "Comment": "Amikacin should not be used in pregnancy due to associated fetal ear toxicity.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 31"
  },
  {
    "Ref": "DRTB0053",
    "Questions": "When should ART be delayed in RR-TB meningitis patients?",
    "A": "Never delay ART",
    "B": "Initiate ART 4-6 weeks after starting RR-TB treatment",
    "C": "Wait until RR-TB treatment is completed",
    "D": "Start immediately",
    "Answer": "B",
    "Comment": "In RR-TB meningitis, initiate ART 4-6 weeks after starting RR-TB medication due to risk of intracranial IRIS.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 33"
  },
  {
    "Ref": "DRTB0054",
    "Questions": "Why should zidovudine and linezolid not be used together?",
    "A": "Drug-drug interactions affecting efficacy",
    "B": "Both drugs can cause bone marrow suppression",
    "C": "Increased risk of lactic acidosis",
    "D": "Both cause peripheral neuropathy",
    "Answer": "B",
    "Comment": "Zidovudine and linezolid should not be used concurrently as both drugs can cause bone marrow suppression.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 34"
  },
  {
    "Ref": "DRTB0055",
    "Questions": "What eGFR level is required for TDF use in adults ≥16 years?",
    "A": ">80 mL/min/1.73 m²",
    "B": ">60 mL/min/1.73 m²",
    "C": ">50 mL/min/1.73 m²",
    "D": ">30 mL/min/1.73 m²",
    "Answer": "C",
    "Comment": "For adults and adolescents ≥16 years, eGFR must be >50 mL/min/1.73 m² for TDF use.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 34"
  },
  {
    "Ref": "DRTB0056",
    "Questions": "What is the recommended metformin dose limit when used with dolutegravir?",
    "A": "No limit",
    "B": "500 mg twice daily maximum",
    "C": "1000 mg daily maximum",
    "D": "250 mg daily maximum",
    "Answer": "B",
    "Comment": "Do not exceed 500 mg twice daily when using metformin with dolutegravir in diabetic patients.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 35"
  },
  {
    "Ref": "DRTB0057",
    "Questions": "How often should sputum be collected during BPaL-L treatment?",
    "A": "Baseline and end of treatment only",
    "B": "Baseline, 2 weeks, 4 weeks, then monthly",
    "C": "Weekly throughout treatment",
    "D": "Only if clinically indicated",
    "Answer": "B",
    "Comment": "TB smear and cultures must be taken at baseline, 2 weeks later, 4 weeks later, and monthly thereafter.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 36"
  },
  {
    "Ref": "DRTB0058",
    "Questions": "What defines a Grade 3 (severe) adverse event?",
    "A": "Minimal interference with activities",
    "B": "Greater than minimal interference with activities",
    "C": "Inability to perform usual social and functional activities",
    "D": "Life-threatening symptoms",
    "Answer": "C",
    "Comment": "Grade 3 (severe) adverse events cause inability to perform usual, age-appropriate, social and functional activities.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 42"
  },
  {
    "Ref": "DRTB0059",
    "Questions": "What constitutes a Serious Adverse Event (SAE)?",
    "A": "Any Grade 3 adverse event",
    "B": "Hospitalization, permanent disability, life-threatening experience, or death",
    "C": "Any side effect requiring medication",
    "D": "Grade 1 or 2 adverse events",
    "Answer": "B",
    "Comment": "SAE results in hospitalization, permanent disability, congenital abnormality, life-threatening experience, or death.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 41"
  },
  {
    "Ref": "DRTB0060",
    "Questions": "What minimum linezolid treatment duration is required before discontinuation?",
    "A": "4 weeks",
    "B": "8 weeks", 
    "C": "12 weeks",
    "D": "16 weeks",
    "Answer": "B",
    "Comment": "Linezolid should be given for at least 8 weeks and must be used for at least 2 months before considering discontinuation.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 23, 38"
  },
  {
    "Ref": "DRTB0061",
    "Questions": "What chest X-ray finding defines severe TB disease in children?",
    "A": "Any infiltrate",
    "B": "Unilateral consolidation",
    "C": "Bilateral disease, cavities, or mediastinal LNs with airway compression",
    "D": "Pleural effusion only",
    "Answer": "C",
    "Comment": "Severe disease includes bilateral disease, cavities, or mediastinal lymph nodes causing airway compression.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 20"
  },
  {
    "Ref": "DRTB0062",
    "Questions": "Which pediatric formulations are available through the donation programme?",
    "A": "Adult tablets only",
    "B": "Delamanid 25mg, levofloxacin 100mg, bedaquiline 20mg, clofazimine 50mg dispersible tablets",
    "C": "Injectable formulations only",
    "D": "Liquid formulations only",
    "Answer": "B",
    "Comment": "Pediatric formulations including delamanid 25mg, levofloxacin 100mg, bedaquiline 20mg, and clofazimine 50mg dispersible tablets are available at selected sites.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 17"
  },
  {
    "Ref": "DRTB0063",
    "Questions": "What is the recommended treatment duration for children with severe RR-TB disease?",
    "A": "6 months",
    "B": "9 or 12 months",
    "C": "18 months",
    "D": "24 months",
    "Answer": "B",
    "Comment": "Children with severe RR-TB disease are likely to require longer treatment for 9 or 12 months.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 19"
  },
  {
    "Ref": "DRTB0064",
    "Questions": "When should bedaquiline and delamanid typically be used in pediatric regimens?",
    "A": "Throughout entire treatment",
    "B": "First 2 months only",
    "C": "Mostly for 6 months but can be extended to 9 months",
    "D": "Final 3 months only",
    "Answer": "C",
    "Comment": "Bedaquiline and delamanid are mostly used for 6 months only but can be extended to 9 months in consultation with an expert.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 19"
  },
  {
    "Ref": "DRTB0065",
    "Questions": "How long can linezolid typically be tolerated in children?",
    "A": "Up to 1 month",
    "B": "Up to 2 months",
    "C": "Up to 6 months",
    "D": "Throughout entire treatment",
    "Answer": "B",
    "Comment": "Linezolid is often only tolerated for up to 2 months in children, though some may benefit from longer duration if tolerated.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 19"
  },
  {
    "Ref": "DRTB0066",
    "Questions": "Which drug should be avoided with high-dose isoniazid in children?",
    "A": "Levofloxacin",
    "B": "Bedaquiline",
    "C": "Terizidone",
    "D": "Clofazimine",
    "Answer": "C",
    "Comment": "Terizidone has been shown to reduce plasma concentrations of INH; concomitant use should be avoided where possible.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 22"
  },
  {
    "Ref": "DRTB0067",
    "Questions": "What is the preferred antiretroviral regimen for children <10 years or <30 kg with RR-TB?",
    "A": "TLD",
    "B": "ALD (abacavir, lamivudine, dolutegravir)",
    "C": "Efavirenz-based regimen",
    "D": "Protease inhibitor-based regimen",
    "Answer": "B",
    "Comment": "ALD (abacavir, lamivudine, dolutegravir) can be used in children <10 years or weighing <30 kg.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 32"
  },
  {
    "Ref": "DRTB0068",
    "Questions": "What should be done if a patient on BPaL-L develops fluoroquinolone resistance?",
    "A": "Switch to individualized long regimen",
    "B": "Continue BPaL-L and stop levofloxacin (use BPaL)",
    "C": "Add injectable agent",
    "D": "Double the levofloxacin dose",
    "Answer": "B",
    "Comment": "If fluoroquinolone resistance is detected, continue BPaL (without levofloxacin) for 6 months.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 14"
  },
  {
    "Ref": "DRTB0069",
    "Questions": "What laboratory parameter requires monitoring every 2 weeks during weeks 2-8 of linezolid treatment?",
    "A": "Liver function tests",
    "B": "Full blood count with differential and platelets",
    "C": "Renal function",
    "D": "Electrolytes",
    "Answer": "B",
    "Comment": "Full blood count with differential and platelets should be monitored every 2 weeks during weeks 2-8 to detect myelosuppression.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 38"
  },
  {
    "Ref": "DRTB0070",
    "Questions": "What constitutes bacteriological conversion in RR-TB treatment?",
    "A": "One negative culture",
    "B": "Two consecutive cultures taken ≥7 days apart that are negative",
    "C": "Negative smear only",
    "D": "Clinical improvement",
    "Answer": "B",
    "Comment": "Bacteriological conversion requires at least two consecutive cultures taken on different occasions at least 7 days apart that are negative.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 43"
  },
  {
    "Ref": "DRTB0071",
    "Questions": "What minimum number of negative cultures defines a 'Cured' outcome?",
    "A": "1 negative culture",
    "B": "2 negative cultures",
    "C": "At least 3 negative cultures during entire treatment",
    "D": "All cultures must be negative",
    "Answer": "C",
    "Comment": "Cured outcome requires at least 3 negative TB cultures during the entire duration of treatment.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 43"
  },
  {
    "Ref": "DRTB0072",
    "Questions": "What chronic condition commonly requires management after RR-TB treatment completion?",
    "A": "Diabetes only",
    "B": "Reactive airway disease, hearing loss, peripheral neuropathy",
    "C": "Hypertension only",
    "D": "Kidney disease only",
    "Answer": "B",
    "Comment": "Common post-treatment conditions include reactive airway disease, hearing loss, and peripheral neuropathy requiring ongoing management.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 44"
  },
  {
    "Ref": "DRTB0073",
    "Questions": "What is the major change in the 2023 guidelines regarding the 9-11 month regimen?",
    "A": "It's now the preferred regimen",
    "B": "It's no longer included in the guidelines",
    "C": "Duration extended to 12 months",
    "D": "Only for children",
    "Answer": "B",
    "Comment": "The previously recommended 9-11 month regimen is no longer included in the 2023 guidelines.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 5"
  },
  {
    "Ref": "DRTB0074",
    "Questions": "What is the efficacy rate of the short BPaLM regimen in clinical trials?",
    "A": "Up to 70%",
    "B": "Up to 80%",
    "C": "Up to 90%",
    "D": "Up to 95%",
    "Answer": "C",
    "Comment": "The short BPaLM regimen showed up to 90% efficacy in clinical trial settings.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 5"
  },
  {
    "Ref": "DRTB0075",
    "Questions": "Which drug in the BPaL-L regimen is considered the most toxic?",
    "A": "Bedaquiline",
    "B": "Pretomanid",
    "C": "Linezolid",
    "D": "Levofloxacin",
    "Answer": "C",
    "Comment": "Linezolid is the most toxic drug in the BPaL-L regimen, requiring careful monitoring for adverse events.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 5"
  },
  {
    "Ref": "DRTB0076",
    "Questions": "What should be done if pretomanid testing shows resistance?",
    "A": "Continue BPaL-L regimen",
    "B": "Switch to individualized long regimen",
    "C": "Double the pretomanid dose",
    "D": "Add injectable agent",
    "Answer": "B",
    "Comment": "Resistance to pretomanid is an indication for individualized long regimen rather than BPaL-L.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 5"
  },
  {
    "Ref": "DRTB0077",
    "Questions": "Where will pretomanid resistance testing be performed?",
    "A": "All provincial laboratories",
    "B": "District laboratories",
    "C": "National TB reference laboratory",
    "D": "Private laboratories only",
    "Answer": "C",
    "Comment": "Pretomanid testing will be performed at the National TB reference laboratory for isolates resistant to fluoroquinolones.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 5"
  },
  {
    "Ref": "DRTB0078",
    "Questions": "What is the key principle for outpatient RR-TB care?",
    "A": "All patients must be hospitalized",
    "B": "Most RR-TB care should be provided in outpatient settings per decentralization plan",
    "C": "Only adults can receive outpatient care",
    "D": "Outpatient care is not recommended",
    "Answer": "B",
    "Comment": "Most RR-TB care and services should be provided in the outpatient setting according to the National decentralization plan.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 8"
  },
  {
    "Ref": "DRTB0079",
    "Questions": "Can children be managed for RR-TB at primary healthcare level?",
    "A": "No, only at central sites",
    "B": "Yes, where there are healthcare staff comfortable with pediatric care",
    "C": "Only if over 10 years old",
    "D": "Only with specialist pediatrician present",
    "Answer": "B",
    "Comment": "Children do not need to be treated by central sites and can be managed closer to home where there are healthcare staff comfortable with pediatric care.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 8"
  },
  {
    "Ref": "DRTB0080",
    "Questions": "What should be done if a patient needs rescue regimen according to PCAC/NCAC recommendations?",
    "A": "Wait for committee meeting",
    "B": "Start empiric rescue regimen while awaiting EDST results",
    "C": "Continue current regimen",
    "D": "Stop all treatment",
    "Answer": "B",
    "Comment": "While awaiting EDST results, an empiric rescue treatment regimen should be started with NCAC input.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0081",
    "Questions": "What is required before using amikacin in rescue regimens?",
    "A": "Patient consent only",
    "B": "Documented susceptibility, formal hearing tests, and informed consent",
    "C": "Blood level monitoring only",
    "D": "Hospital admission only",
    "Answer": "B",
    "Comment": "Amikacin requires documented susceptibility, ability to do formal hearing tests, patient consent after risk/benefit explanation, and therapeutic drug monitoring.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 28"
  },
  {
    "Ref": "DRTB0082",
    "Questions": "What should be considered for patients not responding to long regimens?",
    "A": "Continue same regimen longer",
    "B": "Assess adherence, contributing factors, confirm drug sensitivity, consider surgical consultation",
    "C": "Switch to injectable-only regimen",
    "D": "Stop treatment",
    "Answer": "B",
    "Comment": "Assess adherence, contributing factors (substance use, mental health), confirm BDQ/LZD sensitivity, and consider surgical consultation.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 29"
  },
  {
    "Ref": "DRTB0083",
    "Questions": "How should patients who return after being lost to follow-up be managed?",
    "A": "Restart same regimen",
    "B": "Provide 'welcome back' counselling, assess reasons for LTFU, send reflex testing, consider empiric long regimen",
    "C": "Start first-line treatment",
    "D": "Discharge from care",
    "Answer": "B",
    "Comment": "Provide welcome back counselling, assess LTFU reasons, send sputum for reflex testing and EDST, consider empiric long regimen with PCAC/NCAC input.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 29"
  },
  {
    "Ref": "DRTB0084",
    "Questions": "What is the dose adjustment for ethambutol in renal impairment?",
    "A": "No adjustment needed",
    "B": "15-25 mg/kg three times per week",
    "C": "Increase to daily dosing",
    "D": "Stop the medication",
    "Answer": "B",
    "Comment": "For CrCl <30ml/min, ethambutol should be 15-25 mg/kg per dose three times per week (not daily).",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 30"
  },
  {
    "Ref": "DRTB0085",
    "Questions": "Which drug requires no dose adjustment in any degree of renal impairment?",
    "A": "Levofloxacin",
    "B": "Ethambutol",
    "C": "Linezolid",
    "D": "Terizidone",
    "Answer": "C",
    "Comment": "Linezolid requires no adjustment in renal impairment, unlike other drugs that need dose or frequency changes.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 30"
  },
  {
    "Ref": "DRTB0086",
    "Questions": "What is the key safety concern with ethionamide in pregnancy?",
    "A": "Bone marrow suppression",
    "B": "Potential association with neural tube defects and exacerbation of pregnancy nausea",
    "C": "Liver toxicity",
    "D": "Renal failure",
    "Answer": "B",
    "Comment": "Ethionamide should only be used if no other options as it's potentially associated with neural tube defects and can exacerbate pregnancy-associated nausea/vomiting.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 31"
  },
  {
    "Ref": "DRTB0087",
    "Questions": "Is breastfeeding contraindicated during RR-TB treatment?",
    "A": "Yes, always contraindicated",
    "B": "Only with injectable drugs",
    "C": "No, breastfeeding should be encouraged with proper infection control",
    "D": "Only if mother is HIV positive",
    "Answer": "C",
    "Comment": "Breastfeeding should be encouraged in most women, and RR-TB medications are not a contraindication, with appropriate infection control measures.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 31"
  },
  {
    "Ref": "DRTB0088",
    "Questions": "What is the rationale for treating RR-TB and HIV simultaneously?",
    "A": "Convenience only",
    "B": "To improve chances of RR-TB treatment success through viral suppression",
    "C": "Required by guidelines",
    "D": "To reduce pill burden",
    "Answer": "B",
    "Comment": "All RR-TB/HIV co-infected people should receive ART to suppress viral load to improve chances of RR-TB treatment success.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 32"
  },
  {
    "Ref": "DRTB0089",
    "Questions": "Why is TLD the preferred ART regimen for RR-TB/HIV patients?",
    "A": "Cheapest option",
    "B": "Compatible with all RR-TB drugs, well tolerated, minimizes pill burden",
    "C": "Only option available",
    "D": "Required by international guidelines",
    "Answer": "B",
    "Comment": "TLD is preferred because dolutegravir works with all RR-TB medications, is well tolerated, and minimizes pill burden (one tablet daily).",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 32"
  },
  {
    "Ref": "DRTB0090",
    "Questions": "Should co-trimoxazole be provided to all RR-TB/HIV patients?",
    "A": "Only if CD4 <200",
    "B": "Only if CD4 <350",
    "C": "Yes, regardless of CD4 count as TB is WHO Stage 3",
    "D": "Never with RR-TB treatment",
    "Answer": "C",
    "Comment": "Co-trimoxazole should be provided regardless of CD4 count, as TB is a WHO Stage 3 condition.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 32"
  },
  {
    "Ref": "DRTB0091",
    "Questions": "When can clients on PI-containing regimens switch to TLD same-day?",
    "A": "Never",
    "B": "Only after resistance testing",
    "C": "If VL <1000 c/mL, on regimen <2 years, or <80% adherent",
    "D": "Only if treatment failure",
    "Answer": "C",
    "Comment": "Same-day switch to TLD is possible if VL <1000 c/mL, been on PI regimen <2 years, or <80% adherent to PI regimen.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 33"
  },
  {
    "Ref": "DRTB0092",
    "Questions": "What eGFR level is acceptable for TDF use in children 10-16 years?",
    "A": ">50 mL/min/1.73 m²",
    "B": ">60 mL/min/1.73 m²",
    "C": ">80 mL/min/1.73 m²",
    "D": ">90 mL/min/1.73 m²",
    "Answer": "C",
    "Comment": "For children ≥10 and <16 years, eGFR must be >80 mL/min/1.73 m² using Counahan Barratt formula for TDF use.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 34"
  },
  {
    "Ref": "DRTB0093",
    "Questions": "What screening tool is recommended for substance use in RR-TB patients?",
    "A": "CAGE questionnaire",
    "B": "WHO Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)",
    "C": "Beck Depression Inventory",
    "D": "Mini Mental State Exam",
    "Answer": "B",
    "Comment": "Routine screening should use the WHO Alcohol, Smoking and Substance Involvement Screening Test (ASSIST).",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 35"
  },
  {
    "Ref": "DRTB0094",
    "Questions": "Should RR-TB treatment be delayed until complete sobriety in substance users?",
    "A": "Yes, always wait for sobriety",
    "B": "No, should initiate RR-TB treatment even without complete sobriety",
    "C": "Only if patient is motivated",
    "D": "Depends on type of substance",
    "Answer": "B",
    "Comment": "RR-TB treatment should be initiated even if there is not complete sobriety, with enhanced adherence support.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 35"
  },
  {
    "Ref": "DRTB0095",
    "Questions": "How frequently should clinical evaluation be performed during BPaL-L treatment?",
    "A": "Weekly",
    "B": "Every 2 weeks",
    "C": "Monthly",
    "D": "Every 3 months",
    "Answer": "C",
    "Comment": "Clinical evaluation including assessment of treatment response and adverse events should be performed monthly.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 36"
  },
  {
    "Ref": "DRTB0096",
    "Questions": "When should visual acuity screening be performed?",
    "A": "Only at baseline",
    "B": "Baseline and end of treatment",
    "C": "At each visit during linezolid treatment",
    "D": "Only if symptoms develop",
    "Answer": "C",
    "Comment": "Visual acuity should be checked at every visit when the patient is on linezolid to monitor for optic neuritis.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 39"
  },
  {
    "Ref": "DRTB0097",
    "Questions": "What action is required if visual acuity drops by more than two lines?",
    "A": "Continue treatment and monitor",
    "B": "Reduce linezolid dose",
    "C": "Refer for ophthalmology assessment or permanently discontinue linezolid",
    "D": "Add eye drops",
    "Answer": "C",
    "Comment": "More than two line drop in visual acuity requires ophthalmology referral for full examination or permanent linezolid discontinuation if referral unavailable.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 39"
  },
  {
    "Ref": "DRTB0098",
    "Questions": "Which adverse events must be reported to EDRWeb regardless of grading?",
    "A": "Only Grade 4 and 5 events",
    "B": "Only serious adverse events",
    "C": "All adverse events that lead to drug or treatment interruption",
    "D": "Only unexpected events",
    "Answer": "C",
    "Comment": "All adverse events leading to interruption of a drug or entire treatment regimen must be recorded in folder and EDRWeb regardless of grading.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 41"
  },
  {
    "Ref": "DRTB0099",
    "Questions": "What defines a Grade 4 (potentially life-threatening) adverse event?",
    "A": "Any hospitalization",
    "B": "Inability to perform basic self-care functions OR medical intervention required to prevent permanent impairment",
    "C": "Severe symptoms interfering with activities",
    "D": "Any serious adverse event",
    "Answer": "B",
    "Comment": "Grade 4 events cause inability to perform basic self-care functions OR require medical/operative intervention to prevent permanent impairment, disability, or death.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 42"
  },
  {
    "Ref": "DRTB0100",
    "Questions": "What should be documented during post-treatment follow-up visits?",
    "A": "Clinical assessment only",
    "B": "Physical examination and sputum for TB microscopy and culture",
    "C": "Chest X-ray only",
    "D": "Blood tests only",
    "Answer": "B",
    "Comment": "Post-treatment visits at 6 and 12 months must include physical examination and sputum collection for TB microscopy and culture, with results documented in patient folder and electronic register.",
    "Source": "RR-TB Clinical Guidelines (September 2023) Page 44"
  },
  {
    "Ref": "Paeds0101",
    "Questions": "Which of the following drugs is strictly CONTRAINDICATED in the management of hyperactive delirium in a child with known traumatic brain injury (TBI) due to its potential to lower the seizure threshold and increase intracranial pressure (ICP)?",
    "A": "Lorazepam",
    "B": "Haloperidol",
    "C": "Midazolam",
    "D": "Propofol",
    "Answer": "B",
    "Comment": "Haloperidol, while an effective antipsychotic, can lower the seizure threshold and is often avoided in acute TBI. Benzodiazepines (Lorazepam/Midazolam) are preferred for agitation/seizures in this setting. The TBI management is discussed in Chapter 1.",
    "Source": "Paeds EML (2023) Page 1.30"
  },
  {
    "Ref": "Paeds0102",
    "Questions": "In the management of severe corrosive ingestion, what is the recommended dose and route for the immediate administration of Dexamethasone (if used, as per protocol) for presumed oesophageal injury?",
    "A": "0.1 mg/kg IV, maximum 4 mg, single dose.",
    "B": "0.5 mg/kg IV, maximum 8 mg, single dose.",
    "C": "1 mg/kg IV, maximum 40 mg, daily for 5 days.",
    "D": "2 mg/kg IV, maximum 100 mg, daily for 10 days.",
    "Answer": "B",
    "Comment": "High-dose corticosteroids (Dexamethasone) are sometimes used for severe (Grade 2b or 3) corrosive ingestion to prevent stricture formation, with 0.5 mg/kg IV being a standard initial dose in this context, although their use is controversial and specialist-led.",
    "Source": "Paeds EML (2023) Page 18.9"
  },
  {
    "Ref": "Paeds0103",
    "Questions": "A 6-year-old child presents with a complex partial seizure. What is the recommended first-line prophylactic oral antiepileptic drug (AED) for long-term management in a resource-limited setting?",
    "A": "Carbamazepine",
    "B": "Ethosuximide",
    "C": "Phenobarbitone",
    "D": "Levetiracetam",
    "Answer": "A",
    "Comment": "For focal (partial) seizures, Carbamazepine is a highly effective, cost-effective first-line agent, though drug monitoring and interactions must be managed. Ethosuximide is for absence seizures. Phenobarbitone is often reserved for neonates or refractory cases.",
    "Source": "Paeds EML (2023) Page 13.7"
  },
  {
    "Ref": "Paeds0104",
    "Questions": "What is the primary intervention for a child with suspected heat stroke (Core Temp > 40°C) whose mental status is altered?",
    "A": "Aggressive, passive cooling (tepid sponging).",
    "B": "Rapid active cooling (ice packs, cooling blanket, evaporative cooling) and fluid resuscitation.",
    "C": "Administering oral Dantrolene to relax muscles.",
    "D": "IV Paracetamol and Ibuprofen.",
    "Answer": "B",
    "Comment": "Heat stroke requires immediate, rapid active cooling, prioritised over all other treatments, aiming for a core temperature reduction to 39°C within the first 30 minutes. Fluid resuscitation is supportive.",
    "Source": "Paeds EML (2023) Page 1.25"
  },
  {
    "Ref": "Paeds0105",
    "Questions": "In a child with known Chronic Liver Disease (CLD) and ascites, which diuretic regimen is recommended for initial management?",
    "A": "Furosemide monotherapy.",
    "B": "Spironolactone monotherapy.",
    "C": "Combination of Spironolactone and Furosemide.",
    "D": "Hydrochlorothiazide and Amiloride.",
    "Answer": "C",
    "Comment": "The combination of Spironolactone (as a primary agent for ascites in cirrhosis) and Furosemide (to augment natriuresis and counter hyperkalaemia from Spironolactone) is the standard treatment.",
    "Source": "Paeds EML (2023) Page 2.27"
  },
  {
    "Ref": "Paeds0106",
    "Questions": "For an infant with severe dehydration due to gastroenteritis who is in shock, which specific IV fluid type is the initial replacement fluid of choice?",
    "A": "5% Dextrose in Normal Saline.",
    "B": "0.9% Normal Saline or Ringer's Lactate.",
    "C": "2.5% Dextrose in 0.45% Saline.",
    "D": "50% Dextrose in Water.",
    "Answer": "B",
    "Comment": "Isotonic crystalloids (Normal Saline or Ringer's Lactate) are the only fluids indicated for rapid volume expansion/shock resuscitation to replace fluid loss and expand intravascular volume.",
    "Source": "Paeds EML (2023) Page 1.13"
  },
  {
    "Ref": "Paeds0107",
    "Questions": "Which haematological abnormality is typically expected during the first 6-8 weeks of life in a premature infant (< 32 weeks gestation) and requires iron/folate supplementation?",
    "A": "Thalassaemia Minor.",
    "B": "Anaemia of Prematurity.",
    "C": "Iron Deficiency Anaemia (IDA).",
    "D": "Diamond-Blackfan Anaemia.",
    "Answer": "B",
    "Comment": "Anaemia of prematurity is a physiological, multi-factorial anaemia seen in the first weeks/months of life. While it's largely normocytic/normochromic, it is managed with iron and folate supplementation, and sometimes transfusion.",
    "Source": "Paeds EML (2023) Page 3.7"
  },
  {
    "Ref": "Paeds0108",
    "Questions": "A 10-year-old presents with acute, severe epistaxis refractory to nasal packing. Which pharmacological agent can be administered topically or orally to stabilise the clot?",
    "A": "Desmopressin (DDAVP).",
    "B": "Tranexamic Acid.",
    "C": "Factor IX concentrate.",
    "D": "Recombinant Activated Factor VII (rFVIIa).",
    "Answer": "B",
    "Comment": "Tranexamic acid is an antifibrinolytic agent that stabilises clots and is used both topically (soaked gauze) and orally/IV for refractory bleeding, particularly in ENT and trauma/coagulopathy settings.",
    "Source": "Paeds EML (2023) Page 3.19, 17.15"
  },
  {
    "Ref": "Paeds0109",
    "Questions": "For a child with newly diagnosed Chronic Kidney Disease (CKD) and secondary Hyperparathyroidism, what is the initial therapeutic approach to manage phosphate levels?",
    "A": "Immediate initiation of Cinacalcet (calcimimetic).",
    "B": "Low-dose Vitamin D (e.g., Calcitriol) monotherapy.",
    "C": "Dietary phosphate restriction and initiation of phosphate binders (e.g., Calcium Acetate).",
    "D": "Urgent parathyroidectomy.",
    "Answer": "C",
    "Comment": "The initial management of CKD-Mineral and Bone Disorder (CKD-MBD) focuses on reducing phosphate absorption with dietary restriction and phosphate binders. Vitamin D analogues are added later if PTH remains high.",
    "Source": "Paeds EML (2023) Page 6.22"
  },
  {
    "Ref": "Paeds0110",
    "Questions": "Which of the following signs in a dehydrated child is the most reliable predictor of impending cardiovascular collapse (pre-terminal sign) and necessitates immediate volume resuscitation?",
    "A": "Sunken fontanelle.",
    "B": "Tachypnoea.",
    "C": "Capillary refill time > 4 seconds.",
    "D": "Lethargy/impaired consciousness.",
    "Answer": "D",
    "Comment": "Lethargy/impaired consciousness (AVPU 'P' or 'U') is a critical sign of severe dehydration and shock, indicating reduced cerebral perfusion and impending cardiovascular collapse. Capillary refill > 2s is part of severe dehydration, but a change in consciousness is often terminal.",
    "Source": "Paeds EML (2023) Page 1.13"
  },
  {
    "Ref": "Paeds0111",
    "Questions": "What is the recommended initial dose of oral Prednisone for an adolescent with a severe flare of Ulcerative Colitis (UC)?",
    "A": "0.5 mg/kg daily (max 20 mg).",
    "B": "1-2 mg/kg daily (max 60 mg).",
    "C": "5 mg/kg daily (max 100 mg).",
    "D": "20 mg daily, fixed dose.",
    "Answer": "B",
    "Comment": "High-dose systemic steroids (1-2 mg/kg/day, max 60 mg) are the standard induction therapy for moderate-to-severe flares of Inflammatory Bowel Disease (IBD) to achieve remission.",
    "Source": "Paeds EML (2023) Page 2.45"
  },
  {
    "Ref": "Paeds0112",
    "Questions": "For a child with congenital heart disease (CHD) who develops a new fever, which drug is recommended for empiric antibiotic prophylaxis against Infective Endocarditis (IE) if they are undergoing a high-risk dental procedure?",
    "A": "Oral Amoxicillin, 50 mg/kg (max 2g) 1 hour prior.",
    "B": "Intravenous Vancomycin stat.",
    "C": "Oral Azithromycin, 10 mg/kg 1 hour prior.",
    "D": "Intramuscular Benzathine Penicillin G.",
    "Answer": "A",
    "Comment": "Oral Amoxicillin (or Ampicillin) is the first-line IE prophylaxis for high-risk cardiac lesions undergoing high-risk procedures (e.g., dental extraction). The dose is 50 mg/kg. Clindamycin is used for penicillin allergy.",
    "Source": "Paeds EML (2023) Page 4.38"
  },
  {
    "Ref": "Paeds0113",
    "Questions": "Which of the following is the hallmark finding on electroencephalography (EEG) that confirms the diagnosis of West Syndrome (Infantile Spasms)?",
    "A": "Generalised 3 Hz Spike and Wave pattern.",
    "B": "Hypsarrhythmia (chaotic, high-voltage slowing, and spikes).",
    "C": "Focal epileptiform discharges.",
    "D": "Absence of normal background activity.",
    "Answer": "B",
    "Comment": "Hypsarrhythmia is the pathognomonic EEG pattern for West Syndrome, an epileptic encephalopathy of infancy. The 3 Hz pattern is characteristic of absence epilepsy.",
    "Source": "Paeds EML (2023) Page 13.9"
  },
  {
    "Ref": "Paeds0114",
    "Questions": "A neonate presents with signs of early-onset sepsis. What is the standard empirical combination of IV antibiotics recommended as first-line?",
    "A": "Ceftriaxone and Metronidazole.",
    "B": "Ampicillin and Gentamicin.",
    "C": "Vancomycin and Meropenem.",
    "D": "Penicillin G and Ciprofloxacin.",
    "Answer": "B",
    "Comment": "Ampicillin (to cover *Listeria* and Group B Strep) and Gentamicin (to cover Gram-negative organisms) is the most common first-line empirical regimen for neonatal early-onset sepsis.",
    "Source": "Paeds EML (2023) Page 19.33"
  },
  {
    "Ref": "Paeds0115",
    "Questions": "What is the recommended maximum cumulative dose of Doxorubicin (or similar anthracyclines) in children, due to the risk of dose-dependent cardiotoxicity?",
    "A": "50 mg/m²",
    "B": "150 mg/m²",
    "C": "300 mg/m²",
    "D": "550 mg/m²",
    "Answer": "D",
    "Comment": "Anthracycline cardiotoxicity is a major concern. The guideline mentions monitoring cardiac function with a cumulative dose target often around 300-550 mg/m², with 550 mg/m² being a commonly cited upper limit for high risk.",
    "Source": "Paeds EML (2023) Page 24.5"
  },
  {
    "Ref": "Paeds0116",
    "Questions": "Which of the following is an absolute contraindication to the use of Ibuprofen in a child with a febrile illness?",
    "A": "Asthma.",
    "B": "Known Varicella (Chickenpox) infection.",
    "C": "Known Severe Renal Impairment (CKD Stage 4/5).",
    "D": "Recent immunisation (within 24 hours).",
    "Answer": "C",
    "Comment": "NSAIDs, including Ibuprofen, should be avoided or used with extreme caution in severe renal impairment due to the risk of precipitating or worsening acute kidney injury. It is also generally avoided in dehydration.",
    "Source": "Paeds EML (2023) Page 22.10"
  },
  {
    "Ref": "Paeds0117",
    "Questions": "For an adolescent with Type 2 Diabetes Mellitus (T2DM), what is the first-line oral pharmacological agent, provided there are no contraindications?",
    "A": "Insulin (Basal-bolus regimen).",
    "B": "Glibenclamide (Sulfonylurea).",
    "C": "Metformin.",
    "D": "Glucagon-like peptide-1 (GLP-1) Agonist.",
    "Answer": "C",
    "Comment": "Metformin is the first-line oral agent for T2DM in adolescents due to its efficacy, cost-effectiveness, and minimal risk of hypoglycaemia. Insulin is reserved for severe hyperglycaemia or failure of oral agents.",
    "Source": "Paeds EML (2023) Page 7.21"
  },
  {
    "Ref": "Paeds0118",
    "Questions": "In the management of a child with severe Croup (laryngotracheobronchitis) with respiratory distress, what is the recommended dose and route for Adrenaline (Epinephrine)?",
    "A": "0.5 mL (1:1000) IM.",
    "B": "5 mg (1:1000) nebulised.",
    "C": "0.5 mL/kg (1:1000) nebulised, maximum 5 mL.",
    "D": "0.5 mL (1:1000) nebulised, fixed dose.",
    "Answer": "C",
    "Comment": "Nebulised Adrenaline (usually the 1:1000 concentration) is given as 0.5 mL/kg (max 5 mL) to acutely reduce laryngeal oedema, typically following the administration of a systemic corticosteroid (e.g., Dexamethasone).",
    "Source": "Paeds EML (2023) Page 17.1"
  },
  {
    "Ref": "Paeds0119",
    "Questions": "Which of the following is the most definitive intervention for the primary treatment of a large patent ductus arteriosus (PDA) in a premature infant (non-surgical)?",
    "A": "IV Salbutamol.",
    "B": "IV Prostaglandin E1.",
    "C": "IV Indomethacin or Ibuprofen.",
    "D": "Oral Furosemide.",
    "Answer": "C",
    "Comment": "NSAIDs (Indomethacin or Ibuprofen) inhibit prostaglandin synthesis, which is required to keep the PDA patent, and are the primary medical treatment for closure in premature infants.",
    "Source": "Paeds EML (2023) Page 19.37"
  },
  {
    "Ref": "Paeds0120",
    "Questions": "A 10-month-old infant is diagnosed with acute, mild-to-moderate Hyponatraemia (Na 125 mmol/L) due to gastroenteritis. What is the recommended correction rate to prevent Osmotic Demyelination Syndrome (ODS)?",
    "A": "Rapid correction of 10 mmol/L in the first hour.",
    "B": "Slow correction: aiming for < 10-12 mmol/L increase in the first 24 hours.",
    "C": "Correction rate of 20 mmol/L in 48 hours.",
    "D": "Correction rate of 5 mmol/L per hour until Na > 130 mmol/L.",
    "Answer": "B",
    "Comment": "In non-symptomatic or mildly symptomatic hyponatraemia, the correction must be slow and controlled, aiming for a total rise of no more than 10-12 mmol/L in 24 hours to prevent ODS/Central Pontine Myelinolysis.",
    "Source": "Paeds EML (2023) Page 7.33"
  },
  {
    "Ref": "Paeds0121",
    "Questions": "In the palliative care of a child with intractable vomiting and gastric stasis, which prokinetic agent is generally preferred over Metoclopramide due to a lower risk of extrapyramidal side effects, especially in oncology patients?",
    "A": "Ondansetron",
    "B": "Loperamide",
    "C": "Domperidone",
    "D": "Cyclizine",
    "Answer": "C",
    "Comment": "Domperidone, which does not readily cross the blood-brain barrier, has a lower risk of causing extrapyramidal symptoms compared to Metoclopramide and is a preferred prokinetic in paediatric palliative care.",
    "Source": "Paeds EML (2023) Page 21.4"
  },
  {
    "Ref": "Paeds0122",
    "Questions": "Which of the following conditions is an absolute indication for surgical intervention in a child with Acute Appendicitis?",
    "A": "Tenderness in the right lower quadrant.",
    "B": "Leukocytosis > 15 x 10⁹/L.",
    "C": "Perforation confirmed on imaging or with generalised peritonitis.",
    "D": "Pain duration of > 48 hours.",
    "Answer": "C",
    "Comment": "While clinical suspicion is key for diagnosis, perforation/generalised peritonitis is a complicated appendicitis that mandates emergency surgery (Appendectomy) or interval appendectomy (if abscess is contained).",
    "Source": "Paeds EML (2023) Page 2.41"
  },
  {
    "Ref": "Paeds0123",
    "Questions": "What is the recommended maximum infusion rate for potassium replacement in a child with severe hypokalaemia (K < 2.5 mmol/L) to avoid cardiac arrest?",
    "A": "0.1 mmol/kg/hour",
    "B": "0.5 mmol/kg/hour",
    "C": "1.0 mmol/kg/hour",
    "D": "2.0 mmol/kg/hour",
    "Answer": "B",
    "Comment": "The maximum safe rate for IV potassium replacement in peripheral lines is 0.5 mmol/kg/hour, with faster rates (up to 1.0 mmol/kg/hr) reserved for extreme emergencies via central access and continuous cardiac monitoring.",
    "Source": "Paeds EML (2023) Page 7.36"
  },
  {
    "Ref": "Paeds0124",
    "Questions": "Which clinical feature is most likely to suggest a diagnosis of Acute Epiglottitis (Supraglottitis) over Croup (laryngotracheobronchitis)?",
    "A": "A barking cough.",
    "B": "Gradual onset of symptoms over 3 days.",
    "C": "High fever, toxic appearance, and drooling.",
    "D": "Relief of stridor with nebulised Adrenaline.",
    "Answer": "C",
    "Comment": "Epiglottitis is characterised by rapid onset, high fever, toxic appearance, drooling, and the inability to swallow (tripod position), whereas Croup is characterised by a barking cough and gradual onset.",
    "Source": "Paeds EML (2023) Page 17.2"
  },
  {
    "Ref": "Paeds0125",
    "Questions": "In the management of Iron Deficiency Anaemia (IDA), when should parenteral (IV) iron be considered over oral therapy?",
    "A": "Whenever the haemoglobin is below 7 g/dL.",
    "B": "In all patients with chronic blood loss.",
    "C": "Where there is chronic malabsorption (e.g., IBD) or intolerance to oral iron, or if patient is on Dialysis.",
    "D": "Only if the patient requires an urgent blood transfusion.",
    "Answer": "C",
    "Comment": "IV iron is reserved for failure of oral therapy, malabsorption (coeliac, IBD), chronic blood loss requiring quick correction, or patients on renal replacement therapy (dialysis).",
    "Source": "Paeds EML (2023) Page 3.9"
  },
  {
    "Ref": "Paeds0126",
    "Questions": "Which of the following is the most common primary mechanism leading to mortality in children with severe asthma?",
    "A": "Status epilepticus.",
    "B": "Respiratory acidosis due to air trapping and muscle fatigue.",
    "C": "Severe hypoxaemia due to V/Q mismatch.",
    "D": "Cardiac arrest due to beta-agonist overdose.",
    "Answer": "B",
    "Comment": "In severe/fatal asthma, the immediate cause of death is usually respiratory failure due to muscle fatigue leading to $\text{CO}_2$ retention and respiratory acidosis. Hypoxaemia is also a major factor but acidosis is the critical decompensation point.",
    "Source": "Paeds EML (2023) Page 15.19"
  },
  {
    "Ref": "Paeds0127",
    "Questions": "For an infant with severe Gastro-oesophageal Reflux Disease (GORD) refractory to conservative management (thickened feeds, positional changes), what is the recommended first-line pharmacological agent?",
    "A": "Metoclopramide (Prokinetic).",
    "B": "Omeprazole (Proton Pump Inhibitor).",
    "C": "Ranitidine (H2 Receptor Antagonist).",
    "D": "Domperidone (Prokinetic).",
    "Answer": "B",
    "Comment": "Proton Pump Inhibitors (PPIs) are the most effective class for reducing acid production and are the first-line pharmaceutical treatment for refractory GORD. Prokinetics are reserved for specific motility issues.",
    "Source": "Paeds EML (2023) Page 2.24"
  },
  {
    "Ref": "Paeds0128",
    "Questions": "What is the recommended duration of antibiotic therapy for a child with an uncomplicated Urinary Tract Infection (UTI) who shows prompt clinical improvement with oral antibiotics?",
    "A": "3 days",
    "B": "5 days",
    "C": "7-10 days",
    "D": "14 days",
    "Answer": "C",
    "Comment": "For uncomplicated pyelonephritis (upper UTI) or lower UTI in children, a standard course of 7-10 days is generally recommended. Shorter courses (3-5 days) are sometimes used for cystitis in older children but 7-10 days provides better coverage.",
    "Source": "Paeds EML (2023) Page 6.13"
  },
  {
    "Ref": "Paeds0129",
    "Questions": "Which of the following drugs is the first-line agent for the emergency management of a Tetanus spasm in a child?",
    "A": "Morphine (IV).",
    "B": "Phenytoin (IV).",
    "C": "Diazepam (IV/Rectal).",
    "D": "Baclofen (Intrathecal).",
    "Answer": "C",
    "Comment": "Benzodiazepines, particularly Diazepam or Midazolam, are the first-line treatment for muscle spasms and rigidity in Tetanus, providing both sedation and muscle relaxation.",
    "Source": "Paeds EML (2023) Page 8.34"
  },
  {
    "Ref": "Paeds0130",
    "Questions": "In the management of a child with an unstable cervical spine injury, what is the most critical immediate intervention to prevent secondary spinal cord injury?",
    "A": "Urgent high-dose methylprednisolone.",
    "B": "Immediate application of external heat.",
    "C": "Manual in-line immobilisation and hard cervical collar.",
    "D": "Urgent tracheostomy placement.",
    "Answer": "C",
    "Comment": "Immobilisation (Manual in-line stabilisation, then rigid collar/backboard) is the immediate priority in trauma to prevent movement of an unstable fracture and subsequent cord damage.",
    "Source": "Paeds EML (2023) Page 1.28"
  },
  {
    "Ref": "Paeds0131",
    "Questions": "What is the primary intervention for a symptomatic, moderate-to-large Ventricular Septal Defect (VSD) in a 3-month-old infant with early signs of Heart Failure (HF)?",
    "A": "Surgical VSD closure within 1 week.",
    "B": "Furosemide and Captopril (ACE inhibitor) to manage HF.",
    "C": "Prostaglandin E1 infusion.",
    "D": "Serial monitoring, with no intervention until 1 year of age.",
    "Answer": "B",
    "Comment": "Symptomatic VSDs cause HF due to high pulmonary blood flow. Management is medical (diuretics and ACE inhibitors) to control HF symptoms, while awaiting potential spontaneous closure or planning for surgical closure if symptoms persist/worsen.",
    "Source": "Paeds EML (2023) Page 4.7"
  },
  {
    "Ref": "Paeds0132",
    "Questions": "In a child with known Sickle Cell Anaemia (SCA), which medication is recommended to reduce the frequency of vaso-occlusive crises and the risk of Acute Chest Syndrome (ACS)?",
    "A": "Regular Aspirin.",
    "B": "Daily Hydroxycarbamide (Hydroxyurea).",
    "C": "Monthly IVIG.",
    "D": "Daily Iron Chelation therapy.",
    "Answer": "B",
    "Comment": "Hydroxycarbamide (Hydroxyurea) is a disease-modifying agent that increases Fetal Haemoglobin (HbF), reducing sickling and the incidence of painful crises and ACS.",
    "Source": "Paeds EML (2023) Page 3.6"
  },
  {
    "Ref": "Paeds0133",
    "Questions": "What is the recommended initial dose of Adenosine for treating stable Supraventricular Tachycardia (SVT) in a child (given as rapid IV push)?",
    "A": "0.05 mg/kg",
    "B": "0.1 mg/kg",
    "C": "0.5 mg/kg",
    "D": "1.0 mg/kg",
    "Answer": "B",
    "Comment": "The initial dose of Adenosine is 0.1 mg/kg given as a rapid IV push, followed by a flush. The dose is doubled (0.2 mg/kg) if the initial dose fails to terminate the SVT.",
    "Source": "Paeds EML (2023) Page 4.41"
  },
  {
    "Ref": "Paeds0134",
    "Questions": "A child presents with a new diagnosis of Beta-Thalassaemia Major. What is the key long-term complication that dictates the need for aggressive monitoring and Chelation Therapy?",
    "A": "Refractory macrocytic anaemia.",
    "B": "Recurrent haemolytic crises.",
    "C": "Secondary haemochromatosis (iron overload) due to chronic transfusion.",
    "D": "Acute splenic sequestration crisis.",
    "Answer": "C",
    "Comment": "Chronic, lifelong blood transfusions for Beta-Thalassaemia Major lead to iron overload (haemochromatosis) in organs, particularly the heart and liver, necessitating chelation therapy (e.g., Deferasirox or Desferrioxamine).",
    "Source": "Paeds EML (2023) Page 3.10"
  },
  {
    "Ref": "Paeds0135",
    "Questions": "In the management of a child with severe symptomatic Coarctation of the Aorta (CoA), which drug is crucial to maintain ductal patency prior to surgical/interventional closure?",
    "A": "Furosemide.",
    "B": "Prostaglandin E1 (Alprostadil).",
    "C": "Dobutamine.",
    "D": "Adrenaline (Epinephrine).",
    "Answer": "B",
    "Comment": "Prostaglandin E1 is used in duct-dependent lesions (like severe CoA) to keep the Ductus Arteriosus patent, ensuring blood flow to the systemic circulation distal to the coarctation.",
    "Source": "Paeds EML (2023) Page 4.5"
  },
  {
    "Ref": "Paeds0136",
    "Questions": "Which of the following is the most definitive criterion for diagnosing Immune Thrombocytopaenic Purpura (ITP)?",
    "A": "Platelet count < 100 x 10⁹/L and presence of petechiae/purpura.",
    "B": "Platelet count < 50 x 10⁹/L and presence of giant platelets on peripheral smear.",
    "C": "Exclusion of other causes of thrombocytopenia (diagnosis of exclusion).",
    "D": "Positive direct Coombs' test.",
    "Answer": "C",
    "Comment": "ITP is a diagnosis of exclusion. The guideline stresses that a diagnosis of ITP requires ruling out other causes of isolated thrombocytopenia, such as malignancy, infection, or drug effects.",
    "Source": "Paeds EML (2023) Page 3.16"
  },
  {
    "Ref": "Paeds0137",
    "Questions": "A 10-year-old is on chronic Warfarin therapy for a mechanical heart valve. What is the recommended management if the patient's INR is supratherapeutic (e.g., 5.5) but with no active bleeding?",
    "A": "Omit one dose of Warfarin and recheck INR in 24 hours.",
    "B": "Stop Warfarin and administer IV Fresh Frozen Plasma (FFP).",
    "C": "Stop Warfarin, administer oral low-dose Vitamin K, and monitor closely.",
    "D": "Immediately admit for bridging with low molecular weight heparin (LMWH).",
    "Answer": "C",
    "Comment": "For supratherapeutic INR without bleeding, the guideline advises stopping Warfarin and administering a small dose of oral Vitamin K to gently reduce INR, avoiding rapid reversal that risks thrombosis.",
    "Source": "Paeds EML (2023) Page 4.45"
  },
  {
    "Ref": "Paeds0138",
    "Questions": "What is the recommended duration of secondary prophylaxis with Benzathine Penicillin G for a child who had Rheumatic Fever (RF) but no evidence of carditis?",
    "A": "Until age 16 years, or for 5 years after the last episode (whichever is longer).",
    "B": "Until age 21 years, or for 10 years after the last episode (whichever is longer).",
    "C": "For life.",
    "D": "Only for 6 months after the acute episode.",
    "Answer": "A",
    "Comment": "The duration of prophylaxis varies by carditis severity. For RF without carditis, the shortest duration is recommended: 5 years or until age 16 (whichever is longer).",
    "Source": "Paeds EML (2023) Page 4.13"
  },
  {
    "Ref": "Paeds0139",
    "Questions": "Which haematological disorder is often characterised by the finding of 'spherocytes' on the peripheral blood smear and requires Folic Acid supplementation for life?",
    "A": "Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.",
    "B": "Hereditary Spherocytosis (HS).",
    "C": "Paroxysmal Nocturnal Haemoglobinuria (PNH).",
    "D": "Aplastic Anaemia.",
    "Answer": "B",
    "Comment": "Hereditary Spherocytosis is a defect in the red cell membrane, leading to spherical cells (spherocytes) that are prematurely removed by the spleen. Folic acid is required to support the chronic, increased red cell production.",
    "Source": "Paeds EML (2023) Page 3.11"
  },
  {
    "Ref": "Paeds0140",
    "Questions": "Which congenital heart defect is most often associated with the clinical finding of a continuous, 'machinery-like' murmur heard loudest under the left clavicle?",
    "A": "Atrial Septal Defect (ASD).",
    "B": "Tetralogy of Fallot (TOF).",
    "C": "Patent Ductus Arteriosus (PDA).",
    "D": "Aortic Stenosis (AS).",
    "Answer": "C",
    "Comment": "The continuous, 'machinery-like' murmur is the classic auscultatory finding of a Patent Ductus Arteriosus (PDA).",
    "Source": "Paeds EML (2023) Page 4.2"
  },
  {
    "Ref": "Paeds0141",
    "Questions": "A 1-year-old is diagnosed with Vesicoureteral Reflux (VUR) Grade III following a febrile UTI. What is the recommended primary preventative management strategy to prevent recurrent UTIs?",
    "A": "Long-term low-dose antibiotic prophylaxis (e.g., Trimethoprim/Sulfamethoxazole).",
    "B": "Surgical ureteral re-implantation within 6 months.",
    "C": "Daily high-dose Vitamin C.",
    "D": "Serial monitoring without intervention, as VUR spontaneously resolves.",
    "Answer": "A",
    "Comment": "Continuous Antibiotic Prophylaxis (CAP) remains a key strategy for VUR in young children to prevent recurrent febrile UTIs and subsequent renal scarring, particularly for Grade III and higher.",
    "Source": "Paeds EML (2023) Page 6.13"
  },
  {
    "Ref": "Paeds0142",
    "Questions": "What is the recommended initial IV fluid bolus for a child presenting with severe Hyperkalaemia (K > 6.5 mmol/L with ECG changes) to shift potassium intracellularly?",
    "A": "Calcium Gluconate (10%) alone.",
    "B": "Salbutamol nebulisation alone.",
    "C": "Insulin and Dextrose (Glucose) infusion.",
    "D": "Sodium Bicarbonate.",
    "Answer": "C",
    "Comment": "The combination of Insulin (to drive K intracellularly) and Dextrose (to prevent hypoglycaemia) is the most potent agent for shifting potassium in an emergency, used after Calcium Gluconate (membrane stabilisation).",
    "Source": "Paeds EML (2023) Page 7.35"
  },
  {
    "Ref": "Paeds0143",
    "Questions": "In a child with a known Adrenocortical Tumour, which hormone is the most common to be excessively secreted, leading to specific clinical features?",
    "A": "Thyroxine.",
    "B": "Insulin.",
    "C": "Cortisol (Cushing's Syndrome).",
    "D": "Growth Hormone.",
    "Answer": "C",
    "Comment": "Hypercortisolaemia (Cushing's Syndrome) is one of the most common presentations of adrenal tumours in children, leading to characteristic symptoms like central obesity, striae, and hypertension.",
    "Source": "Paeds EML (2023) Page 7.43"
  },
  {
    "Ref": "Paeds0144",
    "Questions": "For a child with Chronic Kidney Disease (CKD) who is malnourished, what is the key dietary adjustment recommended to slow the progression of renal dysfunction?",
    "A": "Aggressive fluid restriction.",
    "B": "High-protein diet to prevent muscle wasting.",
    "C": "Moderate protein restriction to reduce glomerular hyperfiltration.",
    "D": "Low-calorie, high-fibre diet.",
    "Answer": "C",
    "Comment": "Protein restriction (but sufficient for growth) is a long-standing recommendation in CKD to reduce glomerular hyperfiltration and proteinuria, theoretically slowing the decline in GFR.",
    "Source": "Paeds EML (2023) Page 6.20"
  },
  {
    "Ref": "Paeds0145",
    "Questions": "In the management of Chronic Adrenal Insufficiency (e.g., Congenital Adrenal Hyperplasia, CAH), which electrolyte imbalance is the primary indication for adding a mineralocorticoid (e.g., Fludrocortisone) to the glucocorticoid replacement?",
    "A": "Hypercalcaemia.",
    "B": "Hyponatraemia and Hyperkalaemia (Salt-wasting).",
    "C": "Hypernatraemia.",
    "D": "Hypomagnesaemia.",
    "Answer": "B",
    "Comment": "Mineralocorticoids (like Fludrocortisone) are required to manage the salt-wasting crisis, which presents with hyponatraemia and hyperkalaemia due to deficient Aldosterone production in conditions like CAH.",
    "Source": "Paeds EML (2023) Page 7.42"
  },
  {
    "Ref": "Paeds0146",
    "Questions": "A 14-year-old female presents with primary amenorrhoea and short stature. The initial investigation should include which hormonal test to rule out primary ovarian failure (Turner Syndrome)?",
    "A": "High serum Prolactin.",
    "B": "Elevated Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH).",
    "C": "Low serum Cortisol.",
    "D": "Low serum Thyroid-Stimulating Hormone (TSH).",
    "Answer": "B",
    "Comment": "In primary ovarian failure (e.g., Turner Syndrome), the pituitary gland releases high levels of FSH/LH (hypergonadotropic hypogonadism) in an attempt to stimulate non-functional ovaries.",
    "Source": "Paeds EML (2023) Page 7.45"
  },
  {
    "Ref": "Paeds0147",
    "Questions": "In the context of the management of Diabetic Ketoacidosis (DKA), what is the key concern regarding the use of sodium bicarbonate?",
    "A": "Increased risk of hypokalaemia and paradoxical CNS acidosis.",
    "B": "Increased risk of peripheral oedema.",
    "C": "Slower resolution of ketoacidosis.",
    "D": "No risk, should be routinely used for all DKA patients.",
    "Answer": "A",
    "Comment": "Bicarbonate use in DKA is controversial and generally restricted to very severe acidosis (pH < 6.9) due to the risk of shifting the $\text{CO}_2$ curve, potentially worsening cerebral acidosis, and increasing the risk of hypokalaemia.",
    "Source": "Paeds EML (2023) Page 7.19"
  },
  {
    "Ref": "Paeds0148",
    "Questions": "Which of the following is the hallmark finding on urine analysis suggestive of an upper Urinary Tract Infection (Acute Pyelonephritis)?",
    "A": "Isolated haematuria.",
    "B": "Presence of epithelial cells only.",
    "C": "White cell casts.",
    "D": "Hyaline casts.",
    "Answer": "C",
    "Comment": "White cell casts are highly indicative of inflammation/infection within the renal tubules and are the hallmark finding of pyelonephritis (upper UTI).",
    "Source": "Paeds EML (2023) Page 6.13"
  },
  {
    "Ref": "Paeds0149",
    "Questions": "For a child with Central Diabetes Insipidus (DI), what is the first-line replacement therapy?",
    "A": "Oral Desmopressin (DDAVP).",
    "B": "Thiazide diuretics.",
    "C": "IV 0.9% Normal Saline.",
    "D": "Hydrocortisone replacement.",
    "Answer": "A",
    "Comment": "Desmopressin (synthetic ADH) is the mainstay treatment for Central DI, replacing the deficient hormone and allowing water reabsorption to occur, thus controlling polyuria/polydipsia.",
    "Source": "Paeds EML (2023) Page 7.28"
  },
  {
    "Ref": "Paeds0150",
    "Questions": "A neonate presents with Persistent Pulmonary Hypertension of the Newborn (PPHN). Which inhaled gas is recommended to be administered to the infant to cause selective pulmonary vasodilation?",
    "A": "Heliox.",
    "B": "Nitrous Oxide.",
    "C": "Inhaled Nitric Oxide (iNO).",
    "D": "High-flow Oxygen (100%).",
    "Answer": "C",
    "Comment": "Inhaled Nitric Oxide (iNO) is the specific pulmonary vasodilator used to treat PPHN. It selectively dilates the pulmonary vasculature without causing systemic hypotension.",
    "Source": "Paeds EML (2023) Page 19.30"
  },
  {
    "Ref": "Paeds0151",
    "Questions": "In the context of HIV management, which Antiretroviral (ARV) drug, commonly used in first-line regimens, is known to be associated with significant nephrotoxicity and bone mineral density loss?",
    "A": "Abacavir (ABC).",
    "B": "Efavirenz (EFV).",
    "C": "Tenofovir (TDF).",
    "D": "Dolutegravir (DTG).",
    "Answer": "C",
    "Comment": "Tenofovir Disoproxil Fumarate (TDF) is associated with proximal renal tubular dysfunction (Fanconi syndrome) and bone demineralisation, requiring careful monitoring of renal function and phosphate levels.",
    "Source": "Paeds EML (2023) Page 9.14"
  },
  {
    "Ref": "Paeds0152",
    "Questions": "For a child diagnosed with Tuberculous Lymphadenitis (TB in lymph nodes), what is the recommended total duration of the standard treatment regimen (intensive phase + continuation phase)?",
    "A": "3 months",
    "B": "6 months",
    "C": "9 months",
    "D": "12 months",
    "Answer": "B",
    "Comment": "Extrapulmonary TB (excluding TBM, Bone/Joint) generally follows the standard 6-month regimen: 2 months of HRZE (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol) followed by 4 months of HR.",
    "Source": "Paeds EML (2023) Page 10.11"
  },
  {
    "Ref": "Paeds0153",
    "Questions": "Which of the following is the preferred first-line agent for prophylaxis against *Pneumocystis Jiroveci Pneumonia* (PJP) in high-risk HIV-exposed and infected infants?",
    "A": "Isoniazid.",
    "B": "Fluconazole.",
    "C": "Co-Trimoxazole (Trimethoprim/Sulfamethoxazole).",
    "D": "Azithromycin.",
    "Answer": "C",
    "Comment": "Co-Trimoxazole is the standard and highly effective agent for PJP prophylaxis in infants/children with HIV, initiated according to age and immune status criteria.",
    "Source": "Paeds EML (2023) Page 9.13"
  },
  {
    "Ref": "Paeds0154",
    "Questions": "In a child with known drug-sensitive TB on treatment, which drug is most likely to cause optic neuritis (changes in colour vision and acuity)?",
    "A": "Isoniazid (INH).",
    "B": "Rifampicin (RMP).",
    "C": "Pyrazinamide (PZA).",
    "D": "Ethambutol (EMB).",
    "Answer": "D",
    "Comment": "Ethambutol is notorious for causing dose-dependent optic neuritis, leading to red-green colour blindness and decreased visual acuity, necessitating careful visual monitoring.",
    "Source": "Paeds EML (2023) Page 10.14"
  },
  {
    "Ref": "Paeds0155",
    "Questions": "A child presents with a recent history of a water-borne gastroenteritis and now develops features of haemolytic anaemia, thrombocytopenia, and acute kidney injury (AKI). What is the most likely diagnosis?",
    "A": "Acute Glomerulonephritis.",
    "B": "Haemolytic Uremic Syndrome (HUS).",
    "C": "Systemic Lupus Erythematosus (SLE) flare.",
    "D": "Idiopathic Thrombocytopaenic Purpura (ITP).",
    "Answer": "B",
    "Comment": "The triad of microangiopathic haemolytic anaemia, thrombocytopenia, and AKI, often following a diarrhoeal illness (Shiga-toxin producing E. coli), is characteristic of HUS.",
    "Source": "Paeds EML (2023) Page 6.6"
  },
  {
    "Ref": "Paeds0156",
    "Questions": "Which clinical feature, in a child receiving empiric antibiotic therapy for presumed bacterial Meningitis, is a strong indication for adding Dexamethasone to the regimen?",
    "A": "A history of previous febrile seizures.",
    "B": "Diagnosis of Pneumococcal Meningitis in a child over 6 weeks of age.",
    "C": "Concurrent diagnosis of HIV infection.",
    "D": "High fever (> 40°C).",
    "Answer": "B",
    "Comment": "Dexamethasone is recommended for *Pneumococcal* Meningitis (H. influenzae is also an indication in certain age groups) to reduce inflammation, which can decrease the risk of hearing loss and other neurological sequelae.",
    "Source": "Paeds EML (2023) Page 8.20"
  },
  {
    "Ref": "Paeds0157",
    "Questions": "What is the recommended duration of antibiotic therapy for a child with an uncomplicated Staphylococcal Scalded Skin Syndrome (SSSS)?",
    "A": "3 days of IV antibiotics only.",
    "B": "7-10 days of IV/oral antibiotics.",
    "C": "21 days of IV antibiotics.",
    "D": "No antibiotics needed, only supportive care.",
    "Answer": "B",
    "Comment": "SSSS is caused by a toxin-producing S. aureus and requires systemic antibiotics, often started IV, then switched to oral to complete a course of 7-10 days, alongside wound care.",
    "Source": "Paeds EML (2023) Page 5.8"
  },
  {
    "Ref": "Paeds0158",
    "Questions": "In a child with known HIV on ART, a viral load (VL) of 20,000 copies/mL after 12 months of therapy is classified as which type of failure?",
    "A": "Immunological failure.",
    "B": "Clinical failure.",
    "C": "Virological failure.",
    "D": "Pharmacological failure.",
    "Answer": "C",
    "Comment": "Virological failure is defined as confirmed (two consecutive readings) VL > 1000 copies/mL after at least 6 months of adherence to ART. A VL of 20,000 is clearly virological failure.",
    "Source": "Paeds EML (2023) Page 9.13"
  },
  {
    "Ref": "Paeds0159",
    "Questions": "Which anti-tuberculous drug is typically discontinued in the continuation phase of standard treatment for drug-sensitive pulmonary TB in a child?",
    "A": "Isoniazid (INH).",
    "B": "Rifampicin (RMP).",
    "C": "Pyrazinamide (PZA).",
    "D": "Ethambutol (EMB).",
    "Answer": "C",
    "Comment": "The standard regimen moves from a 4-drug intensive phase (HRZE) to a 2-drug continuation phase (HR), discontinuing Pyrazinamide and Ethambutol after the first 2 months.",
    "Source": "Paeds EML (2023) Page 10.11"
  },
  {
    "Ref": "Paeds0160",
    "Questions": "In the management of community-acquired bacterial pneumonia in a hospitalised child, which antibiotic is the recommended first-line agent, provided the child is not severely septic?",
    "A": "IV Ampicillin/Penicillin G.",
    "B": "IV Gentamicin and Ampicillin.",
    "C": "Oral Amoxicillin/Clavulanate.",
    "D": "IV Ciprofloxacin.",
    "Answer": "A",
    "Comment": "For hospitalised, non-severe pneumonia, Penicillin G or Ampicillin is the standard first-line choice to cover *S. pneumoniae*, the most common causative agent.",
    "Source": "Paeds EML (2023) Page 15.1"
  },
  {
    "Ref": "Paeds0161",
    "Questions": "What is the primary management for a child presenting with Acute Urinary Retention (AUR) due to a posterior urethral valve (PUV)?",
    "A": "Immediate surgical removal of the valve.",
    "B": "Suprapubic catheter placement.",
    "C": "Placement of a small-bore urethral catheter.",
    "D": "High-dose IV Furosemide.",
    "Answer": "C",
    "Comment": "The immediate management is decompression of the bladder with a urinary catheter. This is often difficult in PUV and may require specialist intervention, but it is the first step to prevent further renal damage.",
    "Source": "Paeds EML (2023) Page 6.17"
  },
  {
    "Ref": "Paeds0162",
    "Questions": "A 7-year-old child presents with a life-threatening adrenal crisis (shock, hypoglycaemia, severe hyponatraemia). What is the most critical initial pharmacological intervention?",
    "A": "IV Normal Saline fluid bolus and IV Dextrose (Glucose) bolus.",
    "B": "High-dose IV Hydrocortisone (stress dose).",
    "C": "IV Calcium Gluconate.",
    "D": "IV Midazolam for seizure prophylaxis.",
    "Answer": "B",
    "Comment": "While fluid and glucose correction (Option A) are critical, the administration of high-dose IV Hydrocortisone (stress dose) is the life-saving intervention for an adrenal crisis, treating the underlying cortisol deficiency.",
    "Source": "Paeds EML (2023) Page 7.42"
  },
  {
    "Ref": "Paeds0163",
    "Questions": "Which of the following is the key long-term complication associated with repeated episodes of severe reflux and pyelonephritis in a child with Vesicoureteral Reflux (VUR)?",
    "A": "Acute Glomerulonephritis.",
    "B": "End-Stage Renal Disease (ESRD) due to renal scarring.",
    "C": "Nephrolithiasis (kidney stones).",
    "D": "Bladder cancer.",
    "Answer": "B",
    "Comment": "Recurrent pyelonephritis, especially in the presence of VUR, leads to chronic pyelonephritis, interstitial inflammation, renal scarring, and ultimately End-Stage Renal Disease (ESRD).",
    "Source": "Paeds EML (2023) Page 6.13"
  },
  {
    "Ref": "Paeds0164",
    "Questions": "What is the recommended dose of Vitamin A for a child over 1 year of age who has Severe Acute Malnutrition (SAM) and is admitted to the hospital?",
    "A": "50,000 IU stat.",
    "B": "100,000 IU stat.",
    "C": "200,000 IU stat.",
    "D": "25,000 IU stat.",
    "Answer": "C",
    "Comment": "Children > 1 year with SAM or recent measles receive 200,000 IU stat, repeated the next day and at 4 weeks, to address deficiency and prevent corneal damage.",
    "Source": "Paeds EML (2023) Page 2.37"
  },
  {
    "Ref": "Paeds0165",
    "Questions": "A child presents with a suspected Thyroid Storm. Which anti-thyroid medication is generally preferred over Carbimazole due to its additional property of inhibiting the peripheral conversion of T4 to T3?",
    "A": "Levothyroxine.",
    "B": "Propylthiouracil (PTU).",
    "C": "Methimazole.",
    "D": "Lugol's Iodine solution.",
    "Answer": "B",
    "Comment": "PTU is preferred in Thyroid Storm/Crisis because, in addition to blocking thyroid hormone synthesis, it inhibits the peripheral deiodination of T4 to the more active T3. Carbimazole/Methimazole are preferred for long-term use.",
    "Source": "Paeds EML (2023) Page 7.39"
  },
  {
    "Ref": "Paeds0166",
    "Questions": "In the initial management of suspected Acute Glomerulonephritis (AGN) with volume overload and hypertension, which class of medication is the most appropriate first-line treatment?",
    "A": "Angiotensin Converting Enzyme (ACE) Inhibitors.",
    "B": "Calcium Channel Blockers (CCBs).",
    "C": "Loop Diuretics (e.g., Furosemide).",
    "D": "Central Alpha-agonists (e.g., Clonidine).",
    "Answer": "C",
    "Comment": "AGN-related hypertension is often volume-dependent. Furosemide/Loop Diuretics are the first-line treatment to manage volume overload and control blood pressure. CCBs or ACEIs are added if needed.",
    "Source": "Paeds EML (2023) Page 6.1"
  },
  {
    "Ref": "Paeds0167",
    "Questions": "What is the recommended initial dose of oral Diazepam for an adolescent in the emergency department for severe anxiety associated with a phobia?",
    "A": "1-2 mg, repeated once after 30 minutes if needed.",
    "B": "5 mg stat, not to be repeated.",
    "C": "10-20 mg stat.",
    "D": "0.1 mg/kg, maximum 10 mg.",
    "Answer": "A",
    "Comment": "The recommended dose for acute anxiety/agitation in older children/adolescents is a low dose of 1-2 mg, with caution, as high doses can lead to respiratory depression or paradoxical agitation.",
    "Source": "Paeds EML (2023) Page 14.38"
  },
  {
    "Ref": "Paeds0168",
    "Questions": "Which type of seizure, common in paediatric epilepsy, is best treated with Ethosuximide monotherapy?",
    "A": "Tonic-Clonic seizures.",
    "B": "Infantile spasms (West Syndrome).",
    "C": "Atypical Absence seizures.",
    "D": "Typical Absence seizures.",
    "Answer": "D",
    "Comment": "Ethosuximide is the drug of choice for typical absence seizures (petit mal). It is not effective for tonic-clonic or atypical absence seizures.",
    "Source": "Paeds EML (2023) Page 13.8"
  },
  {
    "Ref": "Paeds0169",
    "Questions": "A 10-year-old child with Type 1 Diabetes Mellitus (T1DM) on an insulin regimen requires treatment for a major infection. What is the key adjustment required for the insulin regimen?",
    "A": "Maintain basal insulin, but decrease mealtime insulin by 50%.",
    "B": "Maintain basal insulin, but increase the overall insulin dose, especially for correction (sick day rule).",
    "C": "Stop all insulin and switch to oral agents.",
    "D": "Stop basal insulin, maintain only rapid-acting insulin.",
    "Answer": "B",
    "Comment": "During illness, stress hormones (cortisol, adrenaline) cause insulin resistance. The rule is to never stop basal insulin, but increase the total dose, often requiring more frequent correction doses to prevent DKA.",
    "Source": "Paeds EML (2023) Page 7.16"
  },
  {
    "Ref": "Paeds0170",
    "Questions": "In the management of Acute Renal Failure (ARF) due to a known toxin, what is the role of continuous renal replacement therapy (CRRT) compared to intermittent haemodialysis (IHD)?",
    "A": "IHD is preferred for haemodynamic instability; CRRT is preferred for stability.",
    "B": "CRRT is preferred in critically ill children with haemodynamic instability.",
    "C": "They are equally preferred for all paediatric ARF.",
    "D": "Neither is used; peritoneal dialysis is always first-line.",
    "Answer": "B",
    "Comment": "CRRT is preferred over IHD in critically ill, haemodynamically unstable children because it allows for slower, more controlled fluid and solute removal, minimising the risk of hypotension.",
    "Source": "Paeds EML (2023) Page 6.16"
  },
  {
    "Ref": "Paeds0171",
    "Questions": "Which specific risk factor is a contraindication for the use of Sodium Valproate (Valproic Acid) in a young girl being treated for epilepsy?",
    "A": "History of mild depression.",
    "B": "Family history of migraine.",
    "C": "Known history of Polycystic Ovarian Syndrome (PCOS).",
    "D": "Recent diagnosis of absence seizures.",
    "Answer": "C",
    "Comment": "Valproate is associated with a risk of developing PCOS and is generally avoided in adolescent females with a history or high risk of PCOS, if alternative effective AEDs are available.",
    "Source": "Paeds EML (2023) Page 13.10"
  },
  {
    "Ref": "Paeds0172",
    "Questions": "What is the recommended duration of empiric IV Aciclovir treatment for a neonate with suspected Herpes Simplex Virus (HSV) Central Nervous System (CNS) disease?",
    "A": "7 days",
    "B": "10 days",
    "C": "14 days",
    "D": "21 days",
    "Answer": "D",
    "Comment": "Neonatal HSV CNS disease requires a prolonged course of IV Aciclovir (21 days) due to the high risk of severe neurological morbidity and mortality.",
    "Source": "Paeds EML (2023) Page 19.34"
  },
  {
    "Ref": "Paeds0173",
    "Questions": "In the management of Chronic Adrenal Insufficiency (CAH), what is the key indicator used to titrate the dose of the glucocorticoid replacement (e.g., Hydrocortisone)?",
    "A": "Serum Aldosterone level.",
    "B": "Clinical growth velocity and signs of Cushing's/Addison's.",
    "C": "Plasma Renin Activity (PRA).",
    "D": "Blood glucose levels.",
    "Answer": "B",
    "Comment": "Hydrocortisone dosing is titrated to balance normal growth and prevent signs of adrenal insufficiency (too low a dose) or Cushing's syndrome (too high a dose). PRA/Aldosterone is used for mineralocorticoid titration.",
    "Source": "Paeds EML (2023) Page 7.42"
  },
  {
    "Ref": "Paeds0174",
    "Questions": "Which of the following is the most appropriate first-line investigation for a child with suspected primary enuresis (bedwetting) after ruling out simple causes (e.g., UTI, constipation)?",
    "A": "Micturating Cystourethrogram (MCUG).",
    "B": "Trial of Desmopressin.",
    "C": "Urine osmolality and volume chart.",
    "D": "Renal biopsy.",
    "Answer": "C",
    "Comment": "Initial investigation should focus on non-invasive assessments, primarily a 48-hour fluid/volume chart and urine concentration tests, before moving to pharmacological or invasive tests.",
    "Source": "Paeds EML (2023) Page 6.18"
  },
  {
    "Ref": "Paeds0175",
    "Questions": "What is the recommended initial dose of oral Prednisone for a child with a severe, initial flare of Systemic Lupus Erythematosus (SLE) without major organ involvement?",
    "A": "0.1-0.2 mg/kg/day.",
    "B": "0.5-1.0 mg/kg/day.",
    "C": "2-3 mg/kg/day.",
    "D": "5 mg/kg/day.",
    "Answer": "B",
    "Comment": "For moderate-to-severe non-life-threatening flares, 0.5-1.0 mg/kg/day is the standard high dose, often for 4-6 weeks before slow weaning. Very high doses/IV pulses are reserved for major organ involvement (e.g., nephritis).",
    "Source": "Paeds EML (2023) Page 12.9"
  },
  {
    "Ref": "Paeds0176",
    "Questions": "A child presents with a high-flow Priapism (prolonged, painful erection) in the setting of Sickle Cell Anaemia (SCA). Which of the following is the key immediate medical management?",
    "A": "Ice pack application and oral Ibuprofen.",
    "B": "Aspiration and irrigation with an Alpha-agonist (e.g., Phenylephrine).",
    "C": "Exchange transfusion.",
    "D": "High-dose IV Morphine monotherapy.",
    "Answer": "B",
    "Comment": "For low-flow priapism (most common), aspiration and irrigation (often with Phenylephrine) are the definitive acute treatments, with exchange transfusion reserved for refractory cases. The guideline differentiates between the two types.",
    "Source": "Paeds EML (2023) Page 3.6"
  },
  {
    "Ref": "Paeds0177",
    "Questions": "In a child being treated for a severe *Clostridium difficile* infection (CDI) in a hospital setting, which oral antibiotic is the first-line treatment?",
    "A": "Oral Ciprofloxacin.",
    "B": "Oral Vancomycin.",
    "C": "Oral Metronidazole.",
    "D": "IV Ceftriaxone.",
    "Answer": "B",
    "Comment": "Oral Vancomycin (or Fidaxomicin) is the first-line treatment for severe CDI as it achieves high intraluminal concentrations, whereas IV Metronidazole/Vancomycin is reserved for complicated/fulminant disease.",
    "Source": "Paeds EML (2023) Page 8.8"
  },
  {
    "Ref": "Paeds0178",
    "Questions": "Which of the following is the most important monitoring parameter when initiating Phenobarbitone for neonatal seizures?",
    "A": "Serum Creatinine and BUN.",
    "B": "Respiratory rate and level of consciousness.",
    "C": "Liver function tests (LFTs) only.",
    "D": "Platelet count.",
    "Answer": "B",
    "Comment": "Phenobarbitone is a respiratory depressant. The most critical immediate monitoring is for sedation and respiratory compromise, especially when loading a patient.",
    "Source": "Paeds EML (2023) Page 13.11"
  },
  {
    "Ref": "Paeds0179",
    "Questions": "For a child with acute Type 1 Diabetes Mellitus (T1DM) presenting with a blood glucose of 18 mmol/L but no acidosis/ketosis, what is the recommended immediate management?",
    "A": "Admit to ICU for DKA protocol.",
    "B": "Administer IV fluid bolus and Insulin infusion.",
    "C": "Initiate subcutaneous basal/bolus insulin regimen and discharge.",
    "D": "Oral rehydration and observation.",
    "Answer": "C",
    "Comment": "This is new-onset diabetes without DKA. The management is to stabilise the child, commence a subcutaneous basal/bolus insulin regimen, provide education, and arrange for follow-up, typically not requiring ICU or DKA protocol.",
    "Source": "Paeds EML (2023) Page 7.15"
  },
  {
    "Ref": "Paeds0180",
    "Questions": "What is the recommended first-line treatment for a child presenting with Acute Pericarditis (pericardial inflammation)?",
    "A": "High-dose Aspirin or NSAIDs (e.g., Indomethacin).",
    "B": "High-dose IV Methylprednisolone.",
    "C": "Pericardiocentesis.",
    "D": "Colchicine monotherapy.",
    "Answer": "A",
    "Comment": "High-dose Aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) are the mainstay of initial treatment for most cases of acute pericarditis to reduce inflammation and pain.",
    "Source": "Paeds EML (2023) Page 4.26"
  },
  {
    "Ref": "Paeds0181",
    "Questions": "In the management of a neonate with symptomatic Necrotizing Enterocolitis (NEC) (Bell’s Stage II/III), which pharmacological agent is an essential component of the initial treatment regimen?",
    "A": "Oral Vancomycin for local gut coverage.",
    "B": "Broad-spectrum IV antibiotics (e.g., Ampicillin, Gentamicin, Metronidazole).",
    "C": "IV Prostaglandin E1 to maintain ductal patency.",
    "D": "High-dose IV Hydrocortisone.",
    "Answer": "B",
    "Comment": "NEC management (medical phase) requires immediate cessation of feeds and the initiation of broad-spectrum IV antibiotics to cover Gram-negative, Gram-positive, and anaerobic organisms.",
    "Source": "Paeds EML (2023) Page 19.35"
  },
  {
    "Ref": "Paeds0182",
    "Questions": "Which type of anaemia is most often associated with chronic renal failure in children?",
    "A": "Macrocytic, hyperchromic.",
    "B": "Microcytic, hypochromic.",
    "C": "Normocytic, normochromic.",
    "D": "Dimorphic (Micro/Normo).",
    "Answer": "C",
    "Comment": "Anaemia of Chronic Kidney Disease is primarily due to erythropoietin deficiency, resulting in a normocytic, normochromic picture. Iron deficiency may coexist, creating a dimorphic picture, but normocytic is the core feature.",
    "Source": "Paeds EML (2023) Page 6.22"
  },
  {
    "Ref": "Paeds0183",
    "Questions": "In a child with a known Type 1 Hypersensitivity reaction (e.g., anaphylaxis) to Penicillin, which of the following alternative antibiotics is the recommended first-line agent for common paediatric infections (e.g., Streptococcus pharyngitis)?",
    "A": "Cephalexin (First-generation Cephalosporin).",
    "B": "Clindamycin or Macrolides (e.g., Erythromycin).",
    "C": "Ciprofloxacin (Quinolone).",
    "D": "Co-Trimoxazole.",
    "Answer": "B",
    "Comment": "For true, severe penicillin allergy, Macrolides (Erythromycin, Azithromycin) or Lincosamides (Clindamycin) are the preferred alternatives for Gram-positive infections. Cephalosporins carry a small cross-reactivity risk.",
    "Source": "Paeds EML (2023) Page 8.41"
  },
  {
    "Ref": "Paeds0184",
    "Questions": "Which of the following is a potential side effect associated with the use of inhaled Corticosteroids (ICS) for chronic asthma control?",
    "A": "Systemic hypertension.",
    "B": "Oropharyngeal candidiasis (thrush).",
    "C": "Growth acceleration.",
    "D": "Hypokalaemia.",
    "Answer": "B",
    "Comment": "Oropharyngeal candidiasis is a common local side effect of ICS, which can be mitigated by using a spacer and rinsing the mouth after use. Systemic effects like growth delay and osteoporosis are rare at typical paediatric doses.",
    "Source": "Paeds EML (2023) Page 15.22"
  },
  {
    "Ref": "Paeds0185",
    "Questions": "In a child being treated for a severe, refractory *C. difficile* infection, what is the recommended second-line agent if oral Vancomycin fails?",
    "A": "IV Metronidazole.",
    "B": "Fidaxomicin.",
    "C": "IV Ceftriaxone.",
    "D": "Oral Amoxicillin.",
    "Answer": "B",
    "Comment": "Fidaxomicin is a macrocyclic antibiotic with a narrow spectrum against *C. difficile* and is increasingly used for initial treatment or recurrence/refractory cases due to its lower recurrence rates.",
    "Source": "Paeds EML (2023) Page 8.8"
  },
  {
    "Ref": "Paeds0186",
    "Questions": "Which electrolyte imbalance is the most common cause of seizures in a neonate (outside of Hypoxic-Ischemic Encephalopathy)?",
    "A": "Hypernatraemia.",
    "B": "Hypocalcaemia.",
    "C": "Hyperkalaemia.",
    "D": "Hypophosphataemia.",
    "Answer": "B",
    "Comment": "Hypocalcaemia, followed by hypoglycaemia and hyponatraemia, is a common metabolic cause of neonatal seizures. Hypocalcaemia requires immediate correction with IV Calcium Gluconate.",
    "Source": "Paeds EML (2023) Page 19.51"
  },
  {
    "Ref": "Paeds0187",
    "Questions": "A child presents with suspected Septic Arthritis of the hip. What is the recommended empirical IV antibiotic regimen for a child over 3 months of age?",
    "A": "Flucloxacillin (or Cefazolin).",
    "B": "Gentamicin and Ampicillin.",
    "C": "Clindamycin only.",
    "D": "Oral Amoxicillin.",
    "Answer": "A",
    "Comment": "Septic arthritis is most commonly caused by *S. aureus* in children. Therefore, an anti-staphylococcal agent like Flucloxacillin or Cefazolin is the first-line empirical choice.",
    "Source": "Paeds EML (2023) Page 8.48"
  },
  {
    "Ref": "Paeds0188",
    "Questions": "For a child with known G6PD deficiency, which anti-malarial drug must be avoided due to the high risk of precipitating acute haemolysis?",
    "A": "Artesunate.",
    "B": "Artemether-Lumefantrine.",
    "C": "Primaquine.",
    "D": "Chloroquine.",
    "Answer": "C",
    "Comment": "Primaquine, used for *P. vivax* and *P. ovale* to clear hypnozoites (liver stage), is an oxidative drug that is contraindicated in G6PD deficiency due to the risk of severe haemolysis.",
    "Source": "Paeds EML (2023) Page 8.16"
  },
  {
    "Ref": "Paeds0189",
    "Questions": "In the management of community-acquired Methicillin-Resistant *S. aureus* (CA-MRSA) skin and soft tissue infection, which oral antibiotic is a common first-line choice?",
    "A": "Amoxicillin.",
    "B": "Clindamycin or Trimethoprim/Sulfamethoxazole (Co-Trimoxazole).",
    "C": "Penicillin V.",
    "D": "Erythromycin.",
    "Answer": "B",
    "Comment": "CA-MRSA is often susceptible to Clindamycin or Co-Trimoxazole, which are the preferred oral agents. Beta-lactams (Amoxicillin/Penicillin V) are generally ineffective.",
    "Source": "Paeds EML (2023) Page 5.2"
  },
  {
    "Ref": "Paeds0190",
    "Questions": "Which of the following is the key long-term complication associated with Hydrocephalus in children?",
    "A": "Spontaneous resolution.",
    "B": "Permanent cognitive and motor impairment.",
    "C": "Development of Cushing's triad.",
    "D": "Systemic hypertension.",
    "Answer": "B",
    "Comment": "Hydrocephalus, especially if not promptly and effectively shunted, leads to increased ICP, causing compression and destruction of white matter, resulting in permanent neurological deficits.",
    "Source": "Paeds EML (2023) Page 13.19"
  },
  {
    "Ref": "Paeds0191",
    "Questions": "Which drug is the recommended first-line agent for the emergency management of a child presenting with a severe, acute migraine attack?",
    "A": "Oral Triptans (e.g., Sumatriptan).",
    "B": "IV Dihydroergotamine.",
    "C": "IV Metoclopramide (or Ondansetron) plus NSAIDs (e.g., Ibuprofen) or Paracetamol.",
    "D": "Prophylactic Amitriptyline.",
    "Answer": "C",
    "Comment": "Acute management of severe migraine often involves combination therapy: a non-opioid analgesic (NSAIDs/Paracetamol) combined with an antiemetic (Metoclopramide or Ondansetron) to treat nausea and potentiate the analgesic.",
    "Source": "Paeds EML (2023) Page 13.2"
  },
  {
    "Ref": "Paeds0192",
    "Questions": "A child presents with a new diagnosis of Juvenile Idiopathic Arthritis (JIA) with polyarticular involvement. What is the recommended first-line systemic disease-modifying anti-rheumatic drug (DMARD)?",
    "A": "High-dose oral Prednisone.",
    "B": "Methotrexate.",
    "C": "Cyclosporine.",
    "D": "Etanercept (Biologic).",
    "Answer": "B",
    "Comment": "Methotrexate is the gold standard, first-line systemic DMARD for all JIA subtypes, often used in combination with NSAIDs and sometimes corticosteroids (initially) to achieve disease control.",
    "Source": "Paeds EML (2023) Page 12.5"
  },
  {
    "Ref": "Paeds0193",
    "Questions": "Which physical examination finding is a mandatory criterion for the clinical diagnosis of Complex Regional Pain Syndrome (CRPS) in a child?",
    "A": "Paresthesia in the affected limb.",
    "B": "Evidence of regional oedema, colour, or temperature change.",
    "C": "Elevated inflammatory markers (ESR/CRP).",
    "D": "Positive X-ray showing diffuse osteoporosis.",
    "Answer": "B",
    "Comment": "CRPS is a clinical diagnosis requiring evidence of sensory, motor, sudomotor/vasomotor (colour/temperature/oedema) abnormalities in the affected limb, disproportionate to the inciting event.",
    "Source": "Paeds EML (2023) Page 13.27"
  },
  {
    "Ref": "Paeds0194",
    "Questions": "In the ongoing palliative care management of chronic pain, which adjuvant medication is recommended to treat neuropathic pain components?",
    "A": "Bisacodyl (Laxative).",
    "B": "Amitriptyline (Tricyclic Antidepressant) or Gabapentin (Anticonvulsant).",
    "C": "Oral Diphenhydramine.",
    "D": "Oral Hydroxyzine.",
    "Answer": "B",
    "Comment": "Neuropathic pain is poorly responsive to opioids alone. Adjuvant medications like Tricyclic Antidepressants (Amitriptyline) or Anticonvulsants (Gabapentin/Pregabalin) are standard for neuropathic pain control.",
    "Source": "Paeds EML (2023) Page 21.16"
  },
  {
    "Ref": "Paeds0195",
    "Questions": "A child is diagnosed with Acute Flaccid Paralysis (AFP). Which of the following is the most critical and time-sensitive step in the immediate management?",
    "A": "Sending stool samples for Poliovirus isolation.",
    "B": "Performing an urgent MRI of the spine.",
    "C": "Commencing Intravenous Immunoglobulin (IVIG).",
    "D": "Assessing and monitoring respiratory muscle strength (Vital Capacity).",
    "Answer": "D",
    "Comment": "AFP (e.g., Guillain-Barré Syndrome, Poliomyelitis) carries a high risk of respiratory failure. Monitoring vital capacity and negative inspiratory force is the priority for detecting impending respiratory compromise that necessitates intubation.",
    "Source": "Paeds EML (2023) Page 13.24"
  },
  {
    "Ref": "Paeds0196",
    "Questions": "What is the recommended drug for the maintenance therapy of a child with status epilepticus who has been successfully controlled with IV loading doses of Phenytoin/Fosphenytoin?",
    "A": "Oral Phenytoin.",
    "B": "Oral Clonazepam.",
    "C": "Oral Levetiracetam.",
    "D": "Rectal Diazepam.",
    "Answer": "A",
    "Comment": "If Phenytoin/Fosphenytoin successfully terminates status epilepticus, the maintenance dose of the same drug (oral Phenytoin) is initiated to prevent recurrence. The other options are for acute rescue (Diazepam) or different seizure types.",
    "Source": "Paeds EML (2023) Page 13.6"
  },
  {
    "Ref": "Paeds0197",
    "Questions": "In the management of an acute exacerbation of Juvenile Idiopathic Arthritis (JIA), what is the primary role of intra-articular corticosteroid injection?",
    "A": "Systemic remission induction.",
    "B": "Treatment of oligoarthritis or monarticular flares, avoiding systemic toxicity.",
    "C": "Long-term disease modification.",
    "D": "Diagnosis of septic arthritis.",
    "Answer": "B",
    "Comment": "Intra-articular steroids are highly effective for local inflammation in oligoarticular JIA or specific joint flares, achieving local control while minimising systemic steroid side effects.",
    "Source": "Paeds EML (2023) Page 12.5"
  },
  {
    "Ref": "Paeds0198",
    "Questions": "Which of the following conditions is an absolute contraindication to the use of Ibuprofen in a child with a febrile illness?",
    "A": "Asthma.",
    "B": "Known Varicella (Chickenpox) infection.",
    "C": "Known Severe Renal Impairment (CKD Stage 4/5).",
    "D": "Recent immunisation (within 24 hours).",
    "Answer": "C",
    "Comment": "NSAIDs, including Ibuprofen, should be avoided or used with extreme caution in severe renal impairment due to the risk of precipitating or worsening acute kidney injury. It is also generally avoided in dehydration.",
    "Source": "Paeds EML (2023) Page 22.10"
  },
  {
    "Ref": "Paeds0199",
    "Questions": "A child presents with a rash, arthritis, and colicky abdominal pain. Which of the following is the key diagnostic feature on skin biopsy suggestive of Henoch-Schönlein Purpura (HSP)?",
    "A": "IgG deposition in the vessel walls.",
    "B": "Leukocytoclastic vasculitis with IgA deposition.",
    "C": "Thrombi formation with negative immunofluorescence.",
    "D": "Eosinophilic infiltration.",
    "Answer": "B",
    "Comment": "HSP (IgA Vasculitis) is characterised by Leukocytoclastic Vasculitis with IgA deposition, typically affecting the small vessels of the skin, joints, GI tract, and kidneys.",
    "Source": "Paeds EML (2023) Page 12.10"
  },
  {
    "Ref": "Paeds0200",
    "Questions": "Which of the following is the most common neurological sequelae in children who survive Bacterial Meningitis?",
    "A": "Spastic hemiplegia.",
    "B": "Cortical blindness.",
    "C": "Sensorineural hearing loss.",
    "D": "Pituitary dysfunction (e.g., DI).",
    "Answer": "C",
    "Comment": "Sensorineural hearing loss is the most common long-term sequelae of bacterial meningitis, particularly if caused by *S. pneumoniae* or *H. influenzae*.",
    "Source": "Paeds EML (2023) Page 8.22"
  },
  {
    "Ref": "Paeds0201",
    "Questions": "In the management of Neonatal Abstinence Syndrome (NAS) due to maternal opioid use, which pharmacological agent is the recommended first-line treatment if non-pharmacological methods fail?",
    "A": "Phenobarbitone.",
    "B": "Oral Morphine Solution.",
    "C": "Clonidine.",
    "D": "IV Fentanyl.",
    "Answer": "B",
    "Comment": "Morphine or Methadone are the first-line pharmacological agents for treating NAS, titrated to control symptoms and weaned slowly. Phenobarbitone is reserved for seizures or if CNS symptoms are refractory to opioids.",
    "Source": "Paeds EML (2023) Page 19.45"
  },
  {
    "Ref": "Paeds0202",
    "Questions": "What is the primary intervention for a neonate born to an HBsAg-positive mother to prevent vertical transmission of Hepatitis B Virus (HBV)?",
    "A": "HBV Immunoglobulin (HBIG) and HBV vaccine at birth.",
    "B": "HBV vaccine only at birth.",
    "C": "HBV Immunoglobulin only at birth.",
    "D": "Start Tenofovir for the infant at birth.",
    "Answer": "A",
    "Comment": "Active-passive immunisation (HBIG and HBV vaccine) within 12 hours of birth is critical for preventing perinatal HBV transmission.",
    "Source": "Paeds EML (2023) Page 19.22"
  },
  {
    "Ref": "Paeds0203",
    "Questions": "A child with chronic kidney disease (CKD) on dialysis develops signs of severe anaemia. Which pharmacological agent is the first-line treatment to stimulate erythropoiesis?",
    "A": "IV Iron Sucrose.",
    "B": "Erythropoiesis-Stimulating Agent (ESA, e.g., Erythropoietin).",
    "C": "Folic Acid.",
    "D": "Daily Blood Transfusions.",
    "Answer": "B",
    "Comment": "Anaemia in CKD is primarily due to Erythropoietin deficiency from the damaged kidneys. ESAs are the mainstay of treatment, though iron status must be adequate first (Option A is often concurrent).",
    "Source": "Paeds EML (2023) Page 6.22"
  },
  {
    "Ref": "Paeds0204",
    "Questions": "Which factor is the most important risk indicator for the development of Chronic Lung Disease (Bronchopulmonary Dysplasia, BPD) in a premature infant?",
    "A": "Low birth weight.",
    "B": "Need for prolonged mechanical ventilation/oxygen.",
    "C": "Maternal smoking history.",
    "D": "Patent Ductus Arteriosus (PDA).",
    "Answer": "B",
    "Comment": "BPD is defined as the continued need for oxygen/ventilatory support at 28 days of life or 36 weeks post-menstrual age (PMA), hence the prolonged ventilation/oxygen use is the defining factor and key risk.",
    "Source": "Paeds EML (2023) Page 19.26"
  },
  {
    "Ref": "Paeds0205",
    "Questions": "For a child on long-term oral Morphine for chronic cancer pain, which concurrent medication is essential to prescribe routinely to prevent a common and debilitating side effect?",
    "A": "Loperamide (Anti-diarrhoeal).",
    "B": "A stimulant laxative and stool softener (e.g., Senna/Lactulose).",
    "C": "Ondansetron (Anti-emetic).",
    "D": "Gabapentin (for neuropathic pain).",
    "Answer": "B",
    "Comment": "Opioid-induced constipation is refractory to tolerance and is an inevitable side effect that requires a prophylactic regimen including both a stimulant and a softener.",
    "Source": "Paeds EML (2023) Page 21.14"
  },
  {
    "Ref": "Paeds0206",
    "Questions": "Which of the following is the definitive intervention for the primary management of a simple, stable fracture in a child with intact neurovascular status?",
    "A": "Surgical open reduction and internal fixation (ORIF).",
    "B": "Closed reduction and immobilisation in a cast/splint.",
    "C": "High-dose IV Morphine for pain.",
    "D": "Immediate physiotherapy.",
    "Answer": "B",
    "Comment": "Most simple, stable paediatric fractures are managed non-surgically with closed reduction (if displaced) and immobilisation until healing is achieved.",
    "Source": "Paeds EML (2023) Page 1.34"
  },
  {
    "Ref": "Paeds0207",
    "Questions": "In the management of paediatric Major Depressive Disorder (MDD), which class of antidepressant is recommended as first-line therapy, alongside psychotherapy?",
    "A": "Monoamine Oxidase Inhibitors (MAOIs).",
    "B": "Selective Serotonin Reuptake Inhibitors (SSRIs, e.g., Fluoxetine).",
    "C": "Tricyclic Antidepressants (TCAs, e.g., Amitriptyline).",
    "D": "Atypical Antipsychotics (e.g., Risperidone).",
    "Answer": "B",
    "Comment": "SSRIs, particularly Fluoxetine, are the only class of antidepressants with consistent evidence and the safest profile for use as first-line pharmacological treatment for MDD in children/adolescents.",
    "Source": "Paeds EML (2023) Page 14.36"
  },
  {
    "Ref": "Paeds0208",
    "Questions": "What is the recommended duration of antibiotic therapy for a child with an uncomplicated Acute Osteomyelitis of a long bone?",
    "A": "2-3 weeks total.",
    "B": "4 weeks total.",
    "C": "6 weeks total (IV followed by oral).",
    "D": "12 weeks total.",
    "Answer": "C",
    "Comment": "The standard duration for uncomplicated acute osteomyelitis is a total of 6 weeks of antibiotics, usually starting with 1-2 weeks of IV therapy followed by oral completion.",
    "Source": "Paeds EML (2023) Page 8.49"
  },
  {
    "Ref": "Paeds0209",
    "Questions": "Which of the following is an absolute indication for the use of intravenous Dexamethasone in a child with an acute flare of Croup (Laryngotracheobronchitis)?",
    "A": "Mild, barking cough only.",
    "B": "Presence of inspiratory stridor at rest.",
    "C": "Fever > 39°C.",
    "D": "Age > 5 years.",
    "Answer": "B",
    "Comment": "Systemic corticosteroids (Dexamethasone) are indicated for all Croup severity levels, but especially for moderate-to-severe Croup (stridor at rest) to reduce laryngeal oedema.",
    "Source": "Paeds EML (2023) Page 17.1"
  },
  {
    "Ref": "Paeds0210",
    "Questions": "A 5-year-old child presents with a severe case of Scabies. What is the recommended first-line pharmacological treatment, given systemically?",
    "A": "Topical Permethrin (5% cream).",
    "B": "Oral Ivermectin.",
    "C": "Oral Praziquantel.",
    "D": "Topical Lindane.",
    "Answer": "B",
    "Comment": "While topical Permethrin is first-line, oral Ivermectin is a preferred systemic agent for severe, crusted, or institutional outbreaks of Scabies, especially when topical treatments fail or are impractical.",
    "Source": "Paeds EML (2023) Page 5.12"
  },
  {
    "Ref": "Paeds0211",
    "Questions": "What is the primary management for a child presenting with Acute Otitis Externa (Swimmer's Ear) without underlying perforation?",
    "A": "Systemic oral Amoxicillin.",
    "B": "Topical antibiotic/steroid ear drops (e.g., Ciprofloxacin/Dexamethasone).",
    "C": "Systemic IV Ceftriaxone.",
    "D": "Myringotomy with Grommet insertion.",
    "Answer": "B",
    "Comment": "Otitis Externa is a localised infection and is primarily treated with topical agents (antibiotics, often combined with steroids for inflammation) to minimise systemic side effects.",
    "Source": "Paeds EML (2023) Page 17.10"
  },
  {
    "Ref": "Paeds0212",
    "Questions": "In a child with known Ventricular Septal Defect (VSD), what is the primary pathophysiological event that leads to the development of pulmonary hypertension (Eisenmenger Syndrome)?",
    "A": "Progressive increase in systemic vascular resistance (SVR).",
    "B": "Chronic, high-volume, high-pressure blood flow to the lungs.",
    "C": "Acute rupture of the interventricular septum.",
    "D": "Development of infective endocarditis.",
    "Answer": "B",
    "Comment": "Chronic, excessive blood flow and pressure from the systemic circulation (left-to-right shunt) through the VSD cause irreversible damage (remodelling) to the pulmonary vasculature, leading to fixed pulmonary hypertension.",
    "Source": "Paeds EML (2023) Page 4.7"
  },
  {
    "Ref": "Paeds0213",
    "Questions": "Which of the following is the most important component of the initial management for a child presenting with a severe, refractory nosebleed (epistaxis)?",
    "A": "Oral iron supplementation.",
    "B": "Bilateral anterior nasal packing (e.g., Merocel).",
    "C": "Immediate CT scan of the head.",
    "D": "Admission to the ward for observation.",
    "Answer": "B",
    "Comment": "Refractory epistaxis management involves applying direct pressure/chemical cautery, followed by anterior nasal packing to achieve local haemostasis, often requiring hospital management.",
    "Source": "Paeds EML (2023) Page 17.15"
  },
  {
    "Ref": "Paeds0214",
    "Questions": "In the management of Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME), which intervention has the strongest evidence base for improving functioning and reducing fatigue?",
    "A": "High-dose Vitamin B12 and Folic Acid.",
    "B": "Cognitive Behavioural Therapy (CBT) and graded exercise therapy.",
    "C": "Antiviral medication (e.g., Valaciclovir).",
    "D": "Long-term use of systemic corticosteroids.",
    "Answer": "B",
    "Comment": "CBT and Graded Exercise Therapy are the established psychological and physical rehabilitation mainstays of CFS/ME management, aiming to address perpetuating factors and functional deconditioning.",
    "Source": "Paeds EML (2023) Page 14.41"
  },
  {
    "Ref": "Paeds0215",
    "Questions": "A neonate presents with a congenital anomaly suggestive of Congenital Hypothyroidism. What is the standard initial replacement dose of Levothyroxine?",
    "A": "5 mcg/kg/day.",
    "B": "10-15 mcg/kg/day.",
    "C": "20 mcg/kg/day.",
    "D": "50 mcg/kg/day.",
    "Answer": "B",
    "Comment": "Neonates require the highest dose of Levothyroxine per kg (10-15 mcg/kg/day) to achieve rapid normalisation of thyroid hormone levels and prevent brain damage.",
    "Source": "Paeds EML (2023) Page 7.37"
  },
  {
    "Ref": "Paeds0216",
    "Questions": "Which of the following is the most definitive clinical criterion for the diagnosis of Acute Respiratory Distress Syndrome (ARDS) in a child?",
    "A": "Bilateral lung infiltrates on chest X-ray and a $\text{PaO}_2/\text{FiO}_2$ ratio < 300.",
    "B": "Oxygen saturation < 90% on room air.",
    "C": "Hypoxaemia and hypercapnia.",
    "D": "Clinical evidence of severe pneumonia.",
    "Answer": "A",
    "Comment": "ARDS diagnosis relies on hypoxaemia (P/F ratio < 300 or < 200 for severe), bilateral infiltrates, and exclusion of cardiogenic pulmonary oedema (elevated left atrial pressure) as the primary cause.",
    "Source": "Paeds EML (2023) Page 1.20"
  },
  {
    "Ref": "Paeds0217",
    "Questions": "In a child with a known Type 1 Diabetes Mellitus (T1DM), which class of medication is strictly CONTRAINDICATED in the long-term management of dyslipidaemia due to the risk of rhabdomyolysis when combined with other drugs?",
    "A": "Fibrates (e.g., Fenofibrate).",
    "B": "HMG-CoA Reductase Inhibitors (Statins, e.g., Simvastatin).",
    "C": "Ezetimibe.",
    "D": "Bile Acid Sequestrants.",
    "Answer": "A",
    "Comment": "The combination of fibrates and statins, often needed for combined hyperlipidaemia, significantly increases the risk of myopathy and rhabdomyolysis, leading to avoidance or extreme caution.",
    "Source": "Paeds EML (2023) Page 7.26"
  },
  {
    "Ref": "Paeds0218",
    "Questions": "What is the recommended pharmacological intervention for a child with severe Croup (stridor at rest, severe retractions) who fails to improve after Nebulised Adrenaline and systemic Dexamethasone?",
    "A": "Immediate intubation and mechanical ventilation.",
    "B": "IV Aminophylline.",
    "C": "Heliox (Helium/Oxygen mixture) and specialist consultation.",
    "D": "IV Furosemide.",
    "Answer": "C",
    "Comment": "Heliox can reduce the density of the gas mixture, easing airflow through the narrowed trachea and providing a temporising measure while awaiting specialist help, often prior to intubation (if imminent respiratory failure).",
    "Source": "Paeds EML (2023) Page 17.1"
  },
  {
    "Ref": "Paeds0219",
    "Questions": "Which of the following is the most definitive intervention for the management of Intussusception (telescoping of the bowel) without signs of perforation or peritonitis?",
    "A": "Laparotomy and manual reduction.",
    "B": "Serial observation with IV fluids and NGT decompression.",
    "C": "Air or hydrostatic enema reduction (radiologically guided).",
    "D": "High-dose intravenous antibiotics.",
    "Answer": "C",
    "Comment": "Non-operative reduction (air or hydrostatic enema) is the standard first-line treatment for uncomplicated intussusception. Surgery is reserved for failure of enema or signs of complication (perforation, peritonitis).",
    "Source": "Paeds EML (2023) Page 2.42"
  },
  {
    "Ref": "Paeds0220",
    "Questions": "A child presents with a high-grade fever, pharyngitis, and a 'sandpaper' rash. What is the recommended first-line oral antibiotic therapy?",
    "A": "Oral Amoxicillin or Penicillin V.",
    "B": "Oral Co-Trimoxazole.",
    "C": "Oral Ciprofloxacin.",
    "D": "Oral Erythromycin.",
    "Answer": "A",
    "Comment": "The presentation is classic for Scarlet Fever, caused by Group A *Streptococcus pyogenes*. Penicillin V (or Amoxicillin) is the drug of choice. Erythromycin is used for penicillin allergy.",
    "Source": "Paeds EML (2023) Page 8.33"
  },
  {
    "Ref": "Paeds0221",
    "Questions": "In the management of Juvenile Idiopathic Arthritis (JIA), which type of medication is the most effective for rapid control of systemic symptoms (e.g., high fever, serositis)?",
    "A": "NSAIDs (e.g., Ibuprofen).",
    "B": "Systemic Corticosteroids (e.g., Prednisone).",
    "C": "Methotrexate.",
    "D": "Tumour Necrosis Factor (TNF) Inhibitors.",
    "Answer": "B",
    "Comment": "Systemic corticosteroids provide the most rapid control of severe inflammation and systemic features, used as a bridge until DMARDs (like Methotrexate) or biologics take effect.",
    "Source": "Paeds EML (2023) Page 12.5"
  },
  {
    "Ref": "Paeds0222",
    "Questions": "Which of the following is an absolute contraindication to the use of a combined oral contraceptive (COC) pill in an adolescent female?",
    "A": "History of irregular menstrual cycles.",
    "B": "Obesity (BMI > 30 kg/m²).",
    "C": "History of migraine with aura.",
    "D": "History of acne vulgaris.",
    "Answer": "C",
    "Comment": "Migraine with aura, or focal neurological symptoms, is a contraindication to oestrogen-containing contraceptives due to the increased risk of ischaemic stroke.",
    "Source": "Paeds EML (2023) Page 14.43"
  },
  {
    "Ref": "Paeds0223",
    "Questions": "In the management of chronic Cerebral Palsy (CP), which drug is commonly used to manage severe spasticity via intrathecal administration?",
    "A": "Diazepam (oral).",
    "B": "Botulinum Toxin A (local injection).",
    "C": "Baclofen (Intrathecal Pump).",
    "D": "Tizanidine (oral).",
    "Answer": "C",
    "Comment": "Intrathecal Baclofen, delivered via a pump, is reserved for severe, generalised spasticity that is refractory to oral medications (like oral Baclofen, Diazepam, Tizanidine), offering a high concentration to the spinal cord with less systemic side effects.",
    "Source": "Paeds EML (2023) Page 13.26"
  },
  {
    "Ref": "Paeds0224",
    "Questions": "What is the recommended initial dose of oral Diazepam for the cessation of an acute, prolonged seizure in a child outside of a hospital setting (pre-hospital)?",
    "A": "0.1 mg/kg IV.",
    "B": "0.5 mg/kg Rectal/Buccal, maximum 10 mg.",
    "C": "0.5 mg/kg IV, maximum 10 mg.",
    "D": "1.0 mg/kg Rectal/Buccal, maximum 20 mg.",
    "Answer": "B",
    "Comment": "The standard pre-hospital dose of Diazepam for acute seizures is 0.5 mg/kg administered via the non-IV route (rectal or buccal) to ensure rapid absorption and ease of administration.",
    "Source": "Paeds EML (2023) Page 13.5"
  },
  {
    "Ref": "Paeds0225",
    "Questions": "A child presents with a severe anaphylactic reaction and profound shock. The primary initial dose of IV Adrenaline is 0.01 mg/kg. What is the concentration of Adrenaline recommended for this IV route?",
    "A": "1:1000",
    "B": "1:10,000",
    "C": "1:100",
    "D": "1:5000",
    "Answer": "B",
    "Comment": "IV Adrenaline for shock/cardiac arrest must be diluted (1:10,000 concentration) to avoid a massive sympathetic surge that can lead to myocardial stunning and dysrhythmias. IM Adrenaline uses 1:1000.",
    "Source": "Paeds EML (2023) Page 1.5"
  },
  {
    "Ref": "Paeds0226",
    "Questions": "Which of the following is the most important monitoring parameter when prescribing Sodium Valproate (Valproic Acid) for a child, especially in the first 6 months of therapy?",
    "A": "Full Blood Count (FBC) for anaemia.",
    "B": "Liver Function Tests (LFTs) for hepatotoxicity.",
    "C": "Serum Creatinine for nephrotoxicity.",
    "D": "Serum TSH for hypothyroidism.",
    "Answer": "B",
    "Comment": "Valproate is associated with a rare but severe risk of fatal hepatotoxicity, particularly in young children (< 2 years) on polytherapy, necessitating routine LFT monitoring.",
    "Source": "Paeds EML (2023) Page 13.10"
  },
  {
    "Ref": "Paeds0227",
    "Questions": "In the management of Neonatal Hypoglycaemia, what is the initial IV bolus dose of 10% Dextrose (Glucose) solution?",
    "A": "0.5 mL/kg.",
    "B": "1.0 mL/kg.",
    "C": "2.0 mL/kg.",
    "D": "5.0 mL/kg.",
    "Answer": "C",
    "Comment": "The standard dose for correcting neonatal hypoglycaemia is 2 mL/kg of 10% Dextrose, which provides 200 mg/kg of glucose.",
    "Source": "Paeds EML (2023) Page 19.50"
  },
  {
    "Ref": "Paeds0228",
    "Questions": "What is the primary management for a child presenting with Acute Respiratory Distress Syndrome (ARDS) that requires mechanical ventilation?",
    "A": "High-frequency oscillatory ventilation (HFOV).",
    "B": "Low tidal volume ventilation (lung-protective strategy).",
    "C": "High tidal volume ventilation (to fully inflate damaged alveoli).",
    "D": "Prone positioning only.",
    "Answer": "B",
    "Comment": "The cornerstone of ARDS management on a ventilator is a lung-protective strategy: low tidal volumes and appropriate PEEP to minimise ventilator-induced lung injury (VILI).",
    "Source": "Paeds EML (2023) Page 1.20"
  },
  {
    "Ref": "Paeds0229",
    "Questions": "For a child with known Type 1 Diabetes Mellitus (T1DM), which of the following is the most common reason for recurrent, unexplained nocturnal hypoglycaemia?",
    "A": "Dawn phenomenon.",
    "B": "Somogyi effect (rebound hyperglycaemia).",
    "C": "Delayed absorption of the evening meal.",
    "D": "Accidental insulin omission.",
    "Answer": "B",
    "Comment": "The Somogyi effect refers to rebound hyperglycaemia in the morning due to a physiological surge of counter-regulatory hormones (glucagon, adrenaline) in response to an undetected hypoglycaemic event (often nocturnal).",
    "Source": "Paeds EML (2023) Page 7.15"
  },
  {
    "Ref": "Paeds0230",
    "Questions": "What is the recommended first-line treatment for a child presenting with a severe, acute exacerbation of Juvenile Idiopathic Arthritis (JIA) who has failed previous NSAID therapy?",
    "A": "Intra-articular steroid injections.",
    "B": "Oral Methotrexate.",
    "C": "Oral Prednisone (high-dose).",
    "D": "Rituximab (Biologic).",
    "Answer": "C",
    "Comment": "Systemic corticosteroids (high-dose oral Prednisone or IV pulses) are used to bridge the time until DMARDs (like Methotrexate) take effect or for patients refractory to NSAIDs, prior to initiating biologics.",
    "Source": "Paeds EML (2023) Page 12.5"
  },
  {
    "Ref": "Paeds0231",
    "Questions": "Which of the following is the most definitive clinical sign of impending cardiac tamponade in a child with a known pericardial effusion?",
    "A": "Tachycardia and wide pulse pressure.",
    "B": "Pulsus paradoxus and muffled heart sounds.",
    "C": "Bounding peripheral pulses.",
    "D": "Respiratory distress only.",
    "Answer": "B",
    "Comment": "Beck's Triad (Hypotension, Muffled heart sounds, Jugular Venous Distension) and Pulsus Paradoxus (exaggerated drop in systolic BP during inspiration) are classic signs of tamponade.",
    "Source": "Paeds EML (2023) Page 4.26"
  },
  {
    "Ref": "Paeds0232",
    "Questions": "In a child with known G6PD deficiency, what is the most important advice regarding medication usage?",
    "A": "Avoid all vaccinations.",
    "B": "Avoid all oxidative drugs (e.g., Primaquine, Sulfa drugs).",
    "C": "Avoid all NSAIDs.",
    "D": "Avoid all iron supplements.",
    "Answer": "B",
    "Comment": "Oxidative drugs can precipitate severe, acute haemolysis in G6PD deficient patients and must be strictly avoided. Sulfa drugs, some anti-malarials, and certain antibiotics are common culprits.",
    "Source": "Paeds EML (2023) Page 3.11"
  },
  {
    "Ref": "Paeds0233",
    "Questions": "What is the minimum recommended duration of dual anti-platelet therapy (Aspirin + Clopidogrel) for a child who has undergone placement of a coronary artery stent?",
    "A": "1 month.",
    "B": "6 months.",
    "C": "12 months.",
    "D": "For life.",
    "Answer": "C",
    "Comment": "Dual anti-platelet therapy (DAPT) is required for at least 12 months (or longer depending on stent type and patient risk) to prevent stent thrombosis following coronary artery stenting, which is a key management point in cardiology.",
    "Source": "Paeds EML (2023) Page 4.45"
  },
  {
    "Ref": "Paeds0234",
    "Questions": "Which oral antibiotic is the recommended first-line agent for the management of non-bullous Impetigo (crusted lesions) in a child?",
    "A": "Topical Mupirocin.",
    "B": "Oral Amoxicillin.",
    "C": "Oral Amoxicillin/Clavulanate.",
    "D": "Oral Flucloxacillin (or Cephalexin).",
    "Answer": "A",
    "Comment": "Non-bullous Impetigo is usually localised and is best treated with topical antibiotics (e.g., Mupirocin or Fusidic Acid). Oral antibiotics are reserved for widespread lesions or systemic signs.",
    "Source": "Paeds EML (2023) Page 5.3"
  },
  {
    "Ref": "Paeds0235",
    "Questions": "In the management of Neonatal Jaundice, what is the recommended monitoring interval for Total Serum Bilirubin (TSB) in an infant on phototherapy who is not yet at exchange transfusion threshold?",
    "A": "Every 24 hours.",
    "B": "Every 12 hours.",
    "C": "Every 4-6 hours.",
    "D": "Every 72 hours.",
    "Answer": "C",
    "Comment": "TSB levels must be closely monitored (4-6 hourly) in infants receiving phototherapy or those near exchange transfusion thresholds to ensure a therapeutic response and prevent neurotoxicity (Kernicterus).",
    "Source": "Paeds EML (2023) Page 19.46"
  },
  {
    "Ref": "Paeds0236",
    "Questions": "Which of the following is the key long-term complication associated with Hydrocephalus in children?",
    "A": "Spontaneous resolution.",
    "B": "Permanent cognitive and motor impairment.",
    "C": "Development of Cushing's triad.",
    "D": "Systemic hypertension.",
    "Answer": "B",
    "Comment": "Hydrocephalus, especially if not promptly and effectively shunted, leads to increased ICP, causing compression and destruction of white matter, resulting in permanent neurological deficits.",
    "Source": "Paeds EML (2023) Page 13.19"
  },
  {
    "Ref": "Paeds0237",
    "Questions": "What is the recommended initial dose of oral Prednisone for an adolescent with a severe flare of Ulcerative Colitis (UC)?",
    "A": "0.5 mg/kg daily (max 20 mg).",
    "B": "1-2 mg/kg daily (max 60 mg).",
    "C": "5 mg/kg daily (max 100 mg).",
    "D": "20 mg daily, fixed dose.",
    "Answer": "B",
    "Comment": "High-dose systemic steroids (1-2 mg/kg/day, max 60 mg) are the standard induction therapy for moderate-to-severe flares of Inflammatory Bowel Disease (IBD) to achieve remission.",
    "Source": "Paeds EML (2023) Page 2.45"
  },
  {
    "Ref": "Paeds0238",
    "Questions": "In the management of Chronic Hepatitis B in children, which criterion MUST be met before initiating Antiviral Therapy (ART)?",
    "A": "Serum HBsAg positive for less than 6 months.",
    "B": "Low viral load (HBV DNA < 2000 IU/mL).",
    "C": "Evidence of significant liver fibrosis, inflammation, or cirrhosis.",
    "D": "Concurrent diagnosis of Chronic Hepatitis C.",
    "Answer": "C",
    "Comment": "Treatment for chronic Hep B is generally reserved for active liver disease, demonstrated by high viral load, elevated ALT/AST, and evidence of significant liver damage (fibrosis/cirrhosis) on biopsy or non-invasive markers.",
    "Source": "Paeds EML (2023) Page 2.31"
  },
  {
    "Ref": "Paeds0239",
    "Questions": "Which of the following drugs is strictly CONTRAINDICATED in the management of hyperactive delirium in a child with known traumatic brain injury (TBI) due to its potential to lower the seizure threshold and increase intracranial pressure (ICP)?",
    "A": "Lorazepam",
    "B": "Haloperidol",
    "C": "Midazolam",
    "D": "Propofol",
    "Answer": "B",
    "Comment": "Haloperidol, while an effective antipsychotic, can lower the seizure threshold and is often avoided in acute TBI. Benzodiazepines (Lorazepam/Midazolam) are preferred for agitation/seizures in this setting. The TBI management is discussed in Chapter 1.",
    "Source": "Paeds EML (2023) Page 1.30"
  },
  {
    "Ref": "Paeds0240",
    "Questions": "A 10-year-old on long-term opioid analgesia for palliative care develops signs of acute spinal cord compression. What is the recommended immediate high-dose Dexamethasone regimen?",
    "A": "Loading dose of 0.5 mg/kg (max 8 mg), followed by 0.25 mg/kg/dose every 6 hours.",
    "B": "Loading dose of 2 mg/kg (max 100 mg), followed by 1 mg/kg/day.",
    "C": "Loading dose of 1 mg/kg (max 16 mg), followed by 0.5 mg/kg/dose every 6 hours.",
    "D": "Loading dose of 4 mg IV stat, followed by 4 mg orally every 6 hours.",
    "Answer": "A",
    "Comment": "The guideline recommends commencing high-dose Dexamethasone with a loading dose of 0.5 mg/kg (max 8 mg) IV/oral, followed by a maintenance dose of 0.25 mg/kg/dose every 6 hours (up to 4 mg/dose).",
    "Source": "Paeds EML (2023) Page 21.19"
  },
  {
    "Ref": "Paeds0241",
    "Questions": "What is the recommended long-term prophylaxis for a child with severe Haemophilia A?",
    "A": "Weekly Factor VIII concentrate infusions.",
    "B": "On-demand Factor VIII concentrate infusions only for bleeds.",
    "C": "Monthly administration of tranexamic acid.",
    "D": "Daily oral Desmopressin (DDAVP).",
    "Answer": "A",
    "Comment": "The standard of care for severe Haemophilia A is regular (often 2-3 times weekly or weekly) prophylactic infusions of Factor VIII concentrate to prevent spontaneous joint bleeds and long-term joint damage.",
    "Source": "Paeds EML (2023) Page 3.12"
  },
  {
    "Ref": "Paeds0242",
    "Questions": "In the management of paediatric Major Depressive Disorder (MDD), which class of antidepressant is recommended as first-line therapy, alongside psychotherapy?",
    "A": "Monoamine Oxidase Inhibitors (MAOIs).",
    "B": "Selective Serotonin Reuptake Inhibitors (SSRIs, e.g., Fluoxetine).",
    "C": "Tricyclic Antidepressants (TCAs, e.g., Amitriptyline).",
    "D": "Atypical Antipsychotics (e.g., Risperidone).",
    "Answer": "B",
    "Comment": "SSRIs, particularly Fluoxetine, are the only class of antidepressants with consistent evidence and the safest profile for use as first-line pharmacological treatment for MDD in children/adolescents.",
    "Source": "Paeds EML (2023) Page 14.36"
  },
  {
    "Ref": "Paeds0243",
    "Questions": "What is the recommended duration of empiric IV Aciclovir treatment for a neonate with suspected Herpes Simplex Virus (HSV) Central Nervous System (CNS) disease?",
    "A": "7 days",
    "B": "10 days",
    "C": "14 days",
    "D": "21 days",
    "Answer": "D",
    "Comment": "Neonatal HSV CNS disease requires a prolonged course of IV Aciclovir (21 days) due to the high risk of severe neurological morbidity and mortality.",
    "Source": "Paeds EML (2023) Page 19.34"
  },
  {
    "Ref": "Paeds0244",
    "Questions": "Which type of anaemia is most often associated with chronic renal failure in children?",
    "A": "Macrocytic, hyperchromic.",
    "B": "Microcytic, hypochromic.",
    "C": "Normocytic, normochromic.",
    "D": "Dimorphic (Micro/Normo).",
    "Answer": "C",
    "Comment": "Anaemia of Chronic Kidney Disease is primarily due to erythropoietin deficiency, resulting in a normocytic, normochromic picture. Iron deficiency may coexist, creating a dimorphic picture, but normocytic is the core feature.",
    "Source": "Paeds EML (2023) Page 6.22"
  },
  {
    "Ref": "Paeds0245",
    "Questions": "What is the primary intervention for a symptomatic, moderate-to-large Ventricular Septal Defect (VSD) in a 3-month-old infant with early signs of Heart Failure (HF)?",
    "A": "Surgical VSD closure within 1 week.",
    "B": "Furosemide and Captopril (ACE inhibitor) to manage HF.",
    "C": "Prostaglandin E1 infusion.",
    "D": "Serial monitoring, with no intervention until 1 year of age.",
    "Answer": "B",
    "Comment": "Symptomatic VSDs cause HF due to high pulmonary blood flow. Management is medical (diuretics and ACE inhibitors) to control HF symptoms, while awaiting potential spontaneous closure or planning for surgical closure if symptoms persist/worsen.",
    "Source": "Paeds EML (2023) Page 4.7"
  },
  {
    "Ref": "Paeds0246",
    "Questions": "Which anti-tuberculous drug is typically discontinued in the continuation phase of standard treatment for drug-sensitive pulmonary TB in a child?",
    "A": "Isoniazid (INH).",
    "B": "Rifampicin (RMP).",
    "C": "Pyrazinamide (PZA).",
    "D": "Ethambutol (EMB).",
    "Answer": "C",
    "Comment": "The standard regimen moves from a 4-drug intensive phase (HRZE) to a 2-drug continuation phase (HR), discontinuing Pyrazinamide and Ethambutol after the first 2 months.",
    "Source": "Paeds EML (2023) Page 10.11"
  },
  {
    "Ref": "Paeds0247",
    "Questions": "In the management of chronic Cerebral Palsy (CP), which drug is commonly used to manage severe spasticity via intrathecal administration?",
    "A": "Diazepam (oral).",
    "B": "Botulinum Toxin A (local injection).",
    "C": "Baclofen (Intrathecal Pump).",
    "D": "Tizanidine (oral).",
    "Answer": "C",
    "Comment": "Intrathecal Baclofen, delivered via a pump, is reserved for severe, generalised spasticity that is refractory to oral medications (like oral Baclofen, Diazepam, Tizanidine), offering a high concentration to the spinal cord with less systemic side effects.",
    "Source": "Paeds EML (2023) Page 13.26"
  },
  {
    "Ref": "Paeds0248",
    "Questions": "A 1-year-old is diagnosed with Vesicoureteral Reflux (VUR) Grade III following a febrile UTI. What is the recommended primary preventative management strategy to prevent recurrent UTIs?",
    "A": "Long-term low-dose antibiotic prophylaxis (e.g., Trimethoprim/Sulfamethoxazole).",
    "B": "Surgical ureteral re-implantation within 6 months.",
    "C": "Daily high-dose Vitamin C.",
    "D": "Serial monitoring without intervention, as VUR spontaneously resolves.",
    "Answer": "A",
    "Comment": "Continuous Antibiotic Prophylaxis (CAP) remains a key strategy for VUR in young children to prevent recurrent febrile UTIs and subsequent renal scarring, particularly for Grade III and higher.",
    "Source": "Paeds EML (2023) Page 6.13"
  },
  {
    "Ref": "Paeds0249",
    "Questions": "What is the recommended initial IV fluid bolus for a child in compensated septic shock (hypovolaemia due to capillary leak) who has no features of cerebral malaria or cardiac failure?",
    "A": "5 mL/kg, repeated up to 2 times.",
    "B": "10 mL/kg, repeated up to 2 times.",
    "C": "20 mL/kg, repeated up to 3 times (total 60 mL/kg).",
    "D": "30 mL/kg, given as a single bolus.",
    "Answer": "C",
    "Comment": "The standard of care for shock involves repeated 20 mL/kg fluid boluses, with the protocol usually permitting up to 60 mL/kg before escalating to vasoactive agents, provided no signs of fluid overload develop.",
    "Source": "Paeds EML (2023) Page 1.15"
  },
  {
    "Ref": "Paeds0250",
    "Questions": "In the management of Neonatal Jaundice, what is the recommended monitoring interval for Total Serum Bilirubin (TSB) in an infant on phototherapy who is not yet at exchange transfusion threshold?",
    "A": "Every 24 hours.",
    "B": "Every 12 hours.",
    "C": "Every 4-6 hours.",
    "D": "Every 72 hours.",
    "Answer": "C",
    "Comment": "TSB levels must be closely monitored (4-6 hourly) in infants receiving phototherapy or those near exchange transfusion thresholds to ensure a therapeutic response and prevent neurotoxicity (Kernicterus).",
    "Source": "Paeds EML (2023) Page 19.46"
  },
  {
    "Ref": "Paeds0251",
    "Questions": "What is the most common cause of Acute Pancreatitis in children?",
    "A": "Biliary stones (Cholelithiasis).",
    "B": "Mumps virus infection.",
    "C": "Trauma or adverse drug reactions (e.g., Valproate).",
    "D": "Cystic Fibrosis (CF).",
    "Answer": "C",
    "Comment": "Trauma (blunt abdominal injury) and adverse drug reactions are the most common causes of acute pancreatitis in the paediatric population. Biliary causes are less common than in adults.",
    "Source": "Paeds EML (2023) Page 2.40"
  },
  {
    "Ref": "Paeds0252",
    "Questions": "Which of the following is the hallmark finding on chest X-ray suggestive of Severe Bronchiolitis?",
    "A": "Consolidation (Lobar or segmental).",
    "B": "Hyperinflation and flattened diaphragm.",
    "C": "Ground-glass appearance.",
    "D": "Perihilar streaking.",
    "Answer": "B",
    "Comment": "Bronchiolitis causes air trapping and distal airway obstruction, leading to hyperinflation of the lungs and flattening of the diaphragm on X-ray, although the X-ray is often normal or non-specific.",
    "Source": "Paeds EML (2023) Page 15.11"
  },
  {
    "Ref": "Paeds0253",
    "Questions": "What is the recommended initial dose of oral Prednisone for an adolescent with a severe flare of Ulcerative Colitis (UC)?",
    "A": "0.5 mg/kg daily (max 20 mg).",
    "B": "1-2 mg/kg daily (max 60 mg).",
    "C": "5 mg/kg daily (max 100 mg).",
    "D": "20 mg daily, fixed dose.",
    "Answer": "B",
    "Comment": "High-dose systemic steroids (1-2 mg/kg/day, max 60 mg) are the standard induction therapy for moderate-to-severe flares of Inflammatory Bowel Disease (IBD) to achieve remission.",
    "Source": "Paeds EML (2023) Page 2.45"
  },
  {
    "Ref": "Paeds0254",
    "Questions": "In the ongoing palliative care management of chronic pain, which adjuvant medication is recommended to treat neuropathic pain components?",
    "A": "Bisacodyl (Laxative).",
    "B": "Amitriptyline (Tricyclic Antidepressant) or Gabapentin (Anticonvulsant).",
    "C": "Oral Diphenhydramine.",
    "D": "Oral Hydroxyzine.",
    "Answer": "B",
    "Comment": "Neuropathic pain is poorly responsive to opioids alone. Adjuvant medications like Tricyclic Antidepressants (Amitriptyline) or Anticonvulsants (Gabapentin/Pregabalin) are standard for neuropathic pain control.",
    "Source": "Paeds EML (2023) Page 21.16"
  },
  {
    "Ref": "Paeds0255",
    "Questions": "For a child on long-term oral Morphine for chronic cancer pain, which concurrent medication is essential to prescribe routinely to prevent a common and debilitating side effect?",
    "A": "Loperamide (Anti-diarrhoeal).",
    "B": "A stimulant laxative and stool softener (e.g., Senna/Lactulose).",
    "C": "Ondansetron (Anti-emetic).",
    "D": "Gabapentin (for neuropathic pain).",
    "Answer": "B",
    "Comment": "Opioid-induced constipation is refractory to tolerance and is an inevitable side effect that requires a prophylactic regimen including both a stimulant and a softener.",
    "Source": "Paeds EML (2023) Page 21.14"
  },
  {
    "Ref": "Paeds0256",
    "Questions": "In the management of an acute exacerbation of Juvenile Idiopathic Arthritis (JIA), what is the primary role of intra-articular corticosteroid injection?",
    "A": "Systemic remission induction.",
    "B": "Treatment of oligoarthritis or monarticular flares, avoiding systemic toxicity.",
    "C": "Long-term disease modification.",
    "D": "Diagnosis of septic arthritis.",
    "Answer": "B",
    "Comment": "Intra-articular steroids are highly effective for local inflammation in oligoarticular JIA or specific joint flares, achieving local control while minimising systemic steroid side effects.",
    "Source": "Paeds EML (2023) Page 12.5"
  },
  {
    "Ref": "Paeds0257",
    "Questions": "What is the primary intervention for a child presenting with Acute Otitis Externa (Swimmer's Ear) without underlying perforation?",
    "A": "Systemic oral Amoxicillin.",
    "B": "Topical antibiotic/steroid ear drops (e.g., Ciprofloxacin/Dexamethasone).",
    "C": "Systemic IV Ceftriaxone.",
    "D": "Myringotomy with Grommet insertion.",
    "Answer": "B",
    "Comment": "Otitis Externa is a localised infection and is primarily treated with topical agents (antibiotics, often combined with steroids for inflammation) to minimise systemic side effects.",
    "Source": "Paeds EML (2023) Page 17.10"
  },
  {
    "Ref": "Paeds0258",
    "Questions": "A 10-month-old infant is diagnosed with acute, mild-to-moderate Hyponatraemia (Na 125 mmol/L) due to gastroenteritis. What is the recommended correction rate to prevent Osmotic Demyelination Syndrome (ODS)?",
    "A": "Rapid correction of 10 mmol/L in the first hour.",
    "B": "Slow correction: aiming for < 10-12 mmol/L increase in the first 24 hours.",
    "C": "Correction rate of 20 mmol/L in 48 hours.",
    "D": "Correction rate of 5 mmol/L per hour until Na > 130 mmol/L.",
    "Answer": "B",
    "Comment": "In non-symptomatic or mildly symptomatic hyponatraemia, the correction must be slow and controlled, aiming for a total rise of no more than 10-12 mmol/L in 24 hours to prevent ODS/Central Pontine Myelinolysis.",
    "Source": "Paeds EML (2023) Page 7.33"
  },
  {
    "Ref": "Paeds0259",
    "Questions": "In the management of Severe Acute Malnutrition (SAM), what is the correct time to introduce the rehabilitation phase feeds (e.g., F-100 formula)?",
    "A": "Immediately upon admission to aggressively treat weight loss.",
    "B": "Only after the child has recovered appetite, no signs of infection, and oedema has resolved (Stabilisation phase complete).",
    "C": "Only after serum albumin has normalized.",
    "D": "48 hours after admission, irrespective of clinical stability.",
    "Answer": "B",
    "Comment": "The rehabilitation phase (with higher energy/protein feeds like F-100) must only be initiated after the critical stabilisation phase is complete, which includes resolution of shock, correction of electrolytes, and return of appetite.",
    "Source": "Paeds EML (2023) Page 2.37"
  },
  {
    "Ref": "Paeds0260",
    "Questions": "Which of the following is the key initial intervention in a child presenting with severe Bleeding Oesophageal Varices (Portal Hypertension)?",
    "A": "Urgent packed red cell transfusion.",
    "B": "Administration of Octreotide/Terlipressin to reduce portal pressure.",
    "C": "Endoscopic Variceal Ligation (EVL).",
    "D": "Placement of a Transjugular Intrahepatic Portosystemic Shunt (TIPS).",
    "Answer": "B",
    "Comment": "Pharmacological reduction of portal pressure (Octreotide/Terlipressin) is initiated immediately upon suspicion, along with supportive care, while arrangements for definitive endoscopic management (EVL) are made.",
    "Source": "Paeds EML (2023) Page 2.29"
  },
  {
    "Ref": "Paeds0261",
    "Questions": "A child presents with a high-grade fever, pharyngitis, and a 'sandpaper' rash. What is the recommended first-line oral antibiotic therapy?",
    "A": "Oral Amoxicillin or Penicillin V.",
    "B": "Oral Co-Trimoxazole.",
    "C": "Oral Ciprofloxacin.",
    "D": "Oral Erythromycin.",
    "Answer": "A",
    "Comment": "The presentation is classic for Scarlet Fever, caused by Group A *Streptococcus pyogenes*. Penicillin V (or Amoxicillin) is the drug of choice. Erythromycin is used for penicillin allergy.",
    "Source": "Paeds EML (2023) Page 8.33"
  },
  {
    "Ref": "Paeds0262",
    "Questions": "What is the recommended duration of antibiotic therapy for a child with an uncomplicated Staphylococcal Scalded Skin Syndrome (SSSS)?",
    "A": "3 days of IV antibiotics only.",
    "B": "7-10 days of IV/oral antibiotics.",
    "C": "21 days of IV antibiotics.",
    "D": "No antibiotics needed, only supportive care.",
    "Answer": "B",
    "Comment": "SSSS is caused by a toxin-producing S. aureus and requires systemic antibiotics, often started IV, then switched to oral to complete a course of 7-10 days, alongside wound care.",
    "Source": "Paeds EML (2023) Page 5.8"
  },
  {
    "Ref": "Paeds0263",
    "Questions": "Which drug is the recommended first-line agent for the emergency management of a Tetanus spasm in a child?",
    "A": "Morphine (IV).",
    "B": "Phenytoin (IV).",
    "C": "Diazepam (IV/Rectal).",
    "D": "Baclofen (Intrathecal).",
    "Answer": "C",
    "Comment": "Benzodiazepines, particularly Diazepam or Midazolam, are the first-line treatment for muscle spasms and rigidity in Tetanus, providing both sedation and muscle relaxation.",
    "Source": "Paeds EML (2023) Page 8.34"
  },
  {
    "Ref": "Paeds0264",
    "Questions": "In a child being treated for a severe *Clostridium difficile* infection (CDI) in a hospital setting, which oral antibiotic is the first-line treatment?",
    "A": "Oral Ciprofloxacin.",
    "B": "Oral Vancomycin.",
    "C": "Oral Metronidazole.",
    "D": "IV Ceftriaxone.",
    "Answer": "B",
    "Comment": "Oral Vancomycin (or Fidaxomicin) is the first-line treatment for severe CDI as it achieves high intraluminal concentrations, whereas IV Metronidazole/Vancomycin is reserved for complicated/fulminant disease.",
    "Source": "Paeds EML (2023) Page 8.8"
  },
  {
    "Ref": "Paeds0265",
    "Questions": "What is the recommended long-term prophylaxis for a child with severe Haemophilia A?",
    "A": "Weekly Factor VIII concentrate infusions.",
    "B": "On-demand Factor VIII concentrate infusions only for bleeds.",
    "C": "Monthly administration of tranexamic acid.",
    "D": "Daily oral Desmopressin (DDAVP).",
    "Answer": "A",
    "Comment": "The standard of care for severe Haemophilia A is regular (often 2-3 times weekly or weekly) prophylactic infusions of Factor VIII concentrate to prevent spontaneous joint bleeds and long-term joint damage.",
    "Source": "Paeds EML (2023) Page 3.12"
  },
  {
    "Ref": "Paeds0266",
    "Questions": "Which of the following is the most important component of the initial management for a child presenting with a severe, refractory nosebleed (epistaxis)?",
    "A": "Oral iron supplementation.",
    "B": "Bilateral anterior nasal packing (e.g., Merocel).",
    "C": "Immediate CT scan of the head.",
    "D": "Admission to the ward for observation.",
    "Answer": "B",
    "Comment": "Refractory epistaxis management involves applying direct pressure/chemical cautery, followed by anterior nasal packing to achieve local haemostasis, often requiring hospital management.",
    "Source": "Paeds EML (2023) Page 17.15"
  },
  {
    "Ref": "Paeds0267",
    "Questions": "What is the most common cause of Acute Pancreatitis in children?",
    "A": "Biliary stones (Cholelithiasis).",
    "B": "Mumps virus infection.",
    "C": "Trauma or adverse drug reactions (e.g., Valproate).",
    "D": "Cystic Fibrosis (CF).",
    "Answer": "C",
    "Comment": "Trauma (blunt abdominal injury) and adverse drug reactions are the most common causes of acute pancreatitis in the paediatric population. Biliary causes are less common than in adults.",
    "Source": "Paeds EML (2023) Page 2.40"
  },
  {
    "Ref": "Paeds0268",
    "Questions": "In the management of Severe Acute Malnutrition (SAM), what is the key therapeutic component added to the F-75 feed during the initial stabilisation phase to address the associated electrolyte disturbances?",
    "A": "Potassium and Magnesium supplementation.",
    "B": "Aggressive Sodium loading.",
    "C": "Bicarbonate for acidosis.",
    "D": "High-dose Calcium infusions.",
    "Answer": "A",
    "Comment": "Children with SAM are invariably potassium and magnesium depleted, which is managed by routine supplementation with these electrolytes during stabilisation, as they are crucial for cardiac function and metabolism.",
    "Source": "Paeds EML (2023) Page 2.37"
  },
  {
    "Ref": "Paeds0269",
    "Questions": "Which clinical feature, in a child receiving empiric antibiotic therapy for presumed bacterial Meningitis, is a strong indication for adding Dexamethasone to the regimen?",
    "A": "A history of previous febrile seizures.",
    "B": "Diagnosis of Pneumococcal Meningitis in a child over 6 weeks of age.",
    "C": "Concurrent diagnosis of HIV infection.",
    "D": "High fever (> 40°C).",
    "Answer": "B",
    "Comment": "Dexamethasone is recommended for *Pneumococcal* Meningitis (H. influenzae is also an indication in certain age groups) to reduce inflammation, which can decrease the risk of hearing loss and other neurological sequelae.",
    "Source": "Paeds EML (2023) Page 8.20"
  },
  {
    "Ref": "Paeds0270",
    "Questions": "What is the primary intervention for a symptomatic, moderate-to-large Ventricular Septal Defect (VSD) in a 3-month-old infant with early signs of Heart Failure (HF)?",
    "A": "Surgical VSD closure within 1 week.",
    "B": "Furosemide and Captopril (ACE inhibitor) to manage HF.",
    "C": "Prostaglandin E1 infusion.",
    "D": "Serial monitoring, with no intervention until 1 year of age.",
    "Answer": "B",
    "Comment": "Symptomatic VSDs cause HF due to high pulmonary blood flow. Management is medical (diuretics and ACE inhibitors) to control HF symptoms, while awaiting potential spontaneous closure or planning for surgical closure if symptoms persist/worsen.",
    "Source": "Paeds EML (2023) Page 4.7"
  },
  {
    "Ref": "Paeds0271",
    "Questions": "In the management of chronic Cerebral Palsy (CP), which drug is commonly used to manage severe spasticity via intrathecal administration?",
    "A": "Diazepam (oral).",
    "B": "Botulinum Toxin A (local injection).",
    "C": "Baclofen (Intrathecal Pump).",
    "D": "Tizanidine (oral).",
    "Answer": "C",
    "Comment": "Intrathecal Baclofen, delivered via a pump, is reserved for severe, generalised spasticity that is refractory to oral medications (like oral Baclofen, Diazepam, Tizanidine), offering a high concentration to the spinal cord with less systemic side effects.",
    "Source": "Paeds EML (2023) Page 13.26"
  },
  {
    "Ref": "Paeds0272",
    "Questions": "What is the key long-term complication associated with Hydrocephalus in children?",
    "A": "Spontaneous resolution.",
    "B": "Permanent cognitive and motor impairment.",
    "C": "Development of Cushing's triad.",
    "D": "Systemic hypertension.",
    "Answer": "B",
    "Comment": "Hydrocephalus, especially if not promptly and effectively shunted, leads to increased ICP, causing compression and destruction of white matter, resulting in permanent neurological deficits.",
    "Source": "Paeds EML (2023) Page 13.19"
  },
  {
    "Ref": "Paeds0273",
    "Questions": "In a child with a known Type 1 Diabetes Mellitus (T1DM), which class of medication is strictly CONTRAINDICATED in the long-term management of dyslipidaemia due to the risk of rhabdomyolysis when combined with other drugs?",
    "A": "Fibrates (e.g., Fenofibrate).",
    "B": "HMG-CoA Reductase Inhibitors (Statins, e.g., Simvastatin).",
    "C": "Ezetimibe.",
    "D": "Bile Acid Sequestrants.",
    "Answer": "A",
    "Comment": "The combination of fibrates and statins, often needed for combined hyperlipidaemia, significantly increases the risk of myopathy and rhabdomyolysis, leading to avoidance or extreme caution.",
    "Source": "Paeds EML (2023) Page 7.26"
  },
  {
    "Ref": "Paeds0274",
    "Questions": "A 10-year-old on long-term opioid analgesia for palliative care develops signs of acute spinal cord compression. What is the recommended immediate high-dose Dexamethasone regimen?",
    "A": "Loading dose of 0.5 mg/kg (max 8 mg), followed by 0.25 mg/kg/dose every 6 hours.",
    "B": "Loading dose of 2 mg/kg (max 100 mg), followed by 1 mg/kg/day.",
    "C": "Loading dose of 1 mg/kg (max 16 mg), followed by 0.5 mg/kg/dose every 6 hours.",
    "D": "Loading dose of 4 mg IV stat, followed by 4 mg orally every 6 hours.",
    "Answer": "A",
    "Comment": "The guideline recommends commencing high-dose Dexamethasone with a loading dose of 0.5 mg/kg (max 8 mg) IV/oral, followed by a maintenance dose of 0.25 mg/kg/dose every 6 hours (up to 4 mg/dose).",
    "Source": "Paeds EML (2023) Page 21.19"
  },
  {
    "Ref": "Paeds0275",
    "Questions": "Which type of seizure, common in paediatric epilepsy, is best treated with Ethosuximide monotherapy?",
    "A": "Tonic-Clonic seizures.",
    "B": "Infantile spasms (West Syndrome).",
    "C": "Atypical Absence seizures.",
    "D": "Typical Absence seizures.",
    "Answer": "D",
    "Comment": "Ethosuximide is the drug of choice for typical absence seizures (petit mal). It is not effective for tonic-clonic or atypical absence seizures.",
    "Source": "Paeds EML (2023) Page 13.8"
  },
  {
    "Ref": "Paeds0276",
    "Questions": "In the management of Neonatal Hypoglycaemia, what is the initial IV bolus dose of 10% Dextrose (Glucose) solution?",
    "A": "0.5 mL/kg.",
    "B": "1.0 mL/kg.",
    "C": "2.0 mL/kg.",
    "D": "5.0 mL/kg.",
    "Answer": "C",
    "Comment": "The standard dose for correcting neonatal hypoglycaemia is 2 mL/kg of 10% Dextrose, which provides 200 mg/kg of glucose.",
    "Source": "Paeds EML (2023) Page 19.50"
  },
  {
    "Ref": "Paeds0277",
    "Questions": "For a child with known G6PD deficiency, which anti-malarial drug must be avoided due to the high risk of precipitating acute haemolysis?",
    "A": "Artesunate.",
    "B": "Artemether-Lumefantrine.",
    "C": "Primaquine.",
    "D": "Chloroquine.",
    "Answer": "C",
    "Comment": "Primaquine, used for *P. vivax* and *P. ovale* to clear hypnozoites (liver stage), is an oxidative drug that is contraindicated in G6PD deficiency due to the risk of severe haemolysis.",
    "Source": "Paeds EML (2023) Page 8.16"
  },
  {
    "Ref": "Paeds0278",
    "Questions": "In the ongoing care of a child with HIV, when is it appropriate to discontinue *Pneumocystis Jiroveci Pneumonia* (PJP) prophylaxis (e.g., Cotrimoxazole)?",
    "A": "Only after the child is older than 5 years of age.",
    "B": "When the child has been on ART for 6 months, irrespective of CD4 count.",
    "C": "When the child is clinically stable and has achieved sustained viral suppression and/or age-appropriate CD4 count recovery.",
    "D": "Prophylaxis must be continued for life once initiated.",
    "Answer": "C",
    "Comment": "PJP prophylaxis is discontinued after clinical and immunological criteria are met, specifically following sustained viral suppression and CD4 count recovery, indicating restored immune function.",
    "Source": "Paeds EML (2023) Page 9.13"
  },
  {
    "Ref": "Paeds0279",
    "Questions": "What is the recommended initial dose of Adenosine for treating stable Supraventricular Tachycardia (SVT) in a child (given as rapid IV push)?",
    "A": "0.05 mg/kg",
    "B": "0.1 mg/kg",
    "C": "0.5 mg/kg",
    "D": "1.0 mg/kg",
    "Answer": "B",
    "Comment": "The initial dose of Adenosine is 0.1 mg/kg given as a rapid IV push, followed by a flush. The dose is doubled (0.2 mg/kg) if the initial dose fails to terminate the SVT.",
    "Source": "Paeds EML (2023) Page 4.41"
  },
  {
    "Ref": "Paeds0280",
    "Questions": "Which of the following is the hallmark finding on chest X-ray suggestive of Severe Bronchiolitis?",
    "A": "Consolidation (Lobar or segmental).",
    "B": "Hyperinflation and flattened diaphragm.",
    "C": "Ground-glass appearance.",
    "D": "Perihilar streaking.",
    "Answer": "B",
    "Comment": "Bronchiolitis causes air trapping and distal airway obstruction, leading to hyperinflation of the lungs and flattening of the diaphragm on X-ray, although the X-ray is often normal or non-specific.",
    "Source": "Paeds EML (2023) Page 15.11"
  },
  {
    "Ref": "Paeds0281",
    "Questions": "What is the primary intervention for a child presenting with Acute Otitis Externa (Swimmer's Ear) without underlying perforation?",
    "A": "Systemic oral Amoxicillin.",
    "B": "Topical antibiotic/steroid ear drops (e.g., Ciprofloxacin/Dexamethasone).",
    "C": "Systemic IV Ceftriaxone.",
    "D": "Myringotomy with Grommet insertion.",
    "Answer": "B",
    "Comment": "Otitis Externa is a localised infection and is primarily treated with topical agents (antibiotics, often combined with steroids for inflammation) to minimise systemic side effects.",
    "Source": "Paeds EML (2023) Page 17.10"
  },
  {
    "Ref": "Paeds0282",
    "Questions": "In a child with a known Adrenocortical Tumour, which hormone is the most common to be excessively secreted, leading to specific clinical features?",
    "A": "Thyroxine.",
    "B": "Insulin.",
    "C": "Cortisol (Cushing's Syndrome).",
    "D": "Growth Hormone.",
    "Answer": "C",
    "Comment": "Hypercortisolaemia (Cushing's Syndrome) is one of the most common presentations of adrenal tumours in children, leading to characteristic symptoms like central obesity, striae, and hypertension.",
    "Source": "Paeds EML (2023) Page 7.43"
  },
  {
    "Ref": "Paeds0283",
    "Questions": "What is the recommended initial IV fluid bolus volume for a child in compensated septic shock (hypovolaemia due to capillary leak) who has no features of cerebral malaria or cardiac failure?",
    "A": "5 mL/kg, repeated up to 2 times.",
    "B": "10 mL/kg, repeated up to 2 times.",
    "C": "20 mL/kg, repeated up to 3 times (total 60 mL/kg).",
    "D": "30 mL/kg, given as a single bolus.",
    "Answer": "C",
    "Comment": "The standard of care for shock involves repeated 20 mL/kg fluid boluses, with the protocol usually permitting up to 60 mL/kg before escalating to vasoactive agents, provided no signs of fluid overload develop.",
    "Source": "Paeds EML (2023) Page 1.15"
  },
  {
    "Ref": "Paeds0284",
    "Questions": "In a child with known Sickle Cell Anaemia (SCA), which medication is recommended to reduce the frequency of vaso-occlusive crises and the risk of Acute Chest Syndrome (ACS)?",
    "A": "Regular Aspirin.",
    "B": "Daily Hydroxycarbamide (Hydroxyurea).",
    "C": "Monthly IVIG.",
    "D": "Daily Iron Chelation therapy.",
    "Answer": "B",
    "Comment": "Hydroxycarbamide (Hydroxyurea) is a disease-modifying agent that increases Fetal Haemoglobin (HbF), reducing sickling and the incidence of painful crises and ACS.",
    "Source": "Paeds EML (2023) Page 3.6"
  },
  {
    "Ref": "Paeds0285",
    "Questions": "What is the recommended initial dose of oral Prednisone for an adolescent with a severe flare of Ulcerative Colitis (UC)?",
    "A": "0.5 mg/kg daily (max 20 mg).",
    "B": "1-2 mg/kg daily (max 60 mg).",
    "C": "5 mg/kg daily (max 100 mg).",
    "D": "20 mg daily, fixed dose.",
    "Answer": "B",
    "Comment": "High-dose systemic steroids (1-2 mg/kg/day, max 60 mg) are the standard induction therapy for moderate-to-severe flares of Inflammatory Bowel Disease (IBD) to achieve remission.",
    "Source": "Paeds EML (2023) Page 2.45"
  },
  {
    "Ref": "Paeds0286",
    "Questions": "In the management of Neonatal Jaundice, what is the recommended monitoring interval for Total Serum Bilirubin (TSB) in an infant on phototherapy who is not yet at exchange transfusion threshold?",
    "A": "Every 24 hours.",
    "B": "Every 12 hours.",
    "C": "Every 4-6 hours.",
    "D": "Every 72 hours.",
    "Answer": "C",
    "Comment": "TSB levels must be closely monitored (4-6 hourly) in infants receiving phototherapy or those near exchange transfusion thresholds to ensure a therapeutic response and prevent neurotoxicity (Kernicterus).",
    "Source": "Paeds EML (2023) Page 19.46"
  },
  {
    "Ref": "Paeds0287",
    "Questions": "A child presents with a high-grade fever, pharyngitis, and a 'sandpaper' rash. What is the recommended first-line oral antibiotic therapy?",
    "A": "Oral Amoxicillin or Penicillin V.",
    "B": "Oral Co-Trimoxazole.",
    "C": "Oral Ciprofloxacin.",
    "D": "Oral Erythromycin.",
    "Answer": "A",
    "Comment": "The presentation is classic for Scarlet Fever, caused by Group A *Streptococcus pyogenes*. Penicillin V (or Amoxicillin) is the drug of choice. Erythromycin is used for penicillin allergy.",
    "Source": "Paeds EML (2023) Page 8.33"
  },
  {
    "Ref": "Paeds0288",
    "Questions": "What is the recommended initial dose of oral Diazepam for the cessation of an acute, prolonged seizure in a child outside of a hospital setting (pre-hospital)?",
    "A": "0.1 mg/kg IV.",
    "B": "0.5 mg/kg Rectal/Buccal, maximum 10 mg.",
    "C": "0.5 mg/kg IV, maximum 10 mg.",
    "D": "1.0 mg/kg Rectal/Buccal, maximum 20 mg.",
    "Answer": "B",
    "Comment": "The standard pre-hospital dose of Diazepam for acute seizures is 0.5 mg/kg administered via the non-IV route (rectal or buccal) to ensure rapid absorption and ease of administration.",
    "Source": "Paeds EML (2023) Page 13.5"
  },
  {
    "Ref": "Paeds0289",
    "Questions": "In a child with known G6PD deficiency, what is the most important advice regarding medication usage?",
    "A": "Avoid all vaccinations.",
    "B": "Avoid all oxidative drugs (e.g., Primaquine, Sulfa drugs).",
    "C": "Avoid all NSAIDs.",
    "D": "Avoid all iron supplements.",
    "Answer": "B",
    "Comment": "Oxidative drugs can precipitate severe, acute haemolysis in G6PD deficient patients and must be strictly avoided. Sulfa drugs, some anti-malarials, and certain antibiotics are common culprits.",
    "Source": "Paeds EML (2023) Page 3.11"
  },
  {
    "Ref": "Paeds0290",
    "Questions": "Which haematological abnormality is typically expected during the first 6-8 weeks of life in a premature infant (< 32 weeks gestation) and requires iron/folate supplementation?",
    "A": "Thalassaemia Minor.",
    "B": "Anaemia of Prematurity.",
    "C": "Iron Deficiency Anaemia (IDA).",
    "D": "Diamond-Blackfan Anaemia.",
    "Answer": "B",
    "Comment": "Anaemia of prematurity is a physiological, multi-factorial anaemia seen in the first weeks/months of life. While it's largely normocytic/normochromic, it is managed with iron and folate supplementation, and sometimes transfusion.",
    "Source": "Paeds EML (2023) Page 3.7"
  },
  {
    "Ref": "Paeds0291",
    "Questions": "In the management of Neonatal Abstinence Syndrome (NAS) due to maternal opioid use, which pharmacological agent is the recommended first-line treatment if non-pharmacological methods fail?",
    "A": "Phenobarbitone.",
    "B": "Oral Morphine Solution.",
    "C": "Clonidine.",
    "D": "IV Fentanyl.",
    "Answer": "B",
    "Comment": "Morphine or Methadone are the first-line pharmacological agents for treating NAS, titrated to control symptoms and weaned slowly. Phenobarbitone is reserved for seizures or if CNS symptoms are refractory to opioids.",
    "Source": "Paeds EML (2023) Page 19.45"
  },
  {
    "Ref": "Paeds0292",
    "Questions": "Which of the following is the key long-term complication associated with Hydrocephalus in children?",
    "A": "Spontaneous resolution.",
    "B": "Permanent cognitive and motor impairment.",
    "C": "Development of Cushing's triad.",
    "D": "Systemic hypertension.",
    "Answer": "B",
    "Comment": "Hydrocephalus, especially if not promptly and effectively shunted, leads to increased ICP, causing compression and destruction of white matter, resulting in permanent neurological deficits.",
    "Source": "Paeds EML (2023) Page 13.19"
  },
  {
    "Ref": "Paeds0293",
    "Questions": "What is the recommended initial dose of oral Prednisone for an adolescent with a severe flare of Ulcerative Colitis (UC)?",
    "A": "0.5 mg/kg daily (max 20 mg).",
    "B": "1-2 mg/kg daily (max 60 mg).",
    "C": "5 mg/kg daily (max 100 mg).",
    "D": "20 mg daily, fixed dose.",
    "Answer": "B",
    "Comment": "High-dose systemic steroids (1-2 mg/kg/day, max 60 mg) are the standard induction therapy for moderate-to-severe flares of Inflammatory Bowel Disease (IBD) to achieve remission.",
    "Source": "Paeds EML (2023) Page 2.45"
  },
  {
    "Ref": "Paeds0294",
    "Questions": "In the management of chronic Cerebral Palsy (CP), which drug is commonly used to manage severe spasticity via intrathecal administration?",
    "A": "Diazepam (oral).",
    "B": "Botulinum Toxin A (local injection).",
    "C": "Baclofen (Intrathecal Pump).",
    "D": "Tizanidine (oral).",
    "Answer": "C",
    "Comment": "Intrathecal Baclofen, delivered via a pump, is reserved for severe, generalised spasticity that is refractory to oral medications (like oral Baclofen, Diazepam, Tizanidine), offering a high concentration to the spinal cord with less systemic side effects.",
    "Source": "Paeds EML (2023) Page 13.26"
  },
  {
    "Ref": "Paeds0295",
    "Questions": "A 10-year-old on long-term opioid analgesia for palliative care develops signs of acute spinal cord compression. What is the recommended immediate high-dose Dexamethasone regimen?",
    "A": "Loading dose of 0.5 mg/kg (max 8 mg), followed by 0.25 mg/kg/dose every 6 hours.",
    "B": "Loading dose of 2 mg/kg (max 100 mg), followed by 1 mg/kg/day.",
    "C": "Loading dose of 1 mg/kg (max 16 mg), followed by 0.5 mg/kg/dose every 6 hours.",
    "D": "Loading dose of 4 mg IV stat, followed by 4 mg orally every 6 hours.",
    "Answer": "A",
    "Comment": "The guideline recommends commencing high-dose Dexamethasone with a loading dose of 0.5 mg/kg (max 8 mg) IV/oral, followed by a maintenance dose of 0.25 mg/kg/dose every 6 hours (up to 4 mg/dose).",
    "Source": "Paeds EML (2023) Page 21.19"
  },
  {
    "Ref": "Paeds0296",
    "Questions": "In the ongoing palliative care management of chronic pain, which adjuvant medication is recommended to treat neuropathic pain components?",
    "A": "Bisacodyl (Laxative).",
    "B": "Amitriptyline (Tricyclic Antidepressant) or Gabapentin (Anticonvulsant).",
    "C": "Oral Diphenhydramine.",
    "D": "Oral Hydroxyzine.",
    "Answer": "B",
    "Comment": "Neuropathic pain is poorly responsive to opioids alone. Adjuvant medications like Tricyclic Antidepressants (Amitriptyline) or Anticonvulsants (Gabapentin/Pregabalin) are standard for neuropathic pain control.",
    "Source": "Paeds EML (2023) Page 21.16"
  },
  {
    "Ref": "Paeds0297",
    "Questions": "For a child on long-term oral Morphine for chronic cancer pain, which concurrent medication is essential to prescribe routinely to prevent a common and debilitating side effect?",
    "A": "Loperamide (Anti-diarrhoeal).",
    "B": "A stimulant laxative and stool softener (e.g., Senna/Lactulose).",
    "C": "Ondansetron (Anti-emetic).",
    "D": "Gabapentin (for neuropathic pain).",
    "Answer": "B",
    "Comment": "Opioid-induced constipation is refractory to tolerance and is an inevitable side effect that requires a prophylactic regimen including both a stimulant and a softener.",
    "Source": "Paeds EML (2023) Page 21.14"
  },
  {
    "Ref": "Paeds0298",
    "Questions": "In the management of Severe Acute Malnutrition (SAM), what is the correct time to introduce the rehabilitation phase feeds (e.g., F-100 formula)?",
    "A": "Immediately upon admission to aggressively treat weight loss.",
    "B": "Only after the child has recovered appetite, no signs of infection, and oedema has resolved (Stabilisation phase complete).",
    "C": "Only after serum albumin has normalized.",
    "D": "48 hours after admission, irrespective of clinical stability.",
    "Answer": "B",
    "Comment": "The rehabilitation phase (with higher energy/protein feeds like F-100) must only be initiated after the critical stabilisation phase is complete, which includes resolution of shock, correction of electrolytes, and return of appetite.",
    "Source": "Paeds EML (2023) Page 2.37"
  },
  {
    "Ref": "Paeds0299",
    "Questions": "Which of the following is the key initial intervention in a child presenting with severe Bleeding Oesophageal Varices (Portal Hypertension)?",
    "A": "Urgent packed red cell transfusion.",
    "B": "Administration of Octreotide/Terlipressin to reduce portal pressure.",
    "C": "Endoscopic Variceal Ligation (EVL).",
    "D": "Placement of a Transjugular Intrahepatic Portosystemic Shunt (TIPS).",
    "Answer": "B",
    "Comment": "Pharmacological reduction of portal pressure (Octreotide/Terlipressin) is initiated immediately upon suspicion, along with supportive care, while arrangements for definitive endoscopic management (EVL) are made.",
    "Source": "Paeds EML (2023) Page 2.29"
  },
  {
    "Ref": "Paeds0300",
    "Questions": "What is the recommended duration of antibiotic therapy for a child with an uncomplicated Staphylococcal Scalded Skin Syndrome (SSSS)?",
    "A": "3 days of IV antibiotics only.",
    "B": "7-10 days of IV/oral antibiotics.",
    "C": "21 days of IV antibiotics.",
    "D": "No antibiotics needed, only supportive care.",
    "Answer": "B",
    "Comment": "SSSS is caused by a toxin-producing S. aureus and requires systemic antibiotics, often started IV, then switched to oral to complete a course of 7-10 days, alongside wound care.",
    "Source": "Paeds EML (2023) Page 5.8"
  },
  { 
    "Ref": "Maternal0141", 
    "Questions": "What is the definition of primary postpartum haemorrhage (PPH)?", 
    "A": "Blood loss >500 mL within 24 hours of birth", 
    "B": "Blood loss >500 mL after 7 days postpartum", 
    "C": "Blood loss >200 mL after caesarean section", 
    "D": "Blood loss >1000 mL within 6 weeks", 
    "Answer": "A", 
    "Comment": "Primary PPH is defined as blood loss exceeding 500 mL within the first 24 hours after delivery.", 
    "Source": "Page 115" 
  },
  { 
    "Ref": "Maternal0142", 
    "Questions": "Which is the leading cause of primary postpartum haemorrhage?", 
    "A": "Retained placenta", 
    "B": "Uterine atony", 
    "C": "Genital tract trauma", 
    "D": "Coagulopathy", 
    "Answer": "B", 
    "Comment": "Uterine atony is the most common cause of PPH.", 
    "Source": "Page 115" 
  },
  { 
    "Ref": "Maternal0143", 
    "Questions": "Which is the first-line uterotonic used in the prevention and management of PPH?", 
    "A": "Methylergometrine", 
    "B": "Oxytocin 10 IU IM/IV", 
    "C": "Misoprostol 25 mcg", 
    "D": "Carboprost", 
    "Answer": "B", 
    "Comment": "Oxytocin is first-line for both prevention and management of PPH.", 
    "Source": "Page 116" 
  },
  { 
    "Ref": "Maternal0144", 
    "Questions": "Which is the correct initial step in managing PPH due to uterine atony?", 
    "A": "Hysterectomy", 
    "B": "Uterine massage and oxytocin", 
    "C": "Start antibiotics", 
    "D": "Wait and observe", 
    "Answer": "B", 
    "Comment": "Uterine massage with oxytocin is the immediate first step for atony-related PPH.", 
    "Source": "Page 116" 
  },
  { 
    "Ref": "Maternal0145", 
    "Questions": "Which drug can be used as an alternative uterotonic where oxytocin is not available?", 
    "A": "Misoprostol 800 mcg rectally", 
    "B": "Aspirin", 
    "C": "Diazepam", 
    "D": "Furosemide", 
    "Answer": "A", 
    "Comment": "Misoprostol 800 mcg rectally is an alternative where oxytocin is unavailable.", 
    "Source": "Page 117" 
  },
  { 
    "Ref": "Maternal0146", 
    "Questions": "Which surgical intervention may be used in refractory PPH before hysterectomy?", 
    "A": "B-Lynch compression suture", 
    "B": "Laparotomy with splenectomy", 
    "C": "Tubal ligation", 
    "D": "Appendectomy", 
    "Answer": "A", 
    "Comment": "B-Lynch sutures can control bleeding and preserve fertility in severe PPH.", 
    "Source": "Page 118" 
  },
  { 
    "Ref": "Maternal0147", 
    "Questions": "Which blood product is preferred in massive obstetric haemorrhage?", 
    "A": "Whole blood or packed red cells with plasma and platelets", 
    "B": "Fresh frozen plasma only", 
    "C": "Platelets only", 
    "D": "Albumin infusion", 
    "Answer": "A", 
    "Comment": "Massive haemorrhage requires balanced resuscitation with red cells, plasma and platelets.", 
    "Source": "Page 119" 
  },
  { 
    "Ref": "Maternal0148", 
    "Questions": "Which is a recognised risk factor for PPH?", 
    "A": "Overdistended uterus (e.g., twins, polyhydramnios)", 
    "B": "Nulliparity with low BMI", 
    "C": "Short duration of labour", 
    "D": "Spontaneous rupture of membranes", 
    "Answer": "A", 
    "Comment": "Overdistension increases risk of uterine atony and PPH.", 
    "Source": "Page 115" 
  },
  { 
    "Ref": "Maternal0149", 
    "Questions": "Which intervention is NOT recommended in PPH management?", 
    "A": "Uterine massage", 
    "B": "Rapid IV oxytocin infusion", 
    "C": "Delaying treatment until Hb results available", 
    "D": "Tranexamic acid within 3 hours", 
    "Answer": "C", 
    "Comment": "PPH management must be immediate, not delayed for investigations.", 
    "Source": "Page 117" 
  },
  { 
    "Ref": "Maternal0150", 
    "Questions": "What is the recommended timing for tranexamic acid administration in PPH?", 
    "A": "Within 3 hours of birth", 
    "B": "Only after 24 hours", 
    "C": "At 6 weeks postpartum", 
    "D": "Before delivery always", 
    "Answer": "A", 
    "Comment": "Tranexamic acid is effective if given within 3 hours of PPH onset.", 
    "Source": "Page 117" 
  },
  { 
    "Ref": "Maternal0151", 
    "Questions": "What is the definition of secondary postpartum haemorrhage?", 
    "A": "Blood loss >500 mL in the first 24 hours", 
    "B": "Excessive bleeding between 24 hours and 6 weeks postpartum", 
    "C": "Bleeding in labour before delivery", 
    "D": "Spotting in early pregnancy", 
    "Answer": "B", 
    "Comment": "Secondary PPH occurs between 24 hours and 6 weeks postpartum.", 
    "Source": "Page 115" 
  },
  { 
    "Ref": "Maternal0152", 
    "Questions": "Which investigation is essential for diagnosing secondary PPH?", 
    "A": "Ultrasound of uterus to detect retained products", 
    "B": "Chest X-ray", 
    "C": "Liver function tests only", 
    "D": "ECG", 
    "Answer": "A", 
    "Comment": "Ultrasound is important to check for retained tissue in secondary PPH.", 
    "Source": "Page 118" 
  },
  { 
    "Ref": "Maternal0153", 
    "Questions": "Which of the following is NOT a component of the 'Four Ts' causes of PPH?", 
    "A": "Tone", 
    "B": "Trauma", 
    "C": "Thyroid disease", 
    "D": "Tissue", 
    "Answer": "C", 
    "Comment": "The 'Four Ts' causes of PPH are Tone, Trauma, Tissue, and Thrombin.", 
    "Source": "Page 115" 
  },
  { 
    "Ref": "Maternal0154", 
    "Questions": "Which is the single most important preventive measure for PPH?", 
    "A": "Active management of third stage of labour", 
    "B": "Routine antibiotics for all women", 
    "C": "Elective caesarean section", 
    "D": "Avoiding breastfeeding", 
    "Answer": "A", 
    "Comment": "AMTSL with oxytocin reduces PPH risk significantly.", 
    "Source": "Page 116" 
  },
  { 
    "Ref": "Maternal0155", 
    "Questions": "Which condition is the most common cause of anaemia in pregnancy?", 
    "A": "Iron deficiency", 
    "B": "Sickle cell disease", 
    "C": "Aplastic anaemia", 
    "D": "Vitamin B12 deficiency", 
    "Answer": "A", 
    "Comment": "Iron deficiency anaemia is the leading cause of maternal anaemia.", 
    "Source": "Page 125" 
  },
  { 
    "Ref": "Maternal0156", 
    "Questions": "Which Hb level defines severe anaemia in pregnancy?", 
    "A": "<11 g/dL", 
    "B": "<10 g/dL", 
    "C": "<7 g/dL", 
    "D": "<5 g/dL", 
    "Answer": "C", 
    "Comment": "Severe anaemia is defined as Hb <7 g/dL in pregnancy.", 
    "Source": "Page 125" 
  },
  { 
    "Ref": "Maternal0157", 
    "Questions": "Which is the recommended first-line treatment for iron deficiency anaemia in pregnancy?", 
    "A": "Oral iron supplementation", 
    "B": "IV fluids only", 
    "C": "Blood transfusion for all cases", 
    "D": "Steroids", 
    "Answer": "A", 
    "Comment": "Oral iron is first-line therapy unless severe or intolerant.", 
    "Source": "Page 126" 
  },
  { 
    "Ref": "Maternal0158", 
    "Questions": "Which is the main risk of untreated severe anaemia in pregnancy?", 
    "A": "Preterm birth and maternal death", 
    "B": "Improved fetal growth", 
    "C": "Reduced PPH risk", 
    "D": "Lower rates of infection", 
    "Answer": "A", 
    "Comment": "Severe anaemia increases maternal morbidity, mortality, and preterm birth risk.", 
    "Source": "Page 125" 
  },
  { 
    "Ref": "Maternal0159", 
    "Questions": "Which test is essential in diagnosing gestational diabetes mellitus (GDM)?", 
    "A": "Oral glucose tolerance test (OGTT)", 
    "B": "HbA1c", 
    "C": "Urine dipstick only", 
    "D": "Random cholesterol", 
    "Answer": "A", 
    "Comment": "OGTT is the diagnostic test for GDM.", 
    "Source": "Page 129" 
  },
  { 
    "Ref": "Maternal0160", 
    "Questions": "Which of the following is NOT a recognised complication of diabetes in pregnancy?", 
    "A": "Macrosomia", 
    "B": "Polyhydramnios", 
    "C": "Congenital anomalies", 
    "D": "Reduced risk of pre-eclampsia", 
    "Answer": "D", 
    "Comment": "Diabetes increases, not reduces, the risk of pre-eclampsia.", 
    "Source": "Page 129" 
  },
  { 
    "Ref": "Maternal0161", 
    "Questions": "Which drug is preferred for glycaemic control in gestational diabetes if lifestyle modification fails?", 
    "A": "Insulin", 
    "B": "Sulfonylureas", 
    "C": "Metformin only", 
    "D": "Warfarin", 
    "Answer": "A", 
    "Comment": "Insulin is the drug of choice for GDM requiring pharmacological treatment.", 
    "Source": "Page 130" 
  },
  { 
    "Ref": "Maternal0162", 
    "Questions": "Which cardiac lesion is particularly high risk in pregnancy?", 
    "A": "Mild mitral valve prolapse", 
    "B": "Severe pulmonary hypertension", 
    "C": "Small VSD", 
    "D": "Atrial septal defect", 
    "Answer": "B", 
    "Comment": "Severe pulmonary hypertension carries high maternal mortality risk.", 
    "Source": "Page 132" 
  },
  { 
    "Ref": "Maternal0163", 
    "Questions": "Which is the safest antihypertensive drug for women with heart disease in pregnancy?", 
    "A": "Methyldopa", 
    "B": "ACE inhibitors", 
    "C": "Spironolactone", 
    "D": "Statins", 
    "Answer": "A", 
    "Comment": "Methyldopa is safe for women with heart disease during pregnancy.", 
    "Source": "Page 132" 
  },
  { 
    "Ref": "Maternal0164", 
    "Questions": "Which is the main risk of asthma in pregnancy if poorly controlled?", 
    "A": "Fetal growth restriction and preterm birth", 
    "B": "Reduced PPH risk", 
    "C": "Lower rates of infection", 
    "D": "Prolonged labour", 
    "Answer": "A", 
    "Comment": "Uncontrolled asthma increases risk of FGR and preterm delivery.", 
    "Source": "Page 134" 
  },
  { 
    "Ref": "Maternal0165", 
    "Questions": "Which asthma medication is considered safe in pregnancy?", 
    "A": "Inhaled corticosteroids", 
    "B": "Isotretinoin", 
    "C": "Warfarin", 
    "D": "ACE inhibitors", 
    "Answer": "A", 
    "Comment": "Inhaled corticosteroids are safe and essential for asthma control in pregnancy.", 
    "Source": "Page 134" 
  },
  { 
    "Ref": "Maternal0166", 
    "Questions": "Which medication is contraindicated for epilepsy in pregnancy due to teratogenicity?", 
    "A": "Valproic acid", 
    "B": "Carbamazepine", 
    "C": "Lamotrigine", 
    "D": "Levetiracetam", 
    "Answer": "A", 
    "Comment": "Valproic acid is highly teratogenic and should be avoided in pregnancy.", 
    "Source": "Page 136" 
  },
  { 
    "Ref": "Maternal0167", 
    "Questions": "Which supplement should all women with epilepsy receive during pregnancy?", 
    "A": "High-dose folic acid", 
    "B": "Vitamin C", 
    "C": "Fish oil", 
    "D": "Iron only", 
    "Answer": "A", 
    "Comment": "High-dose folic acid reduces neural tube defects risk in epileptic mothers.", 
    "Source": "Page 136" 
  },
  { 
    "Ref": "Maternal0168", 
    "Questions": "Which thyroid disorder requires treatment with levothyroxine during pregnancy?", 
    "A": "Hypothyroidism", 
    "B": "Hyperthyroidism", 
    "C": "Thyroid cancer", 
    "D": "Subclinical thyrotoxicosis", 
    "Answer": "A", 
    "Comment": "Hypothyroidism should be treated with levothyroxine to ensure fetal neurodevelopment.", 
    "Source": "Page 138" 
  },
  { 
    "Ref": "Maternal0169", 
    "Questions": "Which drug is preferred for treatment of hyperthyroidism in the first trimester?", 
    "A": "Propylthiouracil (PTU)", 
    "B": "Carbimazole", 
    "C": "Levothyroxine", 
    "D": "Methyldopa", 
    "Answer": "A", 
    "Comment": "PTU is preferred in first trimester as carbimazole is teratogenic.", 
    "Source": "Page 138" 
  },
  { 
    "Ref": "Maternal0170", 
    "Questions": "Which maternal BMI is classified as obesity in pregnancy?", 
    "A": "≥25", 
    "B": "≥30", 
    "C": "≥35", 
    "D": "≥40", 
    "Answer": "B", 
    "Comment": "Obesity in pregnancy is defined as BMI ≥30.", 
    "Source": "Page 140" 
  },
  { 
    "Ref": "Maternal0171", 
    "Questions": "Which is a key maternal complication of obesity in pregnancy?", 
    "A": "Pre-eclampsia and gestational diabetes", 
    "B": "Reduced PPH risk", 
    "C": "Improved fertility", 
    "D": "Lower risk of caesarean section", 
    "Answer": "A", 
    "Comment": "Obesity increases risk of GDM, pre-eclampsia, and caesarean section.", 
    "Source": "Page 140" 
  },
  { 
    "Ref": "Maternal0172", 
    "Questions": "Which intervention is recommended for weight management during pregnancy?", 
    "A": "Dietary counselling and physical activity", 
    "B": "Crash dieting", 
    "C": "Weight loss medication", 
    "D": "Routine bariatric surgery", 
    "Answer": "A", 
    "Comment": "Healthy diet and physical activity are recommended for weight control during pregnancy.", 
    "Source": "Page 140" 
  },
  { 
    "Ref": "Maternal0173", 
    "Questions": "Which is the most common infection complicating pregnancy globally?", 
    "A": "HIV", 
    "B": "Urinary tract infection (UTI)", 
    "C": "Syphilis", 
    "D": "TB", 
    "Answer": "B", 
    "Comment": "UTIs are the most common maternal infection worldwide in pregnancy.", 
    "Source": "Page 142" 
  },
  
  { 
    "Ref": "Maternal0101", 
    "Questions": "Which fundal height measurement suggests a small-for-gestational-age (SGA) fetus?", 
    "A": "SFH within 2 cm of gestational age", 
    "B": "SFH >2 cm below expected for gestational age", 
    "C": "SFH >2 cm above gestational age", 
    "D": "SFH equal to maternal age", 
    "Answer": "B", 
    "Comment": "SFH >2 cm below expected indicates possible SGA, requiring further assessment.", 
    "Source": "Page 80" 
  },
  { 
    "Ref": "Maternal0102", 
    "Questions": "Which investigation is most useful in evaluating suspected fetal growth restriction?", 
    "A": "Chest X-ray", 
    "B": "Ultrasound with Doppler studies", 
    "C": "Amniocentesis", 
    "D": "ECG", 
    "Answer": "B", 
    "Comment": "Ultrasound with Doppler of umbilical artery is recommended for SGA evaluation.", 
    "Source": "Page 80" 
  },
  { 
    "Ref": "Maternal0103", 
    "Questions": "Which maternal factor increases risk of SGA fetus?", 
    "A": "Diabetes", 
    "B": "Smoking", 
    "C": "Multiparity", 
    "D": "Tall stature", 
    "Answer": "B", 
    "Comment": "Maternal smoking is a well-established risk factor for SGA fetuses.", 
    "Source": "Page 81" 
  },
  { 
    "Ref": "Maternal0104", 
    "Questions": "What is the main risk of macrosomia (>4.5 kg)?", 
    "A": "Reduced caesarean rates", 
    "B": "Shoulder dystocia and birth trauma", 
    "C": "Preterm delivery", 
    "D": "Lower risk of PPH", 
    "Answer": "B", 
    "Comment": "Macrosomia increases risk of shoulder dystocia and trauma.", 
    "Source": "Page 82" 
  },
  { 
    "Ref": "Maternal0105", 
    "Questions": "Which is the preferred delivery mode for a transverse lie at term?", 
    "A": "Normal vaginal delivery", 
    "B": "Assisted breech extraction", 
    "C": "Caesarean section", 
    "D": "Induction of labour", 
    "Answer": "C", 
    "Comment": "Transverse lie at term usually requires caesarean section.", 
    "Source": "Page 83" 
  },
  { 
    "Ref": "Maternal0106", 
    "Questions": "Which intervention may be offered to turn a breech fetus to cephalic presentation at 36–37 weeks?", 
    "A": "External cephalic version (ECV)", 
    "B": "Immediate induction", 
    "C": "Emergency caesarean", 
    "D": "MRI-guided repositioning", 
    "Answer": "A", 
    "Comment": "ECV is recommended to reduce breech at term and caesarean rates.", 
    "Source": "Page 84" 
  },
  { 
    "Ref": "Maternal0107", 
    "Questions": "Which is a contraindication to external cephalic version?", 
    "A": "Low amniotic fluid index", 
    "B": "Multiple pregnancy", 
    "C": "Previous vaginal delivery", 
    "D": "Gestation 36 weeks", 
    "Answer": "B", 
    "Comment": "Multiple pregnancy is a contraindication to ECV.", 
    "Source": "Page 84" 
  },
  { 
    "Ref": "Maternal0108", 
    "Questions": "Which twin type has the highest risk of complications?", 
    "A": "Dichorionic diamniotic", 
    "B": "Monochorionic diamniotic", 
    "C": "Monochorionic monoamniotic", 
    "D": "Conjoined twins only", 
    "Answer": "C", 
    "Comment": "MCMA twins carry the highest risk of cord entanglement and perinatal mortality.", 
    "Source": "Page 86" 
  },
  { 
    "Ref": "Maternal0109", 
    "Questions": "Which is the preferred delivery mode for the first twin breech and second twin cephalic?", 
    "A": "Vaginal delivery always", 
    "B": "Caesarean section", 
    "C": "Forceps delivery", 
    "D": "Vacuum delivery", 
    "Answer": "B", 
    "Comment": "If the first twin is breech, caesarean section is generally recommended.", 
    "Source": "Page 87" 
  },
  { 
    "Ref": "Maternal0110", 
    "Questions": "Which intervention is recommended to reduce risk of preterm birth in women with a short cervix?", 
    "A": "Progesterone supplementation", 
    "B": "Routine induction", 
    "C": "Aspirin therapy", 
    "D": "Magnesium sulphate", 
    "Answer": "A", 
    "Comment": "Progesterone can reduce risk of preterm birth in high-risk women.", 
    "Source": "Page 90" 
  },
  { 
    "Ref": "Maternal0111", 
    "Questions": "Which medication is recommended for fetal neuroprotection in imminent preterm delivery?", 
    "A": "Calcium gluconate", 
    "B": "Magnesium sulphate", 
    "C": "Methyldopa", 
    "D": "Indomethacin", 
    "Answer": "B", 
    "Comment": "Magnesium sulphate before preterm delivery provides neuroprotection against cerebral palsy.", 
    "Source": "Page 91" 
  },
  { 
    "Ref": "Maternal0112", 
    "Questions": "Which corticosteroid is recommended for enhancing fetal lung maturity in preterm labour?", 
    "A": "Dexamethasone", 
    "B": "Hydrocortisone", 
    "C": "Prednisone", 
    "D": "Methylprednisolone", 
    "Answer": "A", 
    "Comment": "Dexamethasone is recommended to enhance lung maturity before preterm delivery.", 
    "Source": "Page 91" 
  },
  { 
    "Ref": "Maternal0113", 
    "Questions": "What is the definition of preterm birth?", 
    "A": "Birth before 42 weeks", 
    "B": "Birth before 37 completed weeks", 
    "C": "Birth before 40 weeks", 
    "D": "Birth before 34 weeks only", 
    "Answer": "B", 
    "Comment": "Preterm birth is delivery before 37 completed weeks gestation.", 
    "Source": "Page 90" 
  },
  { 
    "Ref": "Maternal0114", 
    "Questions": "Which tocolytic is preferred for short-term delay of labour?", 
    "A": "Nifedipine", 
    "B": "Methyldopa", 
    "C": "Warfarin", 
    "D": "Labetalol", 
    "Answer": "A", 
    "Comment": "Nifedipine is a commonly used tocolytic to delay preterm labour for steroid administration.", 
    "Source": "Page 92" 
  },
  { 
    "Ref": "Maternal0115", 
    "Questions": "Which is the most common cause of antepartum haemorrhage?", 
    "A": "Placenta praevia", 
    "B": "Placental abruption", 
    "C": "Vasa praevia", 
    "D": "Cervical carcinoma", 
    "Answer": "B", 
    "Comment": "Placental abruption is the most common cause of antepartum haemorrhage.", 
    "Source": "Page 98" 
  },
  { 
    "Ref": "Maternal0116", 
    "Questions": "Which symptom is most suggestive of placenta praevia?", 
    "A": "Sudden painless vaginal bleeding in the second half of pregnancy", 
    "B": "Painful bleeding with uterine tenderness", 
    "C": "Watery discharge", 
    "D": "Hypertension", 
    "Answer": "A", 
    "Comment": "Placenta praevia typically presents with painless vaginal bleeding in the second half of pregnancy.", 
    "Source": "Page 99" 
  },
  { 
    "Ref": "Maternal0117", 
    "Questions": "Which delivery method is usually required in major placenta praevia?", 
    "A": "Vaginal delivery", 
    "B": "Caesarean section", 
    "C": "Instrumental delivery", 
    "D": "Induction of labour", 
    "Answer": "B", 
    "Comment": "Major placenta praevia usually requires delivery by caesarean section.", 
    "Source": "Page 99" 
  },
  { 
    "Ref": "Maternal0118", 
    "Questions": "Which sign is most suggestive of placental abruption?", 
    "A": "Painless bright red bleeding", 
    "B": "Painful vaginal bleeding with a tender, rigid uterus", 
    "C": "Increased fetal movements", 
    "D": "No uterine contractions", 
    "Answer": "B", 
    "Comment": "Placental abruption presents with painful bleeding, uterine tenderness, and rigidity.", 
    "Source": "Page 98" 
  },
  { 
    "Ref": "Maternal0119", 
    "Questions": "Which is the recommended management of concealed placental abruption with maternal shock?", 
    "A": "Bed rest at home", 
    "B": "Immediate resuscitation and delivery", 
    "C": "Wait until term", 
    "D": "Discharge with iron tablets", 
    "Answer": "B", 
    "Comment": "Concealed abruption with maternal shock is an emergency requiring immediate delivery.", 
    "Source": "Page 98" 
  },
  { 
    "Ref": "Maternal0120", 
    "Questions": "Which is a major risk factor for uterine rupture?", 
    "A": "Primigravida", 
    "B": "Previous caesarean section", 
    "C": "Twin pregnancy", 
    "D": "Obesity", 
    "Answer": "B", 
    "Comment": "Previous caesarean section is the major risk factor for uterine rupture.", 
    "Source": "Page 101" 
  },
  { 
    "Ref": "Maternal0121", 
    "Questions": "Which is the safest method of delivery for women with previous classical caesarean section scar?", 
    "A": "Vaginal birth after caesarean (VBAC)", 
    "B": "Elective repeat caesarean section", 
    "C": "Vacuum delivery", 
    "D": "Forceps delivery", 
    "Answer": "B", 
    "Comment": "Classical caesarean scars carry high risk of rupture; repeat caesarean is recommended.", 
    "Source": "Page 101" 
  },
  { 
    "Ref": "Maternal0122", 
    "Questions": "Which maternal factor is a contraindication to VBAC?", 
    "A": "One previous low transverse caesarean", 
    "B": "Previous uterine rupture", 
    "C": "Twin pregnancy", 
    "D": "Post-term pregnancy", 
    "Answer": "B", 
    "Comment": "A history of uterine rupture contraindicates VBAC.", 
    "Source": "Page 101" 
  },
  { 
    "Ref": "Maternal0123", 
    "Questions": "Which delivery method is generally recommended for women with two or more prior caesarean sections?", 
    "A": "VBAC is always safe", 
    "B": "Elective repeat caesarean section", 
    "C": "Home birth", 
    "D": "Vacuum delivery", 
    "Answer": "B", 
    "Comment": "Multiple previous caesarean sections usually require elective repeat caesarean.", 
    "Source": "Page 102" 
  },
  { 
    "Ref": "Maternal0124", 
    "Questions": "Which blood pressure defines hypertension in pregnancy?", 
    "A": "≥120/80 mmHg", 
    "B": "≥130/85 mmHg", 
    "C": "≥140/90 mmHg", 
    "D": "≥150/95 mmHg", 
    "Answer": "C", 
    "Comment": "Hypertension in pregnancy is defined as ≥140/90 mmHg.", 
    "Source": "Page 103" 
  },
  { 
    "Ref": "Maternal0125", 
    "Questions": "Which antihypertensive is contraindicated in pregnancy?", 
    "A": "Methyldopa", 
    "B": "Labetalol", 
    "C": "ACE inhibitors", 
    "D": "Nifedipine", 
    "Answer": "C", 
    "Comment": "ACE inhibitors are contraindicated due to fetotoxic effects.", 
    "Source": "Page 104" 
  },
  { 
    "Ref": "Maternal0126", 
    "Questions": "Which drug is used for seizure prophylaxis in severe pre-eclampsia?", 
    "A": "Diazepam", 
    "B": "Phenytoin", 
    "C": "Magnesium sulphate", 
    "D": "Valproic acid", 
    "Answer": "C", 
    "Comment": "Magnesium sulphate is the drug of choice for eclampsia prophylaxis.", 
    "Source": "Page 105" 
  },
  { 
    "Ref": "Maternal0127", 
    "Questions": "Which is the first-line antihypertensive in severe hypertension of pregnancy?", 
    "A": "Methyldopa orally", 
    "B": "IV labetalol or oral nifedipine", 
    "C": "Hydralazine only", 
    "D": "Warfarin", 
    "Answer": "B", 
    "Comment": "IV labetalol or oral nifedipine are first-line choices in acute severe hypertension.", 
    "Source": "Page 105" 
  },
  { 
    "Ref": "Maternal0128", 
    "Questions": "Which is the diagnostic feature of pre-eclampsia?", 
    "A": "Hypertension and proteinuria after 20 weeks", 
    "B": "Hypertension before 12 weeks", 
    "C": "Hypertension without proteinuria before 20 weeks", 
    "D": "Proteinuria in first trimester only", 
    "Answer": "A", 
    "Comment": "Pre-eclampsia is diagnosed after 20 weeks with hypertension and proteinuria or other end-organ dysfunction.", 
    "Source": "Page 103" 
  },
  { 
    "Ref": "Maternal0129", 
    "Questions": "Which is the correct loading dose of magnesium sulphate for eclampsia?", 
    "A": "4 g IV over 5 minutes + 10 g IM", 
    "B": "20 g IV bolus", 
    "C": "5 g oral solution", 
    "D": "2 g IM only", 
    "Answer": "A", 
    "Comment": "Loading dose: 4 g IV slowly plus 10 g IM (5 g each buttock).", 
    "Source": "Page 106" 
  },
  { 
    "Ref": "Maternal0130", 
    "Questions": "Which is the antidote for magnesium sulphate toxicity?", 
    "A": "Calcium gluconate", 
    "B": "Vitamin K", 
    "C": "Naloxone", 
    "D": "Atropine", 
    "Answer": "A", 
    "Comment": "Calcium gluconate is the antidote to magnesium toxicity.", 
    "Source": "Page 106" 
  },
  { 
    "Ref": "Maternal0131", 
    "Questions": "Which is the main risk of chronic hypertension in pregnancy?", 
    "A": "Preterm labour", 
    "B": "Gestational diabetes", 
    "C": "Eclampsia", 
    "D": "Preeclampsia and growth restriction", 
    "Answer": "D", 
    "Comment": "Chronic hypertension increases risks of pre-eclampsia and fetal growth restriction.", 
    "Source": "Page 104" 
  },
  { 
    "Ref": "Maternal0132", 
    "Questions": "What is HELLP syndrome?", 
    "A": "Haemolysis, Elevated Liver enzymes, Low Platelets", 
    "B": "Haemoglobin, Electrolytes, Lipids, Proteins", 
    "C": "Hyperemesis, Electrolyte imbalance, Low pH", 
    "D": "Hypoglycaemia, Enzyme loss, Liver pathology", 
    "Answer": "A", 
    "Comment": "HELLP = Haemolysis, Elevated Liver enzymes, Low Platelets; a severe pre-eclampsia complication.", 
    "Source": "Page 107" 
  },
  { 
    "Ref": "Maternal0133", 
    "Questions": "Which of the following is a warning sign of impending eclampsia?", 
    "A": "Mild ankle swelling", 
    "B": "Severe headache and visual disturbances", 
    "C": "Polyuria", 
    "D": "Constipation", 
    "Answer": "B", 
    "Comment": "Neurological symptoms like headache and visual changes suggest risk of seizures.", 
    "Source": "Page 105" 
  },
  { 
    "Ref": "Maternal0134", 
    "Questions": "Which maternal complication is most commonly associated with eclampsia?", 
    "A": "Renal failure", 
    "B": "Respiratory failure", 
    "C": "Stroke and intracranial haemorrhage", 
    "D": "Asthma", 
    "Answer": "C", 
    "Comment": "Eclampsia may cause cerebral haemorrhage and stroke, leading to maternal death.", 
    "Source": "Page 107" 
  },
  { 
    "Ref": "Maternal0135", 
    "Questions": "Which investigation is essential for monitoring women on magnesium sulphate?", 
    "A": "Respiratory rate, reflexes, urine output", 
    "B": "Chest X-ray", 
    "C": "MRI brain", 
    "D": "ECG daily", 
    "Answer": "A", 
    "Comment": "Monitoring includes respiratory rate, deep tendon reflexes, and urine output.", 
    "Source": "Page 106" 
  },
  { 
    "Ref": "Maternal0136", 
    "Questions": "Which antihypertensive is suitable for long-term use in pregnancy?", 
    "A": "Methyldopa", 
    "B": "ACE inhibitors", 
    "C": "Diuretics", 
    "D": "Atenolol", 
    "Answer": "A", 
    "Comment": "Methyldopa is safe for long-term use during pregnancy.", 
    "Source": "Page 104" 
  },
  { 
    "Ref": "Maternal0137", 
    "Questions": "Which delivery timing is generally recommended for severe pre-eclampsia at ≥34 weeks?", 
    "A": "Continue pregnancy until 40 weeks", 
    "B": "Immediate delivery after stabilisation", 
    "C": "Delay until 37 weeks", 
    "D": "Discharge home with follow-up", 
    "Answer": "B", 
    "Comment": "Delivery after stabilisation is recommended at ≥34 weeks for severe pre-eclampsia.", 
    "Source": "Page 107" 
  },
  { 
    "Ref": "Maternal0138", 
    "Questions": "Which complication of pre-eclampsia requires urgent caesarean section?", 
    "A": "Fetal distress", 
    "B": "Polyuria", 
    "C": "Constipation", 
    "D": "Mild oedema", 
    "Answer": "A", 
    "Comment": "Fetal distress in pre-eclampsia is an indication for urgent delivery.", 
    "Source": "Page 107" 
  },
  { 
    "Ref": "Maternal0139", 
    "Questions": "Which is the maternal target blood pressure during antihypertensive therapy in pregnancy?", 
    "A": "100/60 mmHg", 
    "B": "120/70 mmHg", 
    "C": "135/85 mmHg", 
    "D": "160/100 mmHg", 
    "Answer": "C", 
    "Comment": "Target BP is 135/85 mmHg to balance maternal safety and uteroplacental perfusion.", 
    "Source": "Page 105" 
  },
  { 
    "Ref": "Maternal0140", 
    "Questions": "Which of the following is recommended follow-up after delivery for women with pre-eclampsia?", 
    "A": "Stop all antihypertensives immediately", 
    "B": "Monitor BP for at least 2 weeks postpartum", 
    "C": "Routine discharge with no follow-up", 
    "D": "High-dose diuretics immediately", 
    "Answer": "B", 
    "Comment": "Women with pre-eclampsia require continued BP monitoring postpartum as complications may persist.", 
    "Source": "Page 108" 
  },
  { 
    "Ref": "Maternal0081", 
    "Questions": "Which tool is recommended for monitoring labour progress and maternal-fetal wellbeing?", 
    "A": "CT scan", 
    "B": "MRI", 
    "C": "Partograph", 
    "D": "Ultrasound only", 
    "Answer": "C", 
    "Comment": "The partograph is recommended for monitoring progress, contractions, fetal heart, and maternal condition.", 
    "Source": "Page 72" 
  },
  { 
    "Ref": "Maternal0082", 
    "Questions": "Which fetal heart rate pattern is concerning and requires immediate action?", 
    "A": "Baseline 120–160 bpm with accelerations", 
    "B": "Baseline bradycardia <100 bpm", 
    "C": "Baseline variability of 5–25 bpm", 
    "D": "Accelerations with movements", 
    "Answer": "B", 
    "Comment": "Fetal bradycardia (<100 bpm) is a sign of fetal distress and requires urgent evaluation.", 
    "Source": "Page 73" 
  },
  { 
    "Ref": "Maternal0083", 
    "Questions": "What is the normal baseline fetal heart rate?", 
    "A": "80–100 bpm", 
    "B": "100–120 bpm", 
    "C": "110–160 bpm", 
    "D": "160–200 bpm", 
    "Answer": "C", 
    "Comment": "The normal baseline fetal heart rate is 110–160 bpm.", 
    "Source": "Page 73" 
  },
  { 
    "Ref": "Maternal0084", 
    "Questions": "Which monitoring method is preferred for low-risk women during labour?", 
    "A": "Intermittent auscultation", 
    "B": "Continuous electronic fetal monitoring (CTG) for all", 
    "C": "MRI monitoring", 
    "D": "Pulse oximetry on the fetus", 
    "Answer": "A", 
    "Comment": "Intermittent auscultation is recommended for low-risk women.", 
    "Source": "Page 72" 
  },
  { 
    "Ref": "Maternal0085", 
    "Questions": "Which of the following is an indication for continuous electronic fetal monitoring (CTG)?", 
    "A": "All normal labours", 
    "B": "Maternal hypertension or fetal growth restriction", 
    "C": "Low-risk multiparas", 
    "D": "Maternal request only", 
    "Answer": "B", 
    "Comment": "High-risk pregnancies such as hypertension and growth restriction require CTG monitoring.", 
    "Source": "Page 73" 
  },
  { 
    "Ref": "Maternal0086", 
    "Questions": "Which feature on a CTG is most reassuring?", 
    "A": "Late decelerations", 
    "B": "Absent variability", 
    "C": "Baseline 140 bpm with accelerations", 
    "D": "Sustained tachycardia", 
    "Answer": "C", 
    "Comment": "A baseline in the normal range with accelerations and good variability is reassuring.", 
    "Source": "Page 73" 
  },
  { 
    "Ref": "Maternal0087", 
    "Questions": "What is the definition of induction of labour?", 
    "A": "Spontaneous onset of contractions at term", 
    "B": "Artificial initiation of labour before its spontaneous onset", 
    "C": "Use of oxytocin to augment contractions after labour begins", 
    "D": "Caesarean delivery", 
    "Answer": "B", 
    "Comment": "Induction is the artificial initiation of labour before it begins naturally.", 
    "Source": "Page 75" 
  },
  { 
    "Ref": "Maternal0088", 
    "Questions": "Which is a common indication for induction of labour?", 
    "A": "Prolonged pregnancy beyond 41 weeks", 
    "B": "All primigravidas", 
    "C": "Maternal request before term", 
    "D": "Elective induction at 20 weeks", 
    "Answer": "A", 
    "Comment": "Prolonged pregnancy is a common and evidence-based indication for induction.", 
    "Source": "Page 76" 
  },
  { 
    "Ref": "Maternal0089", 
    "Questions": "Which is the preferred method for cervical ripening before induction of labour?", 
    "A": "Oral misoprostol or vaginal prostaglandins", 
    "B": "High-dose oxytocin infusion only", 
    "C": "Immediate caesarean section", 
    "D": "Routine amniotomy without assessment", 
    "Answer": "A", 
    "Comment": "Prostaglandins (oral misoprostol or vaginal preparations) are recommended for ripening the cervix.", 
    "Source": "Page 76" 
  },
  { 
    "Ref": "Maternal0090", 
    "Questions": "Which Bishop score indicates a favourable cervix for induction?", 
    "A": "≤3", 
    "B": "4–5", 
    "C": "≥6", 
    "D": "≥10", 
    "Answer": "C", 
    "Comment": "A Bishop score ≥6 is favourable for successful induction.", 
    "Source": "Page 75" 
  },
  { 
    "Ref": "Maternal0091", 
    "Questions": "What is a potential complication of induction with prostaglandins?", 
    "A": "Uterine hyperstimulation", 
    "B": "Asthma", 
    "C": "Anaemia", 
    "D": "Diabetes", 
    "Answer": "A", 
    "Comment": "Prostaglandins may cause uterine hyperstimulation, requiring monitoring.", 
    "Source": "Page 77" 
  },
  { 
    "Ref": "Maternal0092", 
    "Questions": "Which of the following is TRUE about oxytocin induction?", 
    "A": "Oxytocin should always be given as an IV bolus", 
    "B": "Oxytocin infusion should be titrated to achieve 3–4 contractions per 10 minutes", 
    "C": "Oxytocin is contraindicated in labour", 
    "D": "Oxytocin guarantees vaginal delivery", 
    "Answer": "B", 
    "Comment": "Oxytocin should be carefully titrated to achieve adequate but not excessive contractions.", 
    "Source": "Page 77" 
  },
  { 
    "Ref": "Maternal0093", 
    "Questions": "Which is the recommended route for misoprostol when used for induction of labour?", 
    "A": "IV injection", 
    "B": "Oral or vaginal", 
    "C": "Intramuscular", 
    "D": "Subcutaneous", 
    "Answer": "B", 
    "Comment": "Misoprostol can be given orally or vaginally for induction of labour.", 
    "Source": "Page 76" 
  },
  { 
    "Ref": "Maternal0094", 
    "Questions": "Which is a contraindication to induction of labour?", 
    "A": "Hypertension in pregnancy", 
    "B": "Placenta praevia", 
    "C": "Prolonged pregnancy", 
    "D": "Prelabour rupture of membranes at term", 
    "Answer": "B", 
    "Comment": "Placenta praevia is an absolute contraindication to induction of labour.", 
    "Source": "Page 75" 
  },
  { 
    "Ref": "Maternal0095", 
    "Questions": "What is the risk of early amniotomy as a sole induction method?", 
    "A": "Cord prolapse and infection", 
    "B": "Improved cervical ripening", 
    "C": "Reduced need for oxytocin", 
    "D": "Increased breastfeeding rates", 
    "Answer": "A", 
    "Comment": "Amniotomy alone carries risks such as cord prolapse and infection.", 
    "Source": "Page 77" 
  },
  { 
    "Ref": "Maternal0096", 
    "Questions": "Which of the following should be monitored during labour induction with oxytocin?", 
    "A": "Only maternal blood pressure", 
    "B": "Contractions and fetal heart rate", 
    "C": "Blood glucose only", 
    "D": "Liver enzymes", 
    "Answer": "B", 
    "Comment": "Both contraction pattern and fetal heart rate must be closely monitored during oxytocin induction.", 
    "Source": "Page 77" 
  },
  { 
    "Ref": "Maternal0097", 
    "Questions": "Which is the recommended management if uterine hyperstimulation occurs during induction?", 
    "A": "Increase oxytocin dose", 
    "B": "Stop oxytocin infusion and give tocolysis if needed", 
    "C": "Proceed immediately to caesarean section in all cases", 
    "D": "Ignore and continue", 
    "Answer": "B", 
    "Comment": "Stopping oxytocin and giving tocolysis if needed is the correct management.", 
    "Source": "Page 77" 
  },
  { 
    "Ref": "Maternal0098", 
    "Questions": "Which is the preferred induction method for intrauterine fetal demise (IUFD)?", 
    "A": "High-dose oxytocin only", 
    "B": "Misoprostol", 
    "C": "MRI monitoring", 
    "D": "No intervention", 
    "Answer": "B", 
    "Comment": "Misoprostol is effective and safe for induction in IUFD cases.", 
    "Source": "Page 78" 
  },
  { 
    "Ref": "Maternal0099", 
    "Questions": "Which Bishop score factor assesses cervical consistency?", 
    "A": "Position", 
    "B": "Length", 
    "C": "Consistency", 
    "D": "Dilatation", 
    "Answer": "C", 
    "Comment": "The Bishop score includes dilatation, effacement, station, position and consistency.", 
    "Source": "Page 75" 
  },
  { 
    "Ref": "Maternal0100", 
    "Questions": "What is the main maternal risk of induction of labour?", 
    "A": "Hypertension", 
    "B": "Uterine hyperstimulation and rupture", 
    "C": "Anaemia", 
    "D": "Thyroid storm", 
    "Answer": "B", 
    "Comment": "Main maternal risks are hyperstimulation and, rarely, uterine rupture.", 
    "Source": "Page 77" 
  },
  { 
    "Ref": "Maternal0061", 
    "Questions": "Which is the recommended position for a woman during the first stage of labour?", 
    "A": "Supine only", 
    "B": "Any position the woman finds comfortable", 
    "C": "Lithotomy position only", 
    "D": "Trendelenburg position", 
    "Answer": "B", 
    "Comment": "Women should be encouraged to adopt the position they find comfortable during labour.", 
    "Source": "Page 60" 
  },
  { 
    "Ref": "Maternal0062", 
    "Questions": "What is the recommended minimum frequency for monitoring maternal pulse during the active phase of labour?", 
    "A": "Every 30 minutes", 
    "B": "Every 2 hours", 
    "C": "Once at admission only", 
    "D": "Only after delivery", 
    "Answer": "A", 
    "Comment": "Maternal pulse should be monitored every 30 minutes in the active phase of labour.", 
    "Source": "Page 61" 
  },
  { 
    "Ref": "Maternal0063", 
    "Questions": "What is the normal duration of the latent phase of labour in a nulliparous woman?", 
    "A": "Less than 8 hours", 
    "B": "Less than 12 hours", 
    "C": "Less than 18 hours", 
    "D": "Less than 24 hours", 
    "Answer": "C", 
    "Comment": "In nulliparous women, the latent phase normally lasts less than 18 hours.", 
    "Source": "Page 62" 
  },
  { 
    "Ref": "Maternal0064", 
    "Questions": "Which sign best indicates the onset of the active phase of labour?", 
    "A": "Regular contractions with cervical dilatation ≥4 cm", 
    "B": "Backache only", 
    "C": "Maternal perception of fetal movements", 
    "D": "Any uterine tightening", 
    "Answer": "A", 
    "Comment": "The active phase is defined by regular contractions and cervical dilatation of 4 cm or more.", 
    "Source": "Page 62" 
  },
  { 
    "Ref": "Maternal0065", 
    "Questions": "Which is the correct frequency of fetal heart rate monitoring during the active first stage of labour?", 
    "A": "Every 30 minutes", 
    "B": "Every 15–30 minutes", 
    "C": "Hourly", 
    "D": "At admission only", 
    "Answer": "B", 
    "Comment": "Fetal heart rate should be monitored every 15–30 minutes during active labour.", 
    "Source": "Page 61" 
  },
  { 
    "Ref": "Maternal0066", 
    "Questions": "Which method is recommended for routine monitoring of fetal heart rate in low-risk labour?", 
    "A": "Continuous CTG for all women", 
    "B": "Intermittent auscultation with fetoscope or Doppler", 
    "C": "MRI monitoring", 
    "D": "Maternal perception only", 
    "Answer": "B", 
    "Comment": "Intermittent auscultation is recommended for low-risk women in labour.", 
    "Source": "Page 63" 
  },
  { 
    "Ref": "Maternal0067", 
    "Questions": "Which analgesic is considered safe and commonly used for pain relief in labour?", 
    "A": "Pethidine", 
    "B": "Paracetamol", 
    "C": "Aspirin", 
    "D": "Warfarin", 
    "Answer": "B", 
    "Comment": "Paracetamol is safe and commonly used for pain relief in labour.", 
    "Source": "Page 64" 
  },
  { 
    "Ref": "Maternal0068", 
    "Questions": "Which of the following is TRUE regarding the use of epidural analgesia in labour?", 
    "A": "It is contraindicated in all primigravidas", 
    "B": "It may prolong the second stage of labour", 
    "C": "It guarantees faster labour", 
    "D": "It is associated with immediate caesarean section", 
    "Answer": "B", 
    "Comment": "Epidural analgesia can prolong the second stage but is safe when indicated.", 
    "Source": "Page 65" 
  },
  { 
    "Ref": "Maternal0069", 
    "Questions": "What is the recommended frequency of vaginal examinations during active labour if progress is normal?", 
    "A": "Every 1 hour", 
    "B": "Every 2–4 hours", 
    "C": "Every 10 minutes", 
    "D": "Only at admission", 
    "Answer": "B", 
    "Comment": "Vaginal examinations should be done every 2–4 hours in normal labour.", 
    "Source": "Page 63" 
  },
  { 
    "Ref": "Maternal0070", 
    "Questions": "Which is the recommended management of the third stage of labour?", 
    "A": "Physiological management only", 
    "B": "Active management with uterotonic, cord clamping, controlled traction", 
    "C": "Routine caesarean delivery", 
    "D": "No intervention until 2 hours post-birth", 
    "Answer": "B", 
    "Comment": "Active management reduces risk of postpartum haemorrhage and is recommended.", 
    "Source": "Page 67" 
  },
  { 
    "Ref": "Maternal0071", 
    "Questions": "Which uterotonic is recommended as first-line for active management of the third stage of labour?", 
    "A": "Methylergometrine", 
    "B": "Oxytocin 10 IU IM/IV", 
    "C": "Misoprostol 25 mcg", 
    "D": "Carboprost", 
    "Answer": "B", 
    "Comment": "Oxytocin 10 IU given IM/IV is the first-line uterotonic for AMTSL.", 
    "Source": "Page 67" 
  },
  { 
    "Ref": "Maternal0072", 
    "Questions": "Which of the following defines a prolonged second stage of labour in a nulliparous woman with an epidural?", 
    "A": "More than 1 hour", 
    "B": "More than 2 hours", 
    "C": "More than 3 hours", 
    "D": "More than 4 hours", 
    "Answer": "C", 
    "Comment": "In nulliparas with an epidural, second stage >3 hours is prolonged.", 
    "Source": "Page 66" 
  },
  { 
    "Ref": "Maternal0073", 
    "Questions": "Which of the following is recommended practice during the second stage of labour?", 
    "A": "Encouraging delayed pushing until the woman feels urge", 
    "B": "Routine episiotomy for all primigravidas", 
    "C": "Immediate forceps delivery for all women", 
    "D": "Restricting mobility", 
    "Answer": "A", 
    "Comment": "Guidelines support delayed pushing until urge is felt, to reduce exhaustion.", 
    "Source": "Page 65" 
  },
  { 
    "Ref": "Maternal0074", 
    "Questions": "What is the recommended frequency of monitoring fetal heart rate during the second stage of labour?", 
    "A": "Every 15 minutes", 
    "B": "Every 5 minutes", 
    "C": "Every 30 minutes", 
    "D": "Only after crowning", 
    "Answer": "B", 
    "Comment": "During the second stage, fetal heart rate should be monitored every 5 minutes.", 
    "Source": "Page 66" 
  },
  { 
    "Ref": "Maternal0075", 
    "Questions": "What should be done immediately after delivery of the baby?", 
    "A": "Clamp and cut the cord immediately", 
    "B": "Dry and provide skin-to-skin contact", 
    "C": "Separate the baby from the mother", 
    "D": "Give routine antibiotics", 
    "Answer": "B", 
    "Comment": "Immediate drying and skin-to-skin contact are priorities after birth.", 
    "Source": "Page 67" 
  },
  { 
    "Ref": "Maternal0076", 
    "Questions": "Which practice is recommended to support initiation of breastfeeding within the first hour of life?", 
    "A": "Immediate mother–baby separation", 
    "B": "Skin-to-skin contact and early latching", 
    "C": "Bottle feeding with formula", 
    "D": "Waiting until the following day", 
    "Answer": "B", 
    "Comment": "Skin-to-skin and early initiation are key to breastfeeding success.", 
    "Source": "Page 68" 
  },
  { 
    "Ref": "Maternal0077", 
    "Questions": "Which of the following defines a retained placenta?", 
    "A": "Placenta not delivered after 10 minutes", 
    "B": "Placenta not delivered after 30 minutes", 
    "C": "Placenta not delivered after 60 minutes", 
    "D": "Placenta not delivered after 90 minutes", 
    "Answer": "B", 
    "Comment": "A placenta not delivered within 30 minutes is considered retained.", 
    "Source": "Page 68" 
  },
  { 
    "Ref": "Maternal0078", 
    "Questions": "Which of the following is a complication of prolonged rupture of membranes?", 
    "A": "Reduced risk of infection", 
    "B": "Increased risk of chorioamnionitis", 
    "C": "Improved fetal growth", 
    "D": "Reduced preterm labour risk", 
    "Answer": "B", 
    "Comment": "Prolonged rupture of membranes increases risk of intrauterine infection.", 
    "Source": "Page 69" 
  },
  { 
    "Ref": "Maternal0079", 
    "Questions": "Which is the correct definition of obstructed labour?", 
    "A": "Labour that progresses too quickly", 
    "B": "Failure of labour to progress despite good contractions due to mechanical blockage", 
    "C": "Failure to initiate contractions", 
    "D": "Multiple gestations", 
    "Answer": "B", 
    "Comment": "Obstructed labour occurs when progress stops due to mechanical obstruction.", 
    "Source": "Page 70" 
  },
  { 
    "Ref": "Maternal0080", 
    "Questions": "Which of the following is a recommended action in the immediate postpartum period?", 
    "A": "Monitor vital signs every 15 minutes for the first 2 hours", 
    "B": "Discharge immediately if mother feels well", 
    "C": "No need for observation after birth", 
    "D": "Keep mother nil per os", 
    "Answer": "A", 
    "Comment": "Close monitoring in the immediate postpartum period reduces maternal morbidity and mortality.", 
    "Source": "Page 69" 
  },
  { 
    "Ref": "Maternal0041", 
    "Questions": "Which micronutrient supplement is universally recommended during pregnancy to prevent neural tube defects?", 
    "A": "Iron", 
    "B": "Folic acid", 
    "C": "Vitamin D", 
    "D": "Calcium", 
    "Answer": "B", 
    "Comment": "Folic acid supplementation is recommended for all pregnant women to reduce the risk of neural tube defects.", 
    "Source": "Page 47" 
  },
  { 
    "Ref": "Maternal0042", 
    "Questions": "What is the recommended daily iron and folic acid supplementation dose in pregnancy?", 
    "A": "120 mg elemental iron + 5 mg folic acid", 
    "B": "30–60 mg elemental iron + 0.4 mg folic acid", 
    "C": "10 mg iron + 0.1 mg folic acid", 
    "D": "100 mg iron only", 
    "Answer": "B", 
    "Comment": "Daily supplementation with 30–60 mg iron and 0.4 mg folic acid is recommended during pregnancy.", 
    "Source": "Page 47" 
  },
  { 
    "Ref": "Maternal0043", 
    "Questions": "Which dietary advice should be given to pregnant women regarding fish consumption?", 
    "A": "Avoid all fish", 
    "B": "Eat fish but avoid species with high mercury levels", 
    "C": "Only consume raw fish", 
    "D": "Fish should replace all other protein sources", 
    "Answer": "B", 
    "Comment": "Fish is nutritious but some species have high mercury, which should be avoided in pregnancy.", 
    "Source": "Page 48" 
  },
  { 
    "Ref": "Maternal0044", 
    "Questions": "Which of the following is a consequence of maternal undernutrition during pregnancy?", 
    "A": "Increased risk of low birth weight and stillbirth", 
    "B": "Decreased risk of preterm delivery", 
    "C": "Higher chance of macrosomia", 
    "D": "Reduced maternal anaemia risk", 
    "Answer": "A", 
    "Comment": "Undernutrition in pregnancy is associated with LBW, preterm birth, and stillbirth.", 
    "Source": "Page 47" 
  },
  { 
    "Ref": "Maternal0045", 
    "Questions": "Which condition in pregnancy increases calcium requirements the most?", 
    "A": "Twin pregnancy", 
    "B": "Gestational diabetes", 
    "C": "Anaemia", 
    "D": "Asthma", 
    "Answer": "A", 
    "Comment": "Multiple gestations increase calcium demands, making supplementation particularly important.", 
    "Source": "Page 48" 
  },
  { 
    "Ref": "Maternal0046", 
    "Questions": "What is the role of calcium supplementation in pregnancy according to the guideline?", 
    "A": "Reduces the risk of pre-eclampsia", 
    "B": "Prevents gestational diabetes", 
    "C": "Increases fetal growth beyond normal limits", 
    "D": "Prevents asthma in the newborn", 
    "Answer": "A", 
    "Comment": "Calcium supplementation has been shown to reduce the risk of pre-eclampsia.", 
    "Source": "Page 48" 
  },
  { 
    "Ref": "Maternal0047", 
    "Questions": "Which group of women should receive additional nutritional support during pregnancy?", 
    "A": "Women with normal BMI", 
    "B": "Adolescents, undernourished women, and those with HIV or TB", 
    "C": "All women with private healthcare access", 
    "D": "Only women over 40", 
    "Answer": "B", 
    "Comment": "Special groups such as adolescents, undernourished women, and those with chronic infections require additional nutrition support.", 
    "Source": "Page 49" 
  },
  { 
    "Ref": "Maternal0048", 
    "Questions": "Which food safety practice is especially important in pregnancy?", 
    "A": "Consuming unpasteurised milk for calcium", 
    "B": "Avoiding reheating food", 
    "C": "Avoiding raw or undercooked meat to prevent toxoplasmosis", 
    "D": "Eating street food daily", 
    "Answer": "C", 
    "Comment": "Pregnant women should avoid raw or undercooked meat to reduce risk of toxoplasmosis.", 
    "Source": "Page 48" 
  },
  { 
    "Ref": "Maternal0049", 
    "Questions": "Which BMI threshold defines maternal obesity in pregnancy?", 
    "A": "BMI ≥ 25", 
    "B": "BMI ≥ 30", 
    "C": "BMI ≥ 35", 
    "D": "BMI ≥ 40", 
    "Answer": "B", 
    "Comment": "Obesity in pregnancy is defined as BMI ≥30, increasing risks for mother and baby.", 
    "Source": "Page 49" 
  },
  { 
    "Ref": "Maternal0050", 
    "Questions": "What is the recommended management of severe nausea and vomiting (hyperemesis gravidarum)?", 
    "A": "Encourage increased food intake without medication", 
    "B": "IV fluids, antiemetics, thiamine supplementation", 
    "C": "Discharge home with reassurance only", 
    "D": "High-dose steroids as first-line", 
    "Answer": "B", 
    "Comment": "Hyperemesis gravidarum is managed with IV fluids, antiemetics, and thiamine to prevent Wernicke’s encephalopathy.", 
    "Source": "Page 51" 
  },
  { 
    "Ref": "Maternal0051", 
    "Questions": "Which is a key risk factor for miscarriage in early pregnancy?", 
    "A": "Chromosomal abnormalities", 
    "B": "Maternal height", 
    "C": "Mode of delivery in previous pregnancy", 
    "D": "Number of antenatal visits", 
    "Answer": "A", 
    "Comment": "Most miscarriages are due to chromosomal abnormalities.", 
    "Source": "Page 52" 
  },
  { 
    "Ref": "Maternal0052", 
    "Questions": "Which clinical sign is suggestive of an ectopic pregnancy?", 
    "A": "Bilateral leg oedema", 
    "B": "Amenorrhoea with abdominal pain and vaginal bleeding", 
    "C": "Polyuria", 
    "D": "Severe headache", 
    "Answer": "B", 
    "Comment": "The classic triad of ectopic pregnancy is amenorrhoea, abdominal pain and vaginal bleeding.", 
    "Source": "Page 54" 
  },
  { 
    "Ref": "Maternal0053", 
    "Questions": "Which diagnostic test is most helpful in confirming ectopic pregnancy?", 
    "A": "Chest X-ray", 
    "B": "Ultrasound pelvis", 
    "C": "Urine dipstick", 
    "D": "Liver function test", 
    "Answer": "B", 
    "Comment": "Ultrasound of the pelvis is the most useful test to confirm an ectopic pregnancy.", 
    "Source": "Page 54" 
  },
  { 
    "Ref": "Maternal0054", 
    "Questions": "What is the most important first step in managing a woman with suspected ruptured ectopic pregnancy?", 
    "A": "Confirm diagnosis with MRI", 
    "B": "Immediate resuscitation and surgical referral", 
    "C": "Start oral antibiotics", 
    "D": "Prescribe bed rest at home", 
    "Answer": "B", 
    "Comment": "Ruptured ectopic pregnancy is a surgical emergency and requires immediate resuscitation and surgery.", 
    "Source": "Page 55" 
  },
  { 
    "Ref": "Maternal0055", 
    "Questions": "Which medication is sometimes used for the medical management of unruptured ectopic pregnancy?", 
    "A": "Methotrexate", 
    "B": "Aspirin", 
    "C": "Warfarin", 
    "D": "Amoxicillin", 
    "Answer": "A", 
    "Comment": "Methotrexate can be used in selected cases of unruptured ectopic pregnancy as medical management.", 
    "Source": "Page 55" 
  },
  { 
    "Ref": "Maternal0056", 
    "Questions": "Which of the following is a complication of incomplete miscarriage?", 
    "A": "Anaemia and sepsis", 
    "B": "Hypertension", 
    "C": "Asthma", 
    "D": "Thyroid storm", 
    "Answer": "A", 
    "Comment": "Complications of incomplete miscarriage include anaemia, infection and sepsis.", 
    "Source": "Page 53" 
  },
  { 
    "Ref": "Maternal0057", 
    "Questions": "Which method is recommended for uterine evacuation in incomplete miscarriage in facilities without surgical capacity?", 
    "A": "Hysterectomy", 
    "B": "Manual vacuum aspiration (MVA)", 
    "C": "Open laparotomy", 
    "D": "Uterine artery embolisation", 
    "Answer": "B", 
    "Comment": "MVA is the recommended method for uterine evacuation in incomplete miscarriage when available.", 
    "Source": "Page 53" 
  },
  { 
    "Ref": "Maternal0058", 
    "Questions": "Which is a sign of molar pregnancy?", 
    "A": "Excessive nausea and vomiting, very high hCG levels", 
    "B": "Polyuria and polydipsia", 
    "C": "Hypertension at term", 
    "D": "Fetal movements by 16 weeks", 
    "Answer": "A", 
    "Comment": "Molar pregnancy presents with severe nausea, very high hCG and absence of normal fetal development.", 
    "Source": "Page 56" 
  },
  { 
    "Ref": "Maternal0059", 
    "Questions": "What is the recommended management after evacuation of a molar pregnancy?", 
    "A": "No follow-up required", 
    "B": "Serial hCG monitoring until negative", 
    "C": "Immediate hysterectomy for all cases", 
    "D": "Lifelong chemotherapy", 
    "Answer": "B", 
    "Comment": "Follow-up after molar evacuation includes monitoring hCG until negative to exclude gestational trophoblastic neoplasia.", 
    "Source": "Page 56" 
  },
  { 
    "Ref": "Maternal0060", 
    "Questions": "Which complication is most concerning after a molar pregnancy?", 
    "A": "Gestational trophoblastic neoplasia (GTN)", 
    "B": "Anaemia", 
    "C": "Hypertension", 
    "D": "Asthma exacerbation", 
    "Answer": "A", 
    "Comment": "The major concern after molar pregnancy is progression to GTN, requiring follow-up and monitoring.", 
    "Source": "Page 56" 
  },
  { 
    "Ref": "Maternal0021", 
    "Questions": "Which of the following is a common risk factor linked to intimate partner violence (IPV) in pregnancy?", 
    "A": "Strong family support", 
    "B": "History of substance abuse", 
    "C": "Access to antenatal care", 
    "D": "Employment security", 
    "Answer": "B", 
    "Comment": "Substance abuse is one of the major risk factors associated with IPV in pregnancy.", 
    "Source": "Page 30" 
  },
  { 
    "Ref": "Maternal0022", 
    "Questions": "What is the first priority when a healthcare worker identifies IPV during a consultation?", 
    "A": "Refer directly to police without patient consent", 
    "B": "Ensure immediate safety of the woman", 
    "C": "Encourage reconciliation with the partner", 
    "D": "Ignore unless physical injuries are visible", 
    "Answer": "B", 
    "Comment": "Safety planning is the immediate priority when IPV is identified.", 
    "Source": "Page 31" 
  },
  { 
    "Ref": "Maternal0023", 
    "Questions": "Which organisation should women experiencing IPV be referred to for psychosocial support, according to the guideline?", 
    "A": "WHO Geneva", 
    "B": "Non-governmental organisations (NGOs) and social services", 
    "C": "Private insurance companies", 
    "D": "Immigration services only", 
    "Answer": "B", 
    "Comment": "Women should be referred to NGOs, social services, and police as part of a multi-sectoral response to IPV.", 
    "Source": "Page 32" 
  },
  { 
    "Ref": "Maternal0024", 
    "Questions": "Healthcare workers exposed to cases of IPV should receive support because:", 
    "A": "They may be at personal risk and experience stress", 
    "B": "They are legally responsible for the abuse", 
    "C": "They must testify in every IPV case", 
    "D": "They are expected to provide financial support to victims", 
    "Answer": "A", 
    "Comment": "Healthcare workers need wellbeing support due to stress and potential risks when dealing with IPV cases.", 
    "Source": "Page 33" 
  },
  { 
    "Ref": "Maternal0025", 
    "Questions": "Preconception care aims to:", 
    "A": "Treat only existing pregnancy complications", 
    "B": "Identify and address health risks before pregnancy", 
    "C": "Delay antenatal care initiation", 
    "D": "Avoid discussing contraception", 
    "Answer": "B", 
    "Comment": "Preconception care focuses on optimising health before pregnancy to reduce risks during pregnancy.", 
    "Source": "Page 34" 
  },
  { 
    "Ref": "Maternal0026", 
    "Questions": "Which is an example of a teratogenic exposure discussed in antenatal guidelines?", 
    "A": "Folic acid supplementation", 
    "B": "Alcohol consumption", 
    "C": "Balanced diet", 
    "D": "Vaccination against tetanus", 
    "Answer": "B", 
    "Comment": "Alcohol, some medications, and environmental toxins are teratogens that may affect pregnancy outcomes.", 
    "Source": "Page 34" 
  },
  { 
    "Ref": "Maternal0027", 
    "Questions": "Which document is central to record-keeping during antenatal care in South Africa?", 
    "A": "The Road to Health booklet", 
    "B": "The Maternity Case Record (MCR)", 
    "C": "National census data", 
    "D": "Patient-held vaccination card", 
    "Answer": "B", 
    "Comment": "The MCR is the official record for antenatal care, recording history, examination and investigations.", 
    "Source": "Page 35" 
  },
  { 
    "Ref": "Maternal0028", 
    "Questions": "What is the recommended timing for the first antenatal visit?", 
    "A": "Before 12 weeks gestation", 
    "B": "Between 20–24 weeks", 
    "C": "Only at 28 weeks", 
    "D": "At the onset of labour", 
    "Answer": "A", 
    "Comment": "Women should ideally book antenatal care before 12 weeks gestation for optimal screening and planning.", 
    "Source": "Page 35" 
  },
  { 
    "Ref": "Maternal0029", 
    "Questions": "Which method is most accurate for estimation of gestational age before 14 weeks?", 
    "A": "Fundal height measurement", 
    "B": "Ultrasound crown-rump length (CRL)", 
    "C": "Maternal perception of fetal movements", 
    "D": "Last normal menstrual period (LNMP) only", 
    "Answer": "B", 
    "Comment": "Ultrasound CRL before 14 weeks is the most accurate way to estimate gestational age.", 
    "Source": "Page 36" 
  },
  { 
    "Ref": "Maternal0030", 
    "Questions": "Which routine screening test is recommended at the first antenatal visit?", 
    "A": "Hb and Rhesus factor testing", 
    "B": "Amniocentesis", 
    "C": "MRI scan", 
    "D": "CT scan", 
    "Answer": "A", 
    "Comment": "Routine antenatal screening includes haemoglobin, blood group and Rhesus status, and syphilis testing.", 
    "Source": "Page 37" 
  },
  { 
    "Ref": "Maternal0031", 
    "Questions": "Which screening test is NOT routinely offered in the guideline?", 
    "A": "HIV test", 
    "B": "Syphilis test", 
    "C": "Rubella immunity test", 
    "D": "Blood pressure measurement", 
    "Answer": "C", 
    "Comment": "Rubella immunity testing is not offered routinely as per national guidelines.", 
    "Source": "Page 37" 
  },
  { 
    "Ref": "Maternal0032", 
    "Questions": "Which vaccine is generally recommended during pregnancy?", 
    "A": "BCG", 
    "B": "Tetanus, diphtheria, pertussis (Tdap)", 
    "C": "Yellow fever (always)", 
    "D": "HPV", 
    "Answer": "B", 
    "Comment": "Tdap vaccination is recommended during pregnancy for maternal and newborn protection.", 
    "Source": "Page 38" 
  },
  { 
    "Ref": "Maternal0033", 
    "Questions": "At what gestational age is symphysis-fundal height measurement usually initiated to monitor fetal growth?", 
    "A": "Before 12 weeks", 
    "B": "After 20 weeks", 
    "C": "After 34 weeks", 
    "D": "Only during labour", 
    "Answer": "B", 
    "Comment": "SFH measurement is a simple screening tool used after 20 weeks to monitor fetal growth.", 
    "Source": "Page 38" 
  },
  { 
    "Ref": "Maternal0034", 
    "Questions": "How often should follow-up antenatal visits occur after 28 weeks gestation, according to BANC Plus?", 
    "A": "Every 8 weeks", 
    "B": "Every 4 weeks until 36 weeks, then weekly", 
    "C": "Only at 28 and 40 weeks", 
    "D": "Daily until delivery", 
    "Answer": "B", 
    "Comment": "BANC Plus recommends 4-weekly visits until 36 weeks and then weekly until delivery.", 
    "Source": "Page 40" 
  },
  { 
    "Ref": "Maternal0035", 
    "Questions": "Which of the following is considered a high-risk factor requiring closer antenatal follow-up?", 
    "A": "History of pre-eclampsia", 
    "B": "Age 22 with no comorbidities", 
    "C": "Parity of 1", 
    "D": "Access to ANC before 12 weeks", 
    "Answer": "A", 
    "Comment": "A history of pre-eclampsia is a significant risk factor requiring increased surveillance.", 
    "Source": "Page 45" 
  },
  { 
    "Ref": "Maternal0036", 
    "Questions": "Which ultrasound parameter is most reliable for dating a pregnancy before 14 weeks?", 
    "A": "Biparietal diameter (BPD)", 
    "B": "Femur length", 
    "C": "Crown-rump length (CRL)", 
    "D": "Abdominal circumference (AC)", 
    "Answer": "C", 
    "Comment": "CRL is the most accurate biometric parameter for dating in the first trimester.", 
    "Source": "Page 36" 
  },
  { 
    "Ref": "Maternal0037", 
    "Questions": "Which of the following medications is safe and routinely prescribed in pregnancy?", 
    "A": "Folic acid supplementation", 
    "B": "Isotretinoin", 
    "C": "Warfarin", 
    "D": "Valproic acid", 
    "Answer": "A", 
    "Comment": "Folic acid is safe and recommended for all pregnant women to reduce neural tube defects.", 
    "Source": "Page 37" 
  },
  { 
    "Ref": "Maternal0038", 
    "Questions": "Why is early identification of genetic disorders during antenatal care important?", 
    "A": "Allows counselling and timely management options", 
    "B": "Always prevents the disorder", 
    "C": "Avoids the need for further ANC visits", 
    "D": "Is only used for research purposes", 
    "Answer": "A", 
    "Comment": "Identifying risk for genetic disorders early enables counselling, planning, and interventions.", 
    "Source": "Page 34" 
  },
  { 
    "Ref": "Maternal0039", 
    "Questions": "Which information should always be shared with pregnant women during antenatal education?", 
    "A": "Danger signs and when to seek help", 
    "B": "Only diet advice", 
    "C": "Labour theatre policies only", 
    "D": "Information about postnatal contraception only", 
    "Answer": "A", 
    "Comment": "Pregnant women must be informed about danger signs in pregnancy and when to return for care.", 
    "Source": "Page 39" 
  },
  { 
    "Ref": "Maternal0040", 
    "Questions": "Which of the following is a recommended routine vaccination in pregnancy in South Africa?", 
    "A": "Polio", 
    "B": "Tetanus toxoid", 
    "C": "Rotavirus", 
    "D": "MMR (measles, mumps, rubella)", 
    "Answer": "B", 
    "Comment": "Tetanus toxoid is recommended for pregnant women to protect both mother and neonate.", 
    "Source": "Page 38" 
  },
  { 
    "Ref": "Maternal0001", 
    "Questions": "Which of the following is a core component of respectful maternity care according to the guideline?", 
    "A": "Always call women by their preferred name", 
    "B": "Ensure all examinations are conducted in public for transparency", 
    "C": "Turn away women who arrive late for appointments", 
    "D": "Avoid explaining procedures to avoid anxiety", 
    "Answer": "A", 
    "Comment": "Respectful maternity care includes introducing oneself, calling women by their preferred name, maintaining privacy and obtaining informed consent.", 
    "Source": "Page 16" 
  },
  { 
    "Ref": "Maternal0002", 
    "Questions": "Which of the following actions constitutes verbal abuse during maternity care?", 
    "A": "Speaking in a warm, friendly manner", 
    "B": "Telling a woman 'you will kill your baby if you don’t co-operate'", 
    "C": "Encouraging the woman to choose a birth position", 
    "D": "Explaining procedures in simple language", 
    "Answer": "B", 
    "Comment": "The guideline lists shaming, humiliating, and threatening language as verbal abuse.", 
    "Source": "Page 16" 
  },
  { 
    "Ref": "Maternal0003", 
    "Questions": "Which of the following is recommended for ensuring privacy during labour and birth in facilities with shared wards?", 
    "A": "Denying women companions", 
    "B": "Covering women with a sheet and dividing spaces with curtains where possible", 
    "C": "Conducting all examinations in open view", 
    "D": "Avoiding the use of curtains to save time", 
    "Answer": "B", 
    "Comment": "Guidelines emphasise covering women and using curtains when separate rooms are not available.", 
    "Source": "Page 16" 
  },
  { 
    "Ref": "Maternal0004", 
    "Questions": "What is the recommended time frame for triaging a woman who arrives at a labour ward?", 
    "A": "Within 30 minutes", 
    "B": "Within 15 minutes or as soon thereafter as possible", 
    "C": "Only once a doctor is available", 
    "D": "Within 2 hours of arrival", 
    "Answer": "B", 
    "Comment": "Women arriving in labour should be triaged within 15 minutes to assess bleeding, fetal heart rate and stage of labour.", 
    "Source": "Page 16" 
  },
  { 
    "Ref": "Maternal0005", 
    "Questions": "Which intervention is specifically recommended as a low-cost and effective strategy to improve maternity outcomes?", 
    "A": "Routine CTG monitoring for all women", 
    "B": "Allowing women a birth companion of their choice", 
    "C": "Mandatory caesarean section for all primigravidas", 
    "D": "Restricting mobility during labour", 
    "Answer": "B", 
    "Comment": "WHO and the guideline emphasise the right to a birth companion during labour as a low-cost effective intervention.", 
    "Source": "Page 17" 
  },
  { 
    "Ref": "Maternal0006", 
    "Questions": "Which group is identified as particularly vulnerable to disrespectful and abusive maternity care?", 
    "A": "Women with private health insurance", 
    "B": "Only multiparous women", 
    "C": "Adolescents, women with disabilities, migrants, LGBTQI persons", 
    "D": "All women equally, with no vulnerable groups", 
    "Answer": "C", 
    "Comment": "The guideline highlights vulnerable groups requiring particular attention to respectful care.", 
    "Source": "Page 18" 
  },
  { 
    "Ref": "Maternal0007", 
    "Questions": "What is the recommended way for health workers to respond to a client shouting or questioning their competence during labour?", 
    "A": "Argue and assert authority", 
    "B": "Ignore the client completely", 
    "C": "Remain calm, acknowledge emotions, act professionally", 
    "D": "Threaten to withdraw care", 
    "Answer": "C", 
    "Comment": "Guidelines advise remaining calm, acknowledging emotions and acting professionally to manage difficult situations.", 
    "Source": "Page 17" 
  },
  { 
    "Ref": "Maternal0008", 
    "Questions": "Which of the following is NOT part of respectful postnatal care?", 
    "A": "Encouraging skin-to-skin care", 
    "B": "Separating mother and infant unnecessarily", 
    "C": "Ensuring both mother and baby are well before discharge", 
    "D": "Avoiding infant transfers without parental consent", 
    "Answer": "B", 
    "Comment": "Unnecessary separation of mother and baby is contrary to respectful postnatal care.", 
    "Source": "Page 17" 
  },
  { 
    "Ref": "Maternal0009", 
    "Questions": "According to the guidelines, which professional obligation do healthcare workers have when observing abuse?", 
    "A": "Ignore it to maintain team unity", 
    "B": "Report it to senior management", 
    "C": "Only report if patients complain", 
    "D": "Wait for an external audit", 
    "Answer": "B", 
    "Comment": "Health workers have a professional and ethical obligation to report observed abuse to senior management.", 
    "Source": "Page 20" 
  },
  { 
    "Ref": "Maternal0010", 
    "Questions": "Which screening tool is included in the Maternity Case Record for mental health conditions?", 
    "A": "5-item WHO Wellbeing Index", 
    "B": "3-item tool screening for anxiety, depression and suicidality", 
    "C": "Mini-Mental State Examination", 
    "D": "Beck Depression Inventory", 
    "Answer": "B", 
    "Comment": "A 3-item tool validated in South Africa is included in the MCR.", 
    "Source": "Page 22" 
  },
  { 
    "Ref": "Maternal0011", 
    "Questions": "What proportion of women in South Africa experience perinatal anxiety and/or depression?", 
    "A": "1 in 10", 
    "B": "1 in 5", 
    "C": "1 in 3", 
    "D": "1 in 50", 
    "Answer": "C", 
    "Comment": "The prevalence of perinatal anxiety and/or depression in South Africa is approximately 1 in 3 women.", 
    "Source": "Page 21" 
  },
  { 
    "Ref": "Maternal0012", 
    "Questions": "Which is a potential consequence of untreated maternal depression on infants?", 
    "A": "Increased bonding and attachment", 
    "B": "Low birth weight and poor nutrition in infancy", 
    "C": "Accelerated developmental milestones", 
    "D": "Decreased risk of behavioural problems", 
    "Answer": "B", 
    "Comment": "Untreated depression can lead to low birthweight, poor infant nutrition and developmental problems.", 
    "Source": "Page 21" 
  },
  { 
    "Ref": "Maternal0013", 
    "Questions": "Which risk factor is most strongly associated with maternal mental health conditions?", 
    "A": "High socioeconomic status", 
    "B": "Planned pregnancy", 
    "C": "Intimate partner violence and poor support", 
    "D": "Strong social networks", 
    "Answer": "C", 
    "Comment": "IPV, poor relationships and lack of support are major risk factors for maternal mental illness.", 
    "Source": "Page 21" 
  },
  { 
    "Ref": "Maternal0014", 
    "Questions": "What is the recommended first-line medication for moderate to severe depression in pregnancy?", 
    "A": "SSRIs", 
    "B": "Lithium", 
    "C": "Valproic acid", 
    "D": "Tricyclic antidepressants", 
    "Answer": "A", 
    "Comment": "SSRIs are the first-line pharmacological treatment for moderate to severe depression during pregnancy and breastfeeding.", 
    "Source": "Page 23" 
  },
  { 
    "Ref": "Maternal0015", 
    "Questions": "What is the recommended response if a woman answers 'yes' to suicidal ideation on the screening tool?", 
    "A": "Reassure her and ask again in a week", 
    "B": "Refer urgently for mental health assessment", 
    "C": "Prescribe benzodiazepines immediately", 
    "D": "Document only without referral", 
    "Answer": "B", 
    "Comment": "Women with suicidal ideation require urgent referral to a medical officer or mental health professional.", 
    "Source": "Page 22" 
  },
  { 
    "Ref": "Maternal0016", 
    "Questions": "Which perinatal mental health condition is a temporary state and not classified as a disorder?", 
    "A": "Baby blues", 
    "B": "Depression", 
    "C": "Generalised anxiety disorder", 
    "D": "Psychosis", 
    "Answer": "A", 
    "Comment": "The 'baby blues' is a temporary emotional state experienced by up to 80% of women after birth.", 
    "Source": "Page 24" 
  },
  { 
    "Ref": "Maternal0017", 
    "Questions": "Which factor increases the risk of tocophobia (fear of childbirth)?", 
    "A": "Access to skilled midwives", 
    "B": "History of previous traumatic birth or sexual abuse", 
    "C": "Having a supportive birth companion", 
    "D": "Attending antenatal education", 
    "Answer": "B", 
    "Comment": "Tocophobia is often linked to previous traumatic births or sexual abuse.", 
    "Source": "Page 25" 
  },
  { 
    "Ref": "Maternal0018", 
    "Questions": "Which of the following is recommended management for women experiencing pregnancy loss?", 
    "A": "Avoid discussion of the loss", 
    "B": "Encourage expression of grief, offer mementos, provide follow-up support", 
    "C": "Discharge immediately without counselling", 
    "D": "Separate the woman from any support persons", 
    "Answer": "B", 
    "Comment": "Women experiencing pregnancy loss should be offered support, discussion, mementos and follow-up counselling.", 
    "Source": "Page 23" 
  },
  { 
    "Ref": "Maternal0019", 
    "Questions": "Which of the following is considered a type of intimate partner violence (IPV)?", 
    "A": "Respectful counselling", 
    "B": "Physical assault, sexual coercion, emotional abuse and controlling behaviours", 
    "C": "Providing financial support", 
    "D": "Accompanying partner to antenatal care", 
    "Answer": "B", 
    "Comment": "IPV includes physical, sexual, emotional abuse and coercive control.", 
    "Source": "Page 30" 
  },
  { 
    "Ref": "Maternal0020", 
    "Questions": "Which of the following is a possible health outcome associated with intimate partner violence during pregnancy?", 
    "A": "Improved nutrition", 
    "B": "Reduced risk of preterm labour", 
    "C": "Increased risk of miscarriage, preterm birth and low birth weight", 
    "D": "Better mental health", 
    "Answer": "C", 
    "Comment": "IPV is associated with adverse outcomes including miscarriage, preterm birth, low birth weight and maternal mental illness.", 
    "Source": "Page 30" 
  }
]